CfPIE Insights

Risk Assessment in GMP: Proven Tools and Techniques to Boost Compliance

Tue, 24 Jun 2025 13:05:17 GMT

GMP (Good Manufacturing Practices) compliance requires anticipating potential issues before they happen. A solid risk assessment strategy helps pharmaceutical and biotech teams prioritize their efforts, tighten quality control, and avoid costly mistakes.

Keep reading to learn how risk-based approaches can elevate your GMP program and help you stay ahead of regulatory expectations.

Why Risk-Based Thinking Is Essential

Risk assessment helps you allocate time, budget, and attention where they’ll make the most significant impact. Proactively identifying and controlling risk is no longer optional in regulated industries like pharmaceuticals.

Health authorities like the FDA (Food and Drug Administration) and EMA (European Medicines Agency) expect companies to implement a risk-based approach to quality by continuously evaluating what could go wrong in their processes and showing how they’re working to reduce those risks.

Tools That Make Risk Assessment Practical

There’s no one-size-fits-all method, but several proven tools can make risk evaluation more structured and effective.

FMEA (Failure Mode and Effects Analysis): FMEA in pharmaceutical manufacturing helps identify where and how a process might fail and how severe the impact would be. It ranks each risk based on severity, likelihood, and detectability.
HACCP (Hazard Analysis and Critical Control Points): Originally developed for food safety, HACCP for GMP compliance is beneficial when working with raw materials, microbial risks, or sensitive process steps. It identifies critical control points where a failure could compromise product quality or safety.
Fishbone Diagrams (Ishikawa): When problems occur, fishbone diagrams help identify their root causes. Teams map out all possible contributors, people , equipment, materials, or methods so they can fix the right issue rather than applying a temporary patch.

Putting Risk Assessment Into Practice

Integrating risk assessment directly into your core GMP processes can provide stronger outcomes. Start by identifying possible hazards in your workflows. For each one, assess how likely it is to occur and how severe the outcome would be. Then, implement control measures and assign responsibility for follow-up.

This process becomes an extension of your quality management system. However, as your materials, equipment, or procedures change, so should your risk evaluations. Updating these documents prepares your team for audits and helps avoid outdated assumptions.

Stay Transparent

Auditors often look for one key thing: proof that you knew the risks and took action — a perfect example of why documentation is so important.

Be sure to record the risks you identify, the tools you use to evaluate them, and the controls you put in place. Use templates or digital risk assessment tools to help standardize the process across departments.

Collaboration is Key

Teams involving stakeholders from quality assurance, production, R&D, and the supply chain get a complete picture of what could go wrong. These cross-functional discussions can unveil blind spots that one group might miss.

They also help ensure that everyone understands why specific controls are in place, which increases compliance at every level.

Risk Assessment as a Living Process

The best GMP risk programs are reviewed and improved regularly:

Set calendar reminders or internal quality triggers to revisit risk assessments often
Learn from CAPA (corrective and preventative action) outcomes, deviations, and near misses, and use them to fine-tune your evaluations

Risk management becomes part of your company culture when employees feel encouraged to report issues or suggest improvements.

Mastering Risk in GMP Starts With the Right Training

Building a strong risk assessment program takes effort but leads to smoother audits, better products, and stronger teams. Companies can turn compliance challenges into a competitive advantage by using tools like FMEA or HACCP, and reinforcing them with good documentation and collaboration.

If you want to strengthen your knowledge of risk assessment in GMP or improve how your team applies a risk-based approach to quality, CfPIE offers expert-led training designed for real-world application.

See All Courses

Your Roadmap to a Successful GMP Inspection: Timelines, Checklists, and Tips

Tue, 17 Jun 2025 13:11:09 GMT

Featured Courses:

What will the inspector ask first? That’s the question every quality team should be able to answer before a GMP audit. If you’ve laid the groundwork, inspections become easy rather than nerve-wracking. With a clear plan, early preparation, and expert insight, your team can face audits without worry.

Keep reading to learn how to build a clear roadmap with GMP inspection timelines, checklists, and real-world strategies.

Creating a Preparatory Timeline

Preparing for GMP audits should begin six to twelve months before auditors arrive. Starting early allows you to work in phases:

Start with a gap analysis, compare your current practices to regulatory requirements
Once you’ve identified weak spots, schedule corrective actions and set deadlines for completion
The final few months should focus on readiness reviews and documentation audits

If you need a refresher or want your team to learn the key factors that inspectors look for, CfPIE’s Good Manufacturing Practices (cGMP) Training course offers a structured foundation and practical tools to get your systems in order.

Essential Pre-Inspection Checklist Items

Successful inspections depend on what you can show. This high-level checklist can help you get your essentials in order:

Documentation: Every SOP, batch record, logbook, and deviation report should be current, signed, and stored correctly
Facility cleanliness and maintenance: Clean rooms should meet classifications, maintenance logs should be current, and clutter should be kept to a minimum
Employee training records: Train staff on current procedures and make sure they can clearly explain their responsibilities. Training files should show dates, signatures, and content covered.
Equipment calibration and validation: Calibrate all critical equipment on schedule and validate it for its intended use. Keep certificates and maintenance logs easily accessible.

Conducting Mock Audits

Mock audits in GMP compliance help find gaps in knowledge, paperwork, and processes before the real inspection.

Role-playing sessions can set the stage for real-life scenarios. Have supervisors act as inspectors and ask common questions. Can your staff clearly explain how they perform their tasks? Do they know where to find key documents?

Walk through the physical flow of materials, personnel, and waste. Double-check entry and exit points, gowning procedures, and segregation in clean vs. dirty areas. These are places where inspectors often spot oversights.

To strengthen this skill set, CfPIE’s Effective Internal and External Quality Assurance Auditing for FDA Regulated Industries course offers audit strategies and tools you can use immediately on-site.

Dealing with Audit Day Logistics

When inspection day arrives, having a plan in place can make all the difference:

Assign a primary liaison; someone experienced, calm under pressure, and familiar with your systems
Set up a dedicated audit room where reviewers can examine documents without disruption
Brief your team. Remind staff to answer questions honestly and clearly. If they don’t know something, it’s okay to say so and offer to find the answer

Managing Questions and Requests

Have key documents pre-organized, such as SOPs, training records, and validation protocols, so you’re not scrambling to find them. When asked for clarification, keep explanations aligned across departments to avoid contradictions.

Maintain a log of all questions, shared documents, and verbal observations to respond to post-inspection findings more efficiently.

Post-Inspection Follow-Up

Respond quickly and thoroughly if inspectors note any non-conformances or issue a formal report. Outline a clear CAPA (Corrective and Preventive Action) plan and submit it by the requested deadline.

Even if the outcome is positive, take time to reflect. What went well? What could improve? Use each inspection as a learning tool. This strategy improves future inspections and drives long-term quality .

Set Your Team Up for Inspection Success

A well-executed inspection starts with everyday practices, consistent documentation, and confident staff. Prepare early using mock audits and investing in the proper training.

Whether you need audit prep, compliance strategies, or documentation mastery, CfPIE’s expert-led programs will help you confidently lead your next inspection.

See All Courses

Turning Mistakes into Improvements: GMP Deviations and Effective CAPA Systems

Tue, 10 Jun 2025 13:13:25 GMT

Featured Courses

What caused the deviation, and could it happen again? That’s the first question regulators will ask, and the one your team must be ready for. In regulated manufacturing, every deviation is a chance to uncover weak points and prevent bigger compliance failures. When handled correctly, GMP deviations become tools for improvement, not just paperwork.

Keep reading to learn how to investigate, document, and resolve them to reinforce your quality system, not just for the audit, but for the long run.

What Counts as a Deviation?

A deviation occurs when an operation strays from an approved process or documented standard. Some are planned — and some aren’t. Common examples include:

Skipping a required step in a standard operating procedure (SOP)
Operating outside temperature or humidity specifications
Using an unapproved material or component
Delaying a scheduled maintenance, even with approval
Discovering an uncalibrated piece of equipment during production

Document every deviation immediately, no matter the severity. Timely reporting helps teams contain issues faster and investigate them more accurately.

How to Investigate Deviations

A thorough investigation gets to the heart of why something happened. Teams should use root cause analysis GMP tools, like:

Fishbone diagrams (Ishikawa) to break down contributing factors
The 5 Why's to drill deeper into the root cause
Interviews with operators and review of batch records to uncover gaps

Want to sharpen your deviation investigation skills? CfPIE’s Pharmaceutical Root Cause Analysis of Failures & Deviations - Developing an Effective CAPA Strategy course walks through real case studies and RCA frameworks that can improve how your team tackles root cause analysis.

Taking Corrective and Preventive Actions

Corrective actions (CA) resolve the immediate issue. That may mean rejecting a batch, reprocessing materials, or updating a document. Traceability matters — what did you do, when, and who approved it?

Before closing out the CA, teams must verify that it worked. Too often, companies skip this final check, and problems reappear later.

Preventive actions (PA) take things a step further. These are proactive adjustments that stop similar issues from happening again. Some examples include:

Revising SOPs or adding clarification to reduce ambiguity
Updating training programs to address knowledge gaps
Modifying a piece of equipment or process to reduce variation

Tracking patterns in deviation reports is a key strategy. For example, if one site is experiencing recurring documentation errors, that’s a signal to investigate process design, not an individual’s performance.

Encouraging employees to suggest PAs makes this strategy even more effective. Operators are often the first to notice recurring friction points, and a simple adjustment could prevent headaches later.

How to Document CAPA Properly

Track every CAPA in manufacturing environments from start to finish and integrate it into your broader quality system. A good CAPA log includes:

Description of the deviation
Assigned owner for each action
Due dates and closure verification
Status updates and notes from periodic reviews

Need help building consistent and reliable documentation? Check out CfPIE’s Effective Document Management for Pharma, Biotech & Medical Device , covering strategies, workflows, and audit-ready record systems

Common Pitfalls and Best Practices

Some of the most common pitfalls in GMP deviation handling include:

Shallow root cause analysis that blames “human error” without digging deeper
Failing to involve the right people across departments
Letting documentation pile up without timely follow-up

Instead, follow these best practices:

Involve QA, production, supply chain, and training staff in your CAPA reviews
Standardize how you classify and investigate deviations
Reinforce expectations through ongoing training, not just one-time SOP sign-offs

Make CAPA Part of Your Culture

Corrective and preventive actions clean up mistakes and build innovative systems that keep issues from happening in the first place.

If you're ready to improve how your organization responds to deviations or to build a CAPA system from the ground up, check out CfPIE’s full selection of compliance training.

See All Courses

Strengthening Your Supply Chain: GMP Supplier Qualification and Oversight

Tue, 03 Jun 2025 13:13:56 GMT

Featured Courses:

What if a single missing document or subpar raw material derailed your entire operation? That’s the risk when supplier management slips in a GMP-regulated industry. One weak link can trigger compliance failures, recalls, or worse — patient harm.

Strong GMP supplier management is how you build control, consistency, and confidence into every component you source. Keep reading to learn how to qualify, monitor, and work with vendors to protect your supply chain and compliance record.

Initial Supplier Qualification

The most costly vendor mistake? Assuming they're qualified just because they say they are. Before you issue a single PO, do a deep dive into their credibility, compliance, and capacity.

Before you trust a vendor with your supply chain, make sure they’ve earned it. Vendor qualification is a rigorous screening process that looks for:

Verified GMP compliance and records of regulatory inspections (FDA, EMA, etc.)
A proven track record of consistently meeting product specs
ISO certifications or other formal quality credentials

If you're developing or refining your vendor qualification program, CfPIE’s Auditing and Qualifying Suppliers and Vendors course provides in-depth training on risk-based approaches, audit checklists, and regulatory expectations.

Use Risk-Based Supplier Categorization

Not every vendor poses the same level of risk. A supplier of active pharmaceutical ingredients should face more scrutiny than someone delivering packaging materials. Creating a risk-tiered system allows you to directly audit and monitor efforts where they matter most.

High-risk suppliers may require:

Annual audits
More frequent performance reviews
Tighter acceptance criteria on raw material testing

Low-risk vendors may only need periodic documentation reviews or self-assessment forms. Categorization keeps oversight proportional and practical when managing dozens or hundreds of vendors.

Set Clear Quality and Service Level Expectations

Don’t assume your suppliers know what success looks like. Define your expectations for:

Delivery accuracy and timelines
Acceptable defect rates or batch variability
Responsiveness to CAPA in manufacturing or change requests

You’ll also want to set packaging, labeling, and storage parameters, especially for temperature-sensitive materials. Create shared communication protocols so both sides know how to handle deviations or product recalls quickly and collaboratively.

Monitor Supplier Performance and Maintain Compliance

Effective supply chain oversight in manufacturing requires continuous performance monitoring. Many companies use supplier scorecards to track:

On-time delivery rates
Quality inspection failures or rejections
Responsiveness to deviations or investigations

Automated dashboards and early warning alerts can flag underperformance before it becomes a compliance issue. You can also conduct routine audits or send sample lots for independent testing.

To explore performance tracking in more detail, consider CfPIE’s CRO, CDMO and Non-Clinical Vendor Management Fundamentals Industry course, which covers real-world monitoring tools and strategies aligned with global GMP guidelines.

Handle Supplier Deviations with a Shared CAPA Approach

A joint problem-solving approach works best when a supplier's misstep affects your product quality. Start with a thorough root cause analysis and involve both teams in developing the corrective and preventive actions. Some issues may call for:

Process revalidation
Re-training staff
Temporary vendor suspension

Document the entire process in your CAPA log, including timelines, responsible parties, and follow-up verification steps.

Build Collaborative Relationships

When your vendors understand GMP supplier management principles, they become collaborators in maintaining quality, not liabilities. Support those relationships by:

Sharing inspection learnings and quality trends
Offering GMP training for their teams
Inviting suppliers to co-develop process improvements or innovative solutions

Supplier Oversight Is a Compliance Advantage

Strong supplier audits and compliance practices ensure that what enters your facility supports product quality rather than undermines it. Your supply chain becomes more resilient and responsive with documented qualification systems, performance tracking, and collaborative CAPA handling.

If your team is looking to elevate its qualifying vendors under GMP strategy or tighten supply chain controls, CfPIE’s expert-led training programs are for operational teams, auditors, and quality leaders navigating real-world supplier challenges.

See All Courses

Data Integrity in GMP: How to Safeguard Accuracy and Reliability Across Systems

Tue, 27 May 2025 19:51:50 GMT

Maintaining data integrity in GMP environments protects patient safety, ensures product quality, and maintains trust. With digital systems playing a central role in manufacturing, even minor data lapses can lead to regulatory consequences.

Keep reading to learn how to recognize data integrity risks, implement effective governance strategies, and leverage technology to support electronic records compliance and ALCOA+ principles.

Featured Course:

Human Error Prevention (HEP) - Risk Factors and Strategies

Why Data Integrity Matters

Reliable, accurate data is a critical part of GMP compliance. Any discrepancy, intentional or not, can undermine confidence in your products and processes:

Inaccurate or incomplete data can compromise product quality and endanger patient safety
Regulatory bodies like the FDA and EMA regularly issue warnings, citations, and import bans due to data falsification or manipulation
Companies that prioritize data integrity in GMP systems earn stronger reputations, making it easier to build trust with regulators, customers, and business partners

Sources of Data Integrity Issues

Understanding where problems start is key to preventing them. While flawed systems can cause issues, many data integrity breaches come down to human behaviour. Errors like poor documentation habits or accidental overwrites remain among the most common.

Insecure electronic systems with shared passwords or weak login protocols also create openings for unauthorized access. And when metadata like timestamps or user IDs is missing, there’s no way to prove who entered or changed the data, putting you in violation of electronic records compliance standards.

Implementing Robust Data Governance

Strong data governance builds a framework for accuracy, accountability, and transparency across your organization:

Establish clear SOPs for generating, reviewing, storing, and deleting data.
Set role-based access controls so only authorized users can view or modify critical information.
Create audit trails to monitor changes and hold users accountable.
Train employees regularly on ethical data behaviour and the expectations laid out by ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available) principles.

Technology and System Controls

Modern systems can help reduce the risk of data integrity breaches, but only if you properly configure and validate them.

Start by fully validating electronic systems to ensure they capture data accurately and reliably. Implement version control to block unauthorized edits and make sure only approved data moves forward in the process. To protect against accidental loss or tampering, set up automatic backups and secure archiving protocols that keep your data safe and traceable.

Auditing and Monitoring for Data Integrity

Regular audits help uncover hidden risks and maintain a strong compliance posture. Here are some tips:

Perform internal audits focused on data integrity in GMP systems, looking for inconsistencies or gaps
Run trend analyses to detect suspicious patterns, such as repeated entries at the same time or frequent corrections by the same user
Create a culture that encourages whistleblowing or confidential reporting of potential data issues, without fear of retaliation

Handling Breaches and Deviations

No system is perfect. What matters is how your team responds when data issues arise:

Follow a clear investigation protocol, including root cause analysis and appropriate CAPA measures
Communicate openly with regulatory authorities when breaches occur; delayed or dishonest responses often carry harsher penalties
Treat every incident as an opportunity to review and strengthen your policies to prevent similar problems in the future

Building a Culture of Data Integrity

Building a culture of data integrity in GMP starts with people, not just systems. It means reinforcing ethical behaviour and accountability at every level of the organization, from the production floor to the executive suite.

Recognize and celebrate teams that consistently deliver accurate documentation and take a proactive approach to compliance. Invest in training, tools, and leadership that align with and support your data governance goals.

Ready to Strengthen Your Data Integrity Strategy?

Safeguarding your data is a strategic advantage. Whether you're looking to prevent data falsification, meet electronic records compliance, or improve your understanding of ALCOA+ principles, CfPIE has you covered.

Explore our GMP-focused training courses to build stronger systems, more capable teams, and a company culture based on trust and transparency.

See All Courses

Validation & Verification in GMP: Ensuring Consistency from Equipment to Final Product

Tue, 20 May 2025 19:50:47 GMT

Creating safe, effective products under Good Manufacturing Practices means proving every step works exactly as intended. Validation and verification provide that proof.

Keep reading to learn how equipment qualification (IQ, OQ, PQ), process validation in manufacturing, computerized systems validation, and other checks work together to ensure consistent product quality and regulatory compliance.

Featured Courses:

Equipment Qualification

Before you can validate a process, you must confirm the tools you’re using are adequate for the job. Equipment qualification typically includes three phases:

Installation Qualification (IQ)
Operational Qualification (OQ)
Performance Qualification (PQ)

IQ confirms the equipment is installed correctly according to specifications. OQ verifies that it functions as expected under standard conditions. PQ demonstrates that the equipment performs reliably under real production scenarios.

Maintaining calibration schedules and preventive maintenance logs is just as important. Skipping these steps can jeopardize every product batch that follows.

Always keep user manuals and vendor documentation accessible to support qualification efforts. These documents often provide setup, operation, and troubleshooting details; and auditors frequently refer to them during audits.

Process Validation

Manufacturing process validation demonstrates that your production process consistently yields products meeting predetermined specifications.

Start by identifying critical process parameters (CPPs) — the variables that directly impact product quality. Then, test pilot batches or qualification runs to check for repeatability and reliability.

The work doesn’t end after initial validation. Post-validation monitoring ensures the process remains in control. Any drift or deviation from validated parameters should trigger a review to prevent quality issues downstream.

Cleaning Validation

With strict rules around contamination, cleaning validation is another non-negotiable process in GMP-regulated environments. Cleaning procedures effectively remove residue from equipment, including cleaning agents, microbial contaminants, and the product itself.

Standard techniques include swab tests and rinse samples, which help confirm cleanliness to predefined limits. Document and revalidate these procedures whenever you change the cleaning process, equipment, or materials.

Computerized Systems Validation

Modern manufacturing operations rely heavily on software and automation, which means computerized systems validation (CSV) is as critical as validating physical equipment. Systems must meet compliance standards such as 21 CFR Part 11, which governs data integrity in electronic records and signatures.

Companies should implement user access controls, maintain audit trails, and perform regular system backups to ensure compliance. Periodic reviews can catch software updates or configuration changes that may introduce new risks.

Verification Activities

Where validation demonstrates that a process works, verification confirms that it continues to work, batch after batch. Common verification activities include:

In-process testing
Final product inspections
Batch record reviews

These steps help identify and correct problems before they impact the final product. Setting clear acceptance criteria is key to effective verification. Flag and investigate any results that fall outside the defined range.

Documentation and Change Control

Clearly record and store every protocol, result, and deviation. When something changes, like a process, piece of equipment, or raw material, update validation documents accordingly.

Change control , a process for evaluating, approving, and implementing changes, helps ensure changes don’t inadvertently compromise validated systems. If a validation failure occurs, trigger CAPA procedures (Corrective and Preventive Actions) to address the root cause and prevent recurrence.

Master GMP Systems with CfPIE’s Targeted Courses

Validation and verification build confidence in your processes, products, and people. From installation qualifications to routine checks, every element contributes to a culture of quality and control.

Looking to enhance your team’s knowledge of GMP validation and verification? CfPIE offers practical, expert-led training to help your organization navigate everything from equipment qualification, IQ, OQ, and PQ to computerized systems validation.

See All Courses

Fostering a Quality Culture: How to Train Employees for GMP Effectively

Tue, 13 May 2025 19:50:11 GMT

A strong quality culture doesn’t happen by chance; you build it through intentional training, accountability, and daily commitment to GMP principles. When you empower employees with the right knowledge and tools, they become active participants in compliance rather than passive rule followers.

Keep reading to learn how to identify training needs, choose the proper methods, measure results, and reinforce behaviours that support a lasting quality culture.

Featured Courses:

Identifying Training Needs

The first step in developing a high-performing team is understanding where the gaps are. Identifying training requirements ensures that you target your approach properly. You can start by:

Performing a skills gap analysis to uncover where employees may fall short on current GMP expectations
Prioritizing critical roles such as production operators, QA/QC analysts , and maintenance personnel, where errors can impact product safety or compliance
Aligning training goals with GMP requirements and the core competencies for each job

Types of GMP Training

Not all training is created equal. Different phases of employment and job complexity require different learning approaches. A strong GMP program should include:

Onboarding and orientation sessions to introduce company policies and GMP basics
Regular refresher courses to reinforce expectations and keep knowledge current
Specialized modules on documentation practices, equipment use, or cleanroom behaviour, depending on the employee’s role

Engaging Training Methods

Sitting through hours of dry slides typically doesn’t stimulate lasting retention. Employees must engage with the content in relevant, enjoyable, and memorable ways to retain knowledge. You can boost engagement with:

Interactive workshops that encourage problem-solving and collaboration
E-learning modules for on-demand access to core concepts
Hands-on simulations for real-world practice
Gamification elements, like quizzes, leaderboards, or achievement badges to encourage participation
Case studies that explore real compliance successes and failures
Specialized GMP training programs that turn concepts into experience and knowledge into habit

Measuring Training Effectiveness

Training without measurement is guesswork. To ensure your programs work, you must evaluate learning and on-the-job performance outcomes. Key ways to measure include:

Quizzes, written tests, and hands-on assessments to confirm understanding
Anonymous employee surveys to gather feedback on training relevance and delivery
Key Performance Indicators (KPIs) such as reduction in deviations, fewer audit observations, or improved First Time Right (FTR) metrics

Continuous Reinforcement and Accountability

Even excellent training fades without reinforcement. Training must extend beyond formal sessions and into daily routines to keep knowledge fresh and behaviours consistent. Consider:

Hosting regular “toolbox talks” or brief micro-learning sessions on specific GMP topics
Encouraging supervisors to lead by example, modelling good documentation and behavior practices
Linking training participation and performance to employee evaluations or incentive programs

Building a Quality Culture

At its core, a quality culture in GMP has shared values. Compliance becomes part of your identity when every employee, from line operator to senior manager, takes ownership of GMP. Culture change takes time, but by making GMP training a living, breathing part of daily operations, you will build a foundation that can weather any audit or challenge.

To reinforce this process, you should:

Encourage open communication
Create safe spaces for employees to report deviations, near misses, or improvement ideas
Celebrate wins, whether it’s a successful audit, zero deviations, or high training scores

Ensure management consistently allocates time, tools, and budget to support quality initiatives

Elevate Your GMP Training Strategy with CfPIE

Training is one of the most powerful tools for creating a workplace that values quality. When companies invest in professional GMP training programs, they lay the groundwork for long-term compliance, engaged employees, and stronger performance.

CfPIE offers industry-specific courses that can help align your training strategy with regulatory expectations and business goals.

Browse our courses and take the next step toward a more compliant, capable, and quality-driven workforce.

Mastering GMP Documentation: SOPs, Batch Records, and Traceability Essentials

Tue, 06 May 2025 19:49:26 GMT

Proper documentation is more than a formality in regulated industries; it’s the foundation of compliance, product quality, and audit readiness. When manufacturing pharmaceuticals, medical devices, or biotech products, GMP documentation best practices help ensure traceability, accountability, and consistency across every process.

Keep reading to learn how key documents like SOPs, batch records, and traceability systems work and the common mistakes to avoid.

Featured Courses:

Good Manufacturing Practices Training

Standard Operating Procedures (SOPs)

SOPs provide step-by-step instructions to ensure processes are performed the same way, every time, no matter who executes them. Here are a few ways to keep your SOPs and batch records support compliant:

Use a standardized template with clear sections for purpose, scope, responsibilities, and procedures.
Maintain version control by assigning revision numbers and documenting changes with dates and author signatures.
Always define authorship. Subject matter experts should write SOPs, and approvals should come from QA or management.
Schedule regular reviews of SOPs to keep them current with process improvements or regulatory updates.

Batch Records

Batch records document production runs are the historical proof that each step was completed per the approved procedures. An effective batch record should include:

Lot numbers of raw materials and intermediates
Equipment IDs used in the process
Operator initials and timestamps for each step
In-process checks and deviations (if any)

One of the most critical GMP record-keeping rules is documenting activities in real time. Recording actions after the fact increases the risk of missing details or introducing errors.

Traceability Systems

Traceability in manufacturing is central to linking each product back to its raw materials. This end-to-end visibility supports quality assurance, speeds up investigations, and enables a rapid, targeted response during product recalls.

Effective traceability systems often include barcodes for each material and product, RFID tags to track location and movement in real time, and electronic batch record (EBR) systems that automatically capture data across the production cycle.

Together, these tools give manufacturers the power to pinpoint affected batches within minutes, not days, reducing risk, protecting public health, and keeping operations fully compliant with regulatory standards.

Common Documentation Errors

Even the best systems can fail if you don’t train your staff to avoid common documentation mistakes . These errors can raise red flags during audits and create regulatory risk. Look out for:

Missing entries, skipped fields, or illegible handwriting
Post-dated or backdated entries
Unexplained corrections or lack of cross-referencing
Using white-out or erasing entries rather than striking through and initialling changes

Effective Document Control Strategies

Good document control ensures that the right people can access the current version of the document, every time. Best practices for document control include:

Central repositories, either physical file rooms or digital systems, with controlled access
Audit trails that track edits, access, and approvals
Regular internal audits to verify document accuracy and completeness
Clear policies for archiving outdated versions and securely disposing of obsolete documents

Training Employees on Documentation

Documentation errors often stem from employees not understanding the why behind GMP requirements or how to follow procedures consistently. You can build documentation excellence by:

Training employees on formatting, terminology, and expectations for documentation clarity
Reinforcing the importance of legibility, accuracy, and real-time entries
Scheduling regular refreshers to maintain consistency as processes evolve
Implementing supervisory oversight and random checks to identify habits that need correction

Close the Gaps in Your GMP Record-Keeping

Mastering SOPs, batch records, and traceability systems will help improve product quality, audit readiness, and regulatory compliance. By focusing on these, your team can minimize risk, streamline inspections, and maintain operational excellence.

If you're ready to dive deeper, CfPIE offers specialized training programs to help professionals stay current on GMP record-keeping strategies. Explore our upcoming courses to take your documentation practices to the next level.

See All Courses

How to Build a QMS That Meets GMP Standards: A Step-by-Step Guide

Tue, 29 Apr 2025 19:18:56 GMT

A solid Quality Management System (QMS) is your blueprint for delivering consistent, safe, and compliant products. If you’re in life sciences, your QMS must do more than check boxes; it must meet strict GMP expectations.

Keep reading to learn how to write a strong quality policy, structure your documentation and responsibilities, and create a QMS for GMP compliance that supports continuous improvement.

Quality Policy and Objectives

Every QMS starts with a written quality policy that reflects your company’s commitment to GMP principles. This isn’t something you write once and forget. You should revisit it regularly and share it across departments so everyone understands what quality means to your business.

Alongside the policy, you’ll want to set measurable quality objectives, often tracked through KPIs (key performance indicators). These goals help turn your policy into action. Examples include: reduced deviations, faster batch release times, or fewer CAPAs (corrective and preventative actions).

Organizational Structure and Responsibilities

Building a quality management system includes clearly defining roles and responsibilities, such as the difference between Quality Assurance (QA) and Quality Control (QC). QA focuses on the system, while QCing tests and verifies. Both are critical, but they serve different functions.

Equally important is outlining responsibilities for production staff, engineering, and upper management. Everyone should know where they fit in, what they’re responsible for, and who they report to. Internal communication must flow freely when it comes to quality-related decisions.

Documentation Framework

When you think about GMP documentation requirements, you might imagine binders full of SOPs — and you aren’t wrong. However, a sound documentation system has much more, such as work instructions, batch records, and forms that are easy to access and follow.

Version control matters because it shows what changed, when, and why. Every document needs to be approved, dated, and safely stored. Approval workflows stop teams from using anything before it's ready, and audit trails track every edit.

Today, more companies use electronic QMS tools to make this easier, with built—in real-time updates, automatic alerts, and secure backups.

Process Control and Continuous Improvement

You can’t deliver consistent products unless your processes are validated. That means clearly defining, controlling, and tracking every key step, from raw materials to final release, to ensure consistent results. This is where your QMS turns from static documentation into a living system.

To keep improving, you’ll also want a strong CAPA system in place. Your corrections can come from audit findings, customer complaints, or internal reviews. The key is acting fast and documenting every step of the fix.

Training and Competency Management

Without proper training , even the best systems can fall apart. Training metrics help you track which employees are qualified for specific tasks. As your SOPs evolve, refresher sessions should be automatic.

You can also tie employee performance reviews to QMS engagement, such as how well staff follow SOPs or contribute to quality goals. When people know their work matters, they’re more likely to take ownership.

Auditing and Review Mechanisms

Regular management reviews help leadership make informed decisions about resources, staffing, and process improvements.

To know if your QMS is working, you need to audit it. Internal audits check how well your system aligns with GMP requirements and specific goals. They’re a great way to catch issues before regulators or clients do.

You’ll also need to be ready for external audits from certification bodies, regulatory agencies, or even customers doing supplier qualification. A well-maintained QMS makes those audits a lot less stressful.

Compliance and Growth with CfPIE

A great QMS keeps you compliant and helps your team stay organized, accountable, and ready for growth.

CfPIE’s training makes it easier to build and maintain a QMS that truly supports GMP compliance from the ground up.

See All Courses

GMP Audit Pitfalls: Top Mistakes and Proactive Strategies to Prevent Them

Wed, 23 Apr 2025 19:18:08 GMT

Preparing for a GMP audit can feel like prepping for an open-book test until you realize the book is missing pages. Even minor slip-ups can lead to significant consequences, from overlooked records to forgotten training updates.

Keep reading to learn how to improve documentation, sharpen your training, and avoid GMP audit pitfalls that could cost you big.

Featured Program:

GMP Facility Certification Program

Pitfall #1: Poor Documentation Practices

Sloppy paperwork is one of the fastest ways to fail an audit. Missing signatures, incomplete batch records, or corrections with no explanation? Auditors notice these deviations right away. And when you don’t update your records in real-time, your entire system can look shaky.

The fix here is simple but powerful: lock in your GMP documentation requirements with clear SOPs , routine checks, and a culture that values getting it right the first time.

Pitfall #2: Inadequate Training and Competency

Untrained employees can do more than slow down operations. They increase the likelihood of GMP audit pitfalls, and skipped steps or misunderstood procedures can quickly lead to GMP violations.

A strong training program helps prevent these issues. Make sure it covers onboarding, role-specific instruction, and regular refreshers. Use simple assessments or quick check-ins to reinforce key points, and consider linking training milestones to performance reviews to keep everyone accountable.

Pitfall #3: Improper Handling of Deviations

One of the most common GMP mistakes is failing to dig into the root cause , or worse, leaving CAPAs half-finished and forgotten.

Make deviation tracking part of your team’s daily routine. Log issues as they happen and use a structured problem-solving approach to work through them. Every CAPA should have a timeline, clear ownership, and evidence that the fix worked. That kind of follow-through shows auditors you take quality seriously.

Pitfall #4: Neglecting Environmental and Cleaning Protocols

Dust, condensation, and stray particles, which might seem like minor issues, can lead to contamination risks if your cleaning protocols fail. Auditors often head straight for your environmental monitoring logs, especially in cleanroom settings.

Validated cleaning procedures, standardized checklists, and detailed frequency logs keep everything on track. Conduct spot checks to confirm staff follow procedures and train them to ensure they know how to report issues. A clean space with up-to-date records gives auditors peace of mind.

Pitfall #5: Inconsistent Change Control

Change is part of any operation, but every adjustment needs proper documentation in GMP environments. Updating a process or switching out equipment without approval, even with good intentions, can result in major non-conformances if there’s no clear record of what was done and why.

Avoid that risk with a formal change control process . Every modification, whether to a material, equipment, or process flow, should include an impact assessment, approval sign-offs, and a post-implementation review.

Preparing For Audits: Action Steps

Once your core quality systems, such as training programs, documentation controls, deviation tracking, and change management, are running smoothly, focus on these audit readiness tips:

Schedule mock audits and walkthroughs that use actual checklists and scenarios. Do more than rehearse responses; let your team practice locating records, explaining procedures, and answering questions.
Bring in external experts if you’re expanding into new markets, adjusting your QMS, or preparing for a high-stakes inspection. Their outside perspective can help uncover blind spots.
Keep all records easy to access, up to date, and organized by category so there’s no last-minute scramble. When everything's in place, your team can approach audits with confidence, not anxiety.

Avoiding GMP Non-Compliance Starts With Preparation

GMP audits don’t have to be stressful or unpredictable, especially when you've invested in systems that support daily compliance and long-term growth.

With training from CfPIE, your team can avoid GMP audit pitfalls, improve daily processes, and stay ready for anything that comes your way.

See All Courses

Global GMP Standards Demystified: Comparing FDA, EU, WHO, and Beyond

Mon, 21 Apr 2025 19:19:47 GMT

Good manufacturing practices all revolve around one core idea: protecting patient safety. Whether you're dealing with pharmaceuticals, medical devices, or biotech products, GMP compliance earns global trust.

Keep reading to learn how FDA, EU, and WHO GMP guidelines compare, where global harmonization is heading, and how to keep your compliance strategy sharp across borders.

Featured Courses:

FDA GMP Regulations

The U.S. FDA oversees GMP regulations for drugs, medical devices, food, and biologics. These regulations are outlined in the CFR (Code of Federal Regulations), specifically, 21 CFR Parts 210 and 211 for pharmaceuticals and Part 820 for medical devices.

One of the defining features of FDA GMP standards is the emphasis on electronic systems. For example, 21 CFR Part 11 addresses electronic records and signatures, setting a high bar for data integrity, audit trails, and system validation.

Companies under FDA oversight must also prepare for unannounced inspections and strict documentation reviews. Although they have some flexibility in meeting the rules, they require consistency and traceability at every step.

EU GMP Guidelines

Across the Atlantic Ocean, the European Medicines Agency (EMA) coordinates GMP oversight through documents called EudraLex Volume 4. The structure of EU GMPs uses a modular system with Annexes that apply to specific product types or processes, such as Annex 1 for sterile products or Annex 2 for biologics.

A primary difference in the FDA vs. EU GMP conversation is the Qualified Person (QP) requirement in the EU. Before a product is released to market, a QP, typically a highly trained pharmacist or scientist, must certify that each batch meets all regulatory standards. This level of individual accountability doesn’t exist in the U.S. system in quite the same way.

WHO GMP Guidelines

The WHO (World Health Organization) has a distinct influence on global GMP standards , especially in regions where regulatory systems are still developing. These guidelines are a baseline that aims to create consistency across borders and raise the quality bar globally.

They also feed into international procurement programs, like those supported by the United Nations or the Global Fund, which require supplier eligibility based on compliance with WHO standards.

For companies working in emerging markets or with international health organizations, WHO GMPs are often the first standard referenced and sometimes the only one enforced.

Other Global Standards and Harmonization Efforts

Beyond the big three, international GMP compliance involves keeping up with regional authorities and collaborative initiatives. Organizations like the International Council for Harmonization (ICH) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) are in charge of aligning standards.

ICH guidelines, for example, focus on scientific and technical aspects of drug development, while PIC/S promotes a harmonized approach to GMP inspections. Membership in PIC/S now includes over 50 countries, meaning a company inspected under PIC/S rules can use that approval to satisfy multiple regulators.

There are also regulatory powerhouses like China’s NMPA or India’s CDSCO. These agencies are shaping their GMP expectations while aligning with global practices. The more harmonized these standards become, the less duplication companies face when bringing products to multiple markets.

Key Similarities and Differences

Despite different rulebooks, global GMP standards share some core principles:

Preventative mindset rather than reactive
Rigorous documentation and traceability
Cleanliness, hygiene, and environmental controls
Ongoing staff training and competency assessments

Differences include:

Varying labeling expectations
Some regions mandate specific microbiological testing methods
Enforcement can range from collaborative to aggressively punitive

This is why tailoring your approach based on your products' future is so important. A one-size-fits-all compliance plan simply doesn’t work.

Simplify Global Compliance with CfPIE

GMP knowledge is a competitive edge. Whether expanding globally or optimizing day-to-day operations, CfPIE’s expert-led training gives your team the clarity, confidence, and credibility to lead in a regulated world.

See All Courses

Best Practices for Effective CMC Strategies in Drug Development

Mon, 24 Feb 2025 13:38:19 GMT

Bringing a new drug to market requires a well-planned approach to Chemistry, Manufacturing, and Controls (CMC). A good strategy helps streamline processes, align teams, and ensure drug safety and effectiveness.

Want to avoid delays, cut costs, and boost quality? Keep reading for key strategies on CMC drug development.

Featured Courses:

CMC Regulatory Compliance Strategy for Cell & Gene Therapy Medicines

CMC Regulatory Compliance Strategy for Recombinant Proteins, Monoclonal Antibodies, & Biosimilars

Process Optimization

A strong drug development CMC strategy starts with fine-tuning manufacturing for maximum efficiency and consistency.

Making Manufacturing Smoother

The way a drug is made affects everything, from costs to timelines. Cutting waste, improving consistency, and eliminating bottlenecks can make a big difference. Here’s how:

Automation: Speeds up production and reduces human errors
Predictive maintenance: Prevents breakdowns and downtime
Real-time monitoring: Catches problems before they become bigger issues
Standardized workflows: Keep every batch consistent and compliant

Advanced Analytical Techniques

Advanced tools like HPLC, mass spectrometry, and spectroscopy give precise data on a drug’s composition, stability, and purity. Catching impurities early helps avoid costly regulatory setbacks.

Planning for Growth from the Start

Scaling up means making more without costly rework. Engineers must consider raw materials, equipment limits, and production costs early for a seamless transition from small batches to full-scale manufacturing.

Risk Management

Spot problems before they start. Here are some key threats to watch for:

Raw material variability: Supplier differences can throw off formulations.
Equipment failures: Breakdowns slow production and drive up costs.
Regulatory missteps: Rules change, and missing updates can stall approvals.
Stability issues: Environmental shifts can impact drug quality.

Stay ahead of setbacks with safeguards:

Double-check quality : Extra quality control can catch issues before they escalate
Secure backup suppliers : Avoid bottlenecks with reliable alternatives
Plan for disruptions : Have contingency strategies in place to keep production moving

Build Quality into Every Step

Quality by Design (QbD) shifts the focus from testing products after production to ensuring quality from the start. Companies gain greater control and consistency by understanding how formulation and process variables affect the final drug. Instead of relying on inspections to catch defects, QbD integrates quality at every stage of development and manufacturing.

Designing Robust Processes

A well-designed process begins with identifying critical quality attributes (CQAs) and critical process parameters (CPPs). Defining these early ensures the final product remains consistent and meets regulatory standards. Advanced tools like statistical modeling, process analytical technology (PAT), and real-time monitoring help detect variations before they become problems, reinforcing high manufacturing standards.

Continuous Improvement

Continuous improvement keeps processes efficient and compliant long after initial production. A culture of learning, routine data analysis, and feedback loops drive ongoing enhancements. Post-market surveillance helps products keep their intended quality, allowing companies to adapt to new challenges while staying ahead in regulatory compliance.

Strength in Collaboration

When chemists, engineers, regulatory specialists, and manufacturing teams collaborate, they bridge gaps between development and production. Early alignment can prevent expensive modifications, ensure smooth scaling, improve efficiency, and speed up time to market.

Effective Communication

Clear communication ensures critical information reaches the right people at the right time. Establishing standardized documentation practices, holding regular meetings, and sharing real-time data improves coordination and ensures clear communication.

Leverage Technology

Using technology in CMC helps companies work faster, stay efficient, and meet regulations more easily. Machine learning predicts issues before they happen, automation reduces errors and speeds up production, and cloud-based systems make tracking data and submitting regulatory documents easier.

Mastering CMC for a Competitive Edge

Effective CMC drug development strategies integrate process optimization, risk management, regulatory compliance , and cross-functional collaboration. Companies that prioritize quality, embrace technology, and streamline communication will see an improvement in both efficiency and risk reduction.

CfPIE provides the training and expertise to navigate these complexities through courses like CMC Regulatory Compliance Strategy for Cell & Gene Therapy Medicines and CMC Regulatory Compliance Strategy for Recombinant Proteins, Monoclonal Antibodies, & Biosimilars .

Sign Up Today

Understanding Good Laboratory Practice (GLP) Guidelines

Mon, 17 Feb 2025 13:38:15 GMT

The Good Laboratory Practice (GLP) Guidelines outline clear steps and standards for ensuring that laboratory studies are consistent, accurate, and trustworthy.

Implementing GLP improves data quality, prevents costly setbacks, and makes research more efficient. Keep reading to see how these guidelines help organizations refine their processes, avoid regulatory pitfalls, and produce results that stand up to scrutiny.

Featured Course:

Good Laboratory Practices for Nonclinical Laboratory Studies

Featured Certification:

Good Laboratory Practices Certified Compliance Professional

What is Good Laboratory Practice?

In the 1970s, sloppy lab work led to insufficient data, raising red flags about research integrity. To fix this, the FDA and OECD introduced Good Laboratory Practice (GLP) regulations to set clear standards and stop unreliable findings from influencing public health.

GLP ensures that research is accurate, consistent, and trustworthy. It helps regulators assess drug safety, environmental risks, and chemical properties before products reach the market. These rules apply to labs working on non-clinical studies for pharmaceuticals, chemicals, pesticides, and food safety, ensuring that submitted data meets the standards of agencies like the FDA, OECD, and EMA.

Key Components of GLP Guidelines

Implementing Good Laboratory Practice (GLP) means building a system that guarantees accuracy, reliability, and compliance at every research stage. Several key components make this possible:

Organization and Personnel

A solid team is key to GLP compliance. Every team member should know their role, get regular GLP training , and focus on maintaining accurate data. A study director ensures everything runs smoothly and that research meets all regulations.

Facilities and Equipment

A well-maintained lab environment is key to reliable results. Properly calibrating equipment, controlling temperature and humidity, and securely storing raw data and test materials help prevent errors, contamination, and data loss.

Standard Operating Procedures

Standard Operating Procedures (SOPs) lay out clear, step-by-step instructions for lab work, ensuring each study is done the same way.

Study Protocols and Reporting

Study protocols define goals, methods, and expected results, providing a clear roadmap for research.

Importance of GLP in Pharmaceutical Research

GLP guidelines are the foundation of pharmaceutical development, ensuring research is reliable, transparent, and ready for regulatory approval.

Regulatory Compliance

Skipping GLP can lead to rejected data, costly fines, and stalled product approvals. Adhering to GLP ensures that study results can withstand global regulatory scrutiny.

Quality and Reliability

GLP enhances the credibility of laboratory studies by preventing errors, inconsistencies, and fraudulent data manipulation. Reliable research forms the foundation of safe pharmaceutical development.

Global Standards

GLP simplifies international compliance by standardizing research practices worldwide. This consistency promotes better global collaboration and faster market approvals.

Benefits of Adhering to GLP Guidelines

Following Good Laboratory Practice guidelines sets your research up for long-term success.

Stronger Credibility

GLP-compliant research earns the confidence of regulators, investors, and industry partners. With credibility on your side, securing regulatory approvals and funding becomes much easier.

More Efficient Operations

A structured, standardized approach minimizes errors, speeds up workflows, and prevents costly delays. Sticking to GLP can help your team:

Complete studies faster
Avoid rework caused by inaccurate data
Make better use of resources and personnel

A Competitive Advantage

Organizations that commit to GLP stay compliant and build foundations for long-term growth and industry leadership. The benefits include:

A stronger position in the market
Smoother international expansion
A reputation for delivering high-quality, reliable research

Stay on Track with GLP

GLP ensures data integrity and regulatory compliance, keeping research on solid ground. By following these guidelines, labs boost efficiency, earn trust, and increase their chances of regulatory approval while strengthening their industry reputation.

CfPIE offers specialized training courses and programs for professionals looking to master GLP. Their Good Laboratory Practices for Nonclinical Laboratory Studies course and GLPCP (Good Laboratory Practices Certified Compliance Professional) certification program provide the knowledge and credentials to stay ahead in an ever-evolving research landscape.

See All Courses

The Evolution of Combination Products: Key Takeaways from Dr. Michael Drues

Mon, 10 Feb 2025 13:38:11 GMT

Combination products (groundbreaking innovations that combine drugs, devices, or biologics) are reshaping healthcare. Yet, their development and regulation present challenges.

Dr. Michael Drues, biomedical engineer and regulatory expert, offers critical insights into these complexities through his CfPIE course, Introduction to Medical Combination Products . Dr. Drues specializes in regulatory strategy, product development, and connecting engineering with clinical needs.

Keep reading to learn about combination products, the challenges they face, and strategies for streamlining the regulatory process.

Featured Course(s):

Introduction to Medical Combination Products

Understanding Combination Products

Combination products integrate two or more regulated components, such as a drug-eluting stent (device + drug) or a prefilled syringe (biologic + device). These products offer enhanced therapeutic benefits but require careful regulatory navigation.

Market Growth & Trends

Improvements in drug delivery, materials, and personalized medicine drive the growth of combination products. As demand rises, companies find new ways to improve treatments while meeting regulatory requirements.

Regulatory Complexity

Combination products differ from traditional drugs or devices because they must follow multiple rules. Understanding which laws apply and how they work together is key to achieving regulatory approval and succeeding in the market.

Common Challenges in the Regulatory Pathway

Bringing a combination product to market isn’t as straightforward as a standalone drug, device, or biologic. Below are some common challenges:

Multiple Regulatory Pathways

Determining the primary jurisdiction for a combination product can be difficult. The FDA assigns oversight to one of its centers based on the product's primary mode of action. These include CDER (the Center for Drug Evaluation and Research), CDRH (the Center for Devices and Radiological Health), and CBER (the Center for Biologics Evaluation and Research). However, some products blur these lines, leading to complex submission requirements.

Labeling & Classification

Correct classification and labeling affect how regulators review a product. Misclassifying or mislabeling a product can cause delays and extra challenges.

Post-Approval Monitoring

Combination products require ongoing monitoring to track safety, effectiveness, and adverse events. Companies must have systems in place to manage post-market requirements and regulatory reporting.

Key Takeaways from Dr. Michael Drues’ CfPIE Course

Dr. Michael Drues’ CFPIE course helps simplify the complex regulatory process for combination products by covering:

Proactive Regulatory Strategy

Waiting until later stages to address compliance can result in costly setbacks. Dr. Drues’ approach encourages companies to anticipate potential issues, engage with regulators early, and integrate regulatory strategy into product development .

Bridging Engineering and Clinical Insight

Successful combination products require collaboration between engineers, clinicians, and regulatory teams. Dr. Drues advocates for a cross-functional approach, ensuring that technical feasibility aligns with clinical needs. This teamwork helps companies create innovative products that work well in real-world settings.

Communication with Regulators

Working with the FDA and other agencies requires more than just submitting paperwork. Dr. Drues teaches how to communicate effectively, helping companies set expectations, avoid confusion, and speed up approvals.

Impact on Product Development

A strong regulatory strategy helps with approval and shapes the entire product development process, including:

Time to Market

Regulatory delays can seriously affect a product’s launch date. A well-structured regulatory strategy helps avoid obstacles and speeds up time-to-market while ensuring safety and compliance.

Risk Management

A structured risk management approach helps identify potential issues early, from technical failures to regulatory noncompliance. Dr. Drues’ teachings align with the five steps of risk management: identifying, assessing, mitigating, implementing, and monitoring risks to enhance product success.

Long-Term Success

Regulatory landscapes evolve, and ongoing compliance ensures continued market viability. Companies integrating regulatory foresight into their culture better position themselves for long-term innovation and growth.

Regulatory Success Starts with the Right Approach

Dr. Michael Drues offers essential insights into mastering combination products. His proactive strategy, focus on teamwork, and emphasis on effective communication with regulators give companies the edge they need for success.

Sign up for Dr. Michael Drues’ CfPIE course today!

Essential Steps in Aseptic Processing: Cleanroom Technology, Sterilization Methods, and Quality Controls

Mon, 03 Feb 2025 13:38:04 GMT

Aseptic processing is essential in pharmaceutical and biotech manufacturing to keep products sterile and safe. It relies on cleanroom technology, sterilization methods, and strict quality controls to prevent contamination, especially for heat-sensitive products that cannot undergo terminal sterilization.

What is Aseptic Processing?

Aseptic processing sterilizes components separately and assembles them in a controlled environment to maintain sterility. Unlike terminal sterilization, this method protects heat-sensitive products from degradation, ensuring safety and effectiveness throughout production.

Featured Course(s):

Aseptic Processing in the Manufacture of Biotech and Pharmaceutical Products

Cleanroom Fundamentals - Regulation, Science, Design, Practice, Operation & Management

Quality Assurance/Quality Control for Biologics and Biopharmaceuticals

Cleanroom Technology

The cleanroom is central to aseptic processing — a controlled environment that minimizes contaminants like dust, microbes, and aerosol particles.

Cleanroom Classifications

Classifications for cleanrooms depend on the allowable number of particles per cubic meter of air. Standards such as ISO 14644-1 define these classifications, ranging from ISO 1 (the cleanest) to ISO 9. In pharmaceutical manufacturing, ISO 5 (also known as class 100) environments are commonly used for critical processes, ensuring minimal risk of contamination.

Design and Construction

Effective cleanrooms feature materials and finishes that resist particle generation and facilitate easy cleaning. Features include smooth surfaces, minimal ledges, unidirectional (laminar) airflow, and sealed fixtures to prevent particle accumulation.

Environmental Conditions

Strict control over temperature, humidity, and air pressure keeps contamination out and products stable. HEPA filters trap airborne particles, while positive air pressure prevents contaminants from entering critical areas.

Maintenance

A cleanroom stays sterile with regular cleaning, equipment calibration, and fast repairs for facility issues.

Sterilization Methods

Appropriate sterilization methods keep all components in aseptic processing free from viable microorganisms. Common techniques include:

Steam sterilization (autoclaving): Uses saturated steam under pressure to achieve microbial inactivation.
Dry heat sterilization: Employs hot air to sterilize materials that moisture may damage.
Filtration: This method removes microorganisms from liquids and gases by passing them through membrane filters with specific pore sizes.
Radiation and chemical methods: Gamma radiation, ethylene oxide gas, electron beam sterilization, and hydrogen peroxide gas plasma sterilize disposable medical devices and heat-sensitive materials.

Selection Criteria

Choose the proper sterilization method based on the product’s heat sensitivity, material, and potential impact on quality. Each technique must be tested to ensure it sterilizes effectively without damaging the product.

Validation & Monitoring

Validation ensures sterilization works as intended by testing with indicators and monitoring key factors. Regular checks ensure the process stays effective in daily operations.

Quality Controls in Aseptic Processing

Keeping products sterile requires strict quality controls at every stage of aseptic processing.

Sampling & Testing

Frequent air, surface, and personnel sampling helps catch contaminants before they cause issues. Microbiological testing pinpoints harmful microorganisms, allowing quick action to prevent contamination.

Documentation & Record-Keeping

Accurate records track manufacturing steps, environmental conditions, and quality checks. Detailed documentation ensures regulatory compliance and creates a clear audit trail for inspections.

Standard Operating Procedures (SOPs)

SOPs provide step-by-step instructions for equipment use, cleaning, and aseptic techniques. Following these guidelines ensures consistency, reliability, and minimizes risk of human error.

Ongoing Audits & Continuous Improvement

Regular audits confirm compliance and uncover areas that could use optimizing. A commitment to continuous improvement keeps processes efficient, products high-quality, and facilities up to regulatory standards.

Additional Best Practices

Implementing best practices further strengthens aseptic processing operations.

People are the biggest contamination risk in aseptic environments. Proper gowning procedures prevent particles and microbes from compromising sterility.
A well-planned workflow keeps materials moving while preventing cross-contamination. Raw materials, processing areas, and finished products must stay separated to maintain sterility and reduce risks.
Regular risk assessments help identify weak points where contamination could occur. Hazard analyses ensure new risks are caught early, and corrective measures are in place.

Stay Ahead in Pharma & Biotech with Expert Training

Aseptic processing is integral for ensuring product safety and effectiveness in the fast-paced world of pharmaceutical and biotech manufacturing.

To stay ahead in the field, explore CfPIE’s courses, Aseptic Processing in the Manufacture of Biotech and Pharmaceutical Products , Cleanroom Fundamentals - Regulation, Science, Design, Practice, Operation & Management , and Quality Assurance/Quality Control for Biologics and Biopharmaceuticals to strengthen your knowledge and ensure compliance with industry best practices.

The Future of Clinical Trials: Decentralization and Its Regulatory Implications

Mon, 27 Jan 2025 18:05:01 GMT

The way organizations approach clinical trials is undergoing a significant transformation alongside the rise of IoT devices and wearables — decentralized clinical trials (DCTs).

Traditional site-based trials are still in place, but they’ve been facing growing scrutiny over patient recruitment, cost-efficiency, and accessibility. Now, decentralized trials are leveraging digital tools and remote monitoring technologies to revolutionize the entire clinical trial process.

However, pivoting to decentralized trials is far from simple, and it’s still in the development phase. Regulatory challenges, ensuring data integrity, and maintaining patient privacy are all major hurdles that need to be overcome.

So, let’s break down how DCTs are starting to change the industry and how you can stay on top of this emerging transformation facing clinical trials.

Featured Course(s):

GCP Audits - Best Practices for Ensuring Compliance & Detecting Fraud and Misconduct in Clinical Trials

The Rise of Decentralized Clinical Trials

DCTs are a major departure from the traditional model. Instead of requiring participants to visit clinical sites, data is collected remotely using telemedicine, wearable devices, and home-based care.

Digital health technologies (DHTs) underpin the viability of DCTs. These technologies have unlocked entirely new approaches to everything from patient care to R&D.

This model reduces barriers to participation, broadens the geographic reach of studies, and accelerates recruitment timelines. This shift underscores the industry's growing emphasis on patient-centric care by ensuring that clinical research reflects the needs and experiences of diverse populations.

DCTs eliminate the need for frequent travel, making participation more feasible for individuals in rural areas or those with mobility challenges. For organizations, decentralized models reduce operational costs and improve data collection efficiency, especially when real-time monitoring tools are involved.

Regulatory Challenges and FDA Guidelines

The FDA and other regulatory bodies have begun issuing guidance to address these challenges. A few key recommendations include:

Establish a rigorous validation process to assess the accuracy, reliability, and consistency of digital health tools used in data collection.
Implement robust security measures to protect sensitive patient data from unauthorized access, breaches, and data loss.
Ensure compliance with industry standards and regulatory requirements, such as HIPAA, GDPR, and other applicable data protection laws.
Develop comprehensive training programs to equip teams with the skills and knowledge needed to manage remote processes efficiently.

However, technological advancement often outpaces regulatory frameworks. Collaboration between regulators, organizations, and technology providers is critical to establishing clear guidelines and mitigating risks.

Preparing for the Future of DCTs

Organizations looking to adopt DCTs now or in the future must proactively address both operational and regulatory considerations. Let’s quickly break down a few ways you can prepare for the future, such as:

Leverage technology strategically: Any new platform you adopt must be implemented strategically with the goal of enhancing trial efficiency while also ensuring compliance. The fewer platforms you need to conduct DCTs, the better.
Focus on patient engagement: Develop new communication strategies that leverage easy-to-use tools to keep participants engaged and informed throughout the process. Any unnecessary friction may result in disengagement, affecting the entire trial.
Invest in employee training: DCTs represent a major change in how many technicians approach trials. All employees need to be trained in using new technologies and platforms while remaining fully compliant.

It’s crucial to start DCTs thoughtfully and strategically to protect patient privacy and ensure that patients remain fully compliant and to reduce the risk of additional issues, implement new tools and processes slowly.

Training is a Critical Aspect of Adopting DCTs

Traditional clinical trials face a high degree of regulatory scrutiny and DCTs will likely face even greater requirements. Employee training in these new processes, regulations, and technologies is vital to running valuable DCTs.

CfPIE is an industry leader in life sciences training and maintains up-to-date courses with the latest advances in the industry and technology. Are you interested in how DCTs can benefit your clinical processes?

Explore CfPIE’s upcoming courses today to stay up to date on regulatory requirements and learn the latest advancements in clinical trial management.

GMP vs. GLP: Key Differences and How They Impact Your Organization

Tue, 21 Jan 2025 18:04:59 GMT

Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) are foundational frameworks that focus on ensuring quality, safety, and integrity throughout life sciences.

While these two frameworks share a common goal, their focus and application differ significantly. Each impacts organizations uniquely, and understanding these differences is crucial for maintaining compliance and optimizing operations.

We’ll be breaking down these two similar yet distinct standards to understand how they vary — and how they can be combined to enhance your organization.

Featured Course(s):

Good Laboratory Practices (GLP) for Nonclinical Laboratory Studies

GMP Training for the QC Laboratory

Good Manufacturing Practices (cGMP) Training

Overview of GMP and GLP

Before diving deeper into how these two standards vary and intertwine, let’s define them individually.

Good Manufacturing Practices (GMP)

The GMP framework is a set of regulations defining best practices for manufacturing, processing, and packaging products. GMP emphasizes that every step of the production process meets stringent quality standards to guarantee product consistency and safety.

Ultimately, these practices apply to pharmaceutical, medical device, and food industries, emphasizing end-to-end process control.

Good Laboratory Practices (GLP)

GLP is a quality system concerned with the non-clinical safety testing of substances. The goal of GLP is to ensure the reliability, integrity, and traceability of laboratory data, which is a core aspect of regulatory submissions.

These practices are primarily applied during preclinical research and focus on study design, data recording, and validation of results.

GLP vs GMP: Key Differences and Requirements

How do these two standards vary, and how will they impact your organizational processes? Let’s break down a few ways these standards take different approaches.

Scope and Focus

Focus is a core difference between these two standards:

GMP: GMP concentrates on processes at every stage of manufacturing, including packaging, storage, and distribution. The focus of GMP is to make sure products consistently meet quality and safety specifications.
GLP: The focus of GLP is on the preclinical phase. These standards are designed to ensure the credibility and reproducibility of laboratory studies, primarily those used to evaluate safety and efficacy.

Regulatory Application and Enforcement

The way regulators enforce compliance can vary between both standards:

GMP: These standards are enforced by agencies such as the FDA and EMA for commercial production. Non-compliance can result in product recalls or severe penalties.
GLP: GLP applies to laboratories conducting non-clinical research to support product approval. The goal of GLP is to make sure that study data submitted to regulatory bodies are credible and verifiable.

Documentation Requirements

What data needs to be captured and documented to stay compliant?

GMP: GMP compliance requires extensive process documentation, including batch records, validation reports, and standard operating procedures (SOPs).
GLP: While similar, GLP compliance requires meticulous study plans, raw data, and final reports, ensuring transparency and accuracy in research findings.

Integrating GMP and GLP for Compliance

Integrating GMP and GLP frameworks is vital for organizations involved in both research and production. Establishing clear boundaries and workflows between the two ensures seamless transitions from preclinical studies to commercial manufacturing.

A few key processes to go about this include the following:

Develop holistic documentation processes: Standardized documentation systems can go far in minimizing redundancies and upgrading traceability across research and production phases.
Prioritize technology integrations: Leveraging digital tools for quality management systems (QMS) and laboratory information management systems (LIMS) goes far with compliance to both standards and overall efficiency.
Make sure teams are trained in both standards: Teams should be trained to understand the requirements and applications of both GMP and GLP as they pertain to their specific roles.

Recognizing and integrating differences between both standards will empower your organization to maintain regulatory compliance so you can deliver safe, effective products to consumers.

Training is Critical for Compliance with Both Standards

GMP and GLP have distinct yet complementary roles. They ensure quality and compliance throughout the life sciences industry. GMP governs manufacturing and production processes, while GLP focuses on the integrity of pre-clinical research.

As the industry continues to evolve, gaining a comprehensive understanding of GMP and GLP will help drive innovation while maintaining the highest quality and safety standards. Ongoing training is crucial for striking this balance.

CfPIE offers industry-leading life sciences courses to keep your employees informed about the latest standards and how to apply them throughout the organization. Learn more about the following courses to see how we can support continuing education programs:

The Critical Role of Quality Assurance in Pharmaceutical Manufacturing

Tue, 14 Jan 2025 18:04:55 GMT

Safety, efficacy, and product quality are non-negotiable in the life sciences. Regulatory frameworks demand rigorous adherence to standards, and any deviation can have dire consequences for patient health and a company's reputation.

Quality Assurance (QA) and Good Manufacturing Practices (GMP) are cornerstone processes that ensure every product reaching end users is safe and effective.

QA teams and processes make sure every step in the manufacturing process abides by GMP standards, ensuring the safety of medications that reach the end user. Today, we’ll break down how QA and GMP overlap and intertwine to protect patients while ensuring ongoing compliance.

Featured Course(s):

Effective Internal and External Quality Assurance Auditing for FDA Regulated Industries

Quality Assurance/Quality Control for Biologics and Biopharmaceuticals

Good Manufacturing Practices (cGMP) Training

The Role of QA and GMP Compliance

QA teams make sure that every aspect of pharmaceutical manufacturing complies with GMP standards. These standards are globally recognized as the benchmark for product quality and safety.

The processes developed by QA directly reflect GMP standards, applying them to the specific needs and workflows of the organization. From there, QA conducts regular internal audits to ensure every step of the process adheres to GMP standards.

Combined, QA teams leverage GMP standards to minimize risks, enhance operational efficiency, and help manufacturers stay ahead of evolving regulatory requirements.

QA’s Role in Ensuring Product Safety

Patient safety is the ultimate goal of pharmaceutical manufacturing, and QA plays a critical role in protecting safety and the efficacy of pharmaceuticals. Rigorous testing and quality checks help QA make sure that pharmaceuticals are safe and compliant before reaching the market.

QA teams create and implement processes that guarantee consistency and regulatory compliance at every production stage. Everything from sourcing raw materials to packaging the final product must adhere to QA’s processes for documentation, inspection, and validation.

For example, QA teams will validate manufacturing equipment to ensure it operates within specified parameters, preventing contamination or inconsistencies. QA also oversees stability testing to confirm that products remain safe and effective throughout their shelf life.

Building Consumer Trust Through QA

Pharmaceutical manufacturing is an industry that can mean life or death for patients who depend on safe, effective medications. End users are put at risk if a medication doesn’t provide the right therapeutic effects or has contaminated materials.

That’s why QA is crucial for establishing trust in the industry. QA teams and GMP standards ultimately strive to make sure that every medication that reaches end users is safe and effective — helping build trust with consumers.

Additionally, clear labeling, comprehensive documentation, and adherence to quality standards demonstrate a commitment to patient well-being. This commitment builds trust over time as end users and regulators have few issues.

Ultimately, robust QA processes signal to regulatory bodies, healthcare providers, and patients that the company prioritizes quality. This not only enhances reputation but also fosters long-term loyalty among consumers and stakeholders.

Leverage Reputable Training to Underscore Both QA and GMP

Quality assurance is more than a regulatory requirement — it’s a cornerstone process of the industry’s dedication to safeguarding the health and safety of end users. Even minor errors in pharmaceutical manufacturing can have devastating effects on patients.

Focusing on GMP compliance isn’t simply checking boxes to avoid fines, it’s benefitting from industry standards to keep your customers safe. GMP and QA overlap and intertwine to make sure everything possible is being done to manufacture safe and effective treatments.

Providing employees with effective and thorough training is essential to staying fully compliant and protecting consumers.

That’s why CfPIE offers gold-standard courses that keep employees throughout your organization up to date on the latest QA best practices and GMP requirements. Explore our courses today for industry-recognized continuing education:

Have any questions about our courses or rates? Reach out to us today and we’ll help you find the courses you need.

AI and Machine Learning in Regulatory Compliance: A Game Changer for Life Sciences

Mon, 06 Jan 2025 18:00:22 GMT

Regulatory compliance is a cornerstone of life science industries, as they’re designed to ensure all treatments that reach end users are safe, effective, and consistent.

However, the sheer volume and complexity of regulations can create bottlenecks in crucial processes like documentation, auditing, and risk management. That’s where artificial intelligence (AI) and machine learning (ML) come into play.

AI-driven tools are positioned to transform how life science organizations manage regulatory compliance processes by improving efficiency and accuracy.

When implemented correctly, AI tools can significantly streamline how organizations stay compliant. We’ll be breaking down how this technology is poised to change compliance processes across life sciences — and how you can prepare for the future.

Featured Course(s):

Generative AI in Drug Discovery & Development: Navigating the New Frontie r

How AI Enhances Documentation Processes

Documentation is arguably one of the most labor-intensive aspects of regulatory compliance in life sciences. The industry is inundated with a large amount of information that needs to adhere to strict guidelines, ranging from clinical trial data to manufacturing records.

AI and Machine Learning (ML) streamline this process by automating document categorization and review. Natural language processing (NLP) algorithms, a subcategory of AI, can identify inconsistencies, extract relevant data, and ensure alignment with regulatory standards.

For example, AI tools can analyze submission documents for FDA approval by flagging any potential issues a document might have before submission.

Additionally, cloud-based AI platforms ensure that all stakeholders, from researchers to compliance officers, are always on the same page, reducing the risk of errors caused by miscommunication or outdated information.

AI in Auditing and Risk Management

Auditing and risk management are two critical processes that make sure your organization and products are fully compliant. In the past, these tasks required manual reviews of extensive datasets, which left room for human error and was time-intensive.

Now, AI can revolutionize these crucial prospects by enabling continuous, real-time monitoring. A machine learning algorithm can detect anomalies and flag any possible issues before development continues. For example, an AI-driven platform can identify any manufacturing processes that deviate from Good Manufacturing Practices (GMP) prior to being discovered during an internal or external audit.

Risk prediction is another key advantage that’s become more viable with emerging AI models. These tools work by analyzing historical data and trends and then enabling proactive strategies rather than relying on reactive measures. This capability can go far in avoiding possible safety issues.

Key Challenges and Ethical Considerations

While AI has promising use cases across life sciences, it’s not without its hurdles that need to be overcome. A few of these hurdles include:

Lack of standardization: Currently, there is no universal framework for using AI ethically in life sciences. This lack of standards creates possible ethical challenges and also makes integrating AI tools challenging.
Possibility of bias: Valuable AI outputs depend on quality training data, but training data may include historical biases that affect the model’s output. Thorough data sanitization and transparency are essential for building trust in AI-driven processes.
Data security: If improperly implemented and secured, sensitive information used in training data or daily usage of the model may enable a data breach. This risk is much greater for any models that are also public-facing.

Prepare Today to Benefit from the AI Tools of Tomorrow

AI tools can already be a benefit to your organization’s compliance processes, but we expect future tools to have dramatic improvements that will help you stay compliant and avoid bottlenecks.

Preparing for these tools requires learning the ins and outs of how AI is already used throughout the pharmaceutical industry.

CfPIE offers the gold-standard of life science courses that help new or established professionals stay current with the necessary knowledge. We also offer industry-leading training on using AI in drug discovery and development.

Is now the time to prepare with the right training programs? Learn more about our up-to-date generative AI course and start getting ready for the future of compliance.

8 Benefits of Live Stream Instructor-Led Continuing Education Courses in Life Sciences

Tue, 31 Dec 2024 13:12:23 GMT

Life sciences is a dynamic industry that constantly changes due to technological changes, scientific discoveries, and regulatory requirements. Staying on top of these changes is essential for many roles in the field, but relying on in-person training can often be prohibitive.

Live stream courses have emerged as a valuable alternative to traditional in-person training. Trainees learn the same material without extensive travel and job disruption, enabling them to put their new knowledge to work in their daily roles immediately.

So, let's break down the many benefits of live stream instructor-led courses and why this format has become the preferred choice for continuing education in the pharmaceutical, biotech, and medical device industries.

Flexibility to Learn Anywhere, Anytime
No Travel Expenses
Real-Time Interaction with Expert Instructors
Tailored Content with Up-to-Date Materials
Small Class Sizes for Better Interaction
Interactive Exercises and Group Projects
Availability to Global Learners
Opportunities to Expand on Key Topics

1. Flexibility to Learn Anywhere, Anytime

One of the most valuable advantages of live stream instructor-led courses is the flexibility they provide to learners. Unlike in-person courses, which require travel and time away from work, live stream courses allow participants to engage with the content from anywhere with a stable internet connection.

Trainees can join the course from a location that suits their schedule and needs, whether at home, in the office, or while traveling. This benefit is particularly valuable for professionals who want to further their education with minimal disruption to their work-life balance.

Additionally, live stream courses are typically offered in short, focused sessions that last a few hours per day over several days. This format enables trainees to attend the course without taking full days off work, allowing for professional development without compromising productivity.

2. No Travel Expenses

Attending an in-person course can be a significant investment, typically involving airfare, lodging, meals, and other travel-related costs. Live stream instructor-led courses eliminate these expenses and make the learning experience much more affordable.

In addition to saving money on travel and accommodations, live steam courses also minimize lost productivity. Attendees can complete their education while still managing their daily tasks and responsibilities, rather than spending several days away from home and work. For businesses, this means reduced employee downtime and better ROI on training investments.

3. Real-Time Interaction with Expert Instructors

One key benefit that live stream courses offer compared to pre-recorded webinars or self-paced classes — real-time, interactive learning with instructors who are experts in their fields.

Every CfPIE course is led by the expert who created the original course materials or by a qualified successor who has thoroughly updated and taken ownership of the content. As a result, CfPIE ensures that the quality and depth of instruction remain top-notch and aligned with industry standards.

Unlike pre-recorded courses that cannot adapt to the needs of individual learners, live stream instructor-led courses offer opportunities for attendees to engage with the instructor in real-time. Trainees can ask questions, seek clarification on complex topics, and delve deeper into areas of particular interest.

4. Tailored Content with Up-to-Date Materials

Live stream courses allow the instructor to update and tailor the content in real-time, ensuring that the material reflects the most current industry trends and regulations. Updated material is especially critical in fields like pharma, biotech, and medical devices, where regulations and technologies are continuously evolving.

As an example, courses on Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and Good Clinical Practices (GCP) must be constantly updated to reflect the latest guidance and compliance standards.

5. Small Class Sizes for Better Interaction

Smaller classes allow for more intimate, interactive sessions where participants can engage directly with the instructor and other learners. These class sizes lead to better group discussions, increased opportunities to ask questions and a more focused learning environment.

In a smaller class, the instructor can also adjust the course material and pacing to better suit the group’s interests and needs. While the overall agenda is still being followed, live stream courses provide instructors with the flexibility to spend more time on topics that are highly relevant to the attendees.

Being able to adjust for individual needs ensures that the course is both comprehensive and tailored to the specific needs of the group, so attendees can confidently apply their new knowledge to their daily responsibilities.

6. Interactive Exercises and Group Projects

Live stream courses are designed to be interactive, which allows attendees to participate in group exercises and collaborative projects. This approach not only strengthens comprehension but also fosters valuable networking opportunities.

Throughout these group activities, professionals from different organizations can share their experiences, insights, and challenges, enriching the overall learning experience.

Interactive exercises in live stream courses often include case studies, hypothetical scenarios, and group discussions, which help solidify the concepts taught in the session. Attendees will be ready to apply what they’ve learned in a practical context, making the course content relevant and actionable.

7. Availability to Global Learners

Live stream courses offer a distinct advantage for global learners. Unlike in-person courses, which may be limited by geographical location, live stream courses can be attended by professionals from all around the world. Not only is this advantageous for attendees in remote locations, but for everyone else in the class who will benefit from a more diverse group.

Additionally, CfPIE live stream courses provide electronic and physical copies of the course slides, exercises, and references, so attendees are able to revisit the material at their convenience. This makes it easier for professionals in different time zones to participate and review content on their own schedule.

8. Opportunities to Expand on Key Topics

Continuing education is not just about learning new concepts — it’s about staying current with regulatory changes, industry advancements, and emerging technologies.

This is why CfPIE’s live stream instructor-led courses offer a wide-range of topics tailored to the specific needs of professionals across core categories, such as:

Regulatory Compliance: Life sciences are highly regulated, so courses such as those covering GMP , GLP , and GCP can ensure professionals are up-to-date with the latest regulatory requirements.
Technological Advancements: Technology is constantly advancing to meet challenges facing life sciences. Trainees must stay up-to-date on cutting-edge concepts such as LC-MS/MS or Generative AI that are transforming the industry.
Error Prevention and Control Documentation: Preventing human error is critical, but so is understanding the true source of the error and how to maintain proper change control processes.
Technical Writing and Documentation: Courses covering subjects such as Writing SOPs , Technical Writing , or Document Management are ideal for professionals transitioning into new roles or looking to enhance their technical communication and documentation skills - something everyone in life sciences can benefit from.
Medical Devices: Everything from combination products , to post-market surveillance and process validation are covered within a variety of courses specific to the medical device industry.
Drug Development: Whether you are looking for a drug development process overview, or are interested in the development of oncology drugs or vaccines , CfPIE offers a course designed to expand your knowledge.

Live Stream Instructor-Led Courses Are the Future of Continuing Education

Live-stream courses provide a modern, cost-effective solution to continuing education thanks to the flexibility to learn from any location, the ability to interact directly with expert instructors, and the assurance of up-to-date material and tailored content.

We’ve explored how live stream instructor-led courses offer a wealth of benefits that make them an excellent choice for professionals in the pharma, biotech, and medical device industries; however, live stream courses aren’t their only option. CfPIE also offers options for companies looking for customized training which can be provided on a schedule that works best for your team, either live stream, in-person, or a combination of both.

CfPIE is an industry leader in life sciences training that ensures professionals have the latest knowledge and skills to handle their job responsibilities. CfPIE embraces a flexible approach to gaining career-advancing knowledge, either through customized, in-person training or live stream instructor-led courses.

Ready to move on from pre-recorded webinars and in-person training that requires travel and lodging expenses? Reach out to us today to learn more about our customizable on-site course options or browse our live stream instructor-led courses to continue your education journey today!

Michael Pierro: A Leader in Drug Development Education and Regulatory Expertise

Tue, 03 Dec 2024 16:06:50 GMT

Michael Pierro stands out as a respected figure in drug development education and regulatory expertise. His extensive background in pharmaceutical sciences, coupled with decades of hands-on industry experience, positions him as an invaluable resource for professionals seeking comprehensive and practical knowledge in this complex field.

Michael has transformed the way industry professionals approach drug development and regulatory standards through his leadership and innovative teaching.

We’re honored to offer courses led by Michael that leverage his experience-based insights and training, going beyond learning only the basics. We’ll be exploring his background and the value he brings to our courses.

Michael Pierro’s Background and Expertise

Michael Pierro’s career in the pharmaceutical and regulatory sectors spans over 35 years, marked by significant achievements and contributions.

He’s gained an extensive understanding of clinical research as he’s worked in various pivotal roles that have shaped his understanding of regulatory landscapes and the nuances of drug development — let’s explore these two major aspects of his expertise.

Professional Experience

Michael Pierro’s professional journey includes significant roles in both large-scale pharmaceutical firms and niche consultancies. These roles enriched his understanding of various stages of drug development, from initial concept to post-market surveillance.

His contributions have been pivotal in securing regulatory approvals for new drugs across multiple therapeutic areas. Additionally, his work experience has given him insights into the challenges faced by professionals in clinical development, regulatory submissions, and quality assurance.

Throughout his career, Michael has been committed to fostering an environment where adherence to Good Clinical Practices (GCP) and ethical standards are paramount.

His experience has enabled him to lead courses and workshops to prepare trainees for working in this complex field, which include:

Director of business development at Barnett International. At Barnett, his clients included the US federal government, CROs, and University medical centers.
Director of Global Training for Hoechst Marion Roussel’s (Aventis) Global Clinical Quality Assurance Department. Michael worked with drug development centers and other development sites throughout the world.
Additional roles at other major pharmaceutical companies, including Senior CRA, Manager of Phase IV Clinical Operations, and Chairperson of the SOP Steering Committee.

Overall, Michael’s work experience has prepared him to impart to trainees both the necessary knowledge and hands-on experience to enhance their roles.

Regulatory Knowledge

Michael’s in-depth knowledge of regulatory frameworks is one of his most significant assets. He has developed a detailed understanding of how regulatory bodies, such as the FDA and EMA, evaluate new drugs and biologics.

Courses led by Michael help professionals anticipate changes and prepare accordingly so they can make sure the strategies they employ keep them ahead of the curve. His real-world experience in regulatory negotiations and submissions provides students with a comprehensive framework for tackling the often-daunting process of gaining drug approval.

Ultimately, Michael’s decades of experience have given him the expertise to impart a practical guide for course participants who need to navigate complex regulatory pathways efficiently.

Michael Pierro’s Teaching Style and Approach

Michael Pierro’s teaching style is dynamic, engaging, and rooted in practical application. He prioritizes interactive learning by drawing on real-world case studies and scenarios that enable participants to connect theoretical concepts with practical challenges.

Michael’s approach to teaching emphasizes clarity and accessibility, making complex topics manageable and relatable. He also encourages questions and open discussions, fostering an environment where students feel empowered to explore solutions to regulatory and developmental hurdles.

Additionally, Michael’s courses are known for their hands-on learning experiences. Embracing an interactive method ensures that participants not only understand the content but can also apply it effectively in their professional roles.

Real-World Application

One of the hallmarks of Michael’s courses is their strong emphasis on real-world application. He integrates examples from his extensive career to illustrate how regulatory principles play out in practical settings. Providing this context helps participants see beyond theoretical frameworks and understand how regulatory guidelines are implemented in real clinical and business environments.

Michael’s focus on practical orientation prepares them to handle real-life challenges, making them more competent and confident in their roles. Through case studies, role-playing exercises, and practical problem-solving sessions, he also ensures that students gain experience in decision-making and critical thinking.

Key Courses Led by Michael Pierro

We’re honored to have Michael bring his extensive knowledge and expertise to two CfPIE courses, preparing trainees for effectively working in their fields. Let’s quickly review these courses and how they reflect knowledge gained throughout his career.

Good Clinical Practices (GCP) & Risk Based Monitoring - Understanding and Implementing Current Global Requirements

This course is essential for professionals who want to master the evolving standards of GCP and incorporate risk-based monitoring approaches. Michael’s expertise makes sure that attendees leave with actionable insights into global regulatory requirements and how to implement them effectively in clinical trials.

The Drug Development Process from Concept to Market

This comprehensive course covers the entirety of drug development, offering participants a detailed roadmap from initial concept through to market launch. Michael’s firsthand experience brings the content to life and enables students to appreciate the multi-faceted challenges and critical decision points encountered throughout the development process.

Impact on Students and Industry Professionals

Michael’s courses make a profound impact on countless professionals in the pharmaceutical industry and prepare them to work in their fields.

His ability to blend theoretical understanding with practical application ensures that participants acquire skills that directly translate to their work. Attendees often praise his depth of knowledge, approachability, and the confidence they gain from his leadership.

Additionally, Michael’s commitment to preparing students for real-world challenges is evident in the way he designs and delivers his courses. He imparts strategies for overcoming regulatory obstacles, managing cross-functional project teams, and navigating complex compliance landscapes.

Preparing trainees for real-world challenges is critical for professionals who must remain agile and informed in a constantly evolving industry. Trainees will be ready to advance in a lasting career in life sciences.

Why Choose a Course with Michael Pierro?

You have options for life sciences training, so why should you consider a course led by Michael Pierro? There are two powerful reasons why his courses are well worth attending:

Unique Blend of Knowledge and Practicality

Michael Pierro offers a rare combination of extensive regulatory knowledge and practical, hands-on experience. His courses deliver information and teach participants how to think critically and apply what they learn to real-world situations. This dual focus on knowledge and practicality makes his courses an investment in professional growth.

Tailored Support for Professionals

Michael’s courses are designed with the working professional’s needs in mind. He provides tailored advice and feedback, helping participants translate course concepts into their unique work environments. His open, supportive teaching style encourages students to seek guidance and make the most of his extensive experience.

Benefit from Michael Pierro’s Experience at CfPIE

Michael’s influence on drug development education is undeniable. With a career rooted in regulatory expertise and a passion for teaching and consulting, he has become an asset for professionals looking to deepen their understanding and enhance their skills.

CfPIE is a leader in life sciences training, and Michael Pierro is a core member of our team. His courses offer a unique blend of theoretical insight, practical application, and interactive learning that helps trainees advance their careers. Learn more and enroll in his courses today:

An Overview of Drug Discovery: From Idea to Preclinical Testing

Tue, 03 Dec 2024 16:05:06 GMT

Drug discovery is the essential starting point in the research-intensive journey to develop new medications to combat diseases and ultimately enhance human health. This complex process transforms an initial idea into a potential treatment and then moves forward to preclinical testing.

The multi-stage nature of drug discovery requires innovation, meticulous research, and collaboration among diverse teams. Here at CfPIE, our course “The Drug Development Process from Concept to Market” offers comprehensive insights into each stage so trainees are ready to undertake this critical process.

So, what exactly is drug discovery? Keep reading as we dive into the basic concepts of drug discovery and testing, tracing the path from initial concept to ready for preclinical testing.

Identifying Therapeutic Targets

Drug discovery begins by identifying therapeutic targets, which is a major cornerstone of the entire process.

This early phase focuses on selecting the right biological molecules or pathways that are key to a specific disease. Let’s break down the core steps in this first phase of drug discovery.

Understanding the Disease Mechanism

The identification process begins with comprehensive knowledge of the disease’s biological underpinnings. By understanding the mechanisms of underlying diseases, researchers can pinpoint potential targets for intervention.

Researchers will closely study how genetic, molecular, and cellular processes contribute to the onset and progression of the specific condition. Gaining this understanding creates the foundation for identifying which components will most likely be effectively targeted by new therapies.

Choosing Target Molecules

Once a specific disease is mapped out, scientists must choose which target molecules can be modulated to achieve specific therapeutic outcomes.

Target molecules might include proteins, nucleic acids, or other biological structures integral to the disease’s activity. The ideal target is one that, when influenced, will produce the desired therapeutic effect without causing adverse reactions.

Evaluating Target Validity

Evaluating the validity of the chosen targets is crucial to ensure they are appropriate for drug development. This process involves thorough research to determine whether modifying the target’s activity yields a positive therapeutic effect.

Techniques such as gene knockout experiments, RNA interference, and CRISPR-Cas9 editing help verify the target’s role in disease mechanisms. You may use one or more techniques to validate identified targets, but the overall goal is to have evidence that the chosen biological target is the right one to focus on.

Screening and Lead Identification

Once you’ve identified and validated the target, you’ll begin finding potential drug candidates. This process often involves screening a library of compounds to identify any that may interact with the target correctly.

Known as screening and lead identification, the key steps in this phase are:

High-Throughput Screening (HTS): The HTS process is a key method for rapidly testing compounds against the target. This process utilizes automated technology to conduct assays that measure every compound's biological and biochemical activity to identify initial “hits” that show promise.
Hit-to-lead process: Once complete, this process further analyzes possible compounds based on their activity, selectivity, and potential for therapeutic properties. This step involves refining the initial hits to produce “lead” compounds that meet the preliminary criteria for efficacy and safety.
Lead optimization: The final step in the screening phase calls for modifying lead compounds to improve their potency, selectivity, and pharmacokinetic profiles. Successful lead optimization results in one or more candidates ready for the next stage — preclinical evaluation.

This critical middle phase can be aided by leading-edge optimization of search tools and simulation platforms. We’ll likely see advances in AI further improve this process.

Evaluating Drug Safety and Efficacy in Preclinical Studies

Before a drug candidate can progress to human trials, it needs to undergo rigorous preclinical testing to assess its safety and efficacy. This phase is divided into in vitro and in vivo studies, followed by detailed toxicology and pharmacokinetics evaluations — let’s break down these methodologies.

In Vitro Testing

In vitro testing refers to experiments conducted outside of living organisms, using cell cultures or biochemical assays. This type of testing helps researchers understand a compound’s basic pharmacological profile, including its binding affinity, mechanism of action, and initial toxicity levels.

In Vivo Testing

Conversely, in vivo testing involves studies in living organisms, typically animal models. These tests provide critical insights into a drug's behavior within a complex biological system.

During in vivo testing, researchers observe the compound’s distribution, metabolism, excretion, and potential side effects to predict its behavior in human trials. This methodology is crucial for pharmaceutical development and is often time-intensive.

Toxicology and Pharmacokinetics

Both toxicology and pharmacokinetics (PK) data inform decisions on whether a drug candidate is suitable for further development, which are:

PK examines how the body absorbs, distributes, metabolizes, and excretes the compound.
Toxicology studies determine the safety profile of a drug, helping identify any harmful effects, and establishing safe dosage levels.

The data gathered from these processes can be encouraging, validating the initial hypothesis, or show detrimental issues that require exploring other leads.

The Importance of Collaboration in Drug Discovery

Collaboration is a significant driving force behind successful drug discovery. This process thrives on input from multi-disciplinary teams that bring diverse expertise to the table and can include:

Role of multidisciplinary teams: Effective drug discovery typically requires the combined efforts of biologists, chemists, pharmacologists, data scientists, and regulatory experts. Each discipline contributes unique insights that shape new treatments' development, ensuring that no aspect of the process is overlooked.
Collaborations with institutions and the private sector: Beyond internal teamwork, partnerships with academic institutions and private companies are valuable to everyone involved. Collaborations can help integrate cutting-edge research, expand technological capabilities, and share resources to accelerate drug discovery timelines.

Together, you can see how drug discovery is a collaborative process between different organizations and specialists. Embracing this approach, rather than trying to handle everything internally with small teams, is essential to accelerating the drug discovery timeline.

Challenges and Future Innovations in Drug Discovery

Drug discovery is a time-consuming and costly endeavor, often spanning several years and significant financial investments. As a result, there are several challenges and opportunities for innovation throughout the process, let’s explore both sides of the drug discovery coin.

High Costs and Time Requirements

Developing a new drug candidate from concept to preclinical testing is both labor-intensive and expensive. We’ve explored how the process involves extensive trials, data analysis, and adjustments which can compound to increase timelines and budgets.

These challenges make it imperative to streamline research methods and seek cost-effective approaches, such as collaborating with other organizations and capitalizing on new technologies.

Emerging Technologies

The rapid pace of technological advancements is reshaping drug discovery, creating opportunities for increasing efficiency and effectiveness at key stages in the process. Innovations such as Artificial Intelligence (AI), Machine Learning (ML), and High-Content Screening (HCS) are enabling faster identification of potential drug candidates.

AI and ML models can also predict compound-target interactions, optimize lead compounds, and simulate preclinical results, greatly enhancing efficiency and accuracy.

Learn Essential R&D Process Drug Discover with CfPIE

The journey from an initial idea to a drug ready for preclinical testing is a comprehensive process marked by meticulous research, validation, and collaboration. Understanding the basic concepts of drug discovery and testing highlights the intricate efforts of bringing new treatments to the forefront.

Drug discovery, while challenging, remains a beacon of hope for medical advancements and future therapeutic breakthroughs. However, professionals must be trained in the basic concepts of drug discovery and testing to contribute to the team's success.

CfPIE offers industry-leading life sciences training as continuing education for those working in the field. Ready to take the next step in your life sciences training? Enroll in our Drug Development Process from Concept to Market course and gain valuable expertise from our experienced trainer to prepare for the next stage in your career.

Understanding cGMP: What Current Good Manufacturing Practices Are and Why They Matter

Mon, 04 Nov 2024 16:44:46 GMT

In the pharmaceutical, biotech, and food industries, ensuring that products are safe for consumption and effective in their intended use is critical to public health and trust. Current Good Manufacturing Practices (cGMP) are regulations enforced by various governing bodies to guarantee that companies adhere to rigorous standards throughout the manufacturing process.

cGMP guidelines cover every aspect of production, from facility design to staff training, equipment calibration, quality control, and record-keeping. These practices help prevent contamination and errors, safeguarding consumers from harmful products.

Read on to learn the meaning of cGMP, its essential components, and the importance of compliance for companies.

What Does cGMP Mean?

cGMP stands for current Good Manufacturing Practices. These are the latest guidelines and regulations that ensure manufacturers meet the highest safety, quality, and control standards in their production processes. The term "current" highlights the need to continually update and improve practices to align with new technologies and advancements.

While GMP (Good Manufacturing Practices) refers to the foundational guidelines for manufacturing, cGMP emphasizes ongoing improvement and compliance with the most up-to-date standards. This helps companies follow general practices while integrating current methods and technology.

Industries Affected by cGMP

Adhering to cGMP guidelines can help companies comply with regulatory requirements, enhance their reputation, and improve consumer confidence in their products.

You will find cGMP throughout industries where product safety and quality are critical, such as:

Pharmaceuticals: Certifies that medications are safe, effective, and manufactured consistently.
Biologics: Governs the production of biological products like vaccines and gene therapies.
Medical Devices: Ensures devices are safe for use and perform as intended.
Food Manufacturing: Regulates food safety to prevent contamination and ensure consumer protection.

The Importance of cGMP in the Pharmaceutical and Biotech Industries

Current Good Manufacturing Practices set the framework for producing and controlling products to meet high standards, specifically concerning:

Product Safety and Efficacy

cGMP regulations help guarantee that products are produced and monitored under stringent quality controls. These standards help prevent contamination and production errors, minimizing the risk of mix-ups while upholding the integrity of pharmaceutical and biotech products.

Protecting Public Health

Complying with cGMP allows companies to safeguard public health by providing product purity and effectiveness. Violations of cGMP have led to product recalls and significant health risks, highlighting the importance of these standards in maintaining consumer safety.

Regulatory Compliance and Legal Repercussions

Regulatory bodies like the FDA and EMA enforce cGMP compliance, and failure to meet these standards can result in fines, product recalls, facility closures, and severe legal consequences.

Building Consumer Trust

Consistent adherence to cGMP fosters consumer confidence and bolsters brand reputation, giving companies a competitive advantage while ensuring public health and safety.

Core Components of cGMP

Personnel and training are fundamental elements of cGMP in pharmaceutical and biotech manufacturing. A well-structured training program and competent staff maintain high production standards and uphold product safety:

Component #1: Personnel and Training

A well-trained and qualified team is paramount when maintaining compliance and upholding manufacturing standards in any cGMP facility.

Qualified Personnel

A qualified team is the foundation of any cGMP-compliant facility. Employees must have the proper education, skills, and hands-on experience to perform tasks accurately and maintain strict manufacturing standards. In this context, qualified personnel must have the right degrees and practical experience specific to the functions they perform.

Continuous cGMP training helps employees stay current with evolving regulations and best practices. Regulatory bodies, such as the FDA and Health Canada, expect companies to always maintain highly trained personnel. Companies must also keep track of their employees’ qualifications and provide regular updates, ensuring the team adapts to changes in processes or regulations.

An example of compliance issues due to inadequately trained personnel occurred at Apotex, a large pharmaceutical manufacturer in Toronto. In 2014, Health Canada issued a warning to Apotex after an inspection revealed numerous cGMP violations. Among the concerns was insufficient staff training, which contributed to poor documentation practices and failure to meet quality control standards. This led to several product recalls and a temporary halt in exporting certain products to the U.S.

The violations highlighted the importance of maintaining a well-trained, qualified workforce to ensure compliance with Health Canada and FDA regulations . Apotex had to invest in corrective measures, including improving employee training programs and enhancing its documentation systems, to restore compliance and avoid further regulatory actions.

Training Programs and Documentation

Training programs should cover various topics, from the fundamentals of cGMP to specific procedures based on the employee's role. They should be designed to guarantee that personnel understand the general requirements and the precise technical standards they must meet in their daily tasks.

Employees need refresher courses and regular training, especially when regulations change or new equipment is introduced. Training records must be well-maintained and detailed to show that employees are qualified to carry out their responsibilities. Regulatory agencies, like the FDA, often scrutinize these records during inspections. Poorly documented or incomplete training records can lead to warnings, penalties, or even production shutdowns.

A real-world example of the consequences of poorly documented training records comes from the FDA's inspection of Ranbaxy Laboratories , a pharmaceutical company. During the inspection, the FDA discovered numerous GMP violations, including incomplete and inaccurate training records. This lack of proper documentation contributed to Ranbaxy receiving a warning letter from the FDA, facing import bans on several products, and eventually settling with the U.S. Department of Justice for $500 million.

This case highlights how inadequate record-keeping, especially with regard to training, can lead to severe regulatory actions including production halts and costly penalties.

Preventing Human Errors

Human error is a leading cause of cGMP violations, which makes employee training all the more critical. Properly trained staff can better recognize potential risks and avoid mistakes that could lead to contamination, incorrect labeling, or other production errors. For example, a lapse in understanding proper sterilization procedures could lead to contaminated products, resulting in costly recalls and legal liabilities.

Case studies show that the results can be disastrous when manufacturers lack adequate training. A well-known case involving insufficient training is Johnson & Johnson's McNeil-PPC subsidiary, which faced major penalties due to non-compliance with Good Manufacturing Practices.

These violations led to multiple product recalls for popular medications like Children's Tylenol, Motrin, and Benadryl. The root cause of these issues was inadequate training and oversight, which compromised product quality. As a result, the company entered into a consent decree with the FDA, requiring daily fines and extended regulatory supervision until corrective actions were completed.

Improved training, particularly in compliance and quality control, could have prevented these costly errors and protected the company's reputation.

Component #2: Facilities and Equipment

Strong facility design, regular equipment maintenance, and careful record-keeping are key to ensuring product quality and compliance in manufacturing:

Facility Design and Maintenance

Effective facility design helps prevent contamination and ensures easy cleaning and maintenance. Key elements include controlled environments, cleanrooms , and layouts that promote sanitary operations.

Prioritizing these features reduces the risk of contamination and ensures compliance with current Good Manufacturing Practices.

Equipment Calibration and Maintenance

Well-maintained and calibrated equipment produces consistent product quality. Regular maintenance ensures machinery operates at its best and meets cGMP standards. Investing in routine inspections helps minimize errors that could impact the final product.

Documentation and Record Keeping

Accurate, detailed records of equipment use, cleaning processes , maintenance activities, and other operational tasks supports traceability and accountability. These records help identify trends, improve communication, streamline decision-making, and maintain operational consistency.

By keeping thorough records, companies can quickly pinpoint and address potential issues, providing a detailed audit trail during inspections while staying compliant with regulatory standards.

Component #3: Production and Process Control

Strong production and process control relies on standardized operating procedures, in-process monitoring, and a structured approach to managing deviations:

Standard Operating Procedures (SOPs)

SOPs provide clear guidelines for employees, ensuring that all processes follow a consistent approach. Teams develop SOPs through collaboration among subject-matter experts, regularly reviewing and updating them to reflect current best practices and regulatory requirements. This process keeps procedures relevant and effective in maintaining high-quality standards.

Below is an example of an SOP for equipment cleaning:

A pharmaceutical company recognizes the need for a standardized cleaning procedure for its manufacturing equipment to prevent contamination and maintain product quality. To address this, the company initiates the following steps:

Forms a cross-functional team: The company assembles a team of subject-matter experts, including quality assurance and engineering personnel, to collaborate on the SOP development.
Drafts the SOP: The team researches current best practices in equipment cleaning, reviews industry guidelines, and gathers input from operators who perform daily cleaning tasks. They create a draft SOP that outlines step-by-step cleaning procedures, required cleaning agents, and safety precautions.
Reviews and revises: The draft SOP undergoes multiple rounds of review. Team members provide feedback and make revisions to ensure clarity and comprehensiveness. They also check compliance with relevant regulatory requirements, such as cGMP standards.
Training sessions: Once finalized, they distribute the SOPs to all relevant employees. The company offers training sessions to explain the new procedures and the importance of following them consistently.
Implementation and monitoring: Employees begin using the SOP for equipment cleaning. Supervisors monitor compliance and gather feedback from staff on how well the procedure works.
Regular Reviews and Updates: The team establishes a schedule for reviewing the SOP annually. They incorporate user feedback, best practice changes, and any updates to regulatory requirements to keep the SOP relevant.

In-Process Controls and Monitoring

Monitoring critical process parameters helps maintain product quality. In-process controls track crucial variables during production, allowing teams to make immediate adjustments when necessary. By closely tracking these parameters, facilities confirm that products meet quality specifications and regulatory standards.

Examples of these controls include:

pH levels
Temperature
Mixing times
Dissolved oxygen levels
Conductivity
Viscosity
Flow rates
Pressure levels
Chemical concentrations
Time intervals
Sampling frequency
Humidity levels

Deviation Management and Corrective Actions

A structured approach manages these issues to prevent product quality problems when deviations from standard procedures occur. Teams identify the root cause of each deviation and implement corrective and preventive actions (CAPA) to address and prevent future occurrences.

Component #4: Quality Control and Assurance

Here, we outline the elements of quality control, quality assurance , and change control to maintain product integrity:

Quality Control (QC)

Quality control focuses on testing and verifying the quality of raw materials, in-process materials, and finished products. It includes potency and sterility testing, ensuring products are free from harmful microorganisms. Stability testing evaluates how product quality changes over time, helping to determine shelf life and storage conditions.

Quality Assurance (QA)

Quality assurance ensures that the entire manufacturing process meets current cGMP standards. QA professionals audit, review, and approve procedures and records while overseeing product releases.

Their duties include approving SOPs and reviewing production and QC records to identify discrepancies before authorizing product distribution.

Change Control

Change control manages process modifications, equipment, and documentation to maintain product quality. A formal change control system evaluates the potential impact of proposed changes on quality and safety. This strategy typically involves gathering input from relevant stakeholders and maintaining detailed records of all changes.

Component #5 Documentation and Record Keeping

Enhanced documentation and record-keeping can help ensure compliance with cGMP standards:

Importance of Accurate Documentation

Accurate and complete documentation can include batch records , standard operating procedures, and deviation reports. These documents provide a transparent account of manufacturing processes and product quality.

Good Documentation Practices (GDP)

Good Documentation Practices (GDP) focus on accuracy, legibility, consistency, confidentiality, and timely completion. Adhering to these principles helps maintain reliable records that are critical for compliance. Poor documentation can lead to regulatory issues and product recalls, highlighting the need for high standards in record-keeping.

Electronic vs. Paper Records

Electronic records can streamline the documentation process and improve accessibility but pose data integrity and security risks. Implementing strong security measures in electronic systems can protect information and meet regulatory requirements.

Paper records offer a tangible format that some organizations find easier to manage. They can be straightforward and don’t require technical systems or software, making them accessible without digital tools. However, paper records are more prone to physical damage, loss, or deterioration over time.

The Role of cGMP in Continuous Improvement

cGMP helps organizations focus on continuous process improvement. Companies can maintain high standards and pinpoint improvement areas by conducting audits and creating feedback loops.

Advancements in technology, like automation and digitalization, boost cGMP compliance. These technologies streamline manufacturing and improve data management, leading to greater efficiency and fewer errors in production. For instance, automated systems can monitor process parameters in real-time, enabling quick adjustments to support product quality.

Encouraging employees to share their ideas and participate in identifying improvements can increase ownership and accountability. Engaged employees share insights that drive innovation and help organizations adapt to changes in processes or technologies.

How to Achieve and Maintain cGMP Compliance

Here’s a brief rundown on how to achieve and maintain cGMP compliance:

Establish a Quality Management System (QMS): A robust QMS is vital for managing cGMP compliance. Key components include risk management, document control, and training.
Provide regular training and education: Up-to-date training helps maintain compliance. Develop effective training programs tailored to employee needs.
Perform internal audits and inspections: Regular audits identify and correct issues before regulatory inspections. Plan audits focusing on critical areas and avoid common pitfalls.
Prepare for regulatory inspections: Prepare thoroughly for the FDA or EMA inspections . Present clear records, manage inspection teams, and respond to findings.
Implement corrective and preventive actions: Address deviations promptly to prevent recurrence. Investigate issues, determine root causes, and implement corrective measures.

Common Challenges in cGMP Compliance and How to Overcome Them

Common challenges in achieving and maintaining cGMP compliance can pose significant obstacles, but strategies exist to overcome them. One major challenge is maintaining data integrity for electronic and paper records. Organizations can enhance accuracy and security by conducting regular audits and training on effective data management practices.

Another challenge involves managing change control. Issues often arise from resistance to change and inadequate documentation of modifications to processes or equipment. Organizations should implement a structured change control system to address these issues and involve relevant stakeholders to ensure buy-in.

Keeping up with regulatory changes presents a third challenge, as evolving regulations can complicate compliance efforts. Companies can achieve this by subscribing to regulatory updates, attending industry conferences, and participating in professional networks to share knowledge and insights.

Your Path to Compliance Starts with CfPIE

By investing in ongoing education with CfPIE, your organization can build a culture of quality and compliance. This commitment improves operational efficiency and product quality. With continuous training, your employees will gain the latest skills and knowledge, helping to create a proactive approach to compliance that reduces the risk of errors and violations.

Working with CfPIE equips your company to meet regulatory requirements and achieve lasting success in the pharmaceutical and biotechnology industries. As a leader in life sciences training, CfPIE can help you understand and implement cGMP standards effectively.

Ready to get started? Learn more about our courses here .

How the Right Training Courses Can Lead to Professional Development in the Life Sciences Industry

Tue, 08 Oct 2024 17:27:01 GMT

The life sciences industry is fast-paced, highly regulated, and requires ongoing professional development for a lasting career. Professionals in biotech, medical devices, and pharmaceuticals are tasked with an ever-evolving landscape of innovation coupled with increasingly strict and severe regulatory requirements.

Thriving in this industry requires specialized training courses, which are now critical in imparting the knowledge and skills necessary to remain fully compliant and competitive as your career progresses.

Specialized life science courses give professionals the latest knowledge and practical skills to meet new regulatory requirements, effectively leverage advanced research methodologies, and fully understand industry best practices. The right courses prepare you to meet FDA (Food and Drug Administration) and EMA (European Medicines Agency) requirements while still driving innovation.

So, what are life science courses ? They’re ultimately a tool that helps professionals stay on top of the latest developments in their industry, a necessity for continually growing their careers.

CfPIE is an industry-leading provider of core and advanced courses that help professionals stay current, prepare for the future, and enter the industry. Let’s discuss what these courses cover and how they benefit your career.

Defining Life Science Courses for Professionals

Life science courses are designed for working professionals and focus on specific skills that reflect the current needs of the industry. While academic degrees play a crucial initial role, life science courses continue to expand your knowledge and skills as the industry progresses.

Typically, continuing education courses focus on practical, targeted learning that imparts specialized skills relevant to their current or future roles. Life science courses also ensure working professionals stay on top of evolving industry regulations and compliance requirements.

For most roles in life sciences, continuing education is indispensable. Courses in compliance, drug development, and biostatistics allow you to understand how best to conduct your current role.

Lastly, life science courses focus heavily on real-world applications and practical knowledge that result in improvements to your current role and overall career growth. Professionals can stay on top of the latest technologies and requirements as the life science industry continues to evolve and meet the demand for professionals with this specialized knowledge.

Core Areas Covered in Professional Life Science Courses

Life sciences encompasses several industries, each with a wide range of specialized roles. However, several core areas are found throughout life science industries that are crucial in many roles.

Some life science courses focus on these core areas of learning that help professionals gain and update necessary skills that apply to many roles in the industry — let’s explore these types of courses.

1. Regulatory Compliance and Quality Assurance

Regulatory compliance is crucial for life sciences professionals as strict regulatory requirements apply to developing and producing pharmaceuticals and biotech products. Understanding regulatory requirements ensures that all medical and pharmaceutical products meet safety and efficacy standards, protecting both patients and the company.

Courses addressing the complexities of these regulatory frameworks are vital, such as:

By enhancing knowledge of the regulatory landscape, professionals can avoid common pitfalls, maintain product quality, and facilitate smooth market entry.

These training programs also delve into quality assurance practices, reinforcing the importance of adhering to GMP standards and conducting robust internal audits. Gaining a strong understanding of these concepts ensures regulatory compliance and upholds the integrity of the manufacturing process, safeguarding both patients and company reputations.

2. Clinical Trials and Project Management

Clinical trials are a fundamental part of drug development, and their success hinges on effective project management. Courses in this category offer in-depth insights into the planning, execution, and regulatory compliance required throughout the clinical trial process, such as:

Professionals who undertake these courses gain valuable skills in managing clinical trials, ensuring adherence to Good Clinical Practices (GCP), and safeguarding data integrity. These programs are designed to equip professionals with the tools to succeed, whether navigating patient recruitment challenges, managing site operations, or handling complex regulatory submissions.

Incorporating project management methodologies into clinical trials allows for better control over timelines, costs, and resources, ensuring that studies progress smoothly from initiation to completion. Professionals trained in these areas will be ready to manage multidisciplinary teams and ensure that trials meet both regulatory and scientific objectives.

3. Analytical and Laboratory Skills

Analytical precision and laboratory effectiveness are foundational aspects of pharmaceutical and biotech research. Courses in this category focus on ensuring accuracy, reproducibility, and compliance with Good Laboratory Practices (GLP) . A few courses that focus on these areas are:

These courses are crucial in roles throughout research, development, and production as they offer a comprehensive understanding of analytical techniques and regulatory expectations. A strong grasp of related analytical methods is vital to producing safe and effective medical devices and pharmaceuticals.

Additionally, you’ll benefit from learning how to implement effective validation protocols, interpret complex data sets, and apply quality assurance practices. By staying current with the latest techniques and regulatory requirements, they can ensure that their work meets the rigorous standards for product approval.

Specialized Courses for Advanced Skills Development

While the above courses can apply to a wide range of specific roles, there’s also a need for specialized courses that focus on new technologies, best practices, and methodologies in key roles throughout the industry.

So, we’ll explore a few of these specialized courses and how they help working professionals stay fully compliant and operate at their best.

1. Biostatistics and Data Analysis

The ability to effectively analyze and interpret data is crucial to ensuring success, whether addressing a deviation in a manufacturing process or evaluating the outcomes of a clinical trial. These courses are tailored to professionals who may not have a strong background in statistics but need to make informed decisions based on complex data, such as:

These types of courses aim to impart the statistical concepts that underpin clinical research, enabling participants to understand the significance of different data sets, identify trends, and draw meaningful conclusions.

Understanding these processes is especially important in drug development, where biostatistics supports efficacy assessments, safety monitoring, and regulatory submissions. Lacking proficiency in any of these tasks can have severe consequences for the organization and your career.

For professionals tasked with data analysis, these courses provide advanced practical skills that can be immediately applied to their work. The knowledge gained also has lasting benefits for nearly any direction your career might take.

2. Aseptic Processing and Cleanroom Management

Aseptic processing and cleanroom management are vital for ensuring the sterility and quality of pharmaceutical products, especially in the production of biologics and sterile injectables.

These types of courses offer specialized training for professionals responsible for maintaining cleanroom environments and implementing aseptic techniques, such as:

Trainees in these courses learn about the principles of contamination control, facility design, and the proper handling of materials to maintain sterile conditions — which is critical across the life sciences industry.

Having a strong understanding of aseptic processing ensures that products meet strict safety standards and prevent costly recalls or compliance violations. Cleanroom management courses teach professionals how to oversee critical environments, ensuring they remain within regulatory specifications.

Understanding the dynamics of cleanroom operations is essential for anyone involved in the production of sterile pharmaceutical products, as it directly impacts product quality and patient safety.

3. Emerging Technologies and Innovations

As technology continues to advance, the life sciences industry is being transformed by new tools and methodologies. Staying ahead of these innovations is essential for professionals who want to remain competitive.

Courses focusing on leading technologies include:

Emerging technologies like LC-MS/MS (liquid chromatography-mass spectrometry) play a key role in pharmaceutical research, enabling precise and accurate analysis of complex molecules. Similarly, lyophilization (freeze-drying) technology is critical in the stabilization of biological products.

Attending courses focused on these technologies provides hands-on experience with state-of-the-art equipment and methodologies, preparing professionals to implement them in their work. By staying updated on such innovations, professionals can contribute to more efficient manufacturing processes, reduce costs, and improve product stability.

Key Benefits of Continuing Education in Life Sciences

We’ve discussed some of the benefits of life science courses already, but let’s dive deeper into how far these courses can go in enhancing your current role and paving the way for long-term success.

Be aware that your specific benefits will vary based on your goals, current role, and chosen course. However, we can explore some general benefits you can expect to gain after course completion.

Ensure Long-Term Career Growth

Life sciences courses teach core and advanced topics that not only keep you up to date with the industry but also enable you to pursue your career goals. For example, you might start your career in an entry-level position and take specialized courses to move into other roles.

You’re then able to pursue your interests and available opportunities to shape your career and reach your dream role. Earning an advanced certification can pave the way to your next promotion while also strengthening your job security within a company.

Career growth can be challenging in other industries that have less of an emphasis on continuing education and certifications. Fortunately, life sciences value ongoing learning, and it’s well worth making the most of these opportunities.

Strengthen Job Satisfaction

You’re likely aware that job satisfaction is critical for everyone, but how do life science courses strengthen it? There are a few ways these courses can enhance job satisfaction, such as:

Confidence: These courses give you confidence in your current role, eliminating the stress and low performance that often go along with uncertainty. Having confidence can have a range of benefits for your career, like improving your job performance, making this confidence boost a significant benefit of life science courses.
Growth: Low job satisfaction often follows feeling like your current position has no future. Continuing education courses let you keep growing your career and prepare you for moving into a new role or promotion.
Job Security: The practical knowledge and certifications earned from life sciences courses are highly valuable to employers. You’ll be viewed as an asset due to the specialized training you bring to the team, along with signaling that you’re willing to keep learning and are a valuable asset to the company.

Network Within the Industry

Connections can go far in improving your career, whether that includes moving to a new position or sharing knowledge with peers. Life sciences courses can connect you with others in your industry, even through virtual learning, creating the opportunity to meet and connect with other professionals.

Take the time to talk to others in the class, participate in group discussions, and build bonds that can last well beyond the completion of the course. Networking doesn’t have to only happen at conferences.

Respected and Valuable Certifications

Life science courses focus on the skills you need to advance in your current or future role, while also earning you certifications. All courses will give you a certificate of completion that goes far in strengthening your resume and supporting company training requirements, while passing the optional course exam will enable the course to count toward certain certifications.

A few sought after certifications are:

We offer several more certifications you may wish to pursue based on your specific goals.

Current and future employers value certifications as a way to demonstrate your knowledge and expertise. Beyond that, they also demonstrate your commitment to staying on top of industry changes, a valuable trait in any role.

However, choose your learning institution carefully to ensure your certifications are respected within the industry. A completed course or certification from a reputable institution like CfPIE will go further than one from a lesser-known institution.

Choosing the Right Life Science Courses for Your Career

It’s crucial to take the time to carefully consider your future career goals, current skill gaps, and overall industry focus when choosing the right course. Evaluate what you need in the immediate or near future, then consider your ideal long-term goals.

For example, suppose you currently work in a regulatory role. In that case, courses focusing on FDA and EMA compliance will immediately enhance your daily responsibilities and pave the way for future career growth.

Additionally, evaluate several aspects of the course itself, such as:

Course content: Will the course cover the specific topics you’re after?
Instructor expertise : Does the person leading the course have real-world experience in the given topic?
Certifications earned: Will you be earning any certifications that showcase what you’ve learned?

While it may take some time to find the right educational institution and course, it’s worth taking the time to find the best option for your needs that’s also recognized by employers.

Life Science Courses Unlock Lasting Career Growth and Compliant Job Performance

The life science industry is constantly changing and requires working professionals to meet current requirements, which have likely changed since earning a degree. Continuing education with life science courses helps working professionals gain the knowledge, expertise, and skills necessary to have a lasting career in this fast-paced industry.

Specialized courses are designed to impart the latest skills in regulatory compliance, quality assurance, clinical trials, lab techniques, and emerging technologies. However, the right course not only focuses on the present but also lays the groundwork for how the industry may change in the future.

Investing in life science training courses is critical for individuals and organizations alike. Whether professionals need to sharpen analytical skills, master regulatory compliance, or stay at the forefront of emerging technologies, life science courses pave the way for long-term success.

CfPIE is an industry leader in life sciences training helping professionals advance their careers by equipping them with the knowledge and skills necessary to keep up with the fast-paced industry.

Continuous education is critical for staying competitive, making a meaningful impact, and maintaining professional growth. Are you ready for courses designed to help you build a lasting career? Consider the following courses to take the next step in your career:

The Role of Protein Structure Analysis in the Success of Biopharmaceuticals

Tue, 03 Sep 2024 13:19:20 GMT

Protein structure analysis is a fundamental aspect of biopharmaceutical development and plays a crucial role in understanding how proteins function, interact with other molecules, and contribute to disease mechanisms.

Success in the biopharmaceutical industry hinges on a deep understanding of proteins’ structural properties, as these studies inform how therapeutic proteins such as antibodies, vaccines, and enzymes are developed.

So, we’ll be exploring the significance of protein structure analysis in the biopharmaceutical industry, highlighting how it drives innovation and ensures the development of safe and effective therapies — all contributing to why having the right training is critical.

Understanding Protein Structure

Proteins are complex molecules whose three-dimensional structures determine their functionality, stability, efficacy, and safety. As such, protein structure refers to the specific arrangement of amino acids in a protein molecule, ultimately determining the protein's function. A protein’s structure can be described at four hierarchical levels:

The primary structure of a protein is the linear sequence of amino acids linked together by peptide bonds. This sequence is unique to each protein and dictates how it folds into its three-dimensional structure.
Secondary structure refers to local folded structures within a polypeptide due to interactions between the backbone atoms. Common examples include alpha helices and beta sheets, where hydrogen bonds stabilize.
Tertiary structure is the overall three-dimensional shape of a single protein molecule. It results from interactions between amino acids. This level of structure is crucial for the protein’s biological activity.
Quaternary structure describes the arrangement and interaction of multiple polypeptide chains, known as subunits, which assemble into a larger functional complex. These subunits are essential for the protein’s function in many cases.

The overall structure of proteins is critical for their function in biological processes. The specific shape of a protein determines how it interacts with other molecules, such as substrates, inhibitors, or other proteins.

Understanding protein structure is essential for studying the molecular mechanisms of diseases and developing targeted therapies. Misfolded or improperly structured proteins can lead to loss of function or gain of toxic functions and are often associated with diseases such as Alzheimer's, Parkinson's, and cystic fibrosis.

Relevance of Protein Structure and Analysis to Biopharmaceuticals

In biopharmaceutical development, having a deep knowledge of protein structure is of the utmost importance. Therapeutic proteins, including monoclonal antibodies, enzymes, and hormones, use precise structural configurations to perform their intended biological functions.

Any structural alterations in proteins can significantly impact treatment efficacy and safety, whether alterations occur through mutations, modifications, or environmental factors. Protein structure analysis allows scientists to design and engineer proteins with optimal characteristics, ensuring they function correctly in therapeutic applications.

This knowledge is also crucial for predicting how these proteins will behave in the body, guiding the development of safe and effective biopharmaceuticals.

How Protein Structure Relates to Drug Design

Protein structure is at the heart of research and development for many pharmaceuticals. Protein structure informs the initial stages of development, how researchers monitor results and eventual approval. Let’s further explore how protein structure and analysis inform the initial design of new medications:

Rational drug design: Rational drug design is a method of developing new drugs based on the knowledge of the structure and function of target proteins. Scientists can design molecules that specifically bind to the protein and alter its activity by understanding the three-dimensional structure of a disease-related protein. This approach particularly aims to create highly specific and potent therapeutic agents.
Stability factors: Protein stability is a critical factor in the success of biopharmaceuticals. The structure of a protein affects its stability, influencing its folding, aggregation, and degradation. Proteins must fold into their correct three-dimensional structures to be functional, but this process is delicate and can be disrupted by various factors, including temperature, pH, and the presence of other molecules. Misfolding or aggregation can lead to a loss of efficacy or increased immunogenicity, posing significant challenges in developing and storing biopharmaceuticals.
Formulation development: The stability of biopharmaceuticals is a concern not just during production but also during storage and administration. Protein structure analysis is vital in ensuring the therapeutic proteins remain active and effective throughout their shelf life. This process involves selecting appropriate excipients, adjusting pH, and developing delivery systems that protect the protein from degradation.

The Relationship Between Protein Structure and Drug Efficacy

The overall effectiveness of a medication is largely informed by protein structure. There are several different ways protein structure impacts efficacy — let’s explore them.

Mechanism of Action

The mechanism of action of biopharmaceuticals is often directly related to their structure. Protein structure analysis allows researchers to understand these interactions at the molecular level, providing insights into how the drug exerts its therapeutic effects.

Understanding this relationship is essential for optimizing the pharmaceutical's efficacy. By analyzing the therapeutic protein's structure and target, researchers can identify potential changes that enhance binding affinity, reduce off-target effects, or improve the protein’s pharmacokinetics. This iterative structural optimization process can lead to the development of more potent and effective biopharmaceuticals.

Optimization

Optimizing the efficacy of biopharmaceuticals often involves making structural modifications to the protein. Protein structure analysis provides the necessary information to guide these modifications, which can be made through various techniques.

Structural optimizations ensure that biopharmaceuticals perform effectively in the body, delivering the sought-after therapeutic outcomes with minimal side effects. Researchers can design more effective, economical, and easier to produce and administer drugs by leveraging the insights gained from protein structure analysis.

How Protein Structure Informs Drug Safety

Much like efficacy, protein structure plays a significant role in drug safety. Let’s explore how this relationship plays out and the role of protein analysis in ensuring patient safety.

Immunogenicity

Immunogenicity is the ability of a substance to provoke an immune response and is a significant concern in the development of biopharmaceuticals. Protein structure plays a key role in immunogenicity, as the immune system recognizes certain structural features as foreign.

If the immune response is provoked, it leads to the production of anti-drug antibodies. These antibodies can neutralize the therapeutic protein, which may:

Reduce its efficacy
Cause adverse immune reactions
Compromise patient safety in other ways

Toxicity

Toxicity is another critical aspect of treatment safety, and protein structure analysis plays a vital role in identifying and mitigating potential toxicities. Structural features of proteins exposed to certain compounds can lead to toxic effects by promoting aggregation, misfolding, or off-target interactions.

Protein structure analysis allows researchers to predict these issues and design proteins that are less likely to cause toxicity. Analysis of protein structure helps identify these potential interactions and guide the design of more specific and safer enzymes.

Additionally, understanding the structural basis of protein degradation products can help identify potentially toxic metabolites, allowing their exclusion from the final product.

Understanding Protein Structure and Analysis is Critical in Biopharmaceuticals

Protein structure analysis is indispensable in the development of biopharmaceuticals. It influences every aspect of their design, stability, efficacy, and safety. By providing detailed insights into the molecular architecture of therapeutic proteins, this practice:

Enables the rational design of drugs
Ensures the development of stable and effective formulations
Helps mitigate risks associated with immunogenicity and toxicity

As the biopharmaceutical industry continues to grow, protein structure analysis will only become more critical, driving innovation and ensuring the success of new therapies.

Understanding and applying the principles of protein structure analysis is essential for anyone involved in developing biopharmaceuticals, from researchers to clinicians. Training in protein analysis is critical in these roles.

CfPIE is an industry-leading provider of life sciences training. Our courses allow employers to provide effective ongoing training to personnel or help individuals advance their careers.

Are you prepared for the future of protein analysis and biopharmaceuticals? Enroll in our analytical method validation course today and take the next step in creating safe and effective treatments.

The Role of Drug Metabolism in Pharmacokinetics: What You Need to Know

Tue, 03 Sep 2024 13:18:11 GMT

Drug metabolism is a cornerstone of pharmacokinetics, the science exploring how drugs move through the body. Understanding drug metabolism is critical not only for developing new medications but also for optimizing patient treatment plans.

A drug's journey through the body is complex, involving absorption into the bloodstream, distribution to tissues, metabolism to prepare it for elimination, and excretion. Each step is important in determining the drug's efficacy and safety.

Among these, drug metabolism is especially vital because it directly influences how a drug is transformed into active or inactive forms, how long it stays in the body, and how it might interact with other substances.

So, we’ll explore the intricacies of drug metabolism within the broader context of pharmacokinetics to highlight why it is essential for both drug development and clinical practice — and why training in this field is so critical.

Basics of Pharmacokinetics

Pharmacokinetics (PK) is the branch of pharmacology that studies the movement of drugs within the body. PK encompasses four primary processes, often referred to as ADME, which stand for:

Absorption is how a drug enters the bloodstream, possibly through the digestive tract, skin, or other tissues.
Distribution involves the dispersion of the drug throughout the body's fluids and tissues. This step determines where and how quickly the drug reaches its target areas.
Metabolism is the chemical alteration of the drug, primarily in the liver, which transforms it into metabolites.
Excretion is the process of the drug and its metabolites being eliminated from the body, primarily through urine, bile, sweat, or breath.

The study of pharmacokinetics is integral to drug development and patient treatment because it helps determine the appropriate dosage, frequency, and duration of treatment.

Pharmacokinetics guides personalized treatment plans for patients, ensuring that medications are administered to maximize therapeutic benefits while minimizing risks.

Understanding Drug Metabolism

Drug metabolism is the chemical processes that modify a drug within the body, making it easier to eliminate.

The liver is the primary site of drug metabolism, but other organs, such as the intestines, kidneys, and lungs, are also often involved. Metabolism typically occurs in two main phases:

Phase I (Functionalization Reactions): In this phase, the drug undergoes chemical modifications such as oxidation, reduction, or hydrolysis. These reactions often introduce or expose functional groups (-OH, -NH2, -SH), increasing the drug’s reactivity.
Phase II (Conjugation Reactions): Phase II reactions involve conjugating the drug or its metabolites with a molecule such as glucuronic acid, sulfate, or glutathione. These conjugation reactions increase the solubility of the drug, making it easier to excrete.

Enzymes Involved

Enzymes are foundational in drug metabolism, with the CYP450 family being the most significant. These enzymes, predominantly found in the liver, metabolize a wide range of drugs.

The CYP450 family comprises several isoforms with specific substrates, inhibitors, and inducers. For instance, CYP3A4 is one of the most important isoforms, metabolizing approximately 50% of all drugs.

The activity of this family of enzymes can vary greatly among individuals due to genetic differences, environmental factors, and interactions with other drugs. As a result, understanding their function is vital for predicting drug behavior in the body.

Metabolic Pathways

Common metabolic pathways include oxidation, reduction, hydrolysis, and conjugation. Each pathway plays a specific role in the metabolism of drugs:

Oxidation (often via CYP450 enzymes) involves adding an oxygen atom or removing hydrogen, typically increasing the drug’s polarity.
Reduction reactions involve gaining atoms, usually under anaerobic conditions.
Hydrolysis breaks chemical bonds by adding water, often converting some molecules into more soluble forms.
Conjugation in Phase II metabolism typically attaches a polar group to the drug, greatly enhancing its solubility and excretion.

These metabolic pathways are crucial in determining the fate of a drug in the body, influencing its efficacy and potential toxicity.

Factors Influencing Drug Metabolism

Drug metabolism is affected by a wide variety of factors that must be understood during the development of pharmaceuticals, including:

Genetic variability: Genetic differences can significantly impact drug metabolism. Variations in genes affect drug-metabolizing enzymes, particularly CYP450 enzymes, which can lead to differences in how individual patients process medications. This variability can affect drug efficacy and safety. In some scenarios, this may mean personalized treatment plans based on genetic testing.
Age and gender: Typically, metabolic rates decrease due to reduced liver enzyme activity and other physiological changes. Gender differences can also be involved. For instance, women may metabolize certain drugs differently than men due to hormonal differences, body composition, and enzyme activity levels.
Environmental and lifestyle factors: Diet, smoking, and alcohol consumption can also influence drug metabolism. Certain foods can even inhibit CYP450 enzymes and impact the efficacy of medications. Another concern is smoking, which induces specific CYP450 enzymes, potentially reducing efficacy.
Drug Interactions: Drug interactions are a significant concern in pharmacokinetics, as they can alter one or both drugs' metabolism. Additionally, some drugs may induce metabolic enzymes and reduce the effectiveness of the co-administered meds. These interactions underscore the need for careful medication management, particularly in patients taking multiple drugs.

Impact of Drug Metabolism on Drug Efficacy and Safety

We’ve explored some ways metabolism can affect efficacy and safety. So, let’s dive deeper into how these areas must be addressed throughout development.

Efficacy

Drug metabolism profoundly impacts a drug’s efficacy by influencing its concentration and activity within the body. If a drug is metabolized too quickly, it may not reach therapeutic levels, reducing effectiveness. Conversely, if metabolism is too slow, the drug may accumulate and potentially lead to toxicity.

Understanding these dynamics allows for more precise dosing regimens, ensuring that drugs are administered at levels that maximize their therapeutic benefits while minimizing risks.

Toxicity and Adverse Reactions

Improper metabolism can lead to drug toxicity and adverse reactions, posing significant risks to patient safety. Additionally, variations in metabolic enzyme activity can lead to adverse reactions in some patients. Monitoring and adjusting drug dosages based on metabolic activity are crucial in preventing negative outcomes and ensuring patient safety.

Methods of Studying Drug Metabolism

How do researchers understand drug metabolism to ensure safe and effective treatment? A few of these methods include the following:

In vitro studies: In vitro studies involve examining drug metabolism using isolated cells, tissues, or enzymes in a controlled laboratory environment. These studies provide valuable insights into the specific metabolic pathways a drug may undergo and help predict potential drug interactions. In vitro methods are often the first step in drug metabolism studies.
In vivo studies: In vivo studies involve studying drug metabolism within a living organism, typically using animals or human participants. They provide a more comprehensive understanding of how a drug is metabolized in the body, accounting for absorption, distribution, and excretion factors.
Analytical techniques: Advanced analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, are used to study drug metabolism in detail. These techniques allow researchers to identify and assess the impact of genetic, environmental, and lifestyle factors on drug metabolism.

Understanding Drug Metabolism is Critical in Pharmacokinetics

Drug metabolism plays a pivotal role in pharmacokinetics, influencing both the efficacy and safety of medications. By understanding the processes involved in drug metabolism and the factors that affect it, healthcare professionals can optimize treatment plans, minimize adverse reactions, and enhance therapeutic outcomes.

As the field advances, personalized medicine approaches will become increasingly important, allowing for more precise and effective treatments tailored to individual patients. Researchers must stay aware of this field's latest advancements and best practices.

CfPIE offers an industry-leading training program to help professionals stay on top of drug metabolism and pharmacokinetics. Are you ready to advance your career or employees’ understanding? Enroll in our course today to get started.

The Importance of Effective Document Management in Modern Healthcare

Thu, 01 Aug 2024 19:03:05 GMT

Healthcare document management has played a crucial role in pharmaceutical and medical device manufacturing operation and compliance for decades. Everything related to patients, operations, and legal agreements must be managed effectively.

However, modern healthcare faces strict document management compliance requirements, and the latest technologies can further complicate managing these documents.

Effective document management requires efficient organization, storage, and retrieval of a wide range of data and documents. Traditional document management, which was primarily paper-based, introduces several challenges that increase risk, cost, and inefficiency.

Fortunately, adopting modern healthcare document management solutions and best practices can go far in keeping you compliant. We’ll be breaking down why updating to the latest guidance is so critical and how you can get started.

Understanding Healthcare Document Management

Healthcare document management encompasses a wide range of processes and technologies involved in the healthcare field. Document management processes include patient records, insurance claims, and legal documents, among others.

Effective document management makes sure that documents are accurately recorded, securely stored, and easily accessible when needed. Additionally, several aspects of regulatory compliance require abiding by best practices for healthcare document management.

Documents Involved in Healthcare Management

There are several documents that require effective document management, with the primary categories being:

Patient records: This category includes medical histories, current treatment plans, and diagnostic reports.
Billing information: Invoices, payment records, and insurance claims need to be managed effectively.
Legal documents: Legal documents must also be managed effectively, including consent forms, compliance records, and contractual agreements.

Each document must be adequately managed; otherwise, compliance status and patient data protection may be at risk.

Traditional vs. Modern Approaches

Traditional paper-based document management systems are a long-time standard in healthcare. These processes involve storing paper documents in cabinets, which requires significant space and resources to maintain. Paper-based storage introduces a significant time-consuming process to find specific documents and often has high storage costs.

On top of high cost and inefficiencies, paper documents are susceptible to risks ranging from natural disasters to fires to burglary.

Conversely, modern platforms and best practices offer a significant efficiency boost, reduced costs, and improved security. Personnel can quickly access documents, teams can communicate faster, and advanced data analysis capabilities can be explored.

Healthcare companies can also be equipped to file comprehensive compliance reports and be better prepared for audits.

Business Benefits of Effective Document Management

We’ve touched on some of the benefits of embracing the latest practices for effective document management, but let’s dive deeper to demonstrate why training and modern platforms are so beneficial.

Higher Quality Patient Care

Accurate and accessible medical records play a pivotal role in providing high-quality patient care. Healthcare professionals with timely access to complete patient history are ready to make informed decisions, reduce errors, and maintain continuity of care — all of which contribute to better patient outcomes.

For example, if a patient needs to visit an emergency room, providing healthcare professionals with immediate access to the patient’s current medications, allergies, past treatments, and overall medical history allows for more effective and much safer care.

Increased Efficiency

Modern document management reduces the time spent searching for, filing, and handling documents. These streamlined workflows and the possibility of automated processes help eliminate redundancy and reduce administrative burdens, allowing healthcare professionals to focus on patients.

The addition of simple search technology presents immediate efficiency savings over physical systems. For example, processes that require finding or storing patient records can take just a few seconds rather than several minutes or more.

Enhanced Security and Compliance

Data security is critical in modern healthcare as the industry faces a growing number of attacks and regulatory requirements. Protecting against unauthorized access and breaches protects patient data, an essential aspect of a modern healthcare organization.

Modern document management systems and best practices focus on robust security measures such as encryption, access controls, data safeguards, and audit trails. Each of these aspects helps maintain compliance with regulations of the Health Insurance Portability and Accountability Act (HIPAA), which also helps avoid the risk of non-compliance penalties.

Key Components of an Effective Document Management System

What exactly makes up a modern document management system? Let’s define the core components involved in an efficient and secure system.

Digitalization and Electronic Health Records (EHR)

Digital records are at the core of modern healthcare document management. Electronic Health Records (EHR) provide a comprehensive, integrated approach to managing patient information. An EHR system helps boost accuracy, communication between healthcare providers, and enhanced patient engagement.

EHR systems allow healthcare providers to document all interactions digitally, which significantly reduces documentation inaccuracies. On top of accuracy, the legibility of records also helps improve communication between healthcare providers and other facilities.

Document Capture and Storage

Capturing and storing healthcare documents digitally might involve scanning older documents while updating systems to capture new data electronically. Additionally, secure storage solutions are easily retrievable and allow scalability, reliability, and document protection from loss.

Digital storage also allows for backups and other disaster recovery options, ensuring that healthcare documents are protected from data loss that can be rapidly restored in an emergency.

Access and Retrieval

Efficient document management systems ensure only authorized personnel can access and retrieve sensitive documents, which can be configured according to company policies. Tools like metadata tagging, indexing, and advanced search capabilities facilitate rapid access and retrieval, which improves the continuity of patient care.

For instance, healthcare providers can quickly retrieve a patient’s lab results or imaging reports thanks to advanced search tools, which inform diagnosis and treatment. Access controls also make sure that only providers who need access to this data are able to access it while creating audit trails along the way.

Challenges and Solutions in Healthcare Document Management

While healthcare document management can be highly valuable, migrating to and maintaining modern solutions can introduce new challenges to be aware of. Fortunately, each of these challenges has a solution which we’ll explore so you can be prepared to tackle them head-on.

Data Privacy and Security Risks

Managing healthcare documents digitally also invites the risk of unauthorized access, cyber-attacks, or data breaches. These risks are a central reason why the healthcare industry has been slow to digitize as compared to other industries.

The solution to these risks is choosing a solution that includes the latest security technologies, but your team also needs to know how to use them effectively. Encryption, multi-factor authentication, and recurring security audits can help mitigate these risks.

Beyond IT, make sure employees understand how they help keep the company secure in their current roles. Many types of attacks begin with employees, so ongoing security training is crucial for everyone.

Integration with Existing Systems

Integrating new document management systems with existing internal systems is essential, but can be highly challenging. Without integration, you run the risk of creating siloed data, reducing the benefits we explored above.

Taking on this challenge begins by choosing your future solution. You can use application programming interfaces (APIs) with custom configurations to ensure compatibility with existing platforms. Interoperability powered by APIs helps facilitate smoother integrations and overall system efficiency.

A document management system should work with current systems to allow healthcare providers to order tests, review results, document diagnoses, and ensure accuracy at every step. Ideally, providers will work through a single dashboard to manage all the moving pieces involved in patient care.

Staff Training and Adoption

Your team may be resistant to change, which is generally expected when digitizing or making other sweeping changes. Personnel are already used to how they currently work, so they can be resistant to updating to modern document management systems and processes.

You can address possible resistance to change and ensure adoption by including team members early in the process. Let them know you’ll be updating document management tools and practices while soliciting feedback from them on which platforms you’re considering.

Once you’ve deployed the new document management platform, it is imperative to provide comprehensive training and ongoing support in usage for how it changes other procedures. Additionally, make it easy for employees to offer feedback about missing features, utilities they struggle with, and overall opinions about the platform.

Learn Modern Healthcare Document Management Best Practices with CfPIE

Effective healthcare document management is critical for high-quality patient care, enhancing operational efficiency, and ensuring ongoing compliance with regulatory requirements. However, legacy approaches can leave healthcare organizations struggling to meet these goals.

Upgrading from paper management to modern solutions unlocks faster access to information, reduced administrative burdens, and robust data protection. Investing in the latest technologies and training is the only way to reap these benefits.

Earning a certification as a Document Management Certified Professional (DMCP) shows your understanding of the latest best practices and platforms. This certification and related training equips professionals with the practical knowledge and skills required to implement and maintain effective, modernized document management systems.

CfPIE is an industry leader in life sciences certifications and training. Our programs focus on the latest best practices and regulation compliance, enabling trainees to put what they’ve learned to work on improving their company’s operations.

Ready to advance your career with a DMCP certification course? Learn more about CfPIE's training and enroll to start preparing for the future.

Understanding Key Certifications in the Pharmaceutical and Medical Fields

Thu, 01 Aug 2024 18:59:25 GMT

Certifications in the pharmaceutical and medical fields are crucial in maintaining high quality, efficacy, and safety standards in healthcare products and services. Otherwise, there may be too much variance to provide consistent patient healthcare.

Specialized certifications validate the expertise and knowledge of professionals, ensuring they adhere to industry regulations and best practices. Additionally, the training programs that prepare trainees for certification impart the necessary knowledge and skills for future careers.

There are several certifications, and understanding the differences between them will help you upskill employees or guide your own career growth.

So, let’s break down the differences and focus on key certifications in the pharmaceutical and medical device fields to help you make an informed decision.

Current Good Manufacturing Practices (cGMP) Certified Professional (GMPCP)

Current Good Manufacturing Practice (GMP) certification indicates that professionals thoroughly understand and are up to date with the regulatory requirements to manufacture pharmaceutical or medical device products.

cGMP standards are designed to minimize the risks involved in pharmaceutical production, especially those that might not be found in the testing of the final products. cGMP covers several aspects of production, from input materials, facilities, equipment, and personnel training. It is also essential for maintaining compliance with the latest regulatory standards, ensuring manufacturers meet current regulations, prepare for future changes, and prioritize a proactive approach to compliance.

cGMP certification demonstrates that the personnel have a strong knowledge of the framework to produce safe and effective products. Certified employees will be ready to reduce contamination risks, mix-ups, and errors to maintain supply chain integrity and public health.

Several careers benefit from cGMP certification, including:

Quality Assurance Managers: A quality assurance manager supervises key processes and ensures they relate to GMP standards. A GMP certification allows them to implement quality control systems, conduct audits, and coordinate with other departments.
Quality Control Analysts: A quality control analyst guarantees all products meet quality standards throughout every production stage, from input materials to the end product. These analysts will conduct tests, analyze samples, and verify manufacturing processes to produce consistent and high-quality products.
Production Supervisors: These managers oversee production schedules, workflows, and personnel to maintain safety and efficiency. Earning a GMP certification helps maintain adherence to GMP regulations throughout the production process.
Regulatory Affairs Specialists: A regulatory affairs specialist ensures that all operations comply with national and international regulations, including GMP standards. These experts prepare and submit documentation for regulatory approval, stay on top of regulatory changes, and often work directly with regulatory agencies.
Compliance Officers: Compliance officers monitor and enforce adherence to cGMP regulations and other regulatory requirements that may apply. A compliance officer often conducts regular audits, reviews procedures, and ensures that all activities throughout the operation comply with regulatory standards.
Manufacturing Technicians: A manufacturing technician operates equipment used in pharmaceutical or medical device manufacturing and needs to comply with cGMP standards throughout daily operations. These experts must follow precise standards when using, maintaining, or troubleshooting issues, making cGMP compliance crucial.

Certified Medical Writing Professional (CMWP)

The Certified Medical Writing Professional (CMWP) is applicable to professionals involved in creating scientific or regulatory documents. A certified professional validates their ability to produce accurate, clear, and concise medical or scientific documentation.

CMWP certification and related training ensures that all medical writers have the expertise to produce high-quality documents that comply with regulatory standards. Having this certification demonstrates credibility and a commitment to professional development.

Careers that may benefit from CMWP certification include:

Medical Writers: A medical writer may create a wide range of medical documents, including clinical trial reports, scientific publications, or regulatory submissions. A medical writer must know how to comply with regulatory standards throughout document creation, ensuring all information is accurate and ready for regulatory review.
Clinical Research Associates: A clinical research associate prepares and reviews study-related documents and must ensure compliance with clinical standards and regulatory requirements.
Regulatory Writers: A regulatory writer is a specialized medical writer who focuses on developing documentation for regulatory submissions. These writers need to know how to develop documentation to comply with all applicable regulations. As a result, regulatory writers must meet requirements while also being comprehensive and accurate.

Certified Process Validation Professional (CPVP)

The Certified Process Validation Professional (CPVP) certification focuses on the validation of manufacturing processes within the pharmaceutical industry. This certification and related training ensures professionals have the skills to design, analyze, and validate pharmaceutical processes to meet regulatory requirements.

CPVP is critical for ensuring that manufacturing processes consistently produce products that meet specified quality criteria. This certification helps to identify risks, enhance product quality, and ensure overall regulatory compliance.

There are several careers that can benefit from CPVP certification, such as:

Process Validation Engineers: Process validation engineers develop and validate manufacturing processes with a focus on ensuring consistent product quality.
Quality Assurance Specialists: Quality assurance specialists oversee the validation process and ensure compliance with applicable regulatory standards. As a result, they’re able to make sure manufacturing processes maintain the integrity and reliability of the entire operation.
Validation Scientists: These specialists conduct studies with a focus on validating manufacturing processes and equipment. Their work ensures that all manufacturing activities are scientifically sound and comply with regulatory standards.

Chemistry, Manufacturing & Controls (CMC) Certified Professional (CMCCP)

The Chemistry, Manufacturing & Controls (CMCCP) certification is designed for professionals involved in the development and oversight of the CMC component of pharmaceutical manufacturing. This certification prepares personnel to ensure all products are produced and controlled according to regulated quality standards.

CMC certification ensures that professionals have the knowledge and skills to manage the complex processes involved in developing and manufacturing pharmaceuticals. Additionally, this certification is critical for maintaining product quality, safety, and compliance with applicable regulations.

Several careers can benefit from the training and certification in CMC, such as:

CMC Managers: CMC managers oversee the entire operation related to the CMC process, focusing on compliance with regulatory requirements throughout the operation. This essential role is crucial for the successful development of pharmaceutical products.
Regulatory Affairs Professionals: CMC documentation must meet regulatory requirements, which is the focus of a regulatory affairs professional. These specialists prepare, review, and submit regulatory documents, making it critical for regulatory affairs professionals to thoroughly understand CMC guidelines.
Product Development Scientists: This specialty focuses on developing and optimizing manufacturing for new pharmaceutical products. A product development scientist researches, designs, and scales processes from the lab to full-scale production.

Certified Medical Device Compliance Professional (CMDCP)

The Certified Medical Device Compliance Professional (CMDCP) certification is designed for professionals developing medical devices that must comply with regulatory standards. The certification demonstrates knowledge and expertise in navigating the complex regulatory landscape of certified medical device manufacturing.

CMDCP certification ensures that employees fully understand which regulatory requirements apply to their medical devices and how to comply, a vital aspect of product safety and effectiveness. Earning this certification ensures professionals can stay current with regulatory changes and best practices in the medical device industry.

Careers that would benefit from getting a medical device compliance certificate include the following:

Medical Device Compliance Officers: Compliance officers make sure medical devices comply with relevant regulations. These officers will conduct audits, review documentation, and implement compliance programs.
Regulatory Affairs Specialists: Regulatory affairs specialists for medical devices prepare and submit documentation required for regulatory approval.
Quality Assurance Managers: A quality assurance manager in medical device manufacturing manages key processes and must ensure they abide by regulatory requirements and other quality standards.

Become Certified to Advance Your Life Science Career Today

Certifications in the pharmaceutical industry and medical fields are critical for product quality, safety, and regulatory compliance. Each of these certifications validates the expertise of professionals in several fields throughout pharmaceutical and medical device manufacturing.

The right certification helps professionals advance their careers, creating new opportunities for professional growth and development. Anyone involved in medical writing, regulatory compliance, quality assurance, and manufacturing will benefit from earning certifications that demonstrate their expertise.

Staying competitive in this industry requires ongoing education, whether changing fields, staying up on the latest developments, or looking to move into management. Earning the right certification helps you remain competitive and demonstrates your commitment to ensuring safe, effective, and high-quality pharmaceutical and medical devices.

CfPIE is a leading provider of life sciences training, and we can prepare you to begin or advance your career in the industry. Our courses are led by instructors with real-world experience and focus on imparting the practical knowledge and skills to excel in your chosen field.

Are you ready to earn the right certification to advance your career? Explore CfPIE’s courses today to take your next steps.

Meet Dr. Perry G. Wang: Insights from an FDA Chemist and Acclaimed Instructor

Wed, 03 Jul 2024 13:33:46 GMT

Dr. Perry G. Wang is one of our esteemed instructors with extensive real-world experience in life sciences. Since 2008, he has worked as a chemist for the U.S. Food and Drug Administration (FDA) where he developed an in-depth understanding of how the agency regulates pharmaceuticals.

Now, Dr. Wang teaches courses at CfPIE, specializing in Liquid Chromatography with tandem mass spectrometry (LC-MS/MS) method development for drugs, cosmetics, food, and dietary supplements. It should be noted that Dr. Wang teaches these courses in his own capacity as a scientist, not as a representative of the FDA.

His decades of experience in pharmaceuticals from both the manufacturing and regulatory perspectives have given him deep knowledge and insights into the life sciences industry. Read on to learn more about his background and the courses he teaches.

Perry G. Wang's Professional Background

Dr. Perry G. Wang received his Ph.D. from Oregon State University. Once earned, he worked in the medical device and pharmaceutical manufacturing industry prior to joining the FDA.

Throughout his career, Dr. Wang has published over 30 peer-reviewed scientific papers in addition to editing and co-editing five scientific reference books:

“High-Throughput Analysis in The Pharmaceutical Industry”
“Monolithic Chromatography and Its Modern Applications”
“Hydrophilic Interaction Liquid Chromatography (HILIC) and Advanced Applications”
“Counterfeit Medicines”
“High-Throughput Analysis for Food Safety”

His extensive experience publishing scientific papers and reference books has helped him deepen his knowledge and clearly demonstrates his expertise in the subject matter.

We’re proud to have Dr. Wang as one of our many knowledgeable course instructors. CfPIE only hires experienced professionals to teach our courses, and Dr. Wang is a great example of this ongoing dedication.

Courses Taught by Dr. Perry G. Wang

Dr. Wang currently teaches two courses with focuses on LC-MS/MS method development and validation. Each course imparts the foundational knowledge and skills necessary to enhance your career.

Let’s discuss more about these courses and how they draw from Dr. Wang’s expertise.

LC-MS/MS: Bioanalytical Method Validation

This compact 10-hour course focuses on practical training for scientists already working in the pharmaceutical industry. Pharmacology studies, biopharmaceutics, and clinical pharmacology studies all depend on validating bioanalytical methods — requiring both hands-on experience and background knowledge.

This course focuses on bioanalytical method validation specifically using LC-MS/MS. Participants will go through a step-by-step exploration of the concepts and techniques used for this type of validation.

Instruction focuses on the essential concepts from the guidance for Bioanalytical Method Validation issued by the FDA. The course has a strong emphasis on strengthening problem-solving skills while presenting real-world examples and case studies.

The course is further enhanced by Dr. Wang’s decades of experience in the field and provides his hard-earned insights and knowledge. Upon completion, attendees will understand how to independently validate bioanalytical methods and also how to apply them.

LC-MS/MS: Practical Method Development for the Pharmaceutical Industry

Dr. Wang’s practical 10-hour course focuses on actionable training for scientists in the field. Attendees are taken through concepts and techniques to develop LC-MS/MS methods. This course also provides an updated overview and the latest working knowledge of LC-MS/MS.

Attendees will enhance problem-solving skills through practical issues concerning LC-MS/MS methods, while learning from examples and common challenges in the pharmaceutical field. Additionally, regulation and validation concepts related to GLP and GMP will be covered, as this course is specifically focussed on the pharmaceutical industry.

Dr. Wang’s course will teach trainees useful theoretical concepts including instrumental fundamentals and operating principles, column basics and selection guides. Focus will also be placed on understanding the master resolution equation and its application.

Once they’ve completed the course, trainees can independently develop their own LC-MS/MS methods and improve the throughput by taking advantage of LC and MS. This course covers theoretical topics but with a focus on how trainees can apply them to their real-world, daily tasks.

Upcoming Courses and Enrollment Information

Schedule of Upcoming Courses

Are you interested in learning from Dr. Wang? Here are his upcoming courses, dates for the remainder of 2024:

LC-MS/MS: Bioanalytical Method Validation : 10-hour Live Stream on October 21 - 22, 2024, from 12:00pm to 5:00pm ET (9:00 to 2:00 PT).
LC-MS/MS: Practical Method Development for the Pharmaceutical Industry: 10-hour Live Stream on October 15 - 16, 2024, from 12:00pm to 5:00pm ET (9:00 to 2:00 PT).

These courses can also be customized and brought to your team of 10 or more either in-person at your facility or via a private live stream event. Click “Request On-Site Details” to learn more.

How to Enroll

Enrolling in Dr. Wang’s courses can be done on the course pages above. If you’re enrolling for live stream access, this can be done directly on the site, just like any other ecommerce transaction. CfPIE accepts payment via credit card, check, or purchase order.

For on-site course requests, we ask that you complete the form so we can estimate required customization costs. If you need any more general information, you can contact us , and we’ll be happy to answer any questions or concerns.

Learn with CfPIE and Dr. Perry G. Wang. Advance Your Life Sciences Career Today

Dr. Perry G. Wang brings decades of experience in manufacturing and regulation in life sciences and his time as a chemist at the FDA. You can take advantage of his unique insights by attending one of his courses.

Ready to get started? Check for the latest scheduling , decide if the prescheduled live stream or customized on-site option is better for you, and prepare to take your career to the next level!

A Comprehensive Guide to the 4 Main Types of Analytical Chemistry

Thu, 20 Jun 2024 12:27:06 GMT

Analytical chemistry is a crucial branch of chemistry that involves identifying, separating, and quantifying matter in a specific substance. A wide range of tools and methodologies are used to understand the chemical compositions of a solution accurately.

This field of study plays an important role in several scientific fields, such as chemistry, biology, physics, and engineering. Industry-wise, pharmaceuticals, environmental science, and food safety all require precise analytical chemistry to protect end users and ensure compliance.

There are four main types of analytical chemistry: qualitative, quantitative, instrumental, and bioanalytical. Each has varying goals, uses different tools, and uses unique methods to analyze chemical compounds.

So, we’ll be breaking down each type of analytical chemistry, the tools they use, and how they’re applied in specific situations. Read on to gain a better understanding of each of them.

Qualitative Analysis

Qualitative analysis involves identifying the components and elements in a sample without quantifying them. The primary purpose of this method is to determine the presence or absence of particular substances.

Qualitative analysis is fundamental in research and industry to understand material compositions and identify unknown samples. So, let’s explore the foundational techniques and applications of qualitative analysis.

Common Techniques Used in Qualitative Analysis

Qualitative analysis uses several techniques to evaluate the given composition, including the following:

Spectroscopy: This powerful technique involves studying the interaction between matter and electromagnetic radiation, allowing scientists to gather detailed information about the composition and structure of substances. Types of spectroscopy include the following:
UV-Vis spectroscopy measures the absorption of ultraviolet and visible light.
IR spectroscopy examines molecular vibrations to identify varying groups.
NMR spectroscopy provides molecular structure and dynamics insights by observing nuclear magnetic resonance.
Chromatography: This versatile technique separates components in a mixture based on their relation to stationary and mobile phases. By exploiting differences in how substances interact with these phases, chromatography isolates individual components from complex mixtures. Types of chromatography include:
Gas chromatography (GC) vaporizes and separates samples based on volatility and interaction with a stationary phase.
Liquid chromatography (LC) uses liquid solvents to carry analytes through a column packed with a stationary phase.
Chemical tests: These simple yet informative tests aim to identify substances based on their chemical properties. Common examples include flame tests, where the color of the flame indicates the presence of particular metal ions, and precipitation reactions, where the formation of a solid reveals the presence of specific anions and cations.

Applications of Qualitative Analytics

A wide range of industries rely on qualitative analytics to provide safe and compliant results, such as:

Pharmaceuticals: Qualitative analysis is used to identify active ingredients or contaminants to ensure medication efficacy. This analytical method helps verify the composition of pharmaceutical products, detect impurities, and confirm the presence of therapeutic compounds.
Environmental testing: Detecting pollutants and hazardous substances in air, water, and soil to monitor and protect environmental health. Qualitative analysis is used to identify contaminants like heavy metals, organic pollutants, and toxic compounds that can have detrimental and often severe effects on ecosystems and human health.
Food testing: Identifying food products' additives, preservatives, and contaminants to ensure they meet safety and quality standards. This includes detecting harmful substances such as pesticides, heavy metals, and contaminants and verifying the presence of nutritional components and food additives.

Quantitative Analysis

Quantitative analysis determines a substance's precise amount or concentration in a sample. This numerical-focused analysis is crucial for quality control, ensuring that products meet specific standards and regulations. We’ll break down the primary techniques and applications of this type of chemical analysis.

Key Techniques for Quantitative Analysis

Analyzing the precise amount of specific substances in a compound calls for a range of techniques, such as:

Titration: This fundamental technique involves gradually adding a titrant to a solution containing an analyte until the reaction between them reaches completion. A noticeable change, such as a color shift in an indicator or a pH change, usually indicates this endpoint. Titrations are valued for their accuracy and simplicity, making them a staple in educational laboratories and industrial settings. There are several common types of titration, such as:
Acid-base titrations, which measure the concentration of acidic or basic substances
Redox titrations involve the transfer of electrons.
Mass spectrometry: This widely used analytical technique measures the mass-to-charge ratio of ions to identify and quantify molecules within a sample. Mass spectrometry provides detailed information about molecular weight and structure by ionizing chemical species and sorting the ions based on their mass-to-charge ratios.
Gravimetry: This highly precise technique measures the mass of a compound related to the testing substance after it has been converted to a stable, weighable form. The process typically involves filtering, drying, and weighing it. Gravimetry is particularly useful for determining the elemental composition of a sample because of its direct mass measurements and high accuracy.

Applications of Quantitative Analysis

Quantitative analysis is commonly used across multiple scientific disciplines as its techniques allow for accurate, numerical results. A few specific ways this methodology is put to work include:

Determining concentrations: Accurately measuring the concentration of compounds in solutions is essential in many scientific disciplines. Quantitative analysis enables precise determination of concentrations, which is fundamental for product development in chemistry, biology, and environmental science.
Quality control: Ensuring products meet specifications and regulatory requirements is vital in pharmaceuticals and manufacturing. Quantitative analysis monitors and controls the quality of raw materials, intermediates, and finished products, ensuring they comply with safety and efficacy standards. Techniques like titration and mass spectrometry help detect impurities, verify compositions, and maintain consistent product quality.
Clinical diagnostics: Measuring biomarkers and substances in biological samples is crucial for medical diagnoses and monitoring. Quantitative analysis in clinical settings involves determining the levels of various biomarkers and therapeutic drugs in blood, urine, and other body fluids. Mass spectrometry and titration provide accurate and reliable data that guide patient care.

Instrumental Analysis

Instrumental analysis involves using advanced instruments to measure the physical and chemical properties of substances. This type of analysis provides high sensitivity, specificity, and accuracy, making it indispensable in modern chemistry.

Let’s explore the common types of instruments and applications used in this analysis method.

Common Instruments Used in Instrumental Analysis

Instruments are at the heart of instrumental analysis, which leverages advanced and precise tools to measure a wide range of attributes and elements of a chemical substance. Common instruments include:

Spectrophotometers: These sophisticated instruments measure the intensity of light absorbed by a sample at various wavelengths. By analyzing the absorbance, spectrophotometers can determine the concentration and purity of compounds in a sample. Different spectrophotometers, such as UV-Vis, infrared (IR), and fluorescence spectrophotometers, cater to various analytical needs:
UV-Vis spectrophotometers are widely used for measuring the absorbance of ultraviolet and visible light, providing information about electronic transitions in molecules.
Infrared spectrophotometers analyze molecular vibrations, offering insights into molecular structures and functional groups.
Chromatographs: Chromatographs, including gas chromatographs (GC) and liquid chromatographs (LC), are essential for separating complex mixtures into individual components for analysis. Gas chromatography involves vaporizing the sample and carrying it through a column with an inert gas, where different components separate based on their volatility and interaction with the column.
Electrochemical analyzers : These instruments measure the electrical properties of analytes, such as pH, conductivity, and electrochemical potential, to identify and quantify substances. These analyzers include potentiometers, conductometers, and voltammetry devices. Potentiometers measure the voltage of electrochemical cells, commonly used for pH measurements and ion-selective electrode analyses. Conductometers assess the electrical conductivity of solutions.

Applications

How is this type of analysis put to work in real-world environments? A few of the applications of instrumental analysis are:

Advanced material characterization: Instrumental analysis is vital for understanding the composition and properties of new materials, which is crucial for technological applications. Techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), and atomic force microscopy (AFM) provide detailed information about the crystal structure, surface morphology, and mechanical properties of materials.
Forensic analysis: In forensic analysis, instrumental techniques are essential for examining evidence collected from crime scenes, such as drugs, explosives, and biological samples. Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) identify and quantify chemical substances with high precision and sensitivity. DNA analysis using polymerase chain reaction (PCR) and sequencing technologies can link biological samples to individuals, providing crucial evidence in criminal investigations.
Industrial process monitoring: Instrumental analysis ensures the efficiency and safety of chemical processes in manufacturing by providing real-time monitoring and control. Gas chromatography (GC) and high-performance liquid chromatography (HPLC) analyze raw materials, intermediates, and final products, ensuring they meet quality specifications.

Bioanalytical Chemistry

Bioanalytical chemistry focuses on the analysis of biological samples, including proteins, DNA, RNA, and small molecules. This method combines principles from chemistry and biology to develop methods for understanding biological processes and diseases.

So, let’s discuss the primary methods of analytical bioanalytical chemistry and how they are applied.

Techniques Specific to Bioanalytical Chemistry

Bioanalytical chemistry leverages unique and sensitive methods to isolate and measure biological markers and compounds.

Enzyme-Linked Immunosorbent Assay (ELISA): This highly sensitive and specific technique uses antibodies to detect and quantify biological molecules, such as proteins, hormones, and antigens. ELISA involves the binding of an antigen to an antibody, followed by the addition of an enzyme-linked secondary antibody. From there, a color change occurs, indicating the presence and concentration of the target molecule. There are different types of ELISA, including:
Direct
Indirect
Sandwich
Competitive assays
Polymerase Chain Reaction (PCR): PCR is a revolutionary technique that amplifies specific DNA sequences, making detecting and analyzing minute amounts of genetic material possible. The process involves repeated heating and cooling cycles to denature DNA, anneal primers, and extend new DNA strands using a DNA polymerase enzyme.
Biosensors: These innovative devices utilize biological molecules, such as enzymes, antibodies, or nucleic acids, to detect the presence of chemicals, pathogens, or biomolecules. Biosensors consist of a biological recognition element and a transducer that converts the biological response into a measurable signal. Types of biosensors include electrochemical, optical, and piezoelectric sensors.

Applications

There are several different applications of these analytical methods across many disciplines and industries, such as:

Drug development: Bioanalytical chemistry is essential for identifying and quantifying drug candidates and their metabolites throughout various stages. Mass spectrometry and high-performance liquid chromatography (HPLC) are used to screen compound libraries, ensuring the molecular structure, purity, and concentration of potential drugs are accurately determined. Additionally, bioanalytical methods monitor how a drug is absorbed, distributed, and metabolized, providing critical data for optimizing dosage and understanding metabolic pathways.
Medical diagnostics: Bioanalytical chemistry is fundamental in developing advanced diagnostic tests for detecting diseases, genetic disorders, and monitoring patient health. Techniques such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) are employed to detect biomarkers associated with diseases like cancer, infectious diseases, and autoimmune disorders, providing rapid and accurate diagnoses for timely treatment. Genetic screening using PCR and next-generation sequencing (NGS) identifies mutations linked to hereditary diseases, enabling early intervention and management.
Biotechnological research: Bioanalytical chemistry drives biotechnological research by enabling the detailed study of cellular processes, advancing genetic engineering, and developing new biotechnological applications. Techniques such as flow cytometry, proteomics, and metabolomics are used to analyze cell signaling pathways, protein interactions, and metabolic networks, offering insights into cellular functions and disease mechanisms. In genetic engineering, bioanalytical methods are critical for editing genes, cloning, and creating genetically modified organisms, which have applications in medicine, agriculture, and industry.

Receive Training in Analytical Chemistry Principles with CfPIE

Analytical chemistry is a complex yet crucial field of study that requires intensive training in the methods and techniques we’ve explored above. The right certification can help professionals begin or advance their careers in this field.

Companies from pharmaceutical to food and beverage require experts in this field to help with research and development, ensure end-user safety, and meet all regulatory requirements. There is plenty of opportunity for analytical chemists.

CfPIE is an industry leader in life sciences training, and we can help you get started as an analytical chemist. Ready to get started? Learn more about our course, Analytical Chemistry Principles for Pharmaceutical Scientists.

The Importance of Current Good Manufacturing Practice (cGMP) in the Pharma Supply Chain Industry

Tue, 21 May 2024 18:17:51 GMT

The pharmaceutical industry is crucial to the overall health of patients around the world. Pharmaceuticals rely on efficient supply chains to safely develop and distribute essential medications. The extensive pharma supply chain includes procurement, production, and distribution to ensure product availability and control costs.

Current Good Manufacturing Practices (cGMP) is a critical regulatory framework that ensures pharmaceutical products meet high standards, ensuring the efficacy and safety of manufactured medicines. GMP compliance minimizes the risk of contamination and mislabeling, while also safeguarding consumer health by establishing industry-wide standards.

Earning a cGMP certification allows pharmaceutical professionals to gain demonstrable expertise in maintaining production quality and compliance, which is valuable for their employers and individuals aiming to advance their careers.

So, let’s explore how and why cGMP is crucial to ensuring the entire supply chain results in safe and effective medication for patients and why pursuing a cGMP certification is often the right choice for pharmaceutical experts.

Understanding Current Good Manufacturing Practice (cGMP)

cGMP are foundational regulations in the pharmaceutical industry that strive to make sure all medications are produced to the highest standards of safety, quality, and efficacy. The ‘c’ before Good Manufacturing Practice (GMP) indicates the latest edition of GMP guidelines, as new editions are released periodically.

It’s worth noting that the overall cGMP standards also apply more broadly, from medical devices to food products, as these standards establish the necessary processes for safe and effective manufacturing.

The core practices in cGMP cover a range of development and manufacturing processes, a few notable standards including:

Comprehensive testing at multiple stages in development
Sourcing high-quality raw materials from reliable sources
Establish standards and best practices for documentation

While there are certainly more standards involved in cGMP, the overarching purpose is to mitigate risks that may harm patients or reduce efficacy, such as cross-contamination, production errors, or material inconsistencies.

The US Food and Drug Administration (FDA) and the EU’s European Medicines Agency (EMA) play pivotal roles in defining cGMP standards and enforcing adherence to them. These regulatory oversights are crucial for safeguarding public health. Depending on the product and jurisdiction, these agencies may conduct frequent audits, require self-attestation, and request ongoing documentation.

For example, clinical and non-clinical trials are conducted for new medications, updated versions of established medications, or continued evaluation. Understanding how these processes should be conducted, documented, and reported is a critical aspect of maintaining GMP compliance. In the US, the FDA meticulously reviews all documentation before a drug is released to market.

Ultimately, cGMP aims to protect patient health, ensure consistently effective medication, and establish evolving standards that all pharmaceutical companies must follow. These rigorous standards and their enforcement help protect public health and prevent harmful materials or substances from affecting treatment.

The Impact of cGMP on the Pharma Supply Chain

cGMP significantly impacts the pharmaceutical industry and the supply chain manufacturers depend on. While several smaller practices and regulations are involved, the result is ensuring that all medications are produced consistently to provide safe and effective treatment.

Adhering to cGMP guidelines influences every stage of the manufacturing process, from raw materials procurement to the final distribution. Meeting these strict requirements ensures that medication has the same strength and purity regardless of the manufacturer—a necessity for providing consistent medical treatment.

Non-compliance with pharmaceutical manufacturing regulations can have far-reaching and severe consequences for pharmaceutical companies. Violations may lead to product recalls, legal actions, and financial penalties. Each of these possibilities can damage a company’s reputation and patient trust, which can be a challenge to repair.

Regulatory bodies like the FDA and EMA monitor pharmaceutical manufacturers to identify any non-compliant actions. This includes third-party audits that verify your organization is meeting the latest standards.

While meeting these standards can be challenging, keeping patient care at the forefront of compliance efforts is important. You’re not just checking boxes; you’re ensuring that every product released to market is safe and effective for consumer use.

GMP Certification for Career Advancement

Earning a GMP certificate makes individuals an asset to their organizations in many different roles. Individuals may wish to earn certification on their own, while employers may want to send employees to training and certification to upskill or cross-train them.

A cGMP certification prepares employees in various roles throughout the pharma supply chain to stay compliant in their day-to-day tasks. Additionally, earning this certification prepares personnel to step into roles requiring a comprehensive understanding of cGMP standards, such as management or quality assurance.

Individuals currently looking for a new work opportunity can benefit from the added credibility and marketability that’s gained from a cGMP certification, as these certifications require the completion of comprehensive training. Depending on the chosen company, you can attend in-person training or earn a cGMP certification online .

The certification process involves dedicated study and understanding of cGMP guidelines. Certification courses cover a range of essential topics, including:

Quality control
Process validation
Regulatory filings
Audit preparation
Internal auditing

Once the course is completed, a final exam must be passed before a GMP certification is awarded. As a result, everyone with a GMP certification demonstrates their ability to maintain or implement the strict standards necessary to keep the entire supply chain compliant in various roles.

Successfully earning a GMP certification indicates to employers that the employee can protect the company’s compliance standards and ensure patient safety, regardless of the specific role they hold.

Overcoming Challenges in GMP Implementation

Implementing and maintaining cGMP-compliant procedures throughout the organization can often introduce a range of challenges that must be addressed. Additionally, as GMP standards evolve over time, many of the same challenges need to be addressed, and new hurdles may arise.

The complexity of cGMP can vary based on the specific market and type of medication being manufactured, making understanding how to navigate these regulations specific to your own needs critical. So, let’s break down some common challenges and how you can address them.

Robust Quality Management Systems

Establishing and maintaining a quality management system is a foundational practice for becoming and maintaining cGMP compliance. Quality management systems should have clear procedures, effective communication between personnel or departments, and regular internal audits to ensure compliance.

Ideally, your system will not only comply with current GMP standards but also have the flexibility to change with future changes to GMP standards. Additionally, don’t restrict your quality management processes to cGMP, as you may have additional needs to ensure safe and effective manufacturing.

Quality assurance in pharma is critical both for ensuring patients receive a high quality of care and your organization remains fully compliant. Documentation is a cornerstone of quality management systems, making it critical that employees have the necessary training to create effective documentation.

Technology Integration

Relying on manual or low-tech processes can make establishing and maintaining cGMP compliance challenging bordering on impossible. GMP standards have evolved alongside the digital transformation of the pharmaceutical industry and you’ll need to adopt the right systems and integrations for compliance.

Beyond the specifics laid out in GMP standards, implementing automation reduces the risk of human error, which can often lead to non-compliant actions. Additionally, data analytics platforms can provide valuable insights that can be vital for improving quality control and overall optimization.

We’ll explore the future in greater detail below, but for now, it’s vital to keep in mind that technology continues to advance and evolve. As advanced technologies become adopted in the pharmaceutical industry, having existing integrations will establish a baseline for evolving your own systems.

Continuous Education and Training

Training never completely ends for many roles in the pharmaceutical industry, which makes it a challenge that needs to continually be tackled. New standards and technologies will likely require training so that employees are ready to stay compliant throughout their daily roles.

It’s wise to conduct regular training sessions so employees are up to date with the most recent regulations and you’ll be able to reinforce existing standards. Depending on your organization, some refresher training can be provided in house, but it’s worth working with a reliable training provider like CfPIE for more intensive sessions.

An ideal training session will use several different mediums, including interactive training, real-world problem-solving, and instructor-led sessions. While shorter sessions can be handled in-house, working with the experts is wise to ensure all information is understood and retained. If employees aren’t able to implement the training material in their daily tasks, GMP compliance may be at risk.

Engagement and Transparency

A common hurdle with maintaining GMP compliance is lacking employee engagement in following the right processes. Employees need to understand the impact of their work and how it affects product safety and efficacy, as the goal of compliance is not to check boxes, but protect patient care.

Implementing strategies to keep employees engaged in compliance, including transparency across all operations, so employees have a stronger understanding of how their tasks affect the overall organization. Taking a proactive approach to compliance is crucial to establishing and maintaining GMP compliance.

Creating a company-wide culture of compliance and an emphasis on patient safety goes far in keeping employees engaged in the process. While you won’t likely be able to create this culture overnight, it’s well worth the time and effort, as the end result is protecting patients and your compliance standing.

The Future of cGMP in the Pharma Industry

While nobody knows what the future may hold, we can still make educated predictions about how things may change. The pharmaceutical industry will continue to evolve alongside other technologies and medical practices, and these changes will be reflected in future editions of cGMP.

Several innovations affecting other industries will likely find utility in pharmaceutical manufacturing and supply chain management, influencing GMP in the process. A few technologies we may see affect the pharma industry are:

Artificial intelligence and machine learning may unlock new methods of research, development, and production that profoundly affect future GMP standards.
Advanced automation may unlock an entirely new level of efficiency, but configuring and monitoring these systems will be crucial.
Blockchain technology may find some utility in pharmaceutical supply chain management to better document the entire life cycle of materials and medications.

As these technologies find utility, GMP standards will change right alongside them — or even before they become commonplace. Organizations need to be ready to adapt to how these technologies may change the industry.

Certifications Are Critical for cGMP Compliance

GMP standards ensure that all medications are safe and provide the same level of treatment. Meeting these standards is crucial for operating at any level in the pharmaceutical supply chain, from raw materials to the finished product.

Earning a GMP certification prepares personnel to apply these standards to their specific or future roles. Those seeking internal promotions or a new employer can also benefit from the added marketability and credibility that are possible with a certification.

CfPIE provides industry-leading cGMP training and certification that prepares graduates to apply these standards in their current or future roles. Once certified, graduates will be ready to ensure their compliance throughout the pharma supply chain to ensure all medication is safe and effective.

Are you ready to become a GMP-certified expert or upskill your personnel? Learn more about CfPIEs pharmaceutical and life science courses today — take the next step with some of our leading courses:

Guidelines for Enforcing Good Documentation Practice in a GMP-Regulated Plant in 2024

Sat, 20 Apr 2024 14:48:12 GMT

What are good documentation practices? Good Documentation Practices (GDP) is a comprehensive quality standard that informs how documentation is created, stored, and maintained.

GPD-compliant documentation is crucial in the pharmaceutical, biotechnology, and medical device industries, where maintaining accurate and reliable documentation is not just a regulatory requirement but a fundamental component of quality assurance.

The principles of GDP form the backbone of a company's ability to reproduce consistent, reliable products while ensuring compliance with Good Manufacturing Practices (GMP). GMP is an overarching standard to ensure the safety and efficacy of pharmaceutical products.

Understanding, implementing, and enforcing good documentation practices guidelines is of the utmost importance for pharmaceutical manufacturers. So, keep reading as we break down how to develop and ensure GDP practices are followed for a GMP-compliant facility.

Basic Principles of Good Documentation Practices in Pharma, Biotech & Medical Device Industry

GMP good documentation practices guide pharmaceutical manufacturers in developing and implementing procedures for creating and modifying documentation related to their products.

GDP establishes basic principles of pharmaceutical document management as baseline requirements that manufacturers can use to create detailed procedures that meet them. These basic principles are:

Accuracy: Information must be recorded correctly and reflect the truth about what occurred during the process. Accuracy also includes capturing data in real-time to prevent errors or capture the wrong data entirely.
Legibility: All documentation should be readable and understandable without ambiguity. Creating clear and direct documents ensures that anyone who reads the documents can follow and understand them.
Traceability: The documentation should allow anyone to trace each significant step in manufacturing and controlling products, which is necessary for correctly identifying issues and compliance audits.
Completeness: All data, including those that might negatively reflect on the product, must be recorded. Missing data could mean critical information about a product's safety, quality, and efficacy is unknown, which can jeopardize your compliance standing.
Timeliness: Documentation must be updated after any activity or event as soon as possible to preserve data accuracy and relevance. Timeliness also plays into many of the above principles and is always necessary.

These established principles are elaborated on throughout GDP standards as specific processes are explored. Personnel should have a strong understanding of each of them and prioritize using them with any documentation-related task.

GDP in Practice

In a manufacturing plant, applying these principles means rigorously following procedures that support documentation integrity. So, let’s explore a few good documentation practices examples to help demonstrate the above principles:

Batch records: A common example is the creation of batch records, which should be completed in real-time, reviewed for mistakes, and signed off by supervisors daily.
Equipment logs: Maintaining clear and updated logs for equipment use, cleaning, and maintenance. Any issues found during inspections or maintenance should be logged.
Change control records: Document every change in process or equipment, including information such as justifications, approvals, and reviews.

The examples are quick overviews that showcase when documentation is necessary and the attention to detail necessary during creation. The specific requirements found at every step are why GDP training is business-critical.

The Importance of Documentation Training for GMP Compliance

Personnel training is crucial for maintaining GDP and GMP compliance . Learning a single good documentation practices procedure can be a challenging task for a new employee, and since GDP can change over time, current employees can also start missing required details.

Don’t underestimate the importance of initial and ongoing GMP compliance training for operators, managers, and anyone else involved in documentation — let’s break down a few reasons why:

Ensuring compliance with GMP standards : Good Documentation Practices training equips employees with the necessary understanding to effectively implement GMP guidelines . This understanding ensures products are consistently produced and controlled to meet quality standards.
Accuracy and error reduction: Train heavily emphasizes the importance of precision in documentation and includes strategies to minimize errors, such as double-checking entries and using error-proofing methods. These practices improve documentation reliability and enhance product quality and safety.
Impact on regulatory inspections: Well-executed GDP training leads to thorough and accurate documentation, which can streamline regulatory inspections, reduce findings of non-compliance, and speed up approval processes.
Facilitates continual improvement: GDP training encourages continual improvement by teaching employees to document routine operations and deviations precisely. This supports effective root cause analysis and corrective actions, enhancing manufacturing and quality control.

GDP and GMP compliance is not optional for most pharmaceutical and medical device manufacturing businesses. Providing employees with the opportunity to learn practical skills and knowledge is necessary for their performance and business health.

How to Develop or Identify Effective GDP Training

GDP training can be handled in-house, especially for ongoing education, or you can work with a specialized educator like CfPIE. Understanding what makes a GDP training program valuable and effective is necessary for both options.

So, let’s break down the important attributes any GDP training program requires to ensure your employees are prepared to follow documentation processes and maintain compliance.

Key Components of Effective GDP Training

Effective GDP training programs should comprehensively cover all aspects of GDP and bridge the gap between understanding the theory behind each principle and the real-world applications when put into practice.

Ideal GDP training will blend theoretical sessions and practical applications to enhance learning and retention. This blend can include workshops that allow hands-on experience and interactive e-learning tools that cater to different learning styles and paces.

Additionally, regular assessments, such as quizzes, practical demonstrations, and periodic audits of actual documentation, are necessary to ensure the training is effective and that the principles are correctly applied. These reinforce learning and identify areas that may require further training or clarification.

Best Practices for GDP Training Programs

Your training program, or a third-party’s program, should follow fundamental best practices to prepare graduates for real-world application of GDP principles. A few of these practices are:

Customization: GDP training programs should be crafted specifically to the unique operational requirements and challenges your face. Aligning training content with the specific processes and compliance needs of the facility helps employees directly apply what they learn, enhancing the overall effectiveness of the training.
Continuous improvement: Keep GDP training programs dynamic and effective by regularly updating them based on graduate feedback, evolving regulatory standards, and new technologies. An adaptive approach ensures that training remains relevant and effective, helping facilities stay compliant with evolving industry standards.
Engagement: Utilize interactive and visually engaging training materials to enhance understanding and retention. Techniques such as gamification, simulations, and real-life case studies can make learning more appealing and memorable, leading to better application of GDP principles in the workplace.
Feedback and surveys: Actively collect and analyze feedback from graduates through surveys and informal feedback channels after each training session. This feedback is crucial for identifying strengths and weaknesses in the training program and making informed improvements that enhance its effectiveness and relevance.

Each of these practices is designed to maximize the value each graduate is receiving from a GDP training program. Otherwise, you risk developing or partner with an ineffective program that does not prepare attendees for real-world applications.

Assessing the Effectiveness of GDP Training Initiatives

Understanding effectiveness isn’t just about components and best practices — ideal training will have a positive impact on graduates and job performance. Taking the time to evaluate your training initiatives or partner is necessary to avoid future issues with non-compliance or safety concerns.

One way to assess effectiveness is by collecting feedback and surveys post-training to identify areas that need improvement and evaluate graduates' understanding and application of GDP principles. These assessments should occur after all pertinent information has been taught and practiced, possibly as a final exam.

Once back on the job, monitor documentation errors and conduct routine audits to measure improvements and ensure the ongoing application of GDP principles. If applicable, conduct the same audits before training to better gauge improvement.

Lastly, follow-up assessments and regulatory audit outcomes should be used to evaluate the long-term effectiveness of GDP training and the necessity for refreshers. If an audit fails or quality issues emerge, it’s time for additional training.

Effective Training is Crucial for GDP and GMP Compliance

GMP and GDP are strict quality standards that require precise processes and procedures. Nearly every aspect of documentation must meet these standards to stay compliant and ensure safe, effective final products.

Training programs are necessary to teach employees the latest GDP standards and how to put them to work in a practical setting. Otherwise, developing the right workflows that will protect your GMP compliance is challenging.

CfPIE is an industry-recognized leader that provides a wide range of training tailored to pharmaceutical and medical device manufacturing. Our courses turn any graduate into a certified document management professional, ready to develop or follow GDP standards.

Is your GMP-regulated plant following Good Documentation Practices at every step? Initial and ongoing employee training is needed to make sure you are — learn more about CfPIE’s courses today .

About CfPIE

The Center for Professional Innovation and Education (CfPIE) is the global leader in life sciences training, providing specialized courses for pharma/biotech, medical device, and skin/cosmetics topics. Classroom and custom on-site formats, and certification programs help improve personal skills, maintain regulatory compliance, and advance careers. Small class sizes and industry-active course directors promote a dynamic learning environment with excellent student-to-teacher interaction. More information: http://www.cfpie.com

Fundamental Summary of GMP Facility Contamination Control

Thu, 18 Apr 2024 23:13:00 GMT

Any manufacturer in the healthcare and medical industry must meet strict quality standards to keep end users safe and ensure treatment efficacy. The Food and Drug Administration (FDA) requires a wide range of well-designed and documented processes that demonstrate the quality of the final product.

To meet these regulations, pharmaceutical manufacturers implement strict guidelines and controls, such as Good Manufacturing Practices (GMP) , to minimize the risk of contamination and cross-contamination.

If GMP standards are not met, the Food and Drug Administration may impose steep fines or legal penalties, require recalls, or otherwise impede your ability to operate. Some specific aspects of these practices focus on mitigating possible contamination and cross-contamination.

When done correctly, GMP facilities are clean, personnel are properly trained, and processes are designed to segregate different products and stages of production effectively.

Meeting GMP requirements is business-critical, so we’ll be breaking down everything pharmaceutical manufacturers need to know about contamination and cross-contamination control so they can continue providing high-quality products.

What is Contamination and Cross-Contamination in Pharmaceutical Manufacturing?

Looking at the general definition, contamination in manufacturing is the unintended presence of any type of substance or organism in a product. It can occur at any stage of the manufacturing process.

Contamination in pharmaceutical manufacturing, food, and cosmetics environments can compromise product safety and efficacy. That’s why GMP facilities have taken every precaution to produce high-quality pharmaceutical or medical products.

Cross-contamination is best defined as transferring contaminants from one product to another. This subset of contamination typically happens when multiple products are manufactured within the same facility or with shared equipment.

Three Primary Types of Cross-Contamination and Contamination

Contamination and cross-contamination can come in many specific forms that fall under three categories. Understanding the different types of contamination is essential for implementing effective preventive measures:

Physical contamination : This category occurs when physical substances are unintentionally introduced into the product. Common physical contaminants include hair, dirt, dust, and pollen. These materials can come from various sources, such as the production environment, materials, or personnel, and can significantly impact the quality and safety of the product.
Chemical contamination: Chemical contaminants include any unintended chemicals that enter the product. These might be residues of cleaning agents, lubricants used on machinery, or chemicals from other products manufactured in the same facility. This harmful type of contamination can alter the product's chemical composition and possibly lead to harmful reactions or substandard efficacy.
Microbiological contamination: This type of contamination refers to microorganisms such as bacteria, molds, spores, and yeasts in the product. Biological contamination is a significant concern because it can lead to spoilage, product degradation, and even infections in end users.

The above 3 types of contamination are overarching categories, and we can further drill down into specific causes of cross-contamination, such as:

Batch-to-batch contamination occurs when a product batch is contaminated by residues from a previous batch of the same product due to inadequate cleaning or separation during manufacturing processes.
Product-to-product contamination is similar. It occurs when different products contaminate each other due to non-compliant storage or production processes.
Foreign material contamination happens when products not part of the manufacturing process mistakenly enter the product. This is a common source of contamination in areas like the dispensary or storage where raw materials are handled and stored.
Cross-contamination can also occur between different production areas, personnel or through inadequately designed airflow systems that fail to prevent the spread of particulates or microbes.

You can see how strict processes to prevent contamination are necessary to guard against any situation in which unwanted substances negatively affect the end product.

Preventing Cross-Contamination in Your GMP Facility

How can you take steps to keep unwanted substances out of your pharmaceutical products? GMP standards shed light on specific processes to adopt, such as which storage practice could cause cross-contamination.

Ultimately, cross-contamination is prevented by implementing and refining a series of processes that take a holistic approach to keeping contaminants out of your products. So, let’s explore which six control measures will prevent cross-contamination.

Dedicated facilities and equipment: Maintain dedicated spaces and equipment to prevent cross-contamination between production lines. Conduct frequent inspections to ensure these areas meet cleanliness and operational standards.
Proper sanitization and cleaning processes: Implement stringent sanitization and cleaning protocols to remove contaminants effectively. Regularly review and update these processes to adapt to new standards, production needs, or identified concerns.
Documentation and record keeping: Keep thorough records of all processes, deviations, and implemented corrective actions. This documentation is crucial for traceability, GMP compliance , and continuous improvement. Refine documentation creation and storage, which is a strategy for reducing the risk of cross-contamination.
Employee training and hygiene: Conduct comprehensive training programs focused on GMP, proper hygiene practices, the context of pharma manufacturing, and contamination prevention. Have regular refreshers to help maintain high standards and adapt to any necessary changes.
Material handling and storage practices: Manage raw materials with specific protocols for handling and storage to minimize contaminant exposure related to the material’s stated requirements. Proper organization and material segregation are key practices for maintaining product integrity.

Using air control systems: Install advanced air control systems, such as HEPA filters, to manage particulates and microbial contamination in production areas. Develop processes for regular maintenance of these systems to ensure their effectiveness and reliability.

Measures to Control Contamination in Good Manufacturing Practicesph

We’ve explored how to prevent cross-contamination, but how can you prevent contamination overall?

The above prevention measures can certainly apply to other ways foreign substances can become exposed to your products, but it’s worth discussing specific contamination controls to consider other sources of contaminants.

Contamination Control in Cleanrooms

Cleanrooms remaining clean is crucial for maintaining product integrity, but contamination is a constant concern. The main sources of contamination include the surrounding environment outside of the room, operators, and raw materials.

Most cleanrooms are designed with specific airflow patterns and room pressures to protect products. Positive air barriers, dust extractors, and containment hoods keep foreign substances outside to minimize contamination.

Contamination Controls over Incoming Raw Materials

Controls that evaluate incoming goods are essential to the integrity and quality of the materials used in the manufacturing process.

Every lot of material received must be assigned a unique identification number to facilitate traceability. Inspecting these goods for any signs of transit damage or contamination upon arrival is crucial. Once accepted into the facility, the materials should be stored properly to minimize the risk of contamination.

Before being used in manufacturing, materials must undergo additional checks for identity, cleanliness, and the integrity of the storage container or protective wrapping to confirm their suitability.

Contamination Controls for Machinery and Equipment

Contamination control by machinery is necessary, as machinery can often be a source of contamination that is not immediately visible, such as oil or lubricant leaks and metal particles from wear.

To mitigate these risks, personnel must adhere to strict cleaning protocols and follow company procedures meticulously. Operators must ensure that machines are thoroughly cleaned and inspected for cleanliness before and after use.

Additionally, monitoring during operation is necessary to detect any signs of malfunction that could introduce contaminants into the product, such as leaks or unusual wear.

Regular preventive maintenance, rather than just breakdown maintenance, is also critical to minimize the risk of contamination. Schedules should be based on machine age, usage, and specific service needs.

Contamination Controls for Operators and Personnel

Operators are a significant source of possible contamination. A comprehensive approach helps control contamination risks operators pose in production environments, such as:

Strict personal hygiene is vital for all staff, regardless of their direct involvement with the product.
To prevent contamination from skin particles, body oils, and hair, direct contact with exposed products or their containers should be avoided.
Operators should also avoid wearing jewelry during production as it can introduce dirt and debris or inadvertently fall into the product.
Protective garments should be required when handling materials and be replaced with clean ones if wet or dirty.

Personnel adherence to these practices is essential to mitigate the risk of contamination. It’s critical that operators understand and follow these procedures and others unique to your manufacturing process to avoid contamination that can harm patient treatment and risk non-compliance.

Is Your Pharmaceutical Facility cGMP Compliant?

Earning a GMP compliance certification and maintaining compliance is crucial for pharmaceutical manufacturers to prevent non-compliance penalties and protect end users from possible harm.

Contamination and cross-contamination put patients and compliance at risk. Providing employees with ongoing cGMP training is critical to reinforcing practices and processes designed to prevent contamination.

CfPIE is a leader in life sciences training , and we offer programs for facilities and professionals to learn the in-depth knowledge necessary to fully comply with GMP standards. Our courses are designed to impart the understanding of both processes and the practical skills necessary to execute them.

Do your teams need initial or ongoing education to help prevent contamination?

Learn more about our GMP certification program today to see how we prepare your teams to keep patients safe.

Transforming Skill Sets: The Role of Life Science Training Courses in Career Advancement

Tue, 26 Mar 2024 13:28:06 GMT

Continuous learning with life science courses is necessary for career advancement in the fast-evolving life sciences sector. Specialized training courses allow professionals to acquire new skills, stay on top of the latest scientific advancements, and gain a competitive edge in the job market.

Life science certification courses are critical in training professionals in new specialties or providing continuous education. These can transform your skill set by allowing you to focus on critical areas such as regulatory compliance, communication, and many other areas professionals require to succeed.

So, let’s break down why these courses help you succeed in your current role and prepare you for the next step to advance your career.

The Importance of Communication Skills in Life Sciences

Knowing how to communicate in a professional, scientific setting is necessary to succeed in any life sciences role. Life science training courses often cover communication skills as part of a broader focus or as an entire specialty.

Enhancing Interpersonal and Team Communication

Communication skills make sure that teams and stakeholders are aligned, facilitating the seamless exchange of ideas and accelerating project timelines.

Effective communication is the foundation of successful collaboration in the life sciences. Training courses that enhance communication skills can significantly improve project outcomes and stakeholder satisfaction.

Presentation and Public Speaking

Presenting research findings in a compelling way is crucial throughout the life sciences sectors. This skill is vital whether you're influencing decision-makers, securing funding, or sharing results with the scientific community.

Courses that cover public speaking focus on delivering clear, persuasive presentations that engage and inform audiences. Ultimately, effective presentation and public speaking skills can have a profound impact on your career, depending on your specific role.

Mastering Regulatory Compliance Skills

Regulatory compliance skills ensure you perform your current and future role effectively and fully comply with applicable regulations. Additionally, some roles require an even greater and more detailed understanding of regulatory requirements.

Understanding Regulatory Frameworks

The life sciences industry is governed by complex regulatory frameworks that vary across regions. A thorough understanding of these frameworks is essential for ensuring that products meet the necessary safety and efficacy standards.

Training in regulatory compliance provides professionals with an overview of global regulations, helping them navigate the intricacies of the FDA, EMA, and other regulatory bodies. Many items in our life science course list cover complying with regulatory frameworks.

Implementing Compliance Strategies

Compliance is not just about understanding regulations — it's about implementing strategies that ensure ongoing adherence to these standards. Online life science courses in this area equip professionals with the tools and knowledge needed to develop and execute effective compliance strategies, minimizing risk and enhancing operational efficiency.

Technical Writing for Life Sciences Professionals

Technical writing is a crucial skill throughout the life sciences industry. Entry-level certifications in life sciences can help writers enter this career and refine their skills with a focus on the needs of life sciences.

Basics of Technical Writing

Technical writing is a key skill in the life sciences, required for creating a wide range of documents, from research papers to regulatory submissions. A technical writing course covers crucial fundamentals, emphasizing the importance of clarity, accuracy, and conciseness in scientific communication.

Advanced Techniques and Best Practices

Beyond the basics, life science training programs focusing on technical writing delve into strategies for enhancing the clarity and impact of scientific documents. Best practices, including visuals, effective structuring, and audience-specific language, are covered to improve the quality and readability of technical writing.

Advancing Clinical Research Skills

Effectively conducting clinical research in full compliance with regulatory requirements is of the utmost importance. Learning advanced research skills allows graduates to effectively handle these responsibilities to enable safe, effective, and compliant clinical studies.

Fundamentals of Clinical Research

Clinical research is at the heart of medical advancement. Life sciences certifications and training in clinical research start with the basics of clinical trial design and execution. Courses also provide a foundation for understanding how effective studies are conducted, from hypothesis formulation to data analysis.

Advanced Methodologies in Clinical Research

Advanced methodologies in research settings are essential to improve the efficiency and integrity of clinical trials. Courses covering these topics introduce innovative approaches to trial design, patient recruitment, and data management, ensuring high-quality, reliable research outcomes.

Document Management Skills in Life Sciences

Managing documents throughout the entire lifecycle of a pharmaceutical product or medical device is critical for ensuring the safety and efficacy of the end product. Additionally, earning FDA or EMA approval depends on accurate and compliant documentation.

Importance of Document Management

Effective document management is critical for regulatory compliance and efficient knowledge sharing within organizations. This practice includes storing, retrieving, and sharing vital documents, ensuring that information is accessible and secure.

Life science courses online teach students how to manage documents effectively and fully comply with applicable standards.

Best Practices for Effective Document Management

Effective document management training courses focus on best practices and tools for managing documents throughout their lifecycle. Topics include:

Efficient document storage,
Retrieval, and sharing strategies and
Implementing electronic document management systems (EDMS) to streamline processes.

Navigating Regulatory Affairs

Several standards and requirements regulate the medical industry. Professionals must understand how to navigate these regulations to ensure their roles and responsibilities are fully compliant.

Introduction to Pharmaceutical & Medical Device Regulatory Affairs

Regulatory affairs is a dynamic field that plays a pivotal role in the life sciences sector. It ensures that products comply with regulatory standards. The Global regulatory affairs certification program in United States provides an overview of the field and highlights its importance in the development and approval of medical products.

Skills for Success in Regulatory Affairs

Success in regulatory affairs requires specific skills, including an in-depth understanding of regulatory processes, strategic thinking, and effective communication with regulatory bodies. Life science certification courses in this area equip professionals with the expertise to navigate the regulatory landscape and ensure product compliance.

Advance Your Career with Life Science Training from CfPIE

CfPIE offers a range of life science training and certification programs in the United States designed to develop the key skills outlined above. Our courses provide professionals with the skills and knowledge necessary for career advancement and to maintain a competitive advantage in the rapidly changing life sciences sector.

By focusing on the critical areas we’ve explored above, our courses prepare professionals to meet the challenges of the life sciences industry head-on. Life science training courses offer a pathway to enhancing your professional skill set, opening doors to new opportunities and career growth.

Pursuing specialized training is not just an investment in your career — it's a commitment to staying at the forefront of scientific innovation and regulatory excellence. Is it time to take your next steps?

Find the right course to help grow your career today.

Life Science Training Advisors Give You an Edge Over the Competition

Tue, 26 Mar 2024 02:59:43 GMT

Start by Defining Your Path

There are so many different possibilities for branching out from most entry-level positions—you need to define the path from your current position to your ultimate goal. Otherwise, how will you take the next step without knowing where you’re going?

You’ll work with a life science training advisor to help you define and understand exactly where you want to go. We’ll help you break down your specific career milestones, areas of interest, and current credentials to help you define your ultimate career goal.

Once you know what you want to accomplish, you’ll work with your advisor to create a path. You won’t waste money trying out this course or that course; your advisor knows exactly which courses and certifications will help you accomplish your goal.

Learn How to Use Your Certifications as Bargaining Tools for Advancement

Earning certifications is often necessary and helps you stand out from other candidates, but the real challenge lies in translating these achievements into tangible career advancements. Our training advisors are adept at teaching you how to effectively communicate the value of your additional qualifications to hiring managers and decision-makers.

This means that when it’s time to jump on those opportunities, you’re already prepared with the right way to present the hard work you’ve invested in yourself as a great employee. With our guidance, you'll be equipped to showcase your self-improvement efforts as evidence of your value to the company.

Save Money While You Invest in Yourself

Investing in your professional development shouldn't mean indiscriminate spending. Our advisors identify strategies for maximizing the value of your educational investments. For example, they can keep you up to date on early bird discounts for courses on your path to success or discounts through certain partners of CfPIE.

CfPIE's training advisors are dedicated to plotting a course and navigating you through the decision-making process that defines your career advancement journey. Our approach not only enhances your resume but does so cost-effectively, striking a balance between personal investment and prudent financial planning.

By collaborating with us, you'll have the support necessary to achieve your professional goals and make informed choices every step of the way. Ready to strategically plan your career advancement? Book a demo with a training advisor today to start taking tactful steps in the right direction.

The Critical Role of GMP Training in Pharmaceutical Manufacturing: Lessons from ACRL's FDA Inspection

Thu, 29 Feb 2024 14:14:40 GMT

A r ecent FDA audit resulted in a warning lette r sent to Advanced Cosmetic Research Laboratories (ACRL) detailing multiple violations of Good Manufacturing Practices (GMP) standards . ACRL was given time to receive and respond to the warning and implement corrective actions.

We can take several lessons from ACRL’s FDA inspection and resulting warning letter. The key running theme is that GMP standards must be met for organizations to remain in operation. Failing to comply can result in fines, penalties, seizure, and injunctions.

GMP is not optional for many industries, including pharmaceuticals and cosmetics. Non-compliance can result in steep fines or even jeopardize the entire business. Even if auditors do not identify lacking standards, pharma products may be less effective or harm end users.

The ACRL ruling serves as a strong example of why GMP standards must be adhered to, the thoroughness of external audits, and the necessity of continuous GMP training throughout the industry. Keep reading as we dive deeper into this specific case and what it means for all pharma manufacturers. Paragraph

Understanding GMP and Its Importance in Pharma Industry

GMP is a series of regulations enforced by the FDA and other international organizations to ensure all pharmaceutical products that reach end users are produced according to strict quality standards. GMP is applied to several industries, but its application in the pharmaceutical industry is critical to being able to offer products to end users.

GMP in the pharma industry describes standards at every stage in the pharmaceutical manufacturing process, including raw materials, facilities condition, equipment maintenance, and staff training. Non-compliance with GMP standards can result in steep fines and penalties. A recent FDA audit of ACRL is a case study of what may happen when organizations fail to meet GMP standards.

The FDA’s findings highlighted multiple deficiencies in manufacturing processes, including safety and quality concerns with the company’s products. We’ll be exploring this audit as a case study of why maintaining compliance is business-critical for all pharmaceutical companies.

The Impact of Inadequate Training on Pharmaceutical Quality

There is a strong correlation between trained personnel and the quality of pharmaceutical products. GMP training helps professionals throughout the pharma manufacturing process abide by these quality standards to ensure a consistent and effective end product.

Employees who do not have a thorough understanding of these standards will struggle to meet them in their specific roles. GMP training courses designed with a focus on their role are critical to both compliance and ensuring a consistently high-quality end product.

Once trained, employees are able to ensure all pharmaceutical products are manufactured under conditions that avoid contamination, errors, or ingredient mix-ups that can significantly affect the quality of the end result.

Key Components of Effective GMP Training

A comprehensive GMP training program imparts the knowledge and skills necessary to keep up-to-date with regulatory changes. Initial training is certainly important, but employees should undergo continuous training to be aware of changes that affect how they perform their specific roles.

What makes an effective GMP training course? A few components of an effective training program are:

Learning overall GMP requirements
Understanding how to maintain instrumentation or equipment
Proper documentation, records-keeping, and change control as it pertains to the specific role.
How to find the latest version of specific standards when necessary

These items are a high-level, general perspective of what employees should understand after completing a GMP training course.

However, the specific courses will drill deeper into specifics pertaining to the role. For example, the materials covered in GMP Training for the QC Laboratory will vary from Good Manufacturing Practices Training.

Case Study – ACRL’s FDA Inspection

What did the FDA’s inspection of ACRL discover? The FDA’s warning letter is not an all-encompassing breakdown of violations , but we can still explore the overall categories to understand better what went wrong:

Failed to keep the buildings used throughout the manufacturing process in good repair.
The quality control unit failed to conduct its responsibility to ensure all drug products meet Current GPM and meet established standards for “identity, strength, quality, and purity.”
Misbranding violations and unapproved new drugs.

The letter’s conclusion gave ACRL 15 working days to respond and implement corrective action. A reason was required if the necessary changes could not be implemented in time.

What if ACRL ignores the warning or has inadequate corrections? In the FDA’s own words, “Failure to promptly and adequately address this matter may result in regulatory or legal action without further notice including, without limitation, seizure and injunction.”

The overarching lesson from the ACRL is to prioritize GMP from the beginning to avoid finding yourself in a similar situation that may jeopardize the entire business.

How ACRL responds to the FDA’s warning remains to be seen, but it’s clear that every organization involved in pharmaceutical manufacturing needs to ensure all employees are effectively trained to ensure ongoing compliance.

Benefits of Online GMP Training for Pharma Personnel

Providing employees with online GMP training helps organizations to avoid the mistakes made by ACRL. In-person training and online courses are both valuable for imparting the necessary skills to personnel. A few key benefits of online GMP training are:

Develop a culture of compliance and continuous improvement: Online GMP training fosters a culture focused on maintaining a high-quality end product and compliance throughout the organization.
Receive training without requiring travel and related expenses: Employees are able to learn remotely to accommodate their existing schedules and minimize the time spent away from their responsibilities.
Attend courses tailored to the needs of the pharmaceutical industry: GMP has become widely applied to various industries. Attending a course that covers specific pharma GMP standards, best practices, and regulations is vital.
Interactive modules and multi-media training: Learning from a book or PDF can be excellent, but online training allows for a more dynamic learning experience that helps employees better understand and retain course material.
Straightforward continuous education to stay informed: GMP standards have continually changed over the years and will certainly continue to evolve as necessary. Online GMP training courses allow organizations to keep employees up to date on these changes, even if they’ve already gone through initial training.

Employee training is critical to ensure your business maintains GMP standards to avoid non-compliance actions and manufacture a high-quality product. Patients expect reliably consistent medications and medical devices — GMP standards help you meet these expectations.

Continuous GMP Training is Critical for Compliance and Quality

We’ve seen how GMP standards are crucial to avoiding fines and penalties for non-compliance. The FDA and other regulatory agencies globally require GMP compliance for pharmaceutical manufacturing. GMP training courses impart a thorough understanding of these standards and how to meet them in their current roles.

Additionally, GMP training is a regulatory requirement and a fundamental component of pharmaceutical excellence. Even without external audits and the possibility of non-compliance, GMP is the foundation for ensuring products are of high quality and provide the expected medical benefits patients require.

CfPIE is an industry leader in GMP training tailored to several roles throughout pharmaceutical manufacturing. Our programs prepare employees to ensure consistent quality and full compliance with GMP requirements.

Explore the following GMP courses today to prepare your workforce to remain compliant and manufacture high-quality products:

In addition to these courses, CfPIE also offers a GMP Facility Compliance Program that ensures your facility would pass an FDA audit or inspection.

CRISPR and Sickle Cell: A Deep Dive into the Future of Gene Editing and its Regulatory Pathways

Thu, 15 Feb 2024 14:10:35 GMT

CRISPR technology marked a significant leap forward in cell therapy by enabling precise gene editing treatments. This methodology allows for precise edits to DNA to potentially cure genetic disasters and other applications outside of healthcare.

Recently, the FDA approved the first-ever CRISPR-based therapy . The new treatment aims to provide a cure for sickle cell disorders, making it a first-of-its-kind and life-saving therapy.

Cell therapy aims to use living cells to repair damaged tissues and organs. This practice has shown promise for sickle cell treatment, which is a genetic disorder resulting in misshapen red blood cells and resulting in a range of health concerns.

Cell therapy training aims to prepare professionals in this field to develop and document transformative gene editing treatments properly. Keep reading while we explore more about the future of CRISPR, how we got here, and overall regulatory pathways.

The Evolution of CRISPR Cell Therapy

Gene editing has historically involved complex and less efficient techniques that have been cumbersome and often inaccessible to researchers. However, the emergence of CRISPR has created a relatively simple and precise way to explore applications of cell and gene therapies. CRISPR is modeled after bacteria's defense system to enable precise gene editing.

CRISPR’s relative ease and accuracy have revolutionized cell therapy by creating a method for precise editing of DNA. Replacing less effective and more complex methodologies has led to the development of treatments that may help a range of genetic disorders, infectious diseases, and cancers.

However, CRISPR cell therapy was only recently the basis for an FDA-approved treatment for sickle cell disease — previous applications could not earn this necessary approval. Now, researchers can learn from the regulatory pathways and guidelines to guide various applications.

Professionals will need ongoing cell therapy training to keep up with the latest developments in this transformative technology. Staying on top of the latest regulatory requirements, best practices for documentation, and how to prepare for FDA approval is of the utmost importance.

Case Study: CRISPR and Sickle Cell Treatment

Sickle cell treatments have been researched for decades, and CRISPR may become an effective method to combat this genetic illness. Sickle cell is a blood disorder caused by a single mutated gene and results in strokes, intense pain, and organ damage.

The FDA recently approved two sickle cell treatments , one of which uses CRISPR. The specific gene editing treatment known as Exa-cel, or its brand name Casgevy, uses CRISPR to snip DNA to correct the effects of the mutation. Casgevy is the first-ever treatment that uses CRISPR to receive FDA approval. Sickle cell resulting from a single gene mutation makes the disorder a candidate for gene editing, as it does not require multiple modifications.

It’s worth highlighting that Casgevy will be expensive and intensive care and a long period of hospitalization. Due to the possible severity of the disorder, CRISPR sickle cell gene therapy can still be life-saving for some patients.

Casgevy, being the first FDA CRISPR approved treatment, is a turning point in the gene editing methodology. It’s critical for cell therapy professionals to commit to continuous learning and training as CRISPR treatments evolve. Attending a reputable cell therapy training course to stay aware of any changes is crucial for everyone in this industry.

Regulatory Pathways for CRISPR-based Therapies

The sickle cell CRISPR treatment is a landmark approval as the first approved treatment using this technology. The FDA has provided a guidance document for human gene therapy products that use gene editing tools. This document aims to help pharmaceutical researchers ensure their future products have the best chance of receiving approval.

This comprehensive FDA document covers three primary topics:

Considerations for product development: This comprehensive section provides specific details on using gene editing methods, the allowed degree of modification, and delivery methods. Additional guidance is provided for Chemistry, Manufacturing, and Controls (CMC) throughout the process.
Considerations for non-clinical studies: Non-clinical study guidance covers the expectations for product evaluations in these settings. Additional details cover the processes and systems in place to assess activity and safety throughout the studies.
Considerations for clinical studies: The FDA provides detailed considerations for clinical studies, which will be crucial in earning final approval. These topics include the study population, doses and schedules, treatment plans, how patients are monitored, and study endpoints. Additional guidance is provided for any research involving children.

Additionally, guidance is provided for communicating with the FDA when necessary. This section is brief and mentions the correct departments to contact based on your specific needs.

It’s critical that researchers and pharmaceutical professionals working on CRISPR-based gene editing therapies have a comprehensive understanding of FDA’s regulations. Continuous cell and gene therapy training is crucial to have a detailed understanding of what the FDA requires and stay aware of any changes that may occur in the future.

Future Perspectives and Professional Cell Therapy Training

What might the future hold for CRISPR-based therapies? This technology has been around for years but has failed to earn FDA approval. Now that the sickle cell treatment has broken through this barrier, we expect it will create renewed interest in the potential and marketability of cell and gene therapy.

It’s likely that the FDA will continue to refine and update its regulatory requirements and available guidance in the future. New applications that are either denied or approved will help the agency better inform pharmaceutical companies of their expectations.

Cell and gene therapy training provides professionals with the understanding to ensure research, non-clinical, and clinical trials abide by current regulations. Earning FDA approval for new treatments will involve a thorough examination of the entire process, from research to trials, making it crucial for professionals to understand these requirements from the beginning.

Stay Informed Through Cell and Gene Therapy Training Courses

Having a CRISPR-based treatment receive FDA approval is a turning point in cell therapy. Further research into cell and gene therapy applications will likely have renewed interest as regulatory pathways are defined and refined.

CRISPR sickle cell treatments are likely only the beginning of FDA-approved CRISPR treatments. Attending ongoing cell therapy training to stay aware of best practices, regulatory requirements, and the latest advancements is critical for professionals in this field. Otherwise, it’s likely that the final product may fall short of FDA’s requirements.

CfPIE is a leading provider of life sciences training and offers comprehensive training for cell and gene therapy product development and related courses to keep professionals up to date. Our courses prepare professionals to excel throughout the pharmaceutical industry, with courses such as:

The Importance of QA Training in Pharma (2024)

Thu, 01 Feb 2024 20:31:44 GMT

In the demanding and highly regulated pharmaceutical industry, ensuring the quality and safety of biologics and biopharmaceuticals is paramount. The role of Quality Assurance (QA) in this process cannot be overstated, as it directly impacts patient safety, regulatory compliance, and the overall success of pharmaceutical companies.

This blog post has been revised to target individuals interested in Quality Assurance Training Courses in the Pharmaceutical industry, emphasizing the importance of QA and how specialized training can significantly enhance the capabilities of QA professionals.

Emphasizing Quality Assurance in Pharmaceutical Manufacturing

Quality Assurance in pharmaceutical manufacturing is critical due to the strict regulations and the potential impact on patient health. QA teams are tasked with ensuring that products are safe, effective, and meet all industry standards from development through to production and distribution. This involves rigorous testing, adherence to Good Manufacturing Practices (GMP) , and a continuous commitment to quality improvement.

The Pillars of Quality Assurance in Pharmaceuticals

Safety and Efficacy of Products: QA is integral in ensuring that all pharmaceutical products are safe for patient use and perform as intended. This includes rigorous testing and validation of the manufacturing process to meet predefined quality standards.
Adherence to Regulatory Standards: Staying compliant with healthcare regulations, such as GMP, is non-negotiable. QA professionals play a crucial role in maintaining compliance through equipment calibration, meticulous documentation, and thorough quality testing.
Continuous Quality Improvement: The pharmaceutical industry is ever-evolving, and so are its quality standards. Implementing Quality by Design (QbD) and Quality Risk Management (QRM) strategies are essential for continuous improvement and innovation in product development and manufacturing processes.
Building Trust and Reputation: A robust QA program not only ensures regulatory compliance but also builds consumer trust. Pharmaceutical companies with a strong commitment to quality assurance are more likely to succeed in the long term.

Enhancing QA Skills through Specialized Training

Investing in Quality Assurance training is crucial for the professional development of QA personnel. Specialized courses provide the knowledge and skills necessary to navigate the complex regulatory environment, conduct effective audits, and ensure the highest standards of quality are met. Training topics can range from internal and external auditing practices, GMP compliance , to quality control procedures for biologics and biopharmaceuticals.

Choosing the Right Quality Assurance Training Program

When selecting a Quality Assurance training course, it's vital to choose a program that offers comprehensive coverage of QA/QC principles, taught by certified instructors with real-world experience. Courses should cater to various roles within the pharmaceutical industry, including production managers, laboratory managers, and QA auditors, and cover topics relevant to both chemical and biological pharmaceuticals.

For example, courses like " Effective Internal and External Quality Assurance Auditing for FDA Regulated Industries " and " Quality Assurance/Quality Control for Biologics and Biopharmaceuticals " are designed to equip participants with the necessary skills to ensure compliance and promote quality within their organizations.

Takeaways

Quality Assurance is the backbone of the pharmaceutical industry, ensuring the safety, efficacy, and compliance of products. For professionals looking to advance their careers in QA, choosing the right training course is essential. By enhancing their skillset through specialized training, QA professionals can significantly contribute to the success and integrity of their organizations.

For more information on Quality Assurance training courses tailored to the pharmaceutical industry, consider exploring programs offered by CfPIE. CfPIE's courses are an invaluable resource for those committed to maintaining the highest standards of quality and compliance in the fast-paced and highly regulated pharmaceutical sector.

If you need help with these topics or any other related ones, let’s talk .

GCP Audit Checklist for Pharmaceutical Facilities

Sun, 28 Jan 2024 00:55:37 GMT

Good Clinical Practice (GCP) is a global standard for ethical and quality principles in clinical research. The goal of GCP is to ensure the safety and rights of all participants, alongside ensuring reliable trial data.

GCP covers a diverse range of topics, from informed consent documentation to accurate data reporting. Abiding by GCP principles is crucial to creating public trust in medical research, handling participant information, and accurately reporting results.

Compliance with GCP is critical for the ethical integrity of any clinical study. GCP auditing aims to evaluate an organization’s compliance and then provide corrective actions if necessary.

What is a GCP audit, and what items does it investigate? Keep reading to learn more about the different types of audits and a comprehensive checklist that auditors use to evaluate your organization.

What is a GCP Audit?

What is good clinical practice auditing? These thorough inspections aim to ensure clinical trials adhere to specific guidelines. A GCP auditor evaluates compliance with all applicable regulations, participant rights and safety, data integrity, and qualifications of investigators. The process also includes ensuring the correct handling of investigational products, data management, and the adequacy of facilities.

These audits are carried out by regulatory authorities and can occur at any stage of a trial to guarantee ethical conduct, safety, and reliable results. FDA good clinical practice regulations must be adhered to, or there may be fines and other penalties, making it crucial to have the right personnel and systems in place to pass these audits.

Good Clinical Practices Audit Types

GCP compliance audits evaluate several different aspects of a clinical trial. These types of audits serve different purposes and take varying forms, including:

Site audits: This type of audit evaluates the sites being used for clinical trials. These comprehensive evaluations examine how a specific site conducts trials, ensures the safety of participants, manages data, and ensures overall adherence to GCP principles.
Monitoring audits: A monitoring audit focuses on the activities specific to monitors and trial management. They focus on the processes and effectiveness of monitoring participants and results, ensuring the trial is conducted in accordance with GCP regulations.
Full clinical trial audits: A full clinical trial audit covers the entire clinical study at trial sites. This extensive audit covers all aspects of the trial from start to finish, including how participants are recruited, data collection, and reporting processes.
CRO audits: A Contract Research Organization (CRO) is an organization that manages clinical trials on behalf of sponsors. CRO audits evaluate compliance with GCP standards, similar to other audits, and often extend to personnel qualifications.

Each type of audit in clinical trials is crucial to overall GCP compliance. Your organization needs the right people involved to ensure all practices are fully adherent and adequately documented.

Good Clinical Practices (GCP) Facility Audit Checklist

Auditors will follow a checklist when evaluating your organization's adherence to GCP good clinical practice guidelines. We’ve put together a similar checklist that auditors will follow to help you understand your current practices and any gaps that need to be addressed.

Facility Audit

Documentation

Informed Consent

Your Next Step in Professional Excellence Awaits

Prepare for GCP Audits with CfPIE

Meeting good clinical practice regulations is crucial but requires specific training and knowledge about these regulations. Learning principles of good clinical practice is necessary to pass these audits.

Earning a good clinical practice certification demonstrates your understanding of GCP principles and your ability to help organizations pass these audits.

Ready to earn your certification? Learn how to identify common issues seen in clinical trials with CfPIE's GCP training course, or explore other related courses:

The Role of Data Integrity Training in FDA Regulatory Compliance

Mon, 08 Jan 2024 18:52:57 GMT

Regulatory compliance in pharmaceutical, biotechnology, and medical device manufacturing industries is critical for ensuring the safety and efficacy of all products that reach the end user. Meeting all applicable regulatory requirements is a complex process with plenty of moving parts — one of which is data integrity validation.

Data integrity refers to the accuracy of data throughout its lifecycle. Maintaining data integrity is a critical process as it ensures the trustworthiness of all information used in decision-making, pharmaceutical and medical device product evaluation, and compliance audits.

The rapid advancement of technology has also increased the complexity of healthcare-related fields, making data integrity a challenge yet vital. Data integrity training courses aim to prepare those working in the pharmaceutical, biotech and medical device industries to maintain accurate and dependable data throughout the research, prototyping, and manufacturing processes.

So, ready to learn why data integrity is crucial under the lens of regulatory compliance, common issues with data integrity, and how specialized training helps overcome these challenges.

Understanding the Role of Data Integrity in Regulatory Compliance

Data integrity in pharmaceutical and other healthcare industries is necessary to meet regulatory requirements. Agencies such as the Food and Drug Administration (FDA) set strict guidelines to make sure all products on the market are effective and safe for patients. FDA computer system validation is one aspect of the agency’s requirements. The European Medical Agency (EMA) also dictates data validation requirements if you plan on making your product available in the EU.

Pharmaceutical data integrity that meets compliance standards requires accurate data collection, secure data storage, audit trails, and transparent reporting. Any issues in these processes can both affect end-user care and can jeopardize FDA compliance.

Computer systems validation training aims to prepare pharma and medical device personnel to ensure data integrity at every step, avoiding possible consequences of non-compliance.

The Consequences of Non-Compliance with Data Integrity Regulations

What might happen if your data integrity processes are non-compliant? Let’s review some of the possible results to demonstrate why thorough data integrity training is so critical, such as:

Fines and financial issues: Non-compliance can affect your organization’s finances in several ways. Immediate fines from regulatory agencies are an up-front expense that now must be managed. However, there can be long-term financial costs from legal processes, expenses to implement correct actions, lost revenue from recalls, and a decline in stock value. Keep these costs in mind when considering data integrity inspection training.
Public safety concerns: Non-compliance isn’t only about the consequences from agencies — medical devices or pharmaceuticals may become unsafe for the public. The ultimate goal of FDA and EMA standards is to ensure the safety of all pharmaceutical and medical device products on the market, so not meeting these standards can have serious consequences on end users.
Legal repercussions: Depending on the specific situation, imposing fines or recalls may not be where regulatory agency actions end. The FDA and EMA may also take legal action against non-compliant companies, which can include a complete shutdown of all facilities. These actions are costly to resolve and can create lost revenue during the shutdown.
Reputation damage: Non-compliance actions are typically publicly available and may damage the reputation of your organization. Depending on the specific fine, your organization may lose public trust, and it can take years to regain it. There may be a lasting decrease in stock prices and lost revenue long after the specific issue is resolved.

Data integrity relates to all of these issues by ensuring you’re able to prove adherence to all regulations throughout the manufacturing process. While failing to meet specific data integrity standards can result in severe consequences, having non-compliant processes can also snowball into other issues throughout the operation.

Data Integrity Validation Issues Compliance to Address

Your organization will need to demonstrate adherence to all quality and compliance standards by the FDA and EMA. Pharmaceutical and laboratory data integrity training is crucial to preventing any possible non-compliance resulting from inaccurate or inconsistent data. Let’s explore some of the key challenges to overcome with data integrity.

Inaccurate Data Reporting

The FDA has highlighted that a major concern is inaccurate or incorrect reporting when it comes to sterility, microbial, and endotoxin data . Inaccurate data, even a single error, can catalyze widespread inaccuracies throughout the rest of the reported data.

Data integrity training prepares personnel to validate collected data at key intervals to prevent inaccurate reporting. Understanding the right processes and tools involved in capturing, validating, and securing data goes far in ensuring final reporting is error-free.

Data Loss

Losing data can occur due to a wide variety of reasons, such as transitioning to a new system, human error, or cybersecurity incidents. Permanent data loss can quickly result in non-compliance.

New technologies and tools have emerged to help prevent these issues — but your personnel need to know how to use them effectively. One goal of data integrity training is to equip teams with the latest knowledge and skills to effectively use these new tools.

Risk of Data Manipulation

Moving from paperwork to digital data creation and storage has created entirely new challenges and risks, including data manipulation. Everything from unauthorized changes to partial deletion can result in breaching FDA or EMA standards.

Equipping your teams with the right knowledge and skills for properly creating and storing data can go far in maintaining data integrity at every step.

Limited Scope for Investigations

Regulatory agencies have noted poor data quality at pharmaceutical manufacturer facilities in the past, but they don’t always result in comprehensive investigations. As a result, the FDA may be focusing on expanding the scope and launching more rigorous investigations.

Preparing your teams with data integrity training now will make sure you avoid being targeted for rigorous investigations should the FDA expand the scope of data quality issues.

Transform Your Career with Leading-Edge Data Integrity Training

Are you ready to elevate your professional standing in the pharmaceutical, biotech, or medical device industries? Don’t miss the opportunity to be at the forefront of regulatory compliance. Enroll in CfPIE's specialized training courses and gain:

Expert Knowledge: Learn from industry veterans and get insights into FDA and EMA compliance that you can't find anywhere else.

Hands-On Skills: Dive into real-world scenarios with our practical, interactive training modules. Master the art of data integrity validation and become indispensable to your organization.

Career Advancement: Our certification doesn’t just signify your expertise; it opens doors to new career opportunities and marks you as a leader in your field.

Network of Professionals: Connect with a network of peers and industry leaders. Share experiences, challenges, and solutions with those who speak your language.

Your Next Step in Professional Excellence Awaits

With CfPIE, you're not just learning – you're transforming your potential into real-world excellence. Spots are limited, and the demand is high. Secure your place now and become a beacon of compliance and data integrity in your industry!

The Center for Professional Innovation and Education (CfPIE) is a leading provider of training courses designed to help your organization maintain full compliance with all applicable regulations and ensure the safety of all medical products. Some of our courses to consider to help meet these goals include:

Register your personnel today to stay up on the latest data validation practices to help keep your organization FDA compliant.

The Science Behind Pharmaceutical Freeze Drying: Everything You Need to Know

Wed, 27 Dec 2023 19:09:50 GMT

Modern pharmaceutical manufacturing depends on providing consistent efficacy and the longest possible shelf life. Freeze drying, also known as lyophilization, is a core process for achieving these goals to provide patients with safe and effective medications.

What is lyophilization? This complex process leverages key scientific principles and leading technologies to produce medications ready for transportation and storage. Vaccines, antibodies, and proteins degrade with other methods, making lyophilization critical for many modern treatments.

The utility and popularity of freeze drying is evident in the global freeze drying equipment market, which is estimated to reach $3.5 billion in 2030 , up from $1.75 billion in 2022.

Freezing drying pharmaceuticals is an exciting and crucial process. So, keep reading to learn everything you need to know about this central process — and what the future may hold.

Interested in learning about freeze drying? Learn the latest lyophilization technology in our course: Lyophilization Technology - Application of Scientific Principles

Introduction to Pharmaceutical Freeze Drying

Lyophilization, or freeze drying, is a critical process in the pharmaceutical industry. Freeze drying involves freezing a substance while reducing the surrounding pressure, allowing the frozen water to sublime directly from the solid to the water vapor or gas phase.

This time-tested technique is vital for applications in which sensitive biological materials must be preserved, such as vaccines or antibiotics, which may degrade in liquid form. Lyophilization goes straight from solid to gas, bypassing the potentially detrimental liquid phase.

The Importance of Freeze Drying Pharmaceuticals

Why is this process so vital to pharmaceuticals? Lyophilization drugs are crucial for maintaining efficacy for many types of medication, while also extending shelf life without compromising quality or integrity.

Freeze drying also reduces the weight of the final product by removing water, making storage and transportation more efficient. Pharmaceuticals also become more resistant to temperature changes during shipping and storage.

Brief History of Lyophilization Technology

Freeze drying pharmaceuticals began in World War II and were used to preserve penicillin and blood plasma. Lyophilization was a critical breakthrough as it allowed for longer-term storage and overseas transportation of vital supplies.

The technique proved its utility during wartime, and since then, the lyophilization technology has significantly evolved and has become more widely used for a range of pharmaceuticals, especially antibiotics or vaccines, that need the most extended shelf life possible.

The lyophilisation process has recently enabled enhanced automation, quality control, and scalability — making it a critical tool in producing and distributing pharmaceuticals.

The Process of Freeze Drying

The lyophilization process in the pharmaceutical industry plays a vital role in modern pharmaceutical manufacturing and transportation.

Let’s discuss the process of freeze drying, but be aware processes can vary based on specific needs and chosen pharmaceutical formulations. The overall steps in the lyophilization process are:

Formulation and pre-freezing: The process begins by choosing the correct formulation and pre-freezing techniques for the specific pharmaceutical. The chosen liquid formulation and pre-freezing practices affect the size and shape of larger ice crystals, which later impacts the drying phases.
Freezing: The pharmaceutical is brought well below freezing to convert all water into ice. The freezing pattern must be done per the chosen formulation.
Primary drying phase (sublimation): Next, the pressure is lowered, and heat is applied, which causes the ice to sublimate directly to gas. Primary drying removes roughly 95% water from the product, which must be done carefully to ensure the drug's integrity.
Secondary drying phase (absorption): The last step focuses on removing the remaining bonded water molecules from the product by increasing the temperature. This stage strives to achieve the ideal moisture content while ensuring the stability and preservation of the lyophilized drugs.

Careful monitoring, temperature control, and pressure control are critical to ensure the stability and quality of the final product.

The lyophilized product is a dry powder, which may be rehydrated when necessary. The product retains its original chemical properties and biological materials found in the pre-frozen material. Lyophilization proteins, antibodies, and other complex molecules benefit significantly from this method, as heat and environmental conditions are otherwise damaging.

Applications of Pharmaceutical Freeze Drying

Freeze drying is used for several pharmaceutical products. Some types of pharmaceuticals that leverage free drying include:

Vaccines and antibodies that improve longevity and storage, especially when maintaining cold temperatures during transportation are challenging.
Complex proteins, peptides, and other molecules are used throughout many medications but degrade faster when stored in liquid.
Enzymes and hormones can also degrade in liquid form and are used in a range of treatments.
Active pharmaceutical ingredients (APIs) are often biologically derived and freeze dried to remain effective for usage in specific medications.

The freeze drying process improves on other drying methods due to its ability to preserve complex biological products. Lyophilization is a gentle process that minimizes the risk of degradation that can occur with other heat-based methods.

However, one of the limitations of freeze drying is that it’s more time-consuming and energy-intensive — making it more expensive than other methods. Yet, its unique benefits justify the higher costs since it’s able to keep some types of drugs safe and effective during transportation or storage.

Scientific Principles Behind Freeze Drying

Lyophilization is made possible due to physical and chemical scientific principles . We touched on some of these when discussing the process, but let’s dive deeper into the phenomena that make freeze drying possible.

Physical and Chemical Changes

Water in the pharmaceutical product undergoes several changes throughout freeze drying. The liquid water is frozen, then subjected to high pressure, and becomes gas.

Usually, water would have to go through a liquid phase to become a gas — sidestepping this phase preserves the composition and integrity.

Sublimation and Desorption

The direct transition from solid to gas is known as sublimation. Once complete, it’s followed by desorption, a process that removes bound water molecules and further dries the product. Knowing the correct temperatures and pressure levels specific to the chosen formulation is vital to achieving the right results.

The Application of the Phase Diagram

The phase diagram and related temperature points demonstrate the relationship between temperatures and pressure that must be applied to water. Understanding and applying this data is necessary to manufacture a stable product and void degradation.

Equipment and Technology Used in Freeze Drying

Specialized equipment and technologies are what make freeze drying possible. Let’s explore some of the tools necessary for effective freeze drying:

Freeze dryers: Several types of freeze dryers are available depending on the needs of the manufacturing, including industrial-scale, laboratory, and benchtop models. These different types use similar technologies but vary in scale and use case:
Industry-scale models are leveraged for mass production.
Laboratory models are necessary for research and development.
Benchtop models are used during small-scale experimentation.
Vacuum and temperature control systems: This equipment is critical for the sublimation and desorption processes. These systems allow for precise control over the pressure and temperature within the freeze dryer to move through each phase.
Lyophilization trays and condensers: Specialized trays hold the product and are placed within the freeze dryers. These trays are designed to withstand freezing and heating and help provide the necessary environment for sublimation and desorption. Condensers are also located in the freeze dryer and capture the vaporized water, enabling the low pressures necessary for the process.

All of these components work together to create stable and efficient creation of lyophilized products. Each of them is purpose-built to aid in stable and effective workflows.

Challenges and Considerations in Freeze Drying

Freeze drying is not without its unique challenges that need to be understood and addressed. A few of the key challenges include:

Heterogeneity and collapse: A significant challenge with lyophilization is effectively managing the heterogeneity of the product; otherwise, heterogeneity can result in uneven drying and collapse. This results when some areas of the batch dry improperly, and the pharmaceutical materials lose structure. Addressing this challenge depends on precise control of freeze-drying parameters by understanding the materials' thermal properties.
Preventing oxidation and moisture absorption: The quality of product can be significantly compromised during transportation or storage without an effective moisture absorption process. This risk can be mitigated by moisture-resistant packaging and possibly adding antioxidants to the formulation.

Stability testing and formulation: Testing the final product is a critical element of the entire process. Testing involves understanding the stability and shelf life of the freeze dried product. Efficacy should also be evaluated at specific intervals to understand when the product is expired.

Future Advancements and Trends in Pharmaceutical Freeze Drying

Pharmaceutical freeze-drying is a constantly evolving practice that strives to improve the operational efficiency and efficacy of the final product. Some of the advancements and trends currently shaping the future of lyophilization include:

Advanced freeze dryer designs: Freeze dryers are undergoing constant improvements and becoming more sophisticated with each new generation. The core goal is to improve condenser efficiency, performance, and reduce cycle times.

Freeze Drying is a Core Pharmaceutical Process

The process of lyophilization pharmaceutical manufacturing is a central pillar of many types of pharmaceutical manufacturing. Understanding the scientific principles and how they are applied is critical for everyone involved in freeze drying.

Stay updated on the latest developments in the field with CfPIE. We offer continued education or initial training for you or your workforce to learn the latest technologies and processes in the pharmaceutical industry.

Looking for additional training? Learn more about our programs to learn critical skills for the pharmaceutical and biotech industry.

CfPIE Awarded Five Year Contract by FDA to provide Quality System Regulation Training to FDA Professionals

Wed, 13 Dec 2023 18:37:17 GMT

FDA sessions to begin March 2024, presented by Wen Schroeder,

long-time CfPIE course director.

Chester Springs, Pennsylvania, Dec 13, 2023

The Center for Professional Innovation and Education (CfPIE), the global leader in life sciences training, today announced that it has been selected by the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation & Research (CBER) to provide US Medical Device Regulation & Quality Management System Requirements to select FDA professionals, beginning March 2024 with options to continue through September 2028.

“The Agency understands and appreciates the need for Quality Management System (QMS) requirements that can apply to both large and small manufacturers for streamlining and harmonizing the standards for quality systems. As the Agency continues to apply least burdensome concepts for regulations, we recognize there is a need for a globally unified quality system that will reduce burdens to both industry and FDA,” expressed FDA in the Statement of Work. “FDA intends to harmonize QMS requirements for medical devices with the International Standards Organization’s (ISO) requirements for medical devices under the ISO 13485 (QMS Standard).”

“CfPIE, which has been training FDA personnel since 2007, is excited to be part of this new harmonization effort. Our expertise, flexibility, and reputation make us the clear choice to provide direct training support to the FDA, the world’s leader in regulatory promotion and protection of public health,” states Mark Mazzie, CEO of CfPIE.

This fully customized course will be presented by Wen Schroeder, Quality Systems Regulation expert and CfPIE course director for the past 10 years. In addition, Ms. Schroeder will be presenting the following public courses for CfPIE several times throughout 2024, all via live stream:

Visit this page for dates and times of their publicly offered live stream courses, or for information on bringing a fully customized course directly to your facility, either via live stream or in person presentations, visit https://www.cfpie.com/custom-on-site-training.

About CfPIE

The Center for Professional Innovation and Education (CfPIE) is the global leader in life sciences training, providing specialized courses for pharma, biotech and medical device topics. Classroom and custom on-site formats, and certification programs help improve personal skills, maintain regulatory compliance, and advance careers. Small class sizes and industry-active course directors promote a dynamic learning environment with excellent student-to-teacher interaction. More information: https://www.cfpie.com

About Wen Schroeder

Wen Schroeder is the founder and president of SEKI Cosmeticals. With 20+ years of industrial experience, 30 US patents and author of numerous publications, Ms. Schroeder is an internationally recognized lecturer in medical device regulations & regulatory affairs covering a wide range of subject areas, including design product performance & safety testing programs for pharmaceutical, medical devices, and food products. She is a key expert for numerous cross-governmental aid programs including the ASEAN-EU Programme, under the European Commission, for Regional Integration Support in GMP and testing. She has taught numerous training workshops for the European Commission EU-Aid Program covering topics such as, Drugs/Medical Device, Generic Drugs, ACTD, Labelling, Pharma GMP, PICS, ACTR, Stability, BA/BE, Validation, Contract Manufacturing/CRO, Microbiological Controls, and Good Clinical Practices. More information: click here .

About FDA CBER

CBER is the Center within FDA that regulates biological products for human use under applicable federal laws, including the Public Health Service Act and the Federal Food, Drug and Cosmetic Act. CBER protects and advances public health by ensuring that biological products are safe and effective and available to those who need them. CBER also provides the public with information to promote the safe and appropriate use of biological products. More information: click here .

The Benefits of Medical Device Compliance Certification

Fri, 01 Dec 2023 02:36:23 GMT

FDA medical device requirements must be met by any organization researching or manufacturing medical devices. The FDA’s regulations are designed to ensure end users’ safety and the efficacy of manufactured devices.

But who monitors medical device usage for safety compliance? Every organization needs highly qualified medical device compliance professionals ready to make sure all processes and guidelines are strictly adhered to.

A medical device compliance certification ensures that professionals are equipped with the skills and knowledge necessary to meet all FDA standards, protect patients, and build the manufacturer’s reputation.

Read on to learn more about why medical compliance certifications are essential and their benefits to researchers and manufacturers.

What Is Medical Device Compliance?

Medical device compliance is the practice of ensuring all medical devices meet regulatory standards set by agencies such as the FDA in the United States and the EMA in the European Union.

Complying with standards set by these agencies makes sure all medical products on the market are safe and effective. Designing, manufacturing, market release, and post-market monitoring are all regulated — and failing to comply can have severe consequences.

Additionally, compliance is an ongoing process for manufacturers and makes sure they continue to maintain high healthcare standards and ensure device safety.

Why Is Medical Device Compliance Important?

Compliance is crucial for both legal and ethical reasons. FDA medical device regulation is built around providing safe, effective, and reliable medical devices while also blocking unsafe devices from reaching end users.

Medical device compliance isn’t just about meeting legal requirements; compliance also plays a vital role in building trust in end users and creating a positive reputation for the manufacturer.

Training in the latest FDA standards for medical devices is crucial, as devices connected to networks need to meet cybersecurity standards.

So, why is regulatory compliance important? The importance of regulatory compliance in healthcare can’t be overstated — it’s necessary to protect patients and manufacturers.

What FDA Regulation Required for Medical Device Compliance?

FDA regulations medical devices cover every aspect of medical devices. For network-connected devices, this includes strict cybersecurity measures to protect them from malicious parties.

All companies involved in researching, developing, or manufacturing medical devices need to meet strict regulations in order to keep these devices available to end users.

Some of the FDA’s medical device regulatory compliance standards are:

Registration and listing of devices with the FDA, including manufacturing and importers.
Quality System Regulation (QSR), also known as 21 CFR Part 820, is a regulation that creates a framework for quality management systems to ensure consistent design, manufacturing, testing, documentation, and data handling.
Medical Device Reporting (MDR) falls under the FDA’s 21 CFR Part 803, which regulates reporting certain types of adverse events or product problems to the FDA.
Premarket notification, also known as 510(k), is a review process all non-exempt medical devices must undergo to demonstrate that they are safe, effective, and meet any applicable laws.
Premarket approval (PMA) is a rigorous process that is required for some types of devices. PMA involves a thorough review of all clinical data and supporting documentation to ensure safety and efficacy.
Labelling requirements are required, such as instructions for usage, warnings, or any other pertinent information.
Post-market surveillance procedures to identify any issues that may arise after a device is available on the market.
A Unique Device Identification (UDI) system must be in place for most medical devices that identify each specific device. The UDI must be in human and machine-readable form.
High-risk devices require strict clinical trials to gather safety and effectiveness data before being brought to market.
Strict biocompatibility testing is required to ensure that all materials used in the device will not cause adverse reactions in patients, and if allergic reactions or other sensitives may be triggered, they are disclosed.

Non-compliance with these strict regulations can result in recalls, fines, or legal action. This is why regulatory compliance is crucial to the success of researchers and manufacturers.

Why is Documentation Essential for Medical Device Regulatory Compliance?

Thoroughly documenting device compliance is a central process for strict regulatory and quality standards. Some of the reasons why documenting regulatory compliance is crucial include the following:

Proves compliance and quality assurance ; proper documentation proves that devices meet regulatory standards.
Demonstrates risk management procedures and traceability of materials.
Creates legal protection by showing adherence to regulated processes.

The technologies and process for proper documentation are one of the many things students learn when attending a reputable certification course.

Benefits of Medical Compliance Certification Courses

Earning a medical device regulatory compliance certification offers plenty of benefits for individuals and organizations that hire certified professionals. So, let’s explore these benefits and illustrate why certifications are so critical.

Protection Against Government Sanctions and Fines

Adhering to compliance standards is necessary to avoid the severe penalties that accompany non-compliance, which include substantial government sanctions, fines, or a complete recall. Authorities that dictate and monitor medical device regulations in the United States are:

The Food and Drug Administration
The Office of Inspector General
The General Services Administration
The Office of Foreign Assets Control
The Drug Enforcement Administration

Be aware that these are only the federal agencies, as individual states may also regulate activities and have Medicaid policies that influence relationships with manufacturers. State and federal governments are increasingly dedicated to maintaining a strong commitment to making sure companies adhere to all regulations.

Daily workflows need to be well documented, correct actions must be taken for any compliance issues, and companies need to meet external audits. Implementing ongoing training helps avoid fines and possible sanctions for non-compliance.

Addressing Concerns More Consistently

Earning a professional certification creates procedures to address any concerns in a consistent way. Everyone involved in research and development or manufacturing can be on the same page and follow comprehensive workflows. Certifications establish these standards to create better communication and collaboration throughout the organization.

We explored why documentation is so essential earlier, and certifications establish the right processes to document critical areas necessary to prove compliance correctly. Correct documentation enables teams to identify possible issues more efficiently and implement corrective actions.

Boosting Staff and Patient Confidence

The last thing healthcare staff or patients want to hear is, “This device does not meet your organization's compliance requirements.” Ensuring compliance with regulatory requirements avoids this issue and boosts your organization’s credibility and professional expertise.

For manufacturers, requiring certification for new hires shows your staff, clients, and patients that you’re committed to providing safe and effective services. Implementing medical device training shows that your organization is serious about regulatory compliance.

Preventing Unethical Behaviors

Unfortunately, medical negligence can occur in any organization, and it can ruin an organization's credibility. That’s why leading healthcare manufacturers place such a strong emphasis on requiring certifications to meet all FDA requirements.

Medical device compliance certification establishes the processes and procedures to detect any possible unethical behavior. Part of these processes includes creating corrective actions should any issues arise. Your organization will detect any errors, mitigate risks, and have corrective actions in place should any incidents occur.

Advancing Your Career as a Medical Professional

For medical professionals, earning a medical device compliance certification contributes to overall professional development and helps you advance in the medical field.

Compliance certification helps anyone involved in medical devices, from initial research to ongoing market monitoring. You’ll be ready to join any team and contribute to providing end users with safe and effective medical devices. Which, in turn, contributes to a better work environment and high morale.

Meet The FDA Compliance Guidelines With CfPIE's Medical Device Compliance Certification

The Center for Professional Innovation and Education (CfPIE) offers training and certifications for pharmaceutical, biotech, and medical device companies. Our medical device compliance certifications prepare graduates to protect your company from any fines or penalties for failing to meet the FDA’s requirements.

Our courses offer training designed to impart graduates with the latest training and technical aptitude to meet the FDA’s expectations.

Are you ready to provide your employees with medical device compliance training or earn the certification yourself? Learn more about our course or contact our teams today at 1-610-648-7550.

Unlock Your Career Potential with a Medical Writing Certification

Fri, 01 Dec 2023 00:14:45 GMT

Become an Expert in the Field!

The field of medical writing is a sprawling landscape with diverse, specialized focuses. Each specialization has its own standards and prerequisite understanding or expertise. Writers in any specialty must understand the nuances of their specific medical writing niche, whether it’s regulatory writing, patient education, or healthcare marketing.

For instance, writing regulatory documents often requires more advanced qualifications, such as a Master’s or even Doctoral degree, and a comprehensive understanding of clinical trials, compliance frameworks, and scholarly editing. These requirements vary significantly from other specialties, like writing patient education materials.

So, let’s dive into what medical writers are, the roles they may work in, and how medical writer training can help you launch your new career.

What Is a Medical Writer

Before we go further, what does a medical writer do exactly? A medical writer is a necessary component of medical communication, which includes:

Research
Regulatory affairs
Health education
Pharmaceutical marketing
Public health policy formulation

The roles of medical writers vary based on the specific role, but overall, they’re responsible for translating complex technical and medical data into accessible information for various audiences.

Let’s dive deeper into the different types and categories of medical writing to help you better understand the roles you may take in your new career.

Types of Medical Writing

Medical writing certification courses cover a broad spectrum of material to prepare you for various specific roles after graduation. So, let’s break down the different types of medical writing reflected in medical writing courses so you can consider which role sounds most appealing.

Technical vs. Accessible

We can broadly divide medical writing roles into technical and accessible writing styles. Technical writing is intended for audiences familiar with the terms and jargon, such as academic writing, whereas accessible medical writing is intended for a broader audience.

For example, WebMD is an excellent example of medical writing aimed to be accessible to anyone on the Internet rather than people with medical training. Conversely, writing in medical journals aimed at clinicians or researchers will employ more specialized terminology.

Editing vs. Copy Editing vs. General Writing

Multiple experts are involved in creating any medical writing materials, just like other types of writing. The typical roles involved in taking an assignment from idea to final deliverable are:

Writer: The medical writer has in-depth knowledge of the specific domain, allowing them to create accurate and accessible content. The medical writer will typically translate dense technical language into easily understandable material, although this varies based on the specific role.
Editor: A medical editor receives the writer's assignment and then ensures the information's accuracy and consistency. They’ll also catch any errors in grammar or spelling. Editors don’t typically require the same credentials as the writer, but they’ll still need a strong grasp of the topic.
Copy Editor: While the copy editor won’t be present in every project, they’ll often be involved in materials intended for the general public. The copy editor makes the material as understandable, engaging, and interesting as possible.

Each of these roles is crucial in the creation of new material, and getting started with any of them is a great way to begin your career.

Subcategories of Medical Topics

We’ve mentioned that medical writing is a broad category encompassing a variety of specialties, but what are those specialties? Let’s break down the common specialties and keep in mind that any of these can serve as the entry point for your new medical writer career. Possible careers include:

Regulatory writing: You'll focus on creating documents specifically for regulatory agencies and governments. You may draft submissions for legal approvals for pharmaceuticals or medical devices, which need to describe clinical trials.
Education or academic writing: Creating educational content involves detailed descriptions of medical devices or pharmaceuticals for academic purposes. These documents are necessary for healthcare professionals to use for evaluation or reference. Your work may also be used by biotech companies, healthcare facilities, and academic institutions.
Scientific writing: Working in this specialty involves collaborating with researchers to create writeups for scientific documents to submit to peer-reviewed journals, conferences, or professional summaries. You may also write grant proposals to help fund research.
Healthcare communications: A healthcare communications writer creates material intended to give information to patients or the general public. You may write for websites, news outlets in the healthcare industry, and help with press releases.
Promotional writing: This career is similar to healthcare communications but focuses more on advertising materials for pharmaceuticals or medical devices. You’ll need the additional skills of a copywriter to create effective advertising content.

Skills and Knowledge Gained Through a Medical Writing Training Certification

A medical writing certification prepares you with the essential skills and knowledge you need to succeed in this diverse field. You’ll learn several core competencies necessary for a lasting career, such as:

Medical terminology
Regulatory compliance
Ethical standards
How to effectively communicate complex medical information
Writing in a clear and concise manner
Mastering document structures and guidelines
Honing critical thinking skills
Understanding how to conduct research by using reputable sources
Creating evidence-based medical documents

So how do you get started? Attending a certification course will teach you the above skills and background knowledge to help you succeed.

Overview of the Certification Process

The best way to start your new career in this field is by attending one of the many medical writing certification courses from different educators. There are plenty of providers of these courses, but it’s crucial to investigate each educator's reputation and the certifications you’ll walk away with.

The Center for Professional Innovation and Education (CfPIE) is a global leader in high-quality training and certification through a range of life sciences, including medical writing certification.

Our medical writer certification program offers extensive benefits, which include:

Opportunity to earn the title of Certified Medical Writing Professional (CMWP).
Access to comprehensive courses covering documentation, grant submissions, and product marketing specific to medical writing.
Training in both technical and accessible writing to prepare for any career you choose.
Education on regulator requirements from various agencies you’ll likely encounter.
Insights and practical information about the submission process for grant proposals.
Expertise in the guidelines and strategies for effective medical products

You’ll be ready to forge your new career after completing our comprehensive medical writer course , whether that means writing grant proposals or marketing materials.

However, the course alone isn’t the certification — you’ll need to complete a comprehensive exam covering all of the above topics to become certified.

Possible Requirements

We typically recommend having a background in writing or scientific fields. For example, a background in journalism, life sciences, or medicine will go far in preparing you for a career as a medical writer.

Enrolling in a certification course may have strict requirements depending on the educational institution.

Benefits of Becoming a Certified Medical Writer

Why should you become a certified medical writer? Some of the key benefits of earning your certification are:

Earn a credential that speaks to your professional credibility and overall capability to accomplish stated responsibilities.
Certification helps open doors to more employment opportunities, and many organizations may require certification to even land an interview.
Higher salary potential than without a certification; we’ll explore earning potential more below.
Learn how to stay aware of changing regulations, evolving life sciences, and maintaining a leading-edge skill set.
Gain access to a professional network of other students, educators, and possible career placement opportunities based on the course provider.

Job Opportunities and Career Growth in the Field

Anyone considering working in a new field will understandably want to know its earning potential. So, how much do medical writers make? PayScale breaks down a few stats to help understand what you can expect, including:

The average medical writer's salary in 2023 is $81,000 , with the lower end earning $61,000, and the experienced writers on the higher end earning $110,000.
The average medical editor's salary in 2023 is $70,500 , with the range going from $41,000 to $93,000.
For both jobs, certifications, degrees, and experience will help you reach the upper salary range.

Succeeding in this career requires a strong attention to detail, an understanding of compliance requirements, and medical knowledge.

For most people, we don’t advise starting a writing career with medical writing. It’s worth exploring other types of writing beforehand to
get a feel for making a living by writing content.

Grow Your Medical Writing Career by Gaining Experience

Experience is crucial for growing your writing career. You may wish to start off with an internship or junior role to start gaining experience. You can also work in adjacent areas such as account or project management to build up overall industry experience.

On top of work experience, you should also focus on becoming proficient with the leading-edge tools and technologies in medical writing. Instead of simple word processors, there’s a growing shift to advanced content management systems. You may also wish to gain additional skills in technical communication, illustration or graphic design to bring more to the table.

Pursue a Medical Writing Certification and Unlock Your Career Potential

Deciding to start a new career in medical writing can be a great way to blend medical understanding and writing proficiency.

Earning a medical writing certificate is a strong first step, and getting started, from there, you can embark on any of the possible entry points we explored above. You can also earn a medical editor certification to start gaining experience in the industry, and then you can later become a writer or copy editor.

CfPIE is an industry leader in professional certifications for medical and pharmaceutical specialties. We offer medical writers training led by instructors with real-world experience and crafted to prepare students for a lasting career in the industry.

What Skills Do You Need To Thrive In Medical Device Compliance Career

Thu, 02 Nov 2023 18:47:32 GMT

Medical device manufacturers face a wide range of compliance regulations, creating the need for medical device compliance to ensure all processes meet these regulations and are properly documented.

Medical device compliance jobs are crucial for any organization in the field. Individuals with the medical device certifications can fill these roles and protect companies and end-users alike.

What skills do you need for a successful career in the medical device compliance industry? Keep reading to learn the training, knowledge, and expertise necessary to begin and thrive in this evolving specialty in the medical device industry.

Introduction to the Medical Device Compliance Industry

Compliance with multiple regulations is required throughout the medical device sector. New regulations have emerged, and existing frameworks have recently evolved to ensure all medical devices operate as designed — otherwise, the patient’s health can be jeopardized.

Failing to comply with applicable regulations can result in fines and penalties that can significantly disrupt operations. As a result, there’s a growing demand for medical device regulatory compliance experts to protect consumers and the organization.

Professionals involved in medical device compliance must be well-versed in all applicable regulatory frameworks when creating benchmarks for product testing, documentation, and manufacturing processes.

1. Understanding Regulatory Frameworks

Regulatory frameworks are the guiding blueprints that outline the standards, requirements, and guidelines medical devices must meet before being provided to end-users. These frameworks are carefully developed by regulatory bodies and industry experts to ensure that medical devices are safe, effective, and of the highest quality.

Medical device compliance training requires understanding regulatory frameworks, including documenting necessary information and generating audit reports.

The most essential skill for anyone in this field is having an in-depth understanding of regulatory frameworks. The U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) regulations and the European Union Medical Device Regulation (EU MDR) are crucial frameworks to understand.

Both of these frameworks work similarly and regulate vital elements of medical device manufacturing, including:

Quality concerns related to product design
Data validation
Documenting clinical trials
Regulatory filings

Depending on your organization's operational jurisdictions, you may need to learn additional frameworks. It’s common for compliance experts to need to be familiar with not just one country's regulations but multiple international standards, as devices might be marketed across borders.

A thorough understanding of all applicable regulations enables professionals to prevent medical device compliance issues and ensure all devices on the market consistently meet the highest standards of care and safety.

2. Knowledge of Quality Management Systems

Quality Management Systems (QMS) involve processes and technologies that allow organizations to better understand manufacturing processes to improve medical devices and prove compliance with applicable regulations.

You’ll need a comprehensive understanding of QMS to thrive in this career, as these systems are necessary to ensure medical devices meet strict regulatory and safety standards.

The key components of a QMS form the foundation for ensuring compliance in the industry, which include:

Thorough documentation
Controlled processes
Clear performance metrics
Mechanisms for continuous improvement

Compliance professionals need to learn these elements inside and out for theoretical knowledge and practical application. This knowledge allows you to navigate and address complex compliance issues efficiently, ensuring that medical devices are safe and effective for patient use.

Thorough QMS knowledge is a cornerstone for success in a medical compliance career due to the potential health implications and strict regulations in the medical device industry.

3. Risk Management Expertise

The world of medical device certification and compliance is known for its complexities, and the consequences of oversight can directly impact patient safety and health. The device manufacturer may also face fees and penalties if patient safety is affected.

That’s why risk management is not just an administrative procedure — it's a crucial practice to protect both patients and manufacturers. Effective risk management serves as the first line of defense against potential product failures or malfunctions that could adversely affect patient outcomes.

Compliance professionals will need a range of risk management processes and techniques, which may include some of the following:

Failure Mode and Effects Analysis (FMEA)
Fault tree analysis
Risk-benefit analyses

These strategies allow medical device compliance experts to ensure that potential hazards are identified, assessed, and mitigated — all in an effort to make sure devices on the market meet the highest standards of safety and effectiveness.

4. Strong Analytical and Problem-Solving Skills

A career in medical device certifications and compliance will significantly benefit from an analytical mind and exceptional problem-solving abilities.

Professionals in this role frequently face dense regulatory texts and standards that demand meticulous analysis due to the intricacy of medical device manufacturing regulations.

Strong analytical skills enable these experts to break down and interpret these complex regulations and make sure that no detail is overlooked. Additionally, they’ll be ready to hone in on compliance gaps in current processes, which may otherwise lead to breaches, costly fines, or jeopardize patient safety.

Problem-solving is also crucial for thriving in this career. The landscape of medical device compliance is not static — regulations evolve, and new challenges emerge. As a result, medical device compliance professionals need specialized problem-solving strategies and techniques.

These skills may involve root cause analyses on a range of compliance concerns, addressing regulatory ambiguities, or implementing corrective actions to make sure compliance is maintained.

Ultimately, a blend of analytical thinking and problem-solving is essential for those striving to excel in medical device compliance and certification .

5. Effective Communication and Collaboration

While technical skill is necessary, effectively communicating and collaborating is just as necessary to succeed as a medical device compliance expert.

Compliance involves various stakeholders, including research and development teams, manufacturers, regulatory bodies, and end-users. Effective communication ensures that all involved groups understand the intricacies of compliance requirements, vital to ensuring device safety and efficacy.

Communication is not just about relaying information but doing so in a clear, concise, and actionable manner. Additionally, collaboration is crucial in streamlining processes and creating a unified approach towards compliance goals.

How can compliance experts communicate effectively? Tailoring the message to the audience when conveying compliance requirements to different stakeholders is essential. Let’s quickly review the following examples to see how communication varies based on the audience:

For R&D teams, a deep dive into the technical aspects might be warranted, such as explaining the 'why' behind each requirement.
Focusing on the practical implications and procedural adjustments might be more beneficial for manufacturing plants.
You’ll likely require a more formal communication approach for regulatory bodies, detailing adherence procedures and providing evidence of compliance.
Meanwhile, end-users or the general public will benefit from simplified, jargon-free explanations highlighting the importance of such standards for their safety.

You can see how mastering the art of effective communication and collaboration is crucial for any professionals in the medical device compliance field — you’ll make sure all stakeholders are working together to deliver safe and compliant medical devices.

Conclusion and Next Steps

The medical device compliance sector is growing rapidly and needs trained, certified professionals to fill compliance roles. You’ll be involved throughout the manufacturing process, process reports, ensure the right quality management systems are in place, and work with other teams to keep your organization compliant.

Medical device compliance certifications prepare you for working in this industry and show potential employers that you’re ready to help keep them compliant.

CfPIE is an industry leader in medical device compliance certification designed to prepare you for working in the field. Are you ready to get started in this growing field or upskill your employees? Learn more about our program today to see how our programs can help.

How GMP Best Practices Ensure Quality Control in the Pharmaceutical Industry

Thu, 02 Nov 2023 18:43:58 GMT

The pharmaceutical industry is highly regulated due to its effect on patient outcomes. Medications must maintain a consistent level of quality and effectiveness; otherwise, patients pay the price.

The specific regulations vary between jurisdictions, but abiding by Good Manufacturing Practices (GMP) creates the baseline for safe and effective pharmaceutical manufacturing. Drug manufacturers can make specific changes to abide by applicable regulatory requirements from there.

GMP best practices focus largely on quality assurance and quality control (QA/QC), which is a set of processes and inspections, all designed to ensure drugs, biologics and medical devices meet established guidelines and effectiveness.

How exactly does this play out in the pharmaceutical industry? Keep reading to learn more about this crucial topic, including the benefits and challenges of abiding by GMP best practices to ensure quality control.

Importance of Quality Assurance and Quality Control in the Pharmaceutical Industry

Quality Assurance and Quality Control (QA/QC) in the pharmaceutical industry is not only about meeting standards — it's a critical component of public health. Over-the-counter and prescription medications directly affect millions of individuals' health and well-being daily.

Inconsistent quality or the presence of impurities can lead to adverse reactions, diminished efficacy, or even harm patients. QA/QC ensures that every batch of a drug on the market is consistent in strength, purity, and effectiveness. Additionally, comprehensive quality control processes can identify potential issues at an early stage, allowing for corrective actions to be taken before products reach consumers.

QA/QC serves as a protective measure and a cornerstone for maintaining the credibility and reputation of pharmaceutical companies in an industry where trust is of the utmost importance.

What is Quality Control in Manufacturing?

QA/QC ensures that medicine reaching consumers meets the highest quality standards. Quality control encompasses testing products against predefined standards, documenting processes, calibrating instruments, and monitoring the entire manufacturing environment.

Regulatory authorities set these standards to ensure medicinal products are safe and effective. Compliance with all applicable regulations is crucial, and non-compliance can lead to potential recalls or legal repercussions.

Overview of GMP Guidelines and Regulations

QA/QC in the pharmaceutical industry is primarily based on Good Manufacturing Practice (GMP) guidelines and regulations. This framework sets the standards for pharmaceutical manufacturing and quality control.

GMP isn’t exclusive to the pharmaceutical industry — it’s a widely used framework for many industries. Regarding pharmaceutical manufacturing, GMP encompasses various aspects of production, from the starting materials, premises, and equipment to staff training and personal hygiene.

These guidelines and regulations aim to ensure medications are consistently produced and meet the standards related to their intended use. Beyond the manufacturing process, GMP also focuses on comprehensive testing methods for final product release.

Adherence to GMP guidelines is not optional — it's a mandatory aspect of pharmaceutical production, and failure to comply can result in significant penalties, recalls, or even business closures. The only exception is specific jurisdictions, but drugs manufactured in these areas typically cannot be imported into other regions that require GMP.

Critical Components of GMP Best Practices in QA/QC

GMP guidelines strive to guarantee that products have consistent quality in every batch, regardless of the manufacturer. Everyone involved in production and quality management needs to be trained on GMP validation best practices to prevent affecting patient care and incurring steep fines or penalties.

Let’s review some of the vital components of GMP that strive to maintain consistent quality and effectiveness, such as:

Documentation and record-keeping: Comprehensive documentation and meticulous record-keeping are foundational GMP best practices. Good documentation practices ensure traceability, provide evidence of compliance, and enable a thorough review of production processes to facilitate any corrective actions.
Training and qualification of personnel: The proficiency of the personnel directly impacts the quality of the pharmaceutical product. As such, rigorous quality assurance training and regular assessments are vital to ensure staff are equipped with the latest knowledge and skills to uphold GMP standards.
Facility and equipment maintenance: A well-maintained facility and equipment are essential to prevent contamination and errors. Frequent inspections, cleaning, and calibrations ensure the production environment meets regulatory standards.
Raw material control and testing: Ensuring the quality and consistency of raw materials is of the utmost importance. Thorough testing and robust control measures ensure that only materials meeting predefined quality criteria are used in production.
Process validation and monitoring: To guarantee consistent product quality, it's necessary to validate and continuously monitor all processes. Validation ensures that the manufacturing remains within defined parameters and that any deviations can be promptly addressed.
Packaging and labeling control: Correct packaging and accurate labeling are crucial to product integrity and patient safety. Strict controls make sure all primary packaging materials conform to established specifications, that products are packaged to prevent contamination, and that labels provide accurate, precise information.
Product testing and release: All products must pass rigorous testing to meet all safety and efficacy standards before reaching the market. GMP quality assurance makes sure only batches that pass these stringent tests are approved for release.
Complaint handling and product recall procedures: Manufacturers need an effective system for addressing customer complaints and potential product recalls. These procedures should be well-documented and ensure any issues are handled properly to protect public health and maintain the credibility of the pharmaceutical manufacturer.

Benefits of Implementing GMP Best Practices in QA/QC

Adopting best practices in GMP audits and quality control is a significant step forward for pharmaceutical manufacturers. Integrating GMP best practices into an organization’s quality control testing framework and manufacturing processes has several significant benefits.

Let’s break down some of these benefits manufacturers may experience when adhering to GMP best practices.

Consistent Product Quality

GMP prioritizes strict standards to ensure every product batch is consistent. This consistency means that each medication will provide the same therapeutic effect regardless of when or where it's produced.

As a result, healthcare professionals can prescribe these medicines with the certainty that patients will receive the intended benefits without unexpected variations in dosage strength or effectiveness.

Increased Patient Safety

The strict GMP procedures are designed to reduce the risks associated with pharmaceutical manufacturing, such as reducing the chance of errors, contaminations, and inconsistencies. These risks may lead to adverse reactions or lack the necessary effectiveness if left unchecked.

Abiding by GMP best practices ensures the medicine patients depend on is more likely to be safe, pure, and free from harmful impurities.

Better Economic and Operational Efficiency

GMP isn't just about quality — it's also about efficiency. Implementing these best practices can streamline production processes, reduce waste, minimize downtime, and create faster turnaround times. The economic benefits start to add up when manufacturers reduce the likelihood of costly recalls, reworks, or waste.

Reinforced Public Trust

Reputation is everything in the pharmaceutical industry. Medicines are directly linked to personal well-being, and consumers need to trust their products.

Abiding by GMP best practices and standards builds a company's reputation for producing high-quality, reliable medications. Additionally, consistent quality assurance builds public confidence and increases brand loyalty and trust.

Regulatory Compliance

Pharmaceutical regulations are intricate and never stand still. GMP best practices help manufacturers remain agile and compliant while also adapting to new regulatory requirements as they emerge. Manufacturers will also prevent possible legal issues and ensure products can seamlessly enter and remain in markets with rigorous regulatory standards.

Challenges and Potential Solutions in Implementing GMP Best Practices

GMP best practices provide many benefits, but implementing these standards and practices can be challenging. Some of these challenges and possible solutions include the following:

Insufficient training and skill development: Employees may not have adequate knowledge of current GMP standards. This can lead to unintentional non-compliance, jeopardizing product quality and safety. Regular and comprehensive training programs should be implemented. Additionally, these programs should be updated as regulations change.
Outdated infrastructure and equipment: Older manufacturing facilities or machinery might not meet the stringent requirements of modern GMP. Pharmaceutical companies should invest in modern, efficient, and GMP-compliant equipment that ensures regulatory compliance and can enhance production efficiency.
Inconsistent documentation practices: Document errors or omissions can have severe consequences for product traceability and accountability. These issues are also a significant obstacle in demonstrating GMP compliance during audits. Fortunately, digital systems and software tools can automate many aspects of documentation, reducing the potential for human error.
Evolving regulatory standards: GMP and other applicable regulations are not set in stone. Regulations are updated to reflect the most current understanding of safety and efficacy. To address this challenge, companies need to establish dedicated teams or hire experts to monitor and interpret regulatory changes. This proactive approach can also minimize the disruption of adapting to new standards.
Supply chain inconsistencies: The quality and consistency of raw materials sourced from suppliers can vary, creating unwanted variability in the final product. Implementing rigorous vetting processes is crucial, and quality checks upon receipt of materials can alleviate this challenge.

Importance of GMP Best Practices and Ongoing Training

Following GMP best practices protects the reputation of companies, improves patient care, and fosters trust within the global healthcare community.

However, as the pharmaceutical industry evolves, so do the challenges related to compliance and GMP best practices designed to address these challenges. Fortunately, these hurdles can be overcome with proactive solutions like continuous training, investment in infrastructure, and embracing new technologies.

CfPIE is an industry-recognized provider of training and certification courses throughout pharmaceutical manufacturing. Our courses prepare and certify specialists to help keep their employer’s complaint while ensuring effective patient care.

Is it time for your quality assurance specialists to learn the latest GMP best practices and regulations? Learn more about our QA certification course to discover how we can help.

Computer System Validation Training: Best Practices for Successful Implementation

Fri, 29 Sep 2023 20:00:30 GMT

Computer System Validation (CSV) is a crucial process in FDA-regulated industries like pharmaceuticals, focusing on ensuring computerized systems meet predefined requirements, operate reliably, and comply with regulatory standards.

As such, data validation ensures that data is accurate, secure, and compliant with applicable regulations over its entire lifecycle.

Data is the lifeblood of any drug or medical device development project, which means data integrity is a foundational process throughout the industry. The overall goal of a computer validation system in the pharma industry is to prevent possible software failure and help companies maintain data integrity, accuracy, and compliance.

Attending a computer system validation training course will impart the knowledge and skills necessary to keep pharmaceutical companies fully compliant and efficient. Keep reading to learn more about CSV and why specialized training is crucial.

Introduction to Computer System Validation (CSV)

What exactly is computer system validation? CSV is a practice that ensures the reliability of computer systems used for tasks such as data management, quality control, and regulatory reporting.

CSV is vital for the pharmaceutical industry, as a failure can have severe consequences, which can affect patient safety, product quality, and regulatory compliance.

Computer system validation training courses prepare trainees with the skills and knowledge necessary to follow computer system validation procedures to maintain compliance and improve operations.

Regulatory Requirements for Computer System Validation in The Pharmaceutical Industry

Regulatory bodies like the FDA impose stringent requirements on CSV to guarantee the safety and efficacy of pharmaceutical products. Companies must adhere to guidelines such as 21 CFR Part 11 to achieve and maintain compliance.

The FDA stipulates that data security includes protection against loss, tampering alteration, and accidental deletion. It should also be documented whether the data loss is accidental or occurs on purpose; the results for your project will be the same.

Currently, the FDA monitors data integrity, and any breaches or security issues are subject to regulatory action, including warning letters . The FDA is also investing in training for its auditors so that they can recognize potential data integrity issues during systems inspections.

Additionally, now that smartphones have become an integral part of our workplace, and the line between personal and office equipment has blurred in response, data integrity becomes even more critical. For example, using smartphones in the calibration process can be a possible source of a data breach.

Understanding the Validation Life Cycle

The validation lifecycle encompasses planning, specification, design, testing, deployment, and maintenance. Each stage is interconnected and vital to ensuring that computer systems operate reliably and in accordance with regulatory standards. These stages include:

User Requirements Specification (URS)
Functional Requirements Specification (FRS)
Design Specification (DS)
Installation Qualification (IQ)
Operational Qualification (OQ)
Performance Qualification (PQ)

Meticulous planning and documentation are crucial at every stage of CSV. Proper planning ensures validation objectives are met, and comprehensive documentation provides an audit trail to demonstrate compliance.

Best Practices for CSV Implementation

CSV must be implemented appropriately for pharmaceutical companies to stay fully compliant. A few important best practices for effective implementation include the following:

Start by conducting thorough risk assessments: Assessing and identifying risks associated with computerized systems is essential. While complex, undertaking this process helps prioritize validation efforts and focuses resources where they are most needed to mitigate potential issues.
Establishing a validation team: Invest the time in building a cross-functional team with defined roles and responsibilities to ensure that all aspects of CSV are covered, from validation planning to execution and documentation.
Aligning validation with regulatory requirements: A well-structured validation plan outlines the validation effort's scope, approach, and objectives. This plan serves as a roadmap for achieving compliance while minimizing risks and costs.
Creating and maintaining validation documentation: Detailed validation reports and documentation provide evidence of compliance and serve as a reference for future audits. Accurate records of tests, deviations, and changes are crucial.

Validation Testing and Documentation

Computer system validation pharma involves various tests, such as functional and performance testing, focusing on ensuring systems operate as intended. Additionally, related documentation is vital for any pharmaceutical plant to maintain compliance and efficacy.

Properly documenting the results of these tests is vital for demonstrating compliance. Documentation, including any deviations from expected outcomes, provides transparency and enables informed decision-making during the validation process.

Additionally, pharma manufacturers should ensure traceability to make sure all requirements, tests, and changes are linked. The result is a clear audit trail and accountability throughout the validation lifecycle.

Change Control and Configuration Management

Comprehensive change control processes strive to manage system changes. These processes ensure all changes are properly documented, justified, and assessed for their impact on CSV.

Well-defined change control and configuration management processes assess, approve, and document system changes to maintain compliance and avoid unintended consequences.

Additionally, documenting and justifying system changes is essential to demonstrate the impact of changes on system functionality, data integrity, and compliance.

Training and Documentation Control

Comprehensive training for employees involved in CSV and establishing systems for controlling documentation are vital for maintaining consistency and compliance. Reputable CSV training courses will provide the following skills and experience:

Providing comprehensive CSV training: Proper training ensures that personnel understand their roles and responsibilities in CSV, promoting accurate execution and documentation.
Establishing a system for managing documentation: Good documentation practices and control systems make sure that all documents are securely stored, versioned, and accessible to authorized personnel.
Regularly updating training materials: Ongoing review and updates to training materials and documentation are necessary to align with evolving regulations, system changes, and best practices.
Certification when applicable: Many courses will provide trainees with computer system validation certification, allowing employers to have confidence in employees' ability to follow best practices.

Audit and Compliance Considerations

Regular audits to verify compliance with CSV requirements evaluate if systems operate within regulations and best practices.

In addition, it’s important to maintain continuous inspection readiness through well-documented processes and compliance measures. Pharmaceutical companies should always be prepared for regulatory inspections and audits. Routine audits identify areas of non-compliance and provide opportunities for corrective actions, strengthening the overall CSV process.

Addressing audit findings and implementing corrective actions requires the right personnel to follow through on audit results to ensure compliance. Timely resolution of audit findings and implementation of corrective actions are crucial to maintain compliance and prevent recurring issues.

Continuous Improvement and Monitoring

Monitoring and improving operations is an essential aspect of maintaining the effectiveness and compliance of computerized systems in FDA-regulated medical device industries.

It’s crucial to prioritize ongoing efforts to enhance system performance while ensuring systems align with any relevant changes in regulatory standards and industry best practices. Let’s review how to implement effective processes to enhance operations and stay compliant.

Implement a System for Ongoing Monitoring

Establishing a systematic approach for monitoring and measuring system performance is critical. These approaches include real-time monitoring, data collection, and KPI tracking to identify deviations impacting system functionality or compliance.

Identify Areas for Improvement and Implementing Corrective Actions

Continuous improvement requires identifying areas where system performance or compliance is lacking and can be enhanced.

When issues or opportunities for improvement are identified, corrective actions must then be quickly implemented. Embodying a proactive approach helps prevent potential problems and maintains system reliability.

Stay Up to Date with Regulatory Changes and Best Practices

Remaining current with regulatory changes and industry best practices is of the utmost importance. Regulations governing computerized systems in pharmaceuticals are subject to updates, while industry standards also change over time.

Staying informed ensures that systems continue to meet compliance requirements and operate efficiently. Non-compliance with updated regulations can lead to severe consequences, making it crucial to implement regular updates for sustained success and help avoid fines or penalties.

CSV Training is Crucial for Successful Implementation

Providing employees with the correct training in CSV for the pharmaceutical industry is vital to keeping your company compliant and efficient. Additionally, individuals can attend training to receive the training necessary to begin new careers.

CfPIE is a leading provider of high-quality and industry-respected training courses. We offer a computer systems validation training course that prepares trainees for real-world working conditions and CSV requirements.

Our instructors will discuss key concepts in computer system validation, including FDA regulations and non-compliance issues that can result in warning letters, and how to implement a practical but defensible computer validation system for your development programs.

While these foundational topics are excellent for those who are new to data validation and equipment regulations, those already in the field need to stay on top of new technological developments to ensure the success of drug development projects.

If you would like to learn more about data integrity, our knowledgeable instructors are prepared to take questions about this crucial area during the CSV course . You can also contact us to learn more about protecting your data or to request the addition of a data integrity course to our programming.

Medical Technical Writing Skills For 2023 and Beyond?

Fri, 29 Sep 2023 17:56:57 GMT

Technical medical writing plays a crucial role throughout the medical and pharmaceutical industries. What does a technical writer do ? These experts will have different specific roles depending on the company, but overall, they are responsible for documenting and conveying medical materials while staying fully compliant with applicable regulations.

Learning and applying a broad range of skills is essential for a lasting career as a medical writer . You’ll need an understanding of technical writing, guidelines for medical writing , a strong understanding of medical terminologies, and many more.

The skills needed for technical writing can be roughly divided into writing skills, medical skills, and soft skills. Keep reading to learn the different types of pharmaceutical technical writer skills anyone interested in this career will need to possess.

Writing Skills

What skills do you need to be a technical writer? You’ll need to learn and practice a wide variety of skills. We’ll start by exploring the writing skills necessary to succeed in this career path.

Technical Writing Skills

One of the foundational skills of a technical writer in the medical or pharmaceutical industry is mastering technical writing itself.

Technical writing varies from other writing styles and is also found in various industries. Mastery of technical writing creates the foundation for effective and transparent dissemination of critical medical knowledge.

What are technical writing skills in the context of the medical industry? A skilled medical writer excels in clarifying complex medical information, which makes this information accessible to a broad audience, ranging from healthcare professionals to regulators and patients.

The exact responsibilities vary based on the company and specific role. For example, some medical technical writers produce marketing content or clinical study reports, while others create reference guides or educational materials.

Documentation Software

Proficiency in using documentation tools and software is a necessity. Technical documentation skills begin with familiarity with programs like Microsoft Word, Adobe Acrobat, and specialized medical writing software.

Knowing how to use documentation software streamlines document creation and formatting. Additionally, you’ll be able to enhance productivity while ensuring that documents adhere to industry presentation and accessibility standards.

Medical Writing Guidelines

Knowledge of industry-specific writing guidelines is one of the necessary medical technical writer skills. Understanding recognized standards, such as the International Conference on Harmonisation (ICH) guidelines for pharmaceuticals or the CONSORT statement for clinical trials , makes sure your work adheres to established norms. This adherence boosts the credibility and consistency of written materials and fosters confidence in their reliability.

Editing and Proofreading

Strong editing and proofreading skills are essential. These cornerstone skills enable the thorough review and refinement of written materials, ensuring clarity, coherence, and correctness in the final documents.

These two skills are crucial for maintaining the highest standards of accuracy and quality in all written materials, from clinical reports to regulatory submissions.

Medical Skills

A medical technical writer requires a firm grasp of various medical skills to perform different roles accurately and efficiently while maintaining full compliance. Let’s break down the vital medical skills needed to be a technical writer in this industry.

Medical Terminology

A thorough understanding of medical terminology is necessary for a medical technical writer. Terminology encompasses deciphering intricate medical jargon and navigating the complexities of anatomy, physiology, pharmacology, and the subtleties within diverse medical specialties.

This knowledge is required for precisely and accurately communicating medical concepts to a diverse audience, which may not have any medical training depending on the specific task.

Regulatory Knowledge

Comprehensive knowledge of healthcare regulations and guidelines is of the utmost importance for a medical technical writer. This knowledge includes navigating the intricacies of regulatory bodies, such as the FDA, and understanding stipulations governing medical devices and pharmaceuticals.

Regulations may apply directly to the type of material being produced. As such, a deep understanding of healthcare compliance in documentation ensures you can navigate regulatory requirements and industry standards.

Clinical Research

One of the crucial technical writer skills is proficiency in clinical research methodologies and related terminology. A medical technical writer navigates the complexities of data or raw reports from clinical trials and skillfully transforms clinical trial data into coherent, accurate, and reader-friendly content.

This skill is indispensable for creating informative documents that adhere to rigorous scientific standards, which contributes significantly to advancing medical knowledge.

Healthcare Trends

Staying aware of healthcare trends is an important skill and worth the time. You’re expected to be current on emerging technologies, evolving treatment modalities, and breakthroughs in the medical landscape.

You’ll then have a more robust contextual understanding of the entire industry, which goes far in your specific tasks. Cultivating this awareness plays a pivotal role in producing content that mirrors the latest advancements in healthcare, ensuring that documents remain relevant and impactful.

Medical Illustration

Proficiency in incorporating medical illustrations or diagrams introduces a visual element to written materials. This skill enhances the clarity of intricate medical content, facilitating the audience's grasp of complex concepts.

An adept medical technical writer can effectively employ visual elements to complement textual information, ensuring the content is informative and visually engaging.

Documentation Types

A medical writer needs to be familiar with various types of medical documentation. Understanding the unique requirements of each document type is pivotal for creating new content effectively, which includes:

Clinical study reports
Regulatory submissions
Patient education materials
Medical device manuals.

Knowing the differences between these documentation types helps writers produce accurate and customized documents to meet specific objectives.

Compliance and Quality Assurance

Proficiency in quality assurance processes is of utmost importance. A thorough understanding of quality control procedures and the capability to ensure written materials meet strict regulatory and industry standards are critical for upholding document integrity and reliability.

This skill ensures that the documents convey information accurately and adhere steadfastly to established quality benchmarks, enhancing their credibility and utility.

Soft Skills

Many of the characteristics of technical writing involve hard skills, which we considered above. However, soft skills are also necessary to build a long-term medical, technical writing career.

Let’s discuss some of the necessary soft skills you’ll need, and be aware that many of them also include elements of hard skills.

Communication Skills

Effective communication is crucial for working on a team or with medical experts. Interpersonal communication is vital when collaborating closely with subject matter experts, researchers, and regulatory professionals.

The ability to articulate intricate ideas and receive feedback with clarity and professionalism is extremely valuable. This skill ensures that the final document faithfully represents the collective expertise and knowledge amassed by the team.

Ethical Considerations

Understanding ethical principles is necessary for medical writing. Upholding principles such as patient confidentiality and adhering to authorship guidelines is critical.

The commitment to ethical standards safeguards the writer's reputation and the integrity of all documents produced. Ethical standards must be upheld throughout the entire document creation process, assuring the trust and credibility of the content.

Project Management

In certain instances, medical technical writers may work as project managers. Overseeing and coordinating the progress of multiple documents and deliverables is a significant asset to the writer’s team and can help advance their career.

The skills of a project manager ensure punctual delivery of milestones and adherence to stringent quality standards. Simultaneously, a skilled manager maintains an efficient and well-organized documentation process that aligns with the broader objectives of the project, resulting in a positive and productive workflow.

Additionally, project managers need strong intrapersonal skills to effectively work with other writers and their own managers to complete the project effectively.

Scientific Background

A robust scientific background in biology, chemistry, pharmacy, nursing, or another scientific field is an invaluable asset for a medical writer. This knowledge helps the writer understand and explain the intricate scientific and medical concepts with accuracy and credibility.

Beyond enhancing comprehension, a scientific background empowers the writer to evaluate scientific literature critically, helping create documents firmly rooted in sound scientific principles.

Attention to Detail

What makes a good technical writer? One of the core skills of a reliable technical medical writer is meticulous attention to detail. This skill provides precision and accuracy in all medical documents, from scientific data to terminology usage.

Readers rely on these documents for informed decision-making in the healthcare field, making attention to detail a core skill to produce reliable and trustworthy documents.

Become a Technical Writer Today with CfPIE

You can see how becoming a technical writer and succeeding in this career requires many skills. While it may seem daunting, all these skills can be trained and refined as your career progresses.

CfPIE provides a wide range of pharmaceutical and medical training, including the range of skills necessary to become a technical writer. Are you ready to start your new career? Learn more about our medical technical writing courses today.

How to Obtain GMP Certification for Your Manufacturing Facility

Fri, 01 Sep 2023 14:16:52 GMT

Key points to obtain and maintain GMP certification:

Train and educate employees
Develop and implement standard operating procedures in your manufacturing facility
Analyze your current practices to ensure they align with FDA and/or EMA regulatory guidelines
Create a strong quality management system
Conduct Internal Audits and Inspections
Continually assess and make improvements

GMP certification is crucial to the success of any manufacturing facility as it identifies you as a dietary supplement and pharmaceutical manufacturer fully compliant with FDA (Food and Drug Administration) regulations. It also shows that you have the required systems and use established quality standards and controls.

Industries that manufacture products usually consider all aspects before choosing a manufacturing facility, including the idea that consumers view medicinal products with GMP certification labels as having higher quality and are more trustworthy.

While you may understand the importance of Good Manufacturing Practices certification , do you know what it takes to become GMP Certified and stand out from the competition? Read on to learn everything you need to obtain GMP certification for your manufacturing facility.

What are the Requirements for GMP Certification?

GMP certificate standards and guidance require proper design, monitoring, and control of manufacturing facilities and processes, to ensure it meets regulatory authority's standards. The five main components of GMP help manufacturers comply with requirements throughout production: People, Products, Processes, Procedures, and Premises.

Obtain and Maintain Your GMP Certification

Industry standards and technologies are constantly changing, so GMPs must adapt and evolve with them. Staying up-to-date with the latest FDA guidelines and regulations will keep you compliant and ensure quality products.

Develop and Implement Standard Operating Procedures

Standard Operating Procedures (SOPs) are crucial to maintaining consistency and regulatory compliance. Everyone must be on the same page regarding procedures, or results will vary. Standard Operating Procedures ensure manufacturers have control of manufacturing processes, have a structured quality system with qualified employees and an encouraging company culture.

There are seven steps to develop and implement effective SOPs:

Step #1: First Draft

Create a detailed list of everything you need to complete a particular process in sequential order.

Step #2: Planning

Review your list and ask questions such as:

How is the procedure done?
Why is it done that way?
How can an SOP improve it?
How can you measure its performance?

Step #3: Internal Review

Give your first draft to the employees who perform the task to get valuable input.

Step #4: External Review

Seek professional advice from technical advisors, including nutritionists, veterinarians, or extension agents. They may advise on the best way to manage specific steps and, if applicable, revise your procedure accordingly.

Step #5: Testing

To avoid bias, choose an employee unfamiliar with the process to test your procedure by following the steps precisely, then revise as necessary.

Step #6: Final Draft

With all testing complete, create a final draft of the standard operating procedure and ensure all employees are familiar with it.

Step #7: Training

Train all employees who impact production on the new employee practices and highlight the importance of following the procedures precisely.

Conduct a Gap Analysis

A gap analysis is a comparison of your current practices to the regulatory guidelines to help identify if any gaps exist. If your SOPs fall short, you must correct these gaps.

Performing a gap analysis is vital for GMP compliance and should include the following areas:

SOPs
Validation procedures
Laboratory practices
Risk assessment
Data integrity
Documentation practices
Distribution practices
And more

Identify Areas of Improvement Through the Six Steps of Gap Analysis

Test your regulatory compliance by performing six steps:

Identify gap areas: Choose the areas you wish to analyze for gaps and gather the appropriate departmental regulatory documentation. List each area, such as protocols, SOPs, and systems.
Prepare a checklist: Create a checklist of every step in the procedure that delivers the desired result.
Gap analysis: Visit the area of the facility where the process takes place and document each step the employee performs to complete the audit process.
Identify the gaps: Record the differences (gaps) in your regulatory list and the list from the current processes. Where there’s a gap, there’s a risk to product quality. Rate the severity of the risk as low, medium, or high.
Corrective action: Provide a corrective action for every gap according to the regulatory documentation. Issue a copy of the corrective action to the offending department with a deadline corresponding to the severity level, such as 30 days for low risk, 15 days for medium risk, and 7 days for high risk.
Implementation review: Review the results of the corrective actions and record the status

Establish a Robust Quality Management System

A robust quality management system (QMS) is essential for ensuring compliance with regulatory requirements in the manufacturing industry. An effective QMS enhances product safety and quality, mitigates risks, drives consistency and standardization, builds confidence and trust, and enables continuous improvement.

There are seven key components when implementing your QMS.

State your quality policy and objectives: A quality policy is the framework of your QMS. It states your mission, purpose, and commitment to continuous improvement and regulatory compliance. Quality objectives are measurable goals for product performance, safety, efficiency, customer service, and more.
Quality manual: The manual includes regulatory compliance requirements, processes, policies, and more, documenting the scope of the QMS.
Organizational responsibilities and structure: A flow chart can outline the responsibilities of infrastructure, stakeholders, and resources required to achieve objectives.
Internal processes: Establish metrics to measure the performance of defined processes ensuring quality products.
Customer satisfaction: Use surveys, reports, and website reviews to monitor customer satisfaction with product quality.
Continuous improvement: Follow the Plan-Do-Check-Act (PDCA) cycle to ensure continuous improvement. Plan: Identify improvement opportunities and plan for change. Do: Implement small-scale change. Check: Analyze change results utilizing data. Act: If successful, implement the change on a broader scale or start the cycle over if not.
Document control: Have a procedure or policy in place for the review, storage, retention, identification, retrieval, protection, and disposal of documents.

Train and Educate Employees

Training and education are compulsory requirements for GMP certification . This can include various methods such as:

E-learning courses
Classroom sessions
Webinars
Games
Podcasts
And more

CfPIE’s GMP certification course provides your employees with:

Highly qualified life science instructors : Delivering a unique blend of adult learning principles with current industry experience.
Convenient course formats: Choose on-site classroom sessions or interactive virtual ones to suit your schedule.
Industry-recognized certification : The medical device and pharmaceutical industries widely recognize CfPIEs 12 life science Certification Programs .
Knowledgeable training advisors : Trained advisors help you navigate certification, training, and discount options.

Conduct Internal Audits and Inspections

GMP audits and inspections ensure the safety, regulatory compliance, and quality of your products and processes. They’re essential in identifying and correcting gaps in your GMP system.

Here are some basic guidelines for conducting audits and inspections effectively:

Know your scope and purpose so you can focus attention on the more critical and relevant aspects of your GMP system
Follow regulations and guidelines that apply to the district your audit takes place and stay up-to-date with regulation changes.
Seek expert advice, including professional training courses , networks, and associations, if unsure or need assistance with third-party audits and inspections.

Continuous Improvement and Maintenance

Maintain GMP certification by nurturing a culture of constant improvement. This will optimize manufacturing processes, enhance product quality, and reduce costs while increasing your competitiveness in the market.

Ensure ongoing GMP compliance in your manufacturing company with the following strategies and measures:

Establish a quality assurance team using members from every department to ensure diverse knowledge and experience.
Use quality assessments to identify the root causes of problems that can potentially affect GMP compliance. The quality assurance team decides on appropriate improvement measures.
Conduct frequent validation activities to demonstrate that equipment, instruments, processes, and documentation maintain compliance.
Perform unexpected audits to give you an idea of the actual GMP compliance level within your company's different departments. Share the results and solutions with your employees and ask for their input and feedback.
Monitor the performance of employees and equipment to avoid complacencies
Providing compliance training for all employees is the best way to ensure ongoing GMP compliance and offer safe, effective, high-quality pharmaceutical products.

Work with CfPIE in Obtaining GMP Certification for Manufacturing Facilities

Turn to CfPIE for your GMP certification requirements — the industry leader in quality life science training.

From developing and implementing SOPs and a robust QMS to conducting gap analysis and internal audits, CfPIE’s GMP certification training ensures safety and effectiveness.

Maintain regulatory compliance and continuous improvement as a manufacturer of quality products today.

Check our the dates of our upcoming Good Manufacturing Practices Training | GMP Course

About CfPIE

What Are Current Good Manufacturing Practices (cGMP)?

Sat, 26 Aug 2023 00:38:44 GMT

Updated August 2023

Understanding cGMP is an essential skill for anybody working in the medical field, particularly in manufacturing where many of these practices apply. Compliance has a direct impact on the health and safety of your patients, your reputation in the medical industry, and your bottom line.

The U.S. Food & Drug Administration oversees the production and delivery of pharmaceutical products, medical devices, dietary supplements, and certain foods to make sure that they are safe and effective for human consumption. Because the safety of these products impacts public health so profoundly, it’s necessary for these government regulations to be stringent and detailed.

What Is cGMP?

cGMP stands for current Good Manufacturing Practices. These regulations, set by the FDA, dictate the practices and checks medical companies have to follow in order to ensure the safety, effectiveness, quality, and purity of the medicinal products they manufacture and release.

cGMP applies to various industries and markets, from medical device manufacturers to biotechnology firms to pharmaceutical manufacturing facilities. The laws apply to certain processes these businesses undergo:

Facility and equipment maintenance: The conditions in which manufacturing occurs can impact the safety and quality of the finished product. Medical companies should look at calibrating all plant equipment before beginning operations and following SOPs (Standard Operating Procedures).
Raw materials: Pharmaceutical manufacturers have a list of raw materials to be used and a specified formula, which must be followed within specified deviation limits.
Staff readiness: No matter how well-managed the equipment and machinery is, the backbone of medicinal production ultimately lies in the hands of in-house staff. Appropriate training is part of the cGMP requirement.
Process controls: Not only should you document all workflow procedures, but you must also make sure the steps involved are accurate and up-to-date with the latest medical knowledge.
Post-release considerations: After a final product leaves the factory, the business is still responsible for other aspects of the process, such as packaging and labeling operations, and preparing for potential recalls or returns.

It is a proactive approach that ensures the safety and quality of pharmaceutical products before they hit the market. You can consult the official FDA rulings on cGMP here .

cGMP Compared to GMP and GLP

cGMP is not to be confused with regular GMP or another related concept known as GLP.

cGMP vs GMP

Medical professionals need to make the distinction between cGMP and standard GMP. As expected, GMP simply stands for Good Manufacturing Practice.

The medical community is updating its knowledge and changing its best practices regularly to improve quality and cost. For medical regulations to stay up-to-date, GMP must evolve as well, and cGMP ensures the practices being followed remain current.

Compared to GMP, cGMP works with the most up-to-date rules applicable to your industry, also known as current standards. As a result, it requires additional testing, more steps, and greater investment to maintain compliance.

cGMP vs GLP

GLP stands for Good Laboratory Practice. Both cGMP and GLP ensure the safety and quality of drug products, medical devices, and other pharmaceutical products, and both concepts are driven by the FDA; however, GLP primarily deals with the “laboratory” phases of a product’s production such as toxicology, biocompatibility, and pharmacology studies during pre-clinical development.

cGMP, on the other hand, mostly focuses on phases which happen after the end of the pre-clinical stage such as manufacturing operations, testing, and marketing of the product.

Why Does cGMP Matter?

See why the CfPIE’s Current Good Manufacturing Practices, (cGMP) Training attendees find cGMP training courses beneficial for their career development.

When a business is cGMP-compliant, its internal processes and workflows are properly controlled so that its product output is effective and safe. More specifically:

Production facilities conform to all hygienic practices and are in excellent condition
Equipment is calibrated and maintained for safe production
On-site staff have the proper knowledge and training to operate the facility correctly
The production process is well-documented and reliable

Both government agencies and patients care that their pharmaceutical organizations are cGMP compliant because it ensures that the medical products they rely on are up-to-date with the latest industry standards when it comes to safety. cGMP reduces the risk of drug contamination or defective medical devices that could threaten patient health.

It’s worth noting that cGMP originally arose when the U.S. government wanted drug manufacturers to take a proactive approach to safety and ingrain a culture of quality within their business environments. GMP laws, much like other types of laws, take some time to evolve as new information arises.

For these reasons, don’t just wait for GMP regulations to be updated; proactively look at what the new best practices are in the industry and adopt them early on.

Evolving cGMP Regulations

The latest and future potential changes to cGMP regulations reflect the dynamic nature of industries like pharmaceuticals, biotechnology, and medical devices. These regulations adapt to technological advances, scientific understanding, and changing global landscapes. Evolutions aim to enhance product quality, patient safety, and regulatory harmonization.

As science progresses, cGMP standards incorporate innovative manufacturing methods, risk-based approaches, and data integrity practices. Stricter oversight, global collaboration, and emphasis on supply chain transparency ensure that evolving cGMP regulations maintain the highest standards and adaptability to emerging challenges.

How Do You Adhere to cGMP Regulations?

It’s best to start implementing cGMP regulations into the production process as early as possible. This way, your company will have a chance to establish meticulous quality control operations from the beginning and minimize the problems that could arise from regulatory compliance issues. A general breakdown of what cGMP adherence looks like involves:

Quality inspections of your raw materials
Proper internal controls to minimize deviations from acceptable manufacturing processes
Assignment of roles to specific staff members for ensuring cGMP compliance
Reliable testing protocols for discovering and investigating deviations
Regular review of compliance records and reports

If your business outsources some steps of manufacturing, you are still responsible that the contracted party has a quality assurance system in place. A commitment to drug quality involves defined processes for resource management, GMP training for employees, proper internal communication between management and staff, recordkeeping policies, and product lifecycle management.

The Importance of cGMP in the Pharmaceutical Industry

What does cGMP stand for? cGMP stands for Current Good Manufacturing Practices, but what is cGMP? cGMP is a set of practices that strives to improve the quality and safety of the final product made by every industry that abides by them. Each current good manufacturing practice informs how manufacturers can keep their products safe.

The importance of cGMP in the pharmaceutical industry cannot be overstated. It serves as a cornerstone of quality, safety, and efficacy in manufacturing and distributing pharmaceutical products.

What is cGMP in pharma? cGMP regulations ensure that pharmaceutical companies adhere to strict standards throughout their processes, from raw material sourcing to the final product reaching patients.

By establishing rigorous guidelines for manufacturing, processing, testing, and quality control, mitigates the risk of contamination, errors, and substandard products entering the market - cGMP in pharma is vital for patient safety. This directly translates to better patient outcomes.

cGMP aims to improve each of the following areas of the industry:

Patient safety
Quality assurance
Product consistency
Regulatory compliance
Traceability
Research and development
International trade
Public trust

By complying with cGMP, pharmaceutical companies meet regulatory requirements and demonstrate their commitment to excellence and patient wellness.

cGMP Audits and Inspections

cGMP manufacturing process audits and inspections conducted by regulatory authorities are critical to ensuring compliance with quality standards in pharmaceutical manufacturing facilities.

These assessments verify that facilities and relevant processes adhere to the strict guidelines outlined by cGMP regulations. Let’s review how these audits and inspections are typically conducted:

Preparation and planning: Regulatory agencies schedule audits or inspections in advance. Manufacturing facilities must compile comprehensive documentation of their processes, procedures, quality control measures, and records. This documentation is reviewed to gain an understanding of the facility's operations.
On-site inspection: Inspectors visit the manufacturing facility to assess compliance first-hand. They examine various aspects, including equipment maintenance, cleanliness, personnel practices, quality control, and data integrity.
Document review: The auditor meticulously reviews records, documentation, and reports related to manufacturing, testing, quality control, and adverse event reporting. They check for accuracy, completeness, and consistency with cGMP requirements.
Sampling and testing: Regulatory authorities may collect samples of products, raw materials, or intermediates for testing to verify their quality and compliance with specifications.
Observations and findings: During the inspection, inspectors may note observations and findings, both positive and areas of concern. These findings are documented in an inspection report.
Exit meeting: At the end of the inspection, an exit meeting is held between regulatory inspectors and facility representatives. Inspectors provide a preliminary overview of their observations and findings.
Follow-up and compliance action: Based on their findings, regulatory authorities determine whether the facility complies with cGMP regulations. If deficiencies or violations are identified, the facility may be required to implement corrective actions and submit a plan for addressing the issues.
Final inspection report: A comprehensive inspection report is prepared by the regulatory authority, detailing the observations, findings, and any compliance actions required.

cGMP audits and inspections ensure that pharmaceutical manufacturing facilities adhere to the highest quality, safety, and efficacy standards.

These assessments help maintain the integrity of the pharmaceutical industry and safeguard patient health by ensuring that medications are produced in a controlled and consistent manner. Facilities must maintain a culture of continuous improvement and vigilance to remain compliant and ready for regulatory audits.

cGMP and Quality Control

cGMP fosters consistency in product quality, which is why quality control is an integral component of the practices.

The primary goal of quality control is to ensure that pharmaceutical products meet the defined quality standards and specifications, reducing the risk of defects and ensuring patient safety. The cGMP meaning involves describing activities and procedures designed to monitor and control the quality of raw materials, intermediates, and finished products during the manufacturing process.

Compliance with cGMP includes effective quality control measures to ensure that pharmaceutical and medical products are safe, effective, and consistently high-quality.

cGMP and Data Integrity

Pharmaceutical companies must establish robust data integrity practices, including secure data storage, access controls, audit trails, and proper employee training to maintain the highest quality and regulatory compliance standards.

Data integrity is a critical pillar of cGMP compliance, encompassing the accuracy, consistency, and reliability of records, documentation, and data management processes throughout the lifecycle of pharmaceutical products.

Maintaining accurate and reliable data is essential for several reasons, such as:

Properly created and maintained data is essential to demonstrate compliance during regulatory audits and inspections.
Data integrity directly impacts the quality and safety of pharmaceutical products.
Pharmaceutical products directly affect patient health. Data integrity ensures that manufacturing processes are controlled and consistent, minimizing the risk of producing substandard or unsafe medications that could harm patients.
Accurate records and documentation provide traceability, allowing the entire product journey to be tracked and verified.
Reliable data is necessary for making informed decisions about product development, quality control, and process optimization.
Regulatory authorities rely on accurate data to ensure that each batch of pharmaceutical products meets specified quality standards.
Data integration creates accurate records, which enable thorough analysis and root cause investigation to drive ongoing process enhancements.
Trustworthy data allows for effective risk assessment and management. Manufacturers can take proactive measures to prevent problems by identifying potential risks and issues early through reliable data.

Maintaining accurate and reliable records, documentation, and data management processes is indispensable for meeting cGMP requirements.

cGMP in Biotechnology and Medical Device Manufacturing

Like pharmaceuticals, cGMP provides an essential framework for biotechnology and medical device manufacturing , safeguarding product quality, patient safety, regulatory compliance, and the advancement of healthcare.

Current Good Manufacturing Practices cGMP holds immense significance in biotechnology and medical device manufacturing, ensuring product quality, safety, and efficacy in these industries . Adherence to cGMP standards guarantees that biotechnology products, such as biopharmaceuticals, vaccines, and medical devices, are produced and handled under controlled conditions that minimize the risk of contamination, errors, and defects.

Regulatory compliance is a cornerstone of cGMP, with global regulatory agencies requiring biotechnology and medical device manufacturers to meet these standards. Compliance is crucial for approvals, maintaining licenses, and ensuring products can be marketed and distributed.

cGMP Training and Education

cGMP training and education programs are pivotal in enhancing compliance across industries like pharmaceuticals and medical devices.

Through interactive sessions, workshops, and updated learning resources, cGMP training equips professionals with the skills to uphold strict standards, resulting in consistent excellence, patient safety, and streamlined operations in manufacturing and distribution. A reputable training program offers comprehensive training in the following:

Overall cGMP practices
Emphasize industry-specific protocols
Properly creating and storing documentation
Essential quality control practices

Programs also ensure employees understand evolving regulations and foster a culture of adherence. Once complete, benefits include improved product quality, minimized risks, and regulatory alignment

Take Control of cGMP Compliance with GMP Training from CfPIE

Don’t wait for an incident or audit to highlight the importance of cGMP compliance.

Start by taking a Good Manufacturing Practices Training Course , and take it a step further by becoming a Current Good Manufacturing Practices Certified Professional with CfPIE today.

Good Clinical Practices (GCP) & Risk Based Monitoring: Understanding and Implementing Current Global Requirements

Thu, 10 Aug 2023 01:29:14 GMT

As patient recruitment for clinical trials continues to rise, pharmaceutical professionals in the United States and other parts of the world must keep their skills sharp and be up-to-date with the current regulations. With quality assurance and clinical research roles often centered around data collection and supervision relating to patient treatment in clinical trials, employers must be confident that employee knowledge of GCP is unmatched; otherwise, they risk drug recalls or poor inspections that can result in bad press.

With Good Clinical Practice training on your resume, you can bolster your job application and secure your next role. It also helps professionals perform their job more effectively and adhere to necessary clinical trial regulations.

Read on to learn the most popular FAQs regarding GCP and risk-based monitoring and how GCP certification training can help you stand out from the competition.

What Does Clinical Investigation Monitoring Entail?

Clinical investigation monitoring is a quality control tool that determines if companies carry out investigation activities as planned and includes details such as:

Signed and dated patient consent forms prior to any trial procedures
Verified documentation showing the patient meets all criteria for eligibility
Confirms that all necessary materials and equipment are present
Verifies proper storage of materials, drugs, and samples — refrigerate, frozen, or shelf?
Checks that inventory corresponds with current counts
Random reviews of procedures and processes
Cross-check source data versus the case report form (CRF) to ensure proper documentation of adverse events (AEs) and serious adverse events (SAEs)
Confirms the reasoning for trial participant dropout
Checks for proper documentation in the CRF of drug administration modifications, side-effects, and concomitant diseases to transmit reports for round-table discussions with the general coordinator, trial monitor, and the investigator

What is Risk-Based Monitoring (RBM)?

Risk-Based Monitoring is a viewpoint in clinical trial management that centers on identifying, addressing, mitigating, and preventing risks that could impact participant safety, trial quality, or data integrity.

FDA guidance suggests three steps in an RBM approach:

Detection of Processes and Critical Data: Before you can flag critical data as a potential risk, you must first identify the acceptable/expected parameters and values. You can use intelligence from previous studies to help quantify and identify these metrics as low, medium, or high risk. Mitigating an identified risk can change throughout the trial period, so you don’t need to enter the risk category initially. Some examples of high-risk critical data include anything impacting patient safety or trial sites with little experience with endpoint data categories or clinical trials.
Perform a Risk Assessment: After identifying risks, use the ‘traffic light system’ to help visualize the degree of severity — red-high, yellow-medium, and green-minor. You must conduct a risk assessment to convey these findings to the trial site. This involves source data review (investigating the risk and its origin), implementing risk mitigation methodologies, and starting corrective actions to resolve current risks and prevent further ones. Some corrective actions may include motivational visits to the site, re-education of the site, escalating to a global level, amending a recruitment plan, or in extreme cases, issuing warning letters.
Develop a Monitoring Plan to Incorporate a Risk-Based Approach: The RBM approach is quickly becoming an integral concept in clinical research for the pharmaceutical industry. And just in time — the FDA wants to implement a monitoring plan that describes the trial's monitoring methods, requirements, and responsibilities. This document will stipulate the data points and how often they need monitoring, coupled with escalation and communication plans for everybody involved in the trial. The RBM strategy can improve data quality and reduce clinical costs while reducing the time it takes to approve Investigational Medical Products (IMP).

The FDA performs statistical analyses on all submitted data sets and is essential to the approval process. They strongly suggest that all ongoing and not yet commenced clinical studies integrate some degree of statistical monitoring and RBM to meet the recently implemented standards.

How Long Does It Take to Get the Good Clinical Practice Certification?

CfPIE’s Good Clinical Practice course is three days of knowledge-packed hands-on experience with proven techniques in detecting, preventing, and correcting clinical study deficiencies by maximizing risk-based considerations. Attendees will also gain further knowledge of 24 clinical trial-related topics and full GCP certification.

Is the Course Compliant with FDA Regulations?

CfPIE’s GCP course complies with EU and FDA regulations and the ICH Guidelines (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use).

Is the GCP Training Course Regularly Updated?

This course is up-to-date with current regulations and facts. Any new criteria or changes in rules will be part of the course.

What is the GCP Standard for Good Clinical Practice?

Good Clinical Practice is an international, scientific, and ethical quality standard for creating, conducting, documenting, and reporting trials involving the participation of human subjects. Compliance with this standard ensures the public the protection of the trial subject’s rights, safety, and well-being.

What is the GCP Definition of Monitoring?

In terms of Good Clinical Practices, monitoring is the act of supervising the progress of clinical trials and ensuring that conducting, recording, and reporting the clinical trial is in accordance with protocols of SOPs, GCPs, and applicable regulatory requirements such as FDA and ICH Guidelines.

Make the Most of Your Career With CfPIE — The Leader in GCP Training

Exceeding your GCP training requirements not only makes you more effective in your job but it also strengthens your experience and skills and helps you impress future employers. When your skills are up-to-date, you have the necessary tools and knowledge to stand out from the competition and excel in your role.

CfPIE’s GCP certification training provides practical and real-world examples that you can immediately put into practice so there’s no time wasted when bolstering your career.

Are you looking to improve your knowledge of Good Clinical Practices? Explore our in-depth GCP course today.

About CfPIE

cGMP Training: Essential for Pharmaceutical Professionals

Thu, 10 Aug 2023 01:28:13 GMT

The Federal Drug Association (FDA) enforces a quality control system called the current Goods Manufacturing Practices (cGMP) for the pharmaceutical industry. These regulations and guidelines ensure the proper design, monitoring, and control of manufacturing processes and facilities. cGMP also applies to other consumable products like drug ingredients and related pharmaceutical products, diagnostics, and medical devices.

Adhering to cGMP regulations ensures drug products' identity, quality, strength, and purity by enforcing that pharmaceutical manufacturers properly control their manufacturing operations.

When manufacturers adequately execute cGMP standards, they help prevent contamination, product quality deviations, mix-ups, failures, and errors.

Read on to learn why cGMP training is essential for any pharmaceutical professional looking to advance or accelerate their career and stand out from the competition.

The Role of cGMP Training in the Pharmaceutical Industry

Current Goods Manufacturing Processes training is essential in the pharmaceutical industry as it helps manufacturers employ qualified personnel and improve existing processes while ensuring safety for the end consumer. cGMP training can also increase the value of pharmaceutical professionals looking to advance their careers.

cGMP requirements are flexible, so each manufacturer can decide how to implement necessary controls using scientifically sound design, processing procedures, and testing methods. Flexibility enables companies to ensure regulatory compliance and quality standards by using innovative approaches and modern technologies to achieve higher quality through continuous improvements.

Understanding the Principles of cGMP

The fundamental principles of cGMP best practices are:

Creating Standard Operating Procedures (SOPs): Develop and implement clearly defined SOPs that consistently produce high-quality products.
Implementing and enforcing SOPs and work instructions: Follow documented processes and procedures without deviation to eliminate potential errors and hazards.
Documenting processes and procedures: Maintain accurate record-keeping and documentation of all SOPs, including dates, times, batch numbers, and testing results.
Validating the efficiency of SOPs: Ensure the expected level of compliance through all stages of SOPs by using various cross-checking methods to validate results.
Designing and using working systems: Incorporate employee and consumer safety, quality, and productivity into developing and designing equipment and facilities.
Maintaining facilities, systems, and equipment: Proper maintenance reduces risks to employees and consumers, prevents product contamination, and results in fewer equipment breakdowns and building interruptions.
Developing job competence of employees: Every employee affecting the quality of a product should have cGMP training in addition to their regular professional development.
Preventing contamination through cleanliness: Protect the consumer and avoid product contamination by having a contamination control process and following sanitization and cleaning procedures.
Prioritizing quality and integrating it into the workflow: Manufacturing, labeling, packing, marketing, and distributing are all examples of workflow stages. Clearly defined controls at every step ensure quality is a workflow integration.
Conducting regular cGMP audits: Identify how successful your cGMP compliance is through periodic audits. Monitor and evaluate your processes and procedures for efficacy on a revolving schedule to maintain and improve quality.

Because consumers can’t use smell, touch, or sight to detect when drugs are unsafe or effective, pharmaceutical companies must manufacture them under the practices and conditions required by cGMP regulations to ensure quality design and compliance. Therefore, there are crucial cGMP guidelines that pharmaceutical professionals must follow:

Maintain a high level of cleanliness and sanitization throughout the entire drug manufacturing facility
Define and control all processes with distinct definitions and control measures
Use proper precautions to prevent cross-contamination and adulterations
Train and qualify all personnel and operators for the job
Follow Goods Documentation Practices for all processes
Track data history relevant to all processes at all times, including manufacturing steps, distribution, equipment validation details, serialization data, and more

Benefits of cGMP Training and Certification for Professionals

There are many advantages of cGMP training and certification for individuals working in the pharmaceutical industry.

First, cGMP training certification ensures workers understand the importance of keeping their work environment clean and safe. This is crucial as foreign contaminants or substances can compromise the quality and safety of manufactured products.

Second, cGMP certification teaches pharmaceutical professionals how to handle products and materials correctly. Knowing proper handling procedures for hazardous materials also prevents contamination while keeping employees safe.

Third, professionals understanding cGMP procedures can help identify and address potential issues. For example, they may recognize a potential contamination risk and bring it to the relevant personnel’s attention safeguarding against product contamination and breaking compliance with regulatory standards.

Lastly, knowledge of cGMP regulations can increase job prospects and marketability. This is especially true in regulated industries with strict standards and rules for maintaining the quality and safety of their products, such as food manufacturing and pharmaceuticals.

An in-depth understanding of cGMP demonstrates a commitment to safety and quality, which can help individuals stand out in a competitive job market. Employers highly value those familiar with cGMP procedures, so candidates with the required training typically have more job opportunities and better odds of being hired or promoted. Pharmaceutical cGMP training also shows that candidates are proactive in their career development and willing to invest time and effort to acquire new knowledge and skills.

Implementing cGMP in Pharmaceutical Organizations

Pharmaceutical companies must adopt robust operating procedures and good practices to consistently produce safe, high-quality products that meet industry standards and are safe for consumer use. Organizations can successfully implement cGMP standards by:

Enforcing strong communication between departments so everyone understands their role in providing the best compliance possible within the appropriate regulations and laws governing manufacturing operations.
Thorough cGMP employee training is key to familiarizing staff with relevant procedures and policies, ultimately contributing to successful long-term business strategies and providing quality goods while maintaining profitability. Companies can benefit from our customized on site training program . It provides in-depth, quality content delivered by industry-active experts. The convenience of having the training in their own offices is an added advantage.
Implementing proper safety protocols to protect workers against hazards associated with working in manufacturing facilities and creating a supportive workplace culture where professionals feel respected and valued.

Boost Your Marketability With CfPIE’s cGMP Pharmaceutical Training Programs

Stand out from the competition with in-depth knowledge of cGMP regulations, from clinical development through post-approval drug and biotech product manufacturing, with CfPIE’s industry experts.

cGMP courses with CfPIE outline cGMP mandates and provides comprehensive instruction and analysis of how you can bring the best compliance processes to your current or future employer.

Get in touch to learn more about our life science courses and certifications.

About CfPIE

GMP Certification in USA and Europe: A Complete Guide

Mon, 12 Jun 2023 14:34:32 GMT

All you need to know about GMP certification in the Pharmaceutical Industry

Good Manufacturing Practices

Good Manufacturing Practices (GMP) is a set of standards created to instruct the processes of manufacturing a wide range of products. Becoming and remaining GMP compliant is increasingly essential for manufacturers in various industries.

Process standardization is one of the most essential factors in ensuring consistency in manufacturing. And when it comes to manufacturing pharmaceutical products, medical devices, skin products, and cosmetics, consistency is everything.

As a result, the Food and Drug Administration (FDA) formalized GMP to help companies in all industries ensure they consistently manufacture quality products. Keep reading to learn more about these quality standards and why GMP certification is vital for agencies.

What is GMP in the Pharmaceutical Industry?

Manufacturers in the pharmaceutical industry must familiarize themselves with international Good Manufacturing Practices (GMP), the official standards set by the FDA to specify drug quality based on the compliance level of the producer. Even though this is a United States agency, GMP has become popular in many countries globally.

Most drug consumers have no way of verifying the effectiveness of their medications, so these practices function essentially as consumer protection. Becoming GMP certified is one of the best steps you can take as a pharmaceutical manufacturer for several reasons.

What is Covered in GMP?

GMP sets many standards to guide the process of manufacturers to minimize defects or contamination that can create severe consequences for end users.

A GMP certification course aims to impart specific knowledge to employees and teams so they can enact these standards in their workplace. Topics covered include adequate maintenance of equipment or utensils, expected cleanliness of the manufacturing facility, and adequate quality control processes.

However, it’s important to find specific courses suited to your industry. A one-size-fits-all approach often means that manufacturers are ill-equipped to meet the specific challenges of producing a range of products, from biopharmaceuticals and biotechnological medicine to cosmetics and over-the-counter materials.

What Does It Mean to Be GMP Certified?

What is GMP certification? A Good Manufacturing Processes (GMP) certificate is an essential component of the manufacturing process, protecting you, your partner labs, and your reputation and reputation as a quality pharmaceutical manufacturer.

Earning a good manufacturing practices certificate will set you apart from your uncertified competitors, avoid potential fines, and ensure consumer safety.

Is GMP Certification Important?

What is a GMP certificate in the context of your business? The direct effects of GMP certification are staying in compliance and avoiding potential fines.

However, the meaning of GMP certified companies extends beyond simply staying compliant — GMP certifications signal to your peers and customers that your following industry best practices.

What Are the Benefits of GMP Certification?

GMP certification provides plenty of benefits that can help your entire business. Some benefits of receiving a GMP certification include the following:

Promote proper quality control: Undergoing the GMP process means that your manufacturing is consistent and aligned with the best industry practices and that your advertising is accurate to the product you are selling.
Enable process validation: Companies with the certification have their plants constantly monitored and controlled and have quality management systems and positive administrative protocols, such as worker sanitation, personnel qualification, and record keeping.
Prevent cleanliness issues: Contamination with allergens or other harmful materials is common in the pharmaceutical industry. Therefore, GMP-compliant organizations always have hygienic work areas with controls in place to prevent cross-contamination .
Ensure legal compliance: This international standard shows any regulatory authorities, from the US’s FDA to the EU’s EMA, that you take pharmaceuticals seriously and can proactively ensure compliance with high manufacturing standards.
Promote a positive reputation: Drug companies will always look for GMP certification when choosing a manufacturer to produce their products. Customers likewise will see the FDA approval as a sign that the product is held to high standards and worthy of consideration.
Build an incident response system: GMP requires companies to have established protocols in case mistakes occur. For example, records must be made of each step in manufacturing, and all infractions must be documented. A recall system is also mandatory so that defective batches can be withdrawn from sale and appropriate measures can take place to prevent future incidents.
Stay up-to-date: Medical technology is constantly advancing, so it’s also worth taking into account current Good Manufacturing Practices (cGMP) . This specification shows that not only are your processes aligned with GMP guidelines but also that they use the most up-to-date methods available.

It’s well worth earning a GMP certification to ensure customer safety, avoid costly fines, and improve your industry reputation.

What Are the Steps to Get GMP Certified?

Many companies are left wondering one thing: how to get GMP certification? The certification process involves a thorough audit of several aspects of your operations.

The audit process consists of the following:

Analysis of quality systems
Analysis of computer systems
Manufacturing Facilities analysis
Equipment log review
Personnel review
Final decision

How can you prepare for this audit? Providing GMP certification training prepares your workforce to enhance processes and workflows to pass the audit process. Therefore, completing a GMP certification course is strongly recommended before requesting an audit.

Knowledgeable instructors with real-world experience in good manufacturing processes teach CfPIE’s courses. In addition, our best-in-class courses have practical instruction for developing a good-standing workforce with the FDA.

Who Issues GMP Certificates in the USA?

Earning a GMP certification can help avoid potential fines and improve process efficiency while giving you a competitive edge over competitors lacking the certification.

GMP certificates are issued by authorized third parties rather than the FDA itself. The third party will conduct a thorough audit before issuing a GMP certification. Once complete, a certification will be issued, or you will receive a list of violations or deficiencies to address to guarantee you meet all GMP certification requirements.

GMP certification typically lasts for three years, after which you’ll need to conduct a new audit to renew your certification. This timeframe helps make sure companies maintain high standards.

Ready to Begin the Process of Getting GMP Certified?

Becoming GMP certified is crucial for any manufacturer of pharmaceuticals. Even if not strictly enforced, GMP certification improves the safety and efficiency of your manufacturing processes. As a result, you’ll gain a competitive advantage and ultimately better protect consumers.

Are you interested in learning more about our Good Manufacturing Practices certification? CfPIE offers its own facility certification program to streamline the GMP process.

We send our own staff to your factory floor to complete physical checks and auditing. From laboratory quality control to proper administrative practices, we will independently evaluate and ensure the compliance of your business and even offer remediation suggestions if we find any weaknesses.

In this post, we’ve explored many of the benefits of a GMP certification to your organization, so get in touch with us today. Our multi-step process begins with a Discovery Session over the phone or web conference.

Learn more about our GMP training programs and the certification process today.

About CfPIE

Should FDA Pre-Approval Inspection of Manufacturing Plants That Make Over-the-Counter Drugs Be Mandatory?

Wed, 07 Jun 2023 17:31:33 GMT

Pharmaceutical manufacturing must result in safe and reliable medication to ensure efficacy and patient safety. Lacking manufacturing processes can have detrimental effects on the end consumer, ranging from ineffective medication to serious health concerns.

The Food and Drug Administration (FDA) is responsible for ensuring all pharmaceutical manufacturers properly manufacture medications to protect consumers, both within and abroad.

However, there have been recent issues and related concerns with pharmaceutical companies’ safety practices. As a result, it’s become clear the FDA inspection process must be revised to better protect consumers.

One of the chief concerns is the FDA’s policy for over-the-counter drugs. Additionally, the FDA has a backlog of foreign manufacturers without an adequate workforce in place to conduct pre-approval inspections.

How can the FDA ensure better processes from? For example, should the FDA inspection of over-the-counter drug manufacturers be mandatory? Keep reading to explore recent concerns and why you should provide employees with FDA compliance training.

Regulatory Gaps and Lapses in Inspections

The FDA ensures the quality of manufacturing facilities through several processes. One of the primary methods is conducting an FDA pre approval inspection of facilities for any manufacturer producing pharmaceutical products to ensure they are in full compliance with all regulatory requirements. FDA’s Good Manufacturing Practices (GMP) are central to these inspections, and companies must fully comply.

However, the FDA’s processes have been criticized for crucial regulatory gaps, such as controlling imports of drug products coming from overseas. Additionally, some have criticized FDA inspection frequency and the inspection process itself.

Recent Contamination Incident

Safety practices in pharmaceutical manufacturing have come under scrutiny following notable instances of unsafe practices for over-the-counter drugs. One specific incident reflects lacking inspections for imported over-the-counter medications, resulting in blindness and degrading vision from eye drops contaminated with antibiotic-resistant bacteria.

Recently, an Indian company that manufactures artificial tears was suspected of being contaminated with drug-resistant bacteria capable of degrading vision while also being contagious.

Most notably, this bacteria spread person-to-person at a long-term care center in Connecticut. As a result, many patients still have degraded vision. As a result, the FDA blocked imports of the eye drops and issued a recall.

As a result, the FDA’s inspection processes for over-the-counter drugs are now under the microscope. Should inspections be mandatory? Why was this specific manufacturer not inspected and gone through necessary quality checks before its products were made available to consumers?

Changes may take some time to be drafted, agreed upon, and implemented. In the meantime, companies domestic and abroad can help prevent potential issues and stay ahead of possible changes by providing employees with FDA compliance training .

Concerns and Solutions

Allowing the import of contaminated eye drops brought FDA’s inspection and enforcement processes into the spotlight. It’s clear the FDA’s processes are not perfect, especially concerning imported medication and nonprescription drug products.

Many critics have said that the FDA needs to do more to improve safety practices in pharmaceutical manufacturing, domestically and abroad. The incident we discussed above is a prime example, and it’s not the only example of lacking processes.

The U.S. Government Accountability Office (GAO), a federal agency, has raised several concerns regarding FDA’s processes and made specific recommendations. The GAO has provided three detailed recommendations for executive action:

Incorporate leading practices identified by the GAO for designing a program to evaluate the effectiveness and efficiency of unannounced inspections in foreign facilities.
Evaluate the costs and effectiveness of translation services to be made available during foreign inspections to improve these inspections.
Develop new strategies for recruiting, training, and retaining investigators capable of specializing in foreign drug inspections.

The last recommendation aims to solve a primary concern — an insufficient workforce for conducting inspections in foreign manufacturing facilities. As a result, the FDA has a significant backlog of foreign companies to inspect, but many over-the-country companies are still exporting products to the US.

It’s clear the FDA needs to ensure any company that will be manufacturing drugs for the US meets compliance requirements for the safety of consumers. While the FDA may have gaps and lapses, they can also be corrected by taking key actions to improve processes and expand its workforce.

The importance of FDA regulatory compliance training

Pharmaceutical companies need to stay up to date with FDA regulations. This includes hiring qualified personnel, investing in training and education, and utilizing available FDA resources.

FDA compliance changes frequently, and your employees must stay on top of any changes affecting their roles. Compliance training keeps your employees updated with the latest CGMP requirements to help you avoid fines or product quality issues.

While abiding by FDA regulatory compliance requirements is necessary, providing ongoing training also improves your manufacturing processes. In addition, your teams will be aware of process changes that reflect significant studies and analyses from the FDA, allowing for efficiency and effectiveness enhancements throughout the company.

Whether the FDA will make pre-approval mandatory for over-the-counter drugs remains to be seen. However, manufacturers can stay ahead of potential changes by providing compliance training.

CfPIE is a leading provider of life science training, including Good Manufacturing Practices (GMP) courses that keep your workforce in full compliance. Learn more today about how our programs can help keep you in compliance and operating effectively.

About CfPIE

Good Documentation Practices in a GMP-Regulated Plant

Fri, 28 Apr 2023 14:36:13 GMT

Guidelines for enforcing good document management practices in pharma industry

Pharmaceutical and medical device manufacturers adhere to the current good manufacturing practice regulations, and safety guidelines set by the Food and Drug Administration (FDA) to ensure the safety of their product output. Part of that compliance is proper documentation procedures.

Good Documentation Practice (GDocP) enforces best practices for creating and maintaining facility documentation and, by extension, protects the integrity of manufacturing processes. Quality control in the pharmaceutical industry must go beyond batch testing and utilize process verification methods to ensure the production line itself is compliant. And documentation plays a significant role to that effect.

Any GMP-regulated plant will diligently fulfill its regulatory responsibilities in the name of GDocP, which serves as an essential component to an overall pharmaceutical quality system (PQS) and quality risk management (QRM) initiative. GDocP also prepares facilities for inspections and audits and allows them to find the root cause of product issues, deviations, and recalls.

The life sciences industry also refers to Good Documentation Practices as Good Recordkeeping Practices (GRK). However, the abbreviation “GDP” is not recommended, as it refers to a separate concept known as Good Distribution Practices.

Basic Principles of Good Documentation Practices in the Pharma, Biotech & Medical Device Industries

GDocP primarily deals with the data manufacturing facilities collect as part of their GMP compliance . These companies produce many types of guidance documents to support recordkeeping responsibilities.

Records Under the Control of Good Documentation Practices

Pharmaceutical and medical device manufacturers create documents that fall into four categories:

Primary records detail essential production information, including formulas, contracts, and packaging and delivery instructions.
Procedure documentation includes the guidelines for conducting procedures throughout the factory.
Supporting documents allow pharma and medical device businesses to meet their GMP requirements. They include maintenance documents and equipment calibration reports.
Quality control records have to do with product testing procedures and investigations into product recalls.

The life sciences industry deals with dozens of these documents. Only a few examples are batch records, self-inspection reports, clinical study records, certificates of analyses (CoAs), certificates of compliance (CoCs), distribution records, laboratory logs, product and shipping labels, employee policies, standard operating procedures, training materials, and workplace safety reports.

ALCOA

Regulatory authorities expect this information to follow the good documentation practices guidelines of the ALCOA acronym:

Accurate. Facilities must verify that documentation is accurate and not intentionally misleading to prevent fraudulent entries.
Legible. The information in the documents must be easily readable and accessible. It must be available in commonly accepted formats and contain known notations and terms.
Contemporary. Documentation must cover events as they occur. Documenting details well after the fact is not permissible.
Original. GDocP does not accept copies of documentation. Even edited records with fixed mistakes must retain the original text.
Attributable. Documentation must be traceable. Individuals involved in creating the documentation, from recorders to data entry employees, must divulge their identities in the documents.

Recent developments have also expanded on this acronym:

Some companies are planning to make documentation attributable by applying blockchain technology to the recordkeepers.
A new emphasis on digital security and data backups has arisen in response to the increasing digitization of medical records.
To keep documentation contemporary and reporting timely, some facilities are using automated time-stamping alongside digital records.

These guidelines and practices apply to all steps in the product’s lifecycle, including conception and design, clinical trials, manufacturing, distribution, and post-release monitoring.

The Importance of Good Documentation Practices Training

Proper documentation practices are critical to the long-term success of a pharma or medical device manufacturer. Companies in this space invest greatly in GDocP training because it directly contributes to product safety, legal compliance, and audit preparation.

Ensuring Product Safety and Efficacy

Keeping reliable, accurate, and complete records help companies achieve GMP certification and guarantee the safety, effectiveness, and quality of their pharmaceuticals and medical devices.

Dedication to GDocP consequently results in consistent quality products and lower chances of product recalls. Documentation reduces the incidence of errors and can help trace the source of issues if they do arise.

Good documentation practices are especially vital in the life sciences industry, where product quality can impact the health and safety of end users. It also helps combat recent trends in counterfeit medicines and medical devices, which rose by 38% between 2016 and 2020.

Meeting Regulatory Requirements

Implementing good documentation practices procedures also allows pharma or medical device businesses to comply with international quality standards and regional regulations. Examples include:

The FDA’s cGMP requirements that detail current standards for safe manufacturing process.
ISO certifications for tasks like laboratory testing, information security, and medical device manufacturing.
ICH requirements from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Preparing For Compliance Audits and Inspections

GMP inspections—either from the FDA, the EMA, or any other regulatory agency—will certainly survey documentation, recordkeeping, and data integrity systems.

And positive recordkeeping practices start with proper data governance measures. Empower employees to take on the FDA’s expectations through GDocP training .

Why Should Pharmaceutical and Medical Device Companies Turn To Training?

You can’t assign document management to a separate department in the organization and expect good results. Training matters because GDocP requirements apply to employees throughout the organization. ALCOA principles, as mentioned, are necessary throughout the production line from design to post-market activities.

Managerial buy-in is another essential component of GDocP compliance. Recordkeeping contributes to proper data governance measures, which GMP inspections will look for. And upper management can demonstrate dedication to quality recordkeeping by requiring GDocP training for personnel.

Training for good documentation practices proves useful for various types of employees, including:

Contractors
Suppliers and vendors
Warehouse workers and transport services
Logistics and delivery services

Everyone involved in tasks from raw material sourcing to product testing, labeling, quality assurance, and distribution must write and maintain documents as part of the job. GDocP training allows both employees, contractors, and other stakeholders to understand GMP guidelines regarding recordkeeping and documentation maintenance.

Elements of Effective Good Documentation Practices (GDP) Training

When searching for GDocP training courses, you need to find one that covers all your bases.

Broad coverage of international standards and requirements, including GMP, ICH, and ISO.
Guidance on building compliant documentation policies and procedures within a facility.
Lessons on modern recordkeeping tools, such as electronic records and signatures.

Since nearly all your personnel will need training in good documentation practices, look for courses that offer flexible delivery methods, from classroom-based instruction to on-site guidance.

Keep Your Manufacturing Processes Reliable and Verifiable Through Good Documentation Practices

GDocP contributes not only to GMP compliance but also safer and more effective drugs and medical devices. Documentation keeps track of recent audits and inspections and thoroughly details every aspect of your production line, leaving a paper trail to pinpoint potential problems before they impact the finished products.

The most GMP-compliant facilities recognize the need for reliable documentation and prioritize GDocP training for their personnel. Are you looking to reinforce your team with certified document management professionals? Get your staff up to speed by registering for CfPIE’s “ Effective Document Management for Pharma, Biotech & Medical Device ” course today.

What Is Good Laboratory Practice (GLP)? A Quick Guide for Beginners

Sat, 01 Apr 2023 22:35:38 GMT

Updated, April 2023

Quality control is a field every manufacturer is familiar with. To produce something that your customers will be willing to pay for, you have to check the quality of the materials used to make it, the production processes involved, and the final product itself to weed out any defects.

In the medical world, however, defects can manifest in ineffective or even unsafe drugs and medical devices that can harm the health of your users.

This high-stakes environment means that the pharmaceutical industry needs an especially stringent set of quality control standards for medical research, known as GLP or Good Laboratory Practices.

What is Good Laboratory Practice? An Overview

The OECD defines GLP as a “ quality control system covering the organizational process and the conditions under which non-clinical health and environmental studies are planned, performed, monitored, recorded, reported, and retained.”

In other words, testing facilities undergoing research studies must report to the appropriate authorities to ensure their clinical trial activities are safe and controlled. In addition, GLP demands that medical companies fulfill various obligations when it comes to the overall safety of their clinical or exploratory studies:

Testing facilities and equipment must be maintained appropriately for undergoing studies.
Operating procedures and laboratory practice regulations must be standardized and adequately documented.
Data and reports must be collected to keep records of daily operations.
Facility staff, including quality assurance specialists and management teams, must have adequate training and be held accountable to GLP compliance.

GLP Good Laboratory Practice originally began under the United States Food and Drug Administration back in the 1970s, but today has expanded into Canada (with the Standards Council of Canada), Denmark, New Zealand, and now the world through OECD.

So why is there so much interest in GLP among medical organizations worldwide?

History of Good Laboratory Practice

The United States Food and Drug Administration (FDA) developed its Good Laboratory Practices guidelines to cover non-clinical testing and recordkeeping in response to failures in toxicology evaluations in the 1970s.

The specific document, the Guidance for Industry Good Laboratory Practices Regulations , was drafted after executives at Industrial Bio-Test Laboratories falsified the safety data of their products before submitting them for government approval.

The practice now extends to Canada as well, with The Standards Council of Canada (SCC) assisting with not only local testing but also alignment with international standards of testing to facilitate foreign trade. New Zealand and Denmark released their own GLPs in the 1970s as well.

In 1992, The Organization for Economic Co-operation and Development (OECD) officially adopted GLP and began making it applicable on a global scale.

What Are Good Laboratory Practices in the Pharmaceutical Industry?

GLPs matter in the pharmaceutical industry because they allow laboratory studies to collect and verify their data comprehensively and ensure quality control in the final product. In other words, the results of the testing are more reliable under GLP.

QC specialists in the medical field also use GLP to work with various aspects of testing internationally, allowing for comparisons between studies completed in different laboratories.

In the context of pharmaceutical quality control, good lab practices mainly look at the following:

Resources: Supplies, equipment, lab testing facilities, and staff.
Testing: Specifically, what the test is experimenting with and what clinical study subjects are used for testing.
Protocols: Standard operating procedures, rules, and transparency practices.
Reporting: Collection of raw data, generating the report, and archiving the study.

By independently monitoring research and laboratory studies, GLPs hold non-clinical testing up to a high standard no matter where and by whom it’s being conducted.

Why GLP Matters to the Medical Industry

You might wonder why businesses in this field invest in GLP training for their staff. Following Good Laboratory Practice guidelines has several benefits for both public health and the facility’s regular operations.

Improving Operations Through Recorded Measurements

A facility with strong GLP practices understands the importance of keeping a paper trail of all laboratory measurements. This way, figures and data recorded during testing can be traced back to the source whenever necessary.

Once studies have generated findings, verifying those conclusions using empirical data and processes by backtracking where they came from is possible. The end result is a more trustworthy study.

Ensuring Data Quality

Laboratory studies are intended to collect potentially useful information that could lead to the developing of new drugs and treatments. This data is considered more reliable when it’s collected under a GLP-compliant lab, resulting in the following:

More confidence in the conclusions and findings of the laboratory study, which also reduces the need for regulatory compliance investigations.
More productivity when it comes to generating useful results and avoiding false findings.
Stronger reputation for the facility and the company as a whole.

Accelerating the Time-To-Market

These benefits ultimately result in an improved time-to-market for new pharmaceutical products. Instead of wasting time with ineffective studies, additional testing, or going through investigations to find out what went wrong, GLP practices ensure that you have all your data ready from the beginning to empower conclusive results.

What You Can Expect from The Good Laboratory Practices Certification Programs with CfPIE

Knowledge of good laboratory practices is necessary for producing quality, trustworthy medical research, which contributes to developing more effective and safe drugs and medical products. Therefore, CfPIE’s programs were developed to instill the skills and training necessary to enact GLP throughout individuals' and facilities' daily operations.

Good Laboratory Practices Certified Compliance Professional

Our Good Laboratory Practices Certified Compliance Professional (GLPCP) certification is designed for current or future compliance professionals, a high-demand career path that is both rewarding and a site of constant innovation. GLP deals with the consistency and reliability of pharmaceuticals and their manufacture and distribution beyond the lab.

The GLPCP Track offers flexible learning to tailor your coursework to your current or future career. Building on a solid GLP foundation, this track allows you to choose four courses from nine core topics, including biostatistics, clean room fundamentals, SOP creation and validation. These essential skills you learn while receiving Good Laboratory Practice Certification will benefit you and your employer, and choosing GLP-related courses ensures a wide scope of topics to study.

Knowledgeable, student-focused instructors lead courses such as Biostatistics for Non-Statisticians with a mix of real-world applications and a focus on clarity that underscores the course title. Students without a background in mathematics or statistics will find the material practical in focus, spotlighting communication with statistician colleagues for mutual understanding and benefit.

Who Can Attend?

Obtaining a good laboratory practices certification should be a goal for many types of medical specialists looking to advance their career , including:

Regulatory Affairs and Compliance personnel
Laboratory scientists
Study directors
Principal investigators
QA and QC management

But no matter what field you’re from—whether it’s medical device manufacturing, cosmetics, pharmaceuticals, food, or anything else—obtaining a certification on GLP guidelines is thankfully more manageable than ever, thanks to online courses from certified course directors at CfPIE . So if health and safety is your passion, this is an excellent career track.

Good Laboratory Practices (GLP) for Nonclinical Laboratory Studies

Our Good Laboratory Practices (GLP) for Nonclinical Laboratory Studies course will provide participants with a comprehensive understanding of the terminology, regulations, and mandated practices for conducting a study in compliance with GLP regulations.

Those attending will get a thorough briefing on the relevance of accurate documentation, calibration and maintenance of instruments, and validation of relevant methodologies. In addition, we will examine the requirements for training staff, good documentation practices, study protocols and reports, and standard operating procedures.

This course covers a range of essential topics, including:

Issues involving the roles and responsibilities of the Test Site Management and the Study Director in planning, supervising, and managing nonclinical studies.
Audit activities must be conducted to assure management that laboratory studies comply with the regulatory standard stated in the study protocol.
How to manage regulatory inspections and respond to findings of non-compliance noted during a regulatory agency inspection. Inspection results for sponsor companies and CROs are included in these discussions.
The functions of the Quality Assurance Unit (QAU) and the need to effectively audit laboratory activities and data for compliance with GLP regulations and internal SOPs and test methods.

Who Can Attend?

Our three-day GLP training course is designed for all Scientists (managerial and laboratory), Regulatory Affairs, and Compliance personnel who actively participate in regulated laboratory studies. The course will benefit professionals whose job function necessitates the generation, evaluation, assurance, and submission of laboratory data to regulatory agencies. In addition, principal Investigators, Study Directors, Study Monitors, and professionals aspiring to these positions will derive benefit from this course.

This course is also useful for quality assurance and quality control managers, coordinators of multi-site projects, regulatory affairs professionals, auditors, and senior management interested in effective QA techniques. Our course will also benefit professionals from CROs operating under the GLP regulations.

New and experienced staff from the food, pharmaceutical, medical device, nutraceutical, agrochemical, and cosmetics industries will learn the fundamental principles and applications of GLP, particularly in the complex multi-site environments of today’s industry.

GLP Facility Certification Program

CfPIE offers a unique Good Laboratory Practice Training and GLP Facility Certification Program that provides clients with the documentation required to prove that their facilities and quality systems are entirely GLP compliant.

Before starting the 5-step GLP certification process, a CfPIE GLP training course auditor will conduct a Discovery Session to assess your information, starting with a phone call or web conference.

The Audit: CfPIE will thoroughly audit the client's facility, quality systems, and documentation practices.
The Scorecard: The CfPIE audit report will indicate how well the facility scores in key areas such as data integrity, quality assurance, and management practices.
The Review: CfPIE reviews the scorecard results with the client to define areas in need of improvement and suggest a course of action.
The Confirmation: CfPIE returns to re-score the facility based on the implementation of both required and suggested changes. Certification is issued if compliant.
The Follow-Up: CfPIE will perform re-inspections on an annual basis to help ensure that the facility remains fully compliant.

Who Can Attend?

Pharmaceutical industry
Medical Devices industry
CfPIE is unable to provide GLP facility certification for those manufacturing Cannabis, Cosmetics, Supplements, or Food Products.

Instilling GLP Values Into Your Facility Operations

Good Laboratory Practices can’t be implemented overnight. It takes a lot of forward planning and collaboration among everyone in the business to achieve true Good Laboratory Practices.

For instance, an official Quality Management System is necessary to fulfill the basic requirements (such as documenting data and operating procedures), and measuring tools and equipment must be regularly cleaned and calibrated before use.

Most importantly, getting every staff member on board is a major step. Not only does upper management need to be on board, but individual employees and staff members need to have the right knowledge and experience with GLP when it comes to working on the factory floor. Only then can you identify potential quality issues and guarantee compliance.

Are Your Employees GLP Certified? Make Sure They Are with CfPIE

Compliance with GLP is necessary for a heavily regulated environment like the medical industry.

Businesses focusing on GLP compliance can develop and produce new pharmaceuticals and treatments cost-effectively. Compliance managers will also better understand compliance requirements, best practices, and other critical information related to GLP certification .

Are you looking to become GLP certified? CfPIE’s dedicated GLP Certification Program is designed for industry professionals looking to become GLP certified. If your organization or testing facility has more than ten employees looking to get certified, we also offer complete program tracks on-site at your facility.

In addition, if you are looking to get your facility itself certified, CfPIE may be able to help through our GLP Facility Certification Program .

The Center for Professional Innovation & Education to Provide Accredited Pharmaceutical and Biotechnology Courses In-Person at INTERPHEX 2023

Fri, 24 Feb 2023 16:25:28 GMT

CfPIE and INTERPHEX have partnered to offer six in-person training sessions during this year’s event, April 25 - 27, 2023.

Malvern, Pennsylvania, Feb 24, 2023

The Center for Professional Innovation and Education (CfPIE), a global leader in life sciences training, today announced that it will be attending this year's INTERPHEX conference, where it will host six accredited and approved pharmaceutical and biotechnology courses. Course registration will include complimentary access to all three days of the event itself.

INTERPHEX brings together 8000 global pharmaceutical, biotechnology, and device development professionals and suppliers each year. Located at the Javits Center in Manhattan, New York, the event features a unique combination of exhibits, demonstrations, and technical conferences. Hosted and maintained by global event management firm RX Global, the event also offers multiple networking and partnership opportunities.

INTERPHEX 2023 will take place from April 25 - 27, 2023, with CfPIE’s courses being offered during morning hours of the first two days, and afternoon of the third day as to avoid overlap with the exhibit hall and technical conference event hours. Each of the following six courses will be taught in-person by an active, industry expert, providing attendees with 14 hours of instruction, exclusive exhibitor presentations and interaction, and credit toward several CfPIE Certification programs:

Analytical Method Validation for Biologics, Biopharmaceuticals and Other Therapeutic Products. Dr. Judy Carmody presents this course as a comprehensive overview of the complex and challenging quality control methods typically applied in biologics and biopharmaceuticals.
Aseptic Processing in the Manufacture of Biotech and Pharmaceutical Products. Hosted by Acerna Incorporated President Paul Larocque, this course provides an overview of the technical basics governing aseptic processing alongside practical management and troubleshooting advice.
Best Practices for an Effective Cleaning Validation Program. Steven Weitzel, vice president of technical operations at CANI, Inc., Critical Process Cleaning and Biodecontamination for FDA regulated facilities, hosts this course on cleaning validation processes, regulations, and challenges.
Computer System Validation. Dr. G. Raymond Miller hosts this comprehensive class on developing, implementing, and maintaining regulated computer systems.
Lyophilization Technology-Application of Scientific Principles. Under pharmaceutical technology consultant and educator Lisa Hardwick Thompson, participants in this course will receive practical guidance to help them understand the scientific and engineering principles of lyophilization.
Selecting and Managing CROs. Attendees who participate in this course will learn what's involved in successfully outsourcing pharmaceutical programs, courtesy of Kay Monroe, founder of Cayman Scientific Consulting LLC.

“CfPIE is excited to partner with INTERPHEX, the leading global pharmaceutical technical conference, to offer six of our pharmaceutical and medical device training courses live and in-person during the April 2023 event,” says Mark Mazzie, CEO of CfPIE. “Each course will count toward one or more of our industry-recognized certification programs. We’re looking forward to developing an innovative program that brings additional value to INTERPHEX customers.”

“The INTERPHEX Show Management team is always striving to enhance the event and bring additional value to our customers, and we believe the courses being offered by CfPIE will do just that,” says Douglas Lugo, Event Director of INTERPHEX. “For customers looking to advance their careers within the pharmaceutical and biotech industry, CfPIE’s certification courses add credibility and keep you up-to-date with emerging trends and best practices.”

INTERPHEX 2023 is scheduled to take place April 25-27 at the Javits Center in New York City. Course attendees will acquire 14 credit hours through three partial-days of interactive presentation by expert instructors, as well as receive complimentary access to the entire INTERPHEX event, along with exclusive interaction with vendors specific to the course chosen. To register or learn more, click here .

About CfPIE

About INTERPHEX

INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event. Based in New York, it invites attendees to Experience Science through Commercialization. Through a unique combination of exhibits, demonstrations, partnering opportunities, networking and no cost technical conferences, attendees have the chance to learn about, experience, and procure new technologies and devices. Together with INNOPHEX, the International Pharmaceutical Expo, INTERPHEX showcases the very latest intelligence, cutting-edge technologies, and state-of-the-art innovations throughout the product development life cycle.

To continue learning beyond the show floor, follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter or visit www.INTERPHEX.com

About RX Global

RX is in the business of building businesses for individuals, communities, and organizations. We elevate the power of face-to-face events by combining data and digital products to help customers learn about markets, source products, and complete transactions at over 400 events in 22 countries and regions across 43 industry sectors. RX is passionate about making a positive impact on society and is fully committed to creating an inclusive work environment for all our people. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.rxglobal.com

The Different Types of FDA Inspections: What You Need to Know

Mon, 20 Feb 2023 18:58:21 GMT

This article was updated on February 20, 2023

How the FDA Conducts Risk-Based Inspections

Are your facility’s manufacturing processes compliant with the Food and Drug Administration’s (FDA's) current guidelines? Given how strict the FDA is when it comes to the health and safety of consumers, regulatory compliance is an essential consideration of any pharmaceutical, biotech, and medical device company.

But is your organization familiar with the FDA’s risk-based inspection model ? And do you know how the agency handles inspections out in the field, how it chooses facilities to inspect, and how its regulations compare to those of other countries?

How Do FDA Inspections Work?

Any medical organization that manufactures or handles medical devices, pharmaceuticals, or any other products under the control of the Food and Drug Administration should expect the regulatory agency’s inspections to verify compliance. Likewise, any foreign manufacturer looking to operate within the United States must have FDA approval.

The FDA first implemented the risk-based approach in 2005 as part of its “Pharmaceutical Quality for the 21st Century, A Risk-Based Approach” initiative. The agency later increased the minimum inspection interval for domestic drug establishments in 2012.

The risk-based inspection program aims to:

Verify that manufacturers are maintaining compliance with current good manufacturing practices (cGMP). If a company commits a violation, it must prove that dangerous products are not entering the market.
Provide valuable feedback during the inspection process.
Improve current drug manufacturing processes and update CGMP requirements, regulations, and guidance.

How Does the FDA Select Facilities to Inspect?

Based on current guidelines, the FDA prioritizes high-risk sites. The Site Selection Model (SSM) is an inspection list generated by the Office of Pharmaceutical Quality.

The Office of Regulatory Affairs determines the annual capacity. It also helps the FDA analyze regulated products and review imported pharmaceuticals that enter the United States, hence the demand for Office of Regulatory Affairs certification.

But how does the FDA assess an individual company’s risk level? It starts by looking at important risk factors:

General compliance history
History of product recalls
Overall risk of the drugs and medicines the company manufactures
Frequency of the regulatory inspections in the past
Whether the facility underwent an inspection by a foreign government agency as per section 809.

The FDA also scans for other extenuating circumstances that could generate additional risk and may warrant an inspection as a result.

How Do cGMPs Play into FDA Inspections?

Current good manufacturing practices (cGMPs) are the regulations that ensure manufacturing facilities design their workflows and maintain their equipment with proper quality control in mind.

The FDA uses cGMPs indirectly to boost the strength, purity, and safety of medicinal products. Facilities that follow cGMP recommendations have mechanisms to prevent deviations, contamination, and other errors. The term “current” refers to how safety standards change over time.

A company might obtain a cGMP certification through careful quality control practices, vendor management, and reliable testing. cGMP is also fairly flexible, as companies themselves choose how they want to adhere to the recommendations.

Why Do cGMPs Matter?

End users of a drug cannot detect whether it’s safe just by looking at it. As part of its effort to ensure public safety, the FDA designed cGMP to go beyond just testing the final product. It instead digs deep into the drug development process, and how the company made the product and whether the manufacturing conditions are capable of producing high-quality, safe pharmaceuticals.

What Are the Consequences for Failing to Adhere to cGMPs?

The FDA uses inspections to check for cGMP compliance. Highly-trained inspectors visit the sites of any facility involved in production, from the active ingredient manufacturers to the companies that produce the final product.

The FDA considers products created in a non-compliant facility as “adulterated.” This designation does not guarantee that the product is unsafe but merely that the conditions from which it originated are risky. Consumers may choose to continue their drug therapies regardless, as interrupting such therapies could pose a health risk.

The penalty for failing to adhere to cGMP varies depending on the nature of the violation:

The business may voluntarily recall a drug under the FDA’s request. If it refuses, the FDA may seize the pharmaceutical and issue a public warning.
The FDA may bring a seizure or injunction case to court.
Criminal charges may be necessary in extreme cases, involving fines and sentencing.
The company must set up new policies to improve its compliance posture, such as better sanitation, additional testing, or employee training.

In all cases, the intention of cGMP sanctions is to prevent potentially unsafe drugs from entering the consumer market.

How Do Risk-Based Inspections Work in Practice?

To ensure a GMP-compliant environment, pharmaceutical facilities must prepare for risk-based inspections.

Government agencies use the Quality Risk Management methodology to assign risk ratings to individual manufacturers. Depending on that risk rating, it will determine a frequency for routine inspections. Risk refers to either intrinsic risk (the complexity of its operations and the importance of its product output) or compliance risk (the company’s general GMP stature).

Inspection scope and duration depend on other factors, such as whether previous inspections suffered from crucial deficiencies.

What Are the Types of FDA Inspections?

Pre-approval. This inspection is for new products companies submit to the FDA for initial approval. After receiving the application, the inspection verifies the validity of the information presented in the application. The inspectors also will confirm the capability of the facility to manufacture the drug or device. The inspectors then decide on whether the facility passes FDA approval.
Routine. For class II and class II device manufacturers, routine inspections are required by law every 2 years. This inspection follows the methodology known as the Quality System Inspection Technique (QSIT) . QSIT breaks down the processing procedure into 4 subsystems. Inspectors then investigate any combination of the subsystems depending on risk-level whether the inspection is initial or a subsequent routine one.
Compliance follow-up. The FDA conducts follow-up inspections in response to the findings of a previous inspection. Follow-ups look at whether the facility completed the requested actions the agency had recommended. These inspections will be necessary if an earlier inspection led to a Warning Letter or a completed 483 Form . The 483 Form documents concerns found during an inspection and communicates them to the manufacturer. The follow-up inspection will verify compliance or give support for further regulatory action if the facility failed to acknowledge previous recommendations.
For cause. The FDA will trigger a “for cause” inspection if it receives a report about a facility’s products or services. These reports may come from the manufacturer itself in the form of a product recall or from an end user filing a complaint. For cause inspections focus mainly on the specific issue mentioned, though their findings could prompt additional inspections into other parts of the operation.

How the FDA’s Risk-Based Inspection Model Compares Internationally

The FDA and its analogous agency in the European Union, the EMA, have significantly different approaches to ensuring the safety and efficacy of drugs and pharmaceuticals.

Centralization. The FDA functions as the U.S.’s centralized governing body, whereas individual countries in the EU must synchronize their regulations.
Intention. The FDA began as an agency for consumer protection, while the EU intended to harmonize commercial interests across the countries.
Speed. Drug review is shorter at the FDA than at the EMA. A shorter time-to-market reduces the cost of pharmaceuticals and improves outcomes for patients but also shortens the amount of time regulators have to consider a drug.
Transparency. The FDA allows non-published trial data to be viewable online, while the EMA does not, considering such data as “commercially sensitive.”
Approval process. The FDA primarily has a single approval process for drugs post-clinical trial. European approval may involve 4 different paths depending on the nature of the final product.

In the EU, a drug may go through the EMA directly for approval or it may go through each EU state individually. Mutual approval is also an option, where a single approval in one EU state is recognized mutually across all states. Finally, a drug company may submit applications for multiple EU states at once.

The general idea is that the FDA is a centralized governing body with overarching regulations, while the EMA is a network of multiple national bodies across its member states. There are unique challenges to both approaches.

Navigating the Complex Landscape of Risk-Based Inspections with CfPIE

No matter what type of product your facility produces or how low-risk it is, you can’t afford not to prepare for FDA inspections. Setting up process controls and preparing your facilities for in -person inspections are a natural part of cGMP compliance.

Interested in empowering internal teams with the knowledge they need to be FDA-compliant? The Center for Professional Innovation and Education offers professional courses tailored specifically for the FDA’s risk-based methodology, such as “ FDA Inspections - What Regulators Expect and How to Prepare ” and “ Comprehensive Overview of FDA Regulatory Compliance for Drug and Biotech Products .” Register today to strengthen quality control and product quality.

Cell and Gene Therapy Frequently Asked Questions

Thu, 16 Feb 2023 21:37:25 GMT

1. How do you ensure the safety and efficacy of gene and cell therapies throughout the development process?

Ensuring the safety and efficacy of gene and cell therapies is an essential yet daunting task during development. The medicines are highly individualized, and both the European Medicinal Agency (EMA) and the U.S. Food and Drug Administration Agency (FDA) have many regulations outlining the approval of these products. For these reasons, safety and risk minimization for patients begins during medicinal product design. For example, by implementing desired properties of viral vectors.

Novel gene and cell therapies are tested for safety during Proof of Concept (PoC) and non-clinical studies. At that level the bioprocess design is verified and attributes assessed for their impact on the product. Already in the early product and process development, Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) deserve the utmost attention, as well as Good Distribution Practices apply.

To ensure the safety of each product, facilities must carefully inspect their starting materials and manufacturing steps to determine their impact on the final product. Multiple active ingredients may generate unforeseen effects when processed together, so robust quality control is key to addressing safety and efficacy risks in the long term. Some examples of risks related to gene and cell therapy include:

Vector insertional mutagenesis. Vector integration into a host cell genome may change activity of host genes, leading to gene mutation or increased activity of nearby genes.
Viral vector shedding. Excretion or release of virus gene therapy from the patient’s body.
Biodistribution (BD). The distribution and the persistence of the vector/virus to target and nontarget tissues.
Viral replication. When a virus infects a cell, it replicates (creation of new infectious virions) using the cell’s resources and releases itself into the body through it. As indicated by the US FDA in the guidance for industry 'Design and Analysis of Shedding Analysis for Various or Bacteria-based Gene Therapy and Oncolytic Products,' 'shedding' means release of virus or bacteria gene therapy or oncolytic products (VBGT) from the patient through one or all following ways: excreta (feces), secreta (e.g. urine, saliva) or through the skin (e.g. pustules, sores, wounds). It describes how a product is excreted or released from the patient's body.
Clonal outgrowth. Delivery vectors that integrate with the genome run the risk of clonal outgrowth, leading to a large population of cells with the DNA mutation.
Pediatric studies. CGT studies often begin with adult test subjects and slowly transition to younger age groups. Quality control for pediatric products requires long-term attention, which is not always applicable for genetic disorders. Besides, children account for 50% of rare disease patients.

Safety considerations are always at play, even after a CGT product obtains regulatory approval. That’s why follow-up studies, which can last up to 15 years for CGT products, are necessary for ensuring long-term safety and regulatory compliance.

2. How do you navigate the regulatory landscape and obtain necessary approvals from regulatory agencies such as the FDA and the EMA?

Legal compliance is a challenging endeavor in emerging fields of medicine like cell and gene therapy. Developers must consider both the United States Food and Drug Administration (FDA) and the European Union’s European Medicines Agency (EMA) requirements.

The FDA defines CGT medicines as biological products and regulates this market segment under the Center for Biologics Evaluation and Research (CBER). The EU has its own term, Advanced Therapy Medicinal Products (ATMP). Both agencies recognize that CGT is an emerging field with unique safety and efficacy requirements and have introduced new regulatory pathways to accelerate development and compliance.

One of the major pushes is for stronger communication between developers and regulators, which is important for emerging fields with little pre-existing knowledge. The agencies offer Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) meetings for this purpose, replacing the prior CBER pre- pre-Investigational New Drug (IND) meeting process for all products across the center.

Other regulatory considerations to make include:

Cell sourcing. The FDA and EMA have different expectations regarding cell banks and where manufacturers can source their cells. Expectations are very similar in the EU and US. For autologous and allogeneic cells (from healthy donors) leveraged for cell therapies or as ex vivo modified gene therapies, a manufacturer should provide information about the source of cells, the collection procedure, and compliance with donor eligibility requirements (21 CFR 1271). For autologous cells, DE is recommended, but not required (FDA). More Info about MCB, WCB can be found in ICH Q5D and in the US FDA transcripts.
Quality control criteria. CGT manufacturing is notoriously complex, so the criteria for safety and efficacy aren’t always clear. Both the FDA and EMA recommend combining multiple testing methodologies together. This is especially applicable for potency assays. For example, validation of potency assays, n=3 different types of assays are recommended.
A potency assay. The potency assay is a metric of how effectively a product can generate a biological response. Choosing this assay is another consideration for measuring efficacy, though regulatory agencies accept surrogate assays that correlate with functional assays during early studies.
Changes to the manufacturing process. Changes to the manufacturing process over time may introduce variability within each batch of the final product. The EMA cites comparisons between the product batches using calculated standard deviations. In the 'Reflection paper on statistical methodology for the comparative assessment of quality attributes in drug development' EMA suggests discussing the operating characteristics of approaches used to determine reference range, e.g. the range between min-max data points, x-sigma intervals or tolerance intervals. The risk of a false positive should be acceptable low. For smaller amounts of samples, there is uncertainty in the estimates of SD due to the large multiplier.
Non-clinical studies. Before moving on to clinical studies, EU regulators require the Genetically Modified Organism (GMO) application, a prerequisite for in vivo gene therapy prior to Clinical Trials Application (CTA).

Cell and gene therapy operates in a unique regulatory environment. Current standards do not accommodate the new challenges of CGT, so both the EMA and FDA essentially encourage manufacturers to evaluate risks in each step of the manufacturing process on a case-by-case basis.

3. How do you optimize and scale up the manufacturing process for gene and cell therapies, including the selection of appropriate cell lines and vectors?

The medical industry is searching for ways to scale up cell and gene therapy manufacturing. As the field emerges, unique challenges present themselves:

Finding partnerships. Outsourcing will be a key solution in addressing supply chain problems related to CGT manufacturing. Companies must find reliable suppliers for raw materials and enable clear communication to synchronize operations and create realistic milestones and timelines. Because CGT is a personalized medicine (each patient receives a tailored batch), any miscommunication can have serious consequences.
Packaging and transportation. CGT medical products must be shipped with temperature constraints. Cryogenic conditions are often necessary, and packaging must withstand the temperatures involved. Regulatory requirements also ensure that containers withstand pressure differences during flights.
Timing. Controlled freezing and thawing are essential parts of transporting CGT products and materials, but slow freezing can also negatively impact the quality of certain cell lines, RNA, and plasmid DNA.
Tracking shipments. CGT medicines are highly personalized, and sending the wrong shipment to a patient can result in significant toxic effects. The industry is experimenting with end-to-end monitoring of each batch via RFID tags.
Quantity of cells. Different dosages should be assessed during the non-clinical tox study and Phase 2 CTs.

Generating specialized cells starts with pluripotent stem cells (PSCs), which evolve to become tissue-specific and usable in CGT. To scale up manufacturing, the industry is looking to study PSC biology more closely and generate more specialized cells from fewer PSCs. Generally, there are different types of cells used for CGTs.

4. How do you design clinical trials that effectively demonstrate the safety and efficacy of gene and cell therapies in target patient populations?

The clinic al trials for cell and gene therapies are significantly different from those of other medical fields. Clinical studies aim to identify safety concerns within medical products. But while many drugs are chemical in nature and have a direct impact on the patient, CGTs are released into host cells. For example, gene therapies with a viral vector serve as the carrier are released into the nucleus of the host cell.

There are additional risks to human test subjects during CGT clinical trials, such as the side effects of genome insertions.

CGT’s unpredictable interactions with the human body have called for a new approach to clinical trials:

Finding trial participants. CGT clinical trials suffer from a limited pool of potential test subjects, as many of them target rare diseases. And the few that do sign up must agree to long-term follow-ups for up to 15 years afterward. Some companies are contacting patient advocacy groups to help locate patients for testing, even those in separate geographic locations.
Ensuring safety. The risks associated with CGT treatments are currently not fully understood, and some adverse effects may take a long time to manifest in a clinical setting. Additional study will be necessary to determine side effects and how a patient’s medical history and genetic background impact the treatment.
Lack of data. Rare diseases having few treatments available on the market, clinical trials must turn to disease or patient registries to measure the efficacy of their treatments. Finding comparators in currently available data will be a priority for CGT.

5. How to ensure long-term product stability, including the preservation and storage of cell-based therapies and the durability of genetic modifications?

The cell and gene therapy sector will call for cold storage to preserve and transport its medicines and products. The demand for cryogenic facilities, liquid nitrogen, and other storage mediums with temperatures below -80 degrees Fahrenheit rose during COVID-19 to store heat-sensitive CGT products.

It’s worth noting that slow freezing and thawing can also negatively impact the quality of CGT-related products, such as certain cell lines and RNA, so controlled freezing and thawing will be necessary for transport.

The containers carrying cell and gene therapy products must also withstand pressure differences brought on by international flights.

6. How to monitor and manage the risk of adverse events and side effects associated with gene and cell therapies?

Like any emerging field of medicine, cell and gene therapy suffers from limited knowledge. The risk profile for CGT products is relatively unknown. Gene expression is often unpredictable, and clinical trials must measure physiological change carefully in their test subjects.

Developers must establish standards while working closely with regulatory agencies to provide a foundation for CGT. And because the potential toxicity effects of CGT are significant, companies must conduct a careful risk vs. reward assessment when administering treatments.

However, the adverse effects of CGT products are not easy to measure, even in a clinical setting. They may take time to manifest and are heavily reliant on the patient’s medical history and genetic profile. Managing risks in these clinical trials will require long-term observation of at least 3 or 4 weeks.

Shipping and delivery will also require attention. Cell and gene therapies are tailored toward individual patients, so transportation must ensure the correct treatment reaches the correct patient.

7. How to develop appropriate dosing and administration strategies for gene and cell therapies, taking into account factors such as the duration of therapeutic effect and potential for off-target effects?

Determining optimal dosage strategies for cell and gene therapies will be a significant talking point for researchers in the industry. What dosage induces a therapeutic response in the patient without leading to toxicity? How do you prevent issues like liver or kidney damage when administering CGT treatments?

In gene therapy, dosage is a vital topic since re-dosing isn’t always an option and the body’s response to the treatment may be limited. However, new advancements are looking to optimize the adeno-associated virus (AAV), the delivery vector for gene therapy, through directed evolution. The result is a lower necessary dose and a lower chance of toxicity.

In cell therapy, the dosage of cells required for a patient depends on the target organ or tissue. Some applications require over 1 billion specialized cells per dose for cell replacement therapy, while other areas like brain or central nervous system regeneration might require fewer. Cell therapy is currently searching for ways to optimize stem cell engineering to yield more specialized cells from the same stem cell bank.

8. How to foster partnerships and collaborations with academic, industry, and patient organizations to support the development and commercialization of gene and cell therapies?

To empower an emerging field like cell and gene therapy, collaboration among companies, agencies, patients, and academic institutions will be necessary to alleviate bottlenecks and streamline research and commercial manufacturing. Some examples of partnerships that accelerate CGT development include the following:

Patient advocacy groups. There is currently a shortage of qualified participants for CGT-related clinical trials, as many treatments target rare diseases, and potential subjects are dispersed across many geographic regions. In response, the industry is looking to partner with patient advocacy groups.
Raw material suppliers. Plasmid DNA necessary for generating vectors that enable cell and gene therapy are difficult to produce on a commercial scale, and few vendors can supply enough to scale up current manufacturing lines. Close partnerships with suppliers will be a top consideration for companies operating in this field.
Regulators. Industry regulations are still developing for cell and gene therapy, so collaboration between developers and regulatory agencies will be important for this emerging field. For instance, the FDA offers Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) meetings for this purpose.
Academic institutions. Harvard and MIT have started partnerships specifically to reduce the bottlenecks of commercial manufacturing for cell and gene therapies. Combining the capabilities of both private and public entities, academic partnerships can facilitate the development of new knowledge in this field of medicine.

At this stage of cell and gene therapy, partnerships unite teams and infrastructure together, accelerating research and development in this emerging field of medicine. We can expect more effective treatments more quickly thanks to these collaborations.

How to manage the cost-effectiveness and affordability of gene and cell therapies, including the development of reimbursement and pricing strategies?

In addition to developmental challenges, cell and gene therapies are currently set back by high dosage costs and affordability concerns for patients. Zolgensma, one gene therapy drug for treating spinal muscular atrophy, notably costs $2.1 million per dose .

However, a single dose with long-term effects may still be preferable to constant treatments spanning a lifetime. CGT must mainly grapple with making upfront costs more accessible, which may involve:

Working with governmental agencies like health technology assessment bodies to determine cost-effective measures for ensuring affordability.
Designing new payment plans, such as staggered payments.
Turning to performance-based pricing. Instead of using a base price, patients pay based on how well the treatment has performed.

While this latter option is attractive for being patient-focused, it’s also not always easy to determine treatment performance, especially in the long term.

CfPIE Introduces New Course on Ethics in Medical Research

Wed, 14 Dec 2022 14:20:12 GMT

Two-day virtual training session will give participants the skills to identify and address ethical challenges

PRESS RELEASE DEC 14, 2022 09:00 EST

MALVERN, Pa., December 14, 2022 (Newswire.com) - The Center for Professional Innovation and Education (CfPIE), a global leader in life sciences training, has announced a new two-day virtual course addressing responsible, ethical conduct in research. Ethics in Research — Values for Responsible Conduct of Research will provide participants with the necessary concepts and vocabulary to engage with ethical challenges along with the skills to identify and address moral dilemmas.

Hosted by Professor of Philosophy and Health Care Ethics at MCPHS University Ken Richman, Ph.D., the course is founded on and guided by three core ideas:

Ethics is part of our jobs and lives, and the need to apply ethical thinking is not a sign that something has gone wrong.
Science is a profession, and scientific research comes with its own distinct set of standards.
A researcher with the skills and confidence to discuss ethical challenges at work can lower their company's ethical liability risk.

" Given the ever-evolving complexity concerning Ethics in Research, CfPIE is excited to offer our first course devoted to this topic and presented by one of the most respected experts on the subject ," explains Mark Mazzie, CfPIE founder and CEO. " Kenneth Richman, Ph.D., combines philosophical concepts and real-world, practical examples to equip participants with everything they need to apply moral reasoning in both their personal and professional lives. "

Ethics in Research - Values for Responsible Conduct of Research will be hosted online from 9:00 a.m. to 5:00 p.m. CST on Jan. 30 and 31. Participants can register now here .

About CfPIE

The Center for Professional Innovation and Education (CfPIE) is the global leader in life sciences training, providing specialized courses for pharma/biotech, medical device, and skin/cosmetics topics. Classroom and custom on-site formats and certification programs help improve personal skills, maintain regulatory compliance, and advance careers. Small class sizes and industry-active course directors promote a dynamic learning environment with excellent student-to-teacher interaction.

Understanding Good Clinical Practice and How to Become GCP Compliant

Sat, 03 Dec 2022 16:36:04 GMT

Following widespread concern in the 1960s regarding poor oversight of clinical research and drug development processes, many regulatory authorities, the medical community, and the general public pushed for new guidelines to ensure safe pharmaceutical development with proper ethical standards.

What Is GCP Regulation?

What Are the 13 Primary Principles of GCP?

Who Is Responsible for GCP Compliance?

What’s the Difference Between ICH and GCP?

How Do I Prepare for GCP Clinical Trials?

The result was Good Clinical Practice, or GCP, from the World Health Organization. GCP not only defined these new standards but also harmonized them across many countries. Representatives from the United States, Japan, and Europe convened to develop the current GCP guidelines.

Read on to discover the details and intentions of GCP and how your organization can start following its principles.

What Is GCP Regulation?

Good Clinical Practice (GCP) is a globally-renowned ethical and scientific standard that dictates how organizations may design, perform, monitor, and report on clinical trials. The concept got its foundation from the Declaration of Helsinki, a pillar of modern human research ethics.

Governments around the world use this international standard as a framework for designing their medical regulations, particularly regarding:

The treatment of clinical trial participants
Ensuring that the results of the trial are scientifically sound and well-documented
Quality assurance of any drugs or medicinal product the trials help develop

Good clinical practice regulations cover multiple aspects of the clinical trial, ranging from documentation and recordkeeping to facility maintenance, staff training, the use of digital data, and a system of inspections to verify compliance.

And because the World Health Organization formally endorses ICH-GCP guidelines, medical groups worldwide now have a consistent framework to guide their clinical trials and save themselves from redundancies in the development process.

What Are the 13 Primary Principles of GCP?

ICH-GCP is a form of good clinical practice from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). This standard focuses on 13 primary principles regarding clinical trials.

A focus on ethics. Clinical trial design must always have ethical principles in mind according to GCP and other regulatory requirements. Check out our course Ethics in Research
Balancing risk and benefit. All clinical trials come with risks. GCP expects organizations to balance perceived risk with expected benefit when conducting trials.
The rights of human subjects. The safety of the trial participants takes precedence over other interests.
Informed medical decisions. In the same vein, any medical decisions or care subjects receive must be from a qualified physician.
Informed consent. Clinical trial participants must have given full consent before participating in the study.
Subject confidentiality. Protect the records pertaining to subject identity and medical history carefully.
Preliminary data on medical products. A trial that tests an investigational medical product must start with the proper clinical and non-clinical information on that product.
Scientific integrity. A focus on scientifically sound protocols with proper documentation is paramount.
Using approved protocols. An Institutional review board (IRB) or independent ethics committee (IEC) must approve of the protocol with which the trial complies.
Staff certification. Staff involved in the medical trial must have the necessary training and experience.
Data handling. Have proper recording and data storage protocols for handling the information the clinical trial produces. Information is necessary to verify and report on the clinical trial accurately.
Quality assurance. Have a sufficiently robust quality assurance system to protect the trial’s integrity.
Good manufacturing practice. Produce and handle investigational products according to GMP standards.

Who Is Responsible for GCP Compliance?

Medical companies aren’t the only participants in a clinical trial study. The clinical trial process involves many stakeholders, all of whom GCP compliance covers.

The clinical trial sponsor is the organization that conducts the clinical trial. It provides funding and management.
The investigator is the leader of the team responsible for undergoing the actual trial processes.
Pharmacists are on-site to maintain and store investigational products (namely test drugs).
Patients are the human research participants .
Regulatory authorities from governments around the world review clinical data and conduct inspections to verify GCP compliance.
Committees also exist to review the ethical treatment of test subjects.

What’s the Difference Between ICH and GCP?

GCP is a general term for ethical standards that apply to conducting clinical trials, but there may be different interpretations of the concept. The FDA’s GCP framework might be slightly different from the World Health Organization’s, for instance.

The aforementioned International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, or ICH, bridges the gap between the pharmaceutical industry and regulatory authorities for designing and controlling medical studies. The ICH promotes public health through its global standards known as ICH-GCP.

But while ICH-GCP primarily handles the American, European, and Japanese regions, another standard exists from the World Health Organization known as WHO-GCP published in 1995.

Both the WHO and ICH variations experienced similar development cycles by similar experts, but they differ in format and content. ICH is primarily a regulatory standard, while WHO is more of an informative resource, especially for countries without currently existing regulatory standards.

How Do I Prepare for GCP Clinical Trials?

Knowledge of good clinical practice is mandatory for safe and scientifically sound clinical trials. Any organization in drug development and research and anyone involved in clinical trials must understand GCP guidelines and follow their primary principles.

Learn everything you need to know about GCP compliance through CfPIE’s course: GCP Audits - Best Practices for Ensuring Compliance & Detecting Fraud and Misconduct in Clinical Trials .

Fundamentals for Beginning or Growing a Career in Medical Writing

Thu, 01 Dec 2022 02:32:04 GMT

Medical research is a never-ending journey. Fresh hypotheses, innovative methods, and growing clinical experience all contribute to the ever-expanding field of medicine. And with every discovery about a disease or its treatment, information must be effectively conveyed to many audiences, from healthcare professionals and drug regulators to patients and the general public.

Effective medical communication is crucial in research, regulatory processes, education, pharmaceutical marketing, and public health. Becoming an in-demand medical writer requires cultivating a specific skill set.

Medical writers have the uniquely difficult task of distilling what may be highly technical information to a variety of stakeholders. We’ve gathered some simple tips on improving your medical writing and taking your medical writing career to another level.

1. Build Your Knowledge

Every medical writer must have a basic understanding of life science concepts and terminology. However, it goes without saying that a deeper understanding of the topic at hand greatly facilitates many forms of medical writing. Expanding your knowledge of different medical specialties builds a strong foundational knowledge for discussing critical health-related concepts with your intended audience.

Moreover, understanding the review process for drugs and medical devices—alongside the complex reporting requirements put forth by different regulatory bodies—is especially important for writers who produce regulatory documents.

2. Sharpen Your Analytical and Statistical Skills

Medical writers perform a variety of analyses, from data analysis to industry analysis. Regardless of their niche, medical writers scan numerous documents such as medical journals and literature, and compress large amounts of information into concise, clear, and truthful content that reads well to their audience.

When summarizing the results of research studies, statistics are almost always vital to the original authors’ findings and subsequent conclusions. A basic understanding of t-tests, P values, and regression analyses is fundamental for all medical writers, especially those responsible for reporting the results of clinical studies.

3. Stay Consistent and Take Ownership

One of the keys to boosting your success as a medical writer is consistently delivering high-quality work. Clients see consistency as a sign of high personal standards, reliability, and an orientation toward growth.

As a medical writer, taking ownership of your work is imperative. You are expected to remain accountable for each fact you present, whether you’re writing a conference presentation, product information manual or patient education materials. Accuracy and transparency are non-negotiable.

4. Keep Yourself Up-To-Date

Another hallmark of a professional medical writer is staying up-to-date with the industry's newest developments. Subscribing to major journals, attending key events and conferences, and completing ongoing training are all excellent ways to stay abreast of a field that’s constantly expanding.

One attribute recruiters tend to favor is writing certifications . Medical writers who have undergone training at a well-recognized and reputable organization have the necessary credentials to support their portfolio.

5. Practice Plain Language Principles

Writing in plain language is an essential skill for medical writers, and it’s not limited to creating content for laypeople. Indeed, writing in plain language improves clarity for even scientific and medical audiences.

Depending on how you build your medical writing career, being able to write in plain language may become essential to your growth. Some essential plain language principles to start practicing are:

Organizing content to better serve your audience’s needs
Prioritize active voice
Utilize tables and graphs to convey complex information
Create useful headings to separate sections
Use familiar words and terms whenever possible

Practicing these principles now will improve your current assignments and help advance your career, especially if you take on roles focusing on conveying information to the general public.

Six Primary Professional Focus Areas in Medical Communication

Medical writing and communication have several key focus areas to help you advance your medical writing career . If one of these areas grabs your attention, you can start refining your medical writing skills now to work towards it. Medical writing courses will help establish your baseline skill set to prepare you for these advanced specialties.

The American Medical Writers Association has defined potential focus areas into six categories. Specializing in any of these areas can help find clients looking specifically for these skills. Read through the following focuses and see which ones are intriguing. You can then begin medical writing training with your long-term goal in mind.

1. Scientific Publications

Healthcare facilities, pharmaceutical companies, and medical universities frequently submit scientific research papers to journals for publication. These journals help build authority for these organizations while sharing their findings with the greater scientific and medical community.

You’ll be responsible for working with researchers to create and refine research results before submission to scientific journals. A subset of this focus area is medical writers who create summaries of conferences or write medical news articles. A strong understanding of data analytics and the scientific process is necessary for this specialty.

2. Regulatory Writing

Pharmaceutical and biotechnology companies commonly need to convey information to regulatory agencies. These organizations require specific documentation to have drugs, medical devices, or biological agents approved by applicable regulatory parties.

Regulatory writers create these documents by leveraging data visualization, structured content management, and lay summaries to help their clients earn approval. Specializing in this type of writing requires a high amount of attention to detail and an understanding of current regulations. Additional medical writing certification courses are worth considering to prepare you for regulatory writing.

3. Grantsmanship

Grants are vital for continual research and development for many medical organizations worldwide. Grantsmanship is the skill of writing grant proposals for your clients, and it’s a skill that’s always in need.

You’ll be responsible for writing and editing grant proposals and potentially finding grant opportunities. This type of medical writing requires many of the same skills as other specialties but also requires an element of persuasive writing to demonstrate why your client should receive grant funding.

4. Promotional Writing

Companies throughout the medical industry require promotion writing, such as press releases, promotional articles, and potentially social media advertisements. Additionally, you may create content for promotion to other medical or healthcare organizations rather than the general public.

An essential skill for medical promotional writing is understanding regulations regarding promoting drugs or medical devices. While working within these guidelines, you’ll need to convey the benefits and effects of the given product effectively.

5. Health Communication

This focus area encompasses many materials intended to communicate important health information to laypeople, public health agencies, and journalists. This type of health communication is not always concerned with marketing but with accurately and concisely conveying information to those needing it.

You’ll need a strong understanding of plain language principles, cultural awareness, and visual aid leveraging as a supplement to written content. Additionally, it’s essential to understand all applicable regulations regarding promoting and marketing medical products, as health communication may fall under those guidelines.

6. Education for Professionals

Professionals throughout the medical industry require continued education, and this focus area will prepare you for writing educational materials. Medical education companies typically produce this type of content and frequently produce new content for nurses, doctors, field-based sales staff, and administrative staff.

Medical writing focusing on education requires similar medical and scientific proficiency as other areas, but with the addition of understanding adult learning principles. You may also work with other media formats or with a team of graphic designers and video production professionals.

Become a Certified Medical Writing Professional (CMWP)

Are you ready to begin or grow your career in medical writing? Having the right medical technical writing training is essential. The Center for Professional Innovation and Education (CfPIE) is a leading global provider of high-quality life sciences training.

Become a Certified Medical Writing Professional (CMWP) with CfPIE’s comprehensive CMWP program, which gives participants the following:

Hands-on training for medical and technical writing
Essential lessons regarding regulatory compliance
Critical insights into the submission process
Official certification for medical writing

Are you interested in improving your medical writing skills with ongoing training? Our online medical writing courses can help you continually grow your career. Contact the CfPIE team at 1-610-648-7550 or info@cfpie.com to get started today.

The Importance of Quality Control in the Manufacturing of Medical Devices

Wed, 09 Nov 2022 01:11:45 GMT

What do insulin pumps, defibrillators, implants, and anesthesia systems have in common? They're all examples of medical devices—instruments, implants, or other devices that diagnose, prevent, or treat medical conditions. They're also examples of products that have undergone urgent FDA recalls due to quality issues and potentially dangerous defects.

How Does Quality Control Work in Medical Device Manufacturing?

What Are the Benefits of Establishing QMS in Medical Device Manufacturing?

How Can Medical Device Manufacturers Improve Quality Control?

What Does ISO 13485 Mean In Medical Device Manufacturing?

Kickstart Your Medical Device Training Program with CfPIE

While medical devices play a significant role in improving the lives of their users, any malfunctions, defects, or quality performance issues can also cause severe harm. It's imperative for medical device manufacturers to maintain proper quality control over their output so that their products are both effective and safe to use.

Production facilities must establish a medical device quality policy into their workflows to keep up with modern compliance standards and protect the health and safety of their end users.

How Does Quality Control Work in Medical Device Manufacturing?

Quality Control (QC), a reactive step in the manufacturing process, typically occurs at the end of production before the medical devices ship out to customers. QC staff inspect individual or batches of products and check for defects, ensuring facility output aligns with pre-determined specifications.

QC teams use a variety of metrics to determine whether a product passes inspection:

Acceptable criteria. The FDA requires quality control teams to provide formal documentation on the criteria they use to pass or fail products. These batch records describe what specifications medical devices must conform to before shipping.
Product testing protocols. The FDA allows manufacturers to create their own QC procedures, but also requires detailed documentation on the process. This way, the FDA can assess whether a company's verification methods are sufficient.
CAPA management. If quality control discovers a nonconforming product, corrective and preventive action (CAPA) is implemented to investigate the problem, determine its root cause, and address it. Corrective action can also occur after a product is on the market and in use.

Your staff's knowledge, certifications, and general competence contribute significantly to your quality control posture. Medical devices are complicated, so only well-trained inspectors with extensive knowledge of how the products work can accurately assess defective products, hence the high demand for medical device training for QC teams.

What Are the Benefits of Establishing QMS in Medical Device Manufacturing?

A quality management system, or QMS, is a systematic method for ensuring that appropriate quality standards are present before medical devices leave the factory. An entire ISO standard calls for businesses to use QMS, as it demonstrates to customers and regulators that you follow safety requirements.

Quality Control vs. Quality Assurance

A quality management system handles both quality control (QC) and quality assurance (QA) . QA looks at the manufacturing process for potential flaws in its steps. QC looks at the final product instead and tests for defects in the batches coming out of the facility.

Why Quality Control Matters in QMS

The obvious benefit of having a solid medical device quality control system is the health and safety of patients. Should an insulin pump administer the wrong amount of glucose, or a defibrillator ship with a broken electronic component, the manufacturer is ultimately liable for any injuries or deaths that occur as a result. Robust quality control contributes to higher customer satisfaction rates for this reason.

But the benefits go beyond just safety. QC is part of the regulatory requirements facilities must follow when bringing new medical devices to market. Both the FDA and the European Union's Medical Device Regulation mention it specifically, and ISO includes it as part of its standards.

Skimping on quality control ends up costing more in the long-run due to remediation steps and delayed time-to-market for new products. Studies show that, on average, poor QC costs the industry between $2.5 billion and $5 billion a year on average.

The Advantages of an Automated QMS

Medical device manufacturers must evolve past the paper-based system when it comes to quality control management. Newer, software-based QMS solutions have a variety of advantages:

Managing documentation. Documentation is a recurring theme of quality control, and software makes it easy to organize and search through the right files when needed.
Enabling collaboration. Multiple teams work together to develop a medical device - from the vendors providing the components to the staff on the factory floor responsible for quality control. If a QC issue comes up, a QMS system must notify everyone involved for a comprehensive investigation.
Providing proactive prevention. Internet-of-Things (IoT) enabled sensors found on machinery can complement quality control efforts by providing data on the inner workings of the factory.

How Can Medical Device Manufacturers Improve Quality Control?

Proper quality control begins with a quality management plan comprising all the policies and resources that contribute to medical device testing and verification. The ISO 13485 standard we will discuss later details how such a plan works, but a few focal points include:

Roles and responsibilities. Companies must consider what roles QC plays within an overall QMS, or what responsibilities each QC team takes on.
Collaboration. The QC department can benefit from discussions with the product development team, since they know more about how your medical devices work and can clarify how to design QC tests accordingly.
Change management. Changes are inevitable throughout a medical device's product lifecycle. Use a tool known as a traceability matrix to visually link the design inputs, outputs, user needs, and other factors. Any adaptations you run into may also impact your acceptance criteria when it comes to QC inspections.

What Does ISO 13485 Mean In Medical Device Manufacturing?

The ISO 13485 standard covers quality management systems in medical devices. Any organization that designs, produces, installs, or maintains medical devices must follow it, and even external parties refer to the standard for auditing purposes.

Like all ISO standards, 13485 receives continual updates every few years. The modern version is ISO 13485:2016, which contains the latest QMS practices, technologies, and regulatory expectations. There's a larger emphasis on risk management in the supply chain in this latest installment.

Adhering to this standard starts with medical device certification. While certification is not a prerequisite according to ISO, it does help immensely for demonstrating compliance to regulators and keeping personnel up-to-date with the latest developments.

ISO itself does not offer certification programs, so manufacturing facilities must work with third-party service providers.

Kickstart Your Medical Device Training Program with CfPIE

Quality control for medical devices prevents defective units from entering the market and harming end users. Manufacturing facilities use batch testing protocols and tools like quality management systems to stay in line with industry specifications, like FDA guidelines and ISO standards.

But quality control can be a challenge given the complexity of medical devices, and your level of compliance relies heavily on the expertise of your QC personnel. So whom can you trust to provide reliable medical device training courses that will prepare your staff for the notoriously stringent quality control regulations inherent to the medical device industry?

CfPIE offers hundreds of virtual and on-site training courses that can fit into any busy medical professional's schedule. Don't delay signing up for the " US Medical Device & Quality System Regulations - Design Controls & Validation " course if you're serious about improving quality control for your medical devices.

FDA Process Validation in the Pharmaceutical Industry: A Basic Guide

Tue, 08 Nov 2022 23:14:09 GMT

The U.S. government has diligently monitored the safety of drugs and pharmaceuticals to protect public health. Medicine is inherently a high-risk industry, so basic testing of the final product alone is insufficient.

The U.S. Food and Drug Administration (FDA) continues to emphasize process validation for medical manufacturing organizations, including those in the pharmaceutical, biotechnology, medical device, and cosmetic industries.

What Is the Validation Process in the Pharmaceutical Industry?

What’s the Right Data to Collect For Premarket Validation?

What Are the 3 Main Stages of Pharmaceutical Process Validation?

What Other FDA Regulatory Requirements Are Worth Knowing?

What is the Importance of Process Validation Training?

Compliance and quality assurance professionals in these markets must understand the FDA’s process validation guidelines, which apply to the large-scale commercial manufacturing of medical products. Read on to discover how to scale up drug production while boosting product quality, effectiveness, and safety.

What Is the Validation Process in the Pharmaceutical Industry?

The primary mindset behind process validation is that quality assurance must be built into the manufacturing process rather than just the final pharmaceutical product. It looks at quality control throughout the entire lifecycle of a drug, covering initial planning and development all the way to full-scale commercial production.

The concept arose in the mid-70s, though the first official guidance from the FDA began in 1987. Today, official documentation from the FDA details how medical businesses can keep their internal production systems compliant with the agency’s current Good Manufacturing Practices (cGMP) . The document focuses on collecting data and evaluating standard operating procedures to show that a manufacturing process consistently meets quality standards.

But the importance of process validation goes beyond the safety and efficacy of the final drug. It’s instead a proactive approach that looks at every step of the manufacturing process

individually and ensures that product quality and design specifications match compliance obligations at every stage. Even minor variations in the Active Pharmaceutical Ingredients (APIs) can significantly compromise drug quality, so plan to assess variations and implement controls for them.

Companies must have these considerations figured out before scaling up manufacturing to a commercial level. Those that do not, risk FDA audits, increased scrutiny from regulatory agencies, forced recalls, and even facility closures

What’s the Right Data to Collect For Premarket Validation?

The premarket phase occurs when a drug candidate goes from development to production. This is a critical step in pharmaceutical process validation, as obtaining FDA approval for mass manufacturing involves proving that your production protocols are both safe and replicable.

It’s easy to collect too much data in the premarket phase. Even the most experienced medical professionals occasionally have trouble extracting valuable insights from the massive amount of information available, so how do you collect the right data for validation?

You need careful planning and rigorous reporting procedures at every stage of drug development. Use software-powered reporting tools to focus on the correct data that matters at that stage. You can also consult the FDA’s guidance document on balancing premarket and postmarket data collection, which covers devices but can also apply to drugs and other medical products.

What Are the 3 Main Stages of Pharmaceutical Process Validation?

The FDA recommends businesses instill process validation strategies into these 3 stages of the drug manufacturing process .

Process design stage defines the commercialized manufacturing procedure.
Process qualification looks at that design and determines whether it’s reproducible in the field.
Process verification is the continued assurance that the validated process is controllable.

These three steps contribute to more consistently performing drugs, higher customer loyalty and trust, and a more reliable finished product to help you compete in the market. You’ll also help avoid FDA audits and improve your compliance posture.

Manufacturing Process Design Stage

Designing a process for the mass production of medical products is a complicated task. You must:

Guarantee regular and consistent quality at every stage for every unit of output.
Consider the limitations of your critical equipment and machinery.
Take into account potential variations in the final product due to manufacturing tolerances.
Implement process controls to address potential variations and avoid process failure.
Provide documentation of the process, especially for studies on how each step in the procedure contributes to the final product.

While the early stages of process design don’t necessarily have to follow cGMP requirements or undergo thorough testing, the FDA still recommends facilities follow sound scientific principles.

Process Qualification (PQ)

Once you have a manufacturing process in mind, it’s time to qualify it by checking whether it’s ready for commercial production use. Doing so involves designing the facility itself and selecting the right piece of equipment.

Progress Performance Qualification (PPQ) occurs at this stage, as the business continually checks for cGMP compliance . All departments must be on board, including the quality assurance team. From there, the company can start moving products into commercial distribution.

The FDA mandates cGMP principles for designing the manufacturing facility and its equipment and systems. The company must verify objectively that equipment runs within acceptable specifications. Written documentation of protocols and expected outcomes is also necessary to record data collection policies, manufacturing conditions, and required testing methodologies.

Ongoing Process Verification

This stage is primarily for maintenance - preventing unexpected mistakes during production and ensuring that the process remains valid and compliant throughout the commercial manufacturing run.

Ongoing verification proactively searches for problems and addresses them before they impact the finished product. For instance, the facility must keep the quality of raw materials in check at all times.

The FDA once again calls for cGMP compliance during process verification. An ongoing effort is necessary to collect and analyze data regarding product quality and identify variability in the final product. Businesses perform these steps by sampling data obtained from the process qualification stage and maintaining the facility and equipment accordingly.

What Other FDA Regulatory Requirements Are Worth Knowing?

It’s also worth investing in a change management system to supplement the three stages of process validation above. If the manufacturing process ever needs to adapt, change management overlaps with ongoing verification to assess the potential impact of new changes and oversee their implementation.

Process changes can come from many sources:

New steps in the manufacturing process
New manufacturing equipment
Switching suppliers that provide the raw materials
New specifications of the final product
Corrective management due to previous compliance audits

cGMP is a recurring theme of the FDA’s process validation guidance. The current Good Manufacturing Practices touch on many legally enforceable requirements from the FDA. A few of them are below for your reference.

Data handling. Always review your data collection policies, particularly those involved in quality assurance and improving manufacturing practices.
Facilities and equipment. The FDA specifically mentions that production facilities and equipment must be “of acceptable size, construction, and location to meet required needs.” Regular inspections and calibrations are then necessary to stay within industry standards.
Written documentation. Process verification and control require written procedures and detailed documentation to keep track of processes.
Stability testing. Testing for stability is vital throughout the drug development process. Have a well-documented stability testing program in place to ensure pharmaceuticals are both consistent and not impacted by cross - contamination.
Sample testing. Facilities must also have controls in place for sample testing. Use statistics so that a sample is representative of a whole batch during analysis.
Adulterated drugs. The FDA considers a drug “adulterated” when it no longer meets minimum standards for consistency or reliability. Being able to identify adulterated products is an important skill to have for a medical manufacturing organization.

Regarding process validation, the FDA recommends that businesses take a team-based approach, where representatives from various departments and groups within the company collaborate to decide on policies and best practices.

Process controls must also be a focus, including controls over the quality of product output, raw materials, major equipment, and operating procedures appropriate for the associated level of risk.

What is the Importance of Process Validation Training?

Pharmaceutical validation is a team effort, and empowering your teams with relevant training will assist you in upgrading your process validation efforts. Quality assurance staff, factory floor workers, and management teams need the right knowledge to focus properly on process design, process qualification, and ongoing verification.

CfPIE’s “ Process Validation for Drugs and Biologics ” course is perfect for any medical professional involved in process-validation-related fields like drug manufacturing, process development, or quality assurance. Even those in related fields, like risk and supplier management, will benefit from knowing how process validation integrates with other parts of the business.

Anyone from operational personnel who conduct process validations to individuals in management will learn everything they need to establish comprehensive process validation programs and ensure that their organizations comply with requirements from the FDA, the European Medicines Agency, and other regulatory bodies.

How ADME Studies Contribute To Drug Development

Thu, 06 Oct 2022 16:01:03 GMT

Production facilities and regulators in the medical industry know that drug testing needs to go beyond just effectiveness. To protect the health and well-being of customers in this space, businesses have had to withdraw pharmaceuticals from the market for toxicity concerns or unexpected drug interactions.

Medicine is a complicated field, and even a seemingly precise treatment can have unexpected side effects that make the product not worth the risk. ADME studies aim to integrate this testing directly into the discovery and development process. What is ADME, and how does it relate to similarly vital studies like toxicology, drug metabolism, and pharmacokinetics?

An Overview of Pharmacokinetics and Drug Metabolism

Before we dive into ADME, we need to cover the relationship between ADME and DMPK. These related studies in Drug Metabolism (DM) and Pharmacokinetics (PK) help medical research companies determine which drug candidates are worthy of further investigation.

Drug metabolism looks at how the body processes drugs into other compounds, primarily in the liver with drug-modifying enzymes (DME). These studies are particularly interested in whether the final products are potentially toxic.

What is a PK study? Pharmacokinetics measures how much of the drug is present throughout all parts of the body over time. PK gives deeper insight into how the pharmaceutical affects the patient and provides a benchmark to determine optimal dosage.

Understanding the Requirements For ADME, PK/TK, and DM Studies

So what Is ADME in pharmacology? ADME is a medical acronym that covers several essential parameters drug companies analyze during pharmaceutical development. You might hear of it as ADMET, which adds another critical step, toxicology.

Absorption determines how quickly and efficiently the body can move the drug from the administration area into the bloodstream. The technical term is bioavailability. Absorption depends on the drug’s properties, including molecule size, ionization, solubility, and concentration.
Distribution is the rate and extent the human body can distribute a single dose of drug around the body. In addition to the bloodstream, pharmaceuticals often pass through body tissues to reach the target site.
Metabolism involves the mechanism the body uses to process the drug. As the medicine passes through bodily organs, metabolic enzymes break down the agent accordingly. This aspect looks at the final products of drug metabolism and determines whether they’re toxic.
Elimination occurs after the drug has performed its purpose. Organs like the lungs and kidneys remove the substance through sweat, saliva, excrement, and various other methods also called elimination pathways.
Toxicology studies the potentially toxic effects on organs and other bodily systems. Toxicokinetics (TK) compares the expected level of toxicity with the amount of exposure to a specific drug.

Why Are ADME Studies Vital To Drug Development?

Because of how important ADME studies are to drug safety, these processes often occur early in the discovery process and are essential for regulatory approval. For instance, a drug candidate must pass these tests to continue on to later clinical programs.

ADME and pharmacokinetic studies will be necessary whenever a company wants to file for an Investigational New Drug (IND), New Drug Application (NDA), or a Biologics Licensing Application (BLA) from the FDA.

While FDA guidelines allow both in vitro and in vivo testing for ADME studies, only the latter method can evaluate pharmacokinetic properties. The FDA produces various guidelines to help the industry verify drug safety and efficacy. A few examples include:

Safety Testing of Drug Metabolites
In Vitro Metabolism and Transporter-Mediated Drug-Drug Interactions Studies
Clinical Drug Interaction Studies
General Good Laboratory Practices for Nonclinical Laboratory Studies

Some testing conducted under the supervision of the Association of Assessment and Accreditation of Laboratory Animal Care (AAALAC) involves laboratory animals like rodents. If more detailed PK data is necessary, primates may be the test subjects for bioavailability, distribution, and exposure studies.

Stay Up to Date with CfPIE’s ADME Training Course

ADMET and PK studies play major roles in drug discovery and production, verifying exactly how the human body absorbs, processes, and excretes drug compounds. Therefore, companies must pay attention to these studies to choose suitable research candidates for testing and to verify compliance with FDA guidelines.

Whether you’re a team leader, you’re involved in preclinical studies, drug development process, or a clinical researcher, learning more about these vital studies is paramount to your success in future pharmaceutical development.

Are you looking to improve your knowledge of ADME, PK/TK, and drug metabolism? We recommend registering for:

ADME, PK/TK & Drug Metabolism in Drug Discovery and Development

Have questions about our courses? Get in touch with our team today.

What Does It Mean for a Manufacturing Facility To Be GMP-Compliant?

Thu, 06 Oct 2022 15:11:27 GMT

Creating drugs and medical products can be a daunting task. Any mistakes in manufacturing can result in contamination or deviations in the finished product, which lead to negative impacts on the health and well-being of the end users.

GMP stands for “ good manufacturing practices .” A GMP-compliant facility knows how to control its risks and implement a substantial quality control standard in all aspects of production to prevent or minimize defective products. We will discuss what GMPs cover, why they matter in medical manufacturing, and how implementing a strong quality management system can guarantee safety and quality in your organization.

Starting Facts About Current Good Manufacturing Practices

cGMP goes beyond batch testing. Instead of batch testing the facility’s product output, cGMP aims to address flaws at the source by inspecting the manufacturing process beforehand.
The FDA proactively scans for cGMP violations through inspections. Safe manufacturing conditions are not only an ethical obligation but also a legal one.
cGMP legislation is common all around the world. The Food and Drug Administration (FDA) oversees good manufacturing processes in the United States to protect consumers from contaminated or otherwise dangerous products. Other analogous international agencies include the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA).

What Is cGMP?

First off, GMP comprises all the policies and systems medical production facilities undergo to ensure that their final products are consistent and up to quality standards. It goes beyond just testing the finished product and dives into the processes happening inside the facility.

Whether you produce pharmaceuticals or medical devices, GMP will cover every aspect of the job, including starting raw materials, cleanliness of the facility and equipment, and the expertise of your staff. In addition, it will document every step of the manufacturing procedure to prove that each one follows proper minimum standards.

cGMP adds the term “current” into the acronym, implying that manufacturers must use up-to-date technologies and best practices to comply with government GMP requirements. In other words, GMP is a continuous process rather than a “one and done” effort.

cGMP is necessary because GMP standards are constantly changing. Regulations improve over time; new findings shed light on how facilities should run; and better best practices arise. So go the extra mile and make sure you’re adhering to current standards of GMP manufacturing.

What Does It Mean For a Manufacturing Facility To Be GMP-Compliant?

A business that looks after good manufacturing practices goes beyond only testing the final product and dives deeper into the production steps at the factory level. Such a facility looks at GMP regulatory compliance in terms of:

Staff who must be knowledgeable about GMP and know how to identify and address risks. Employees are often a weak point without relevant up-to-date training, a willingness to share questions and concerns, and clearly-defined roles.
Equipment which requires sanitation and calibration prior to the workday. Workplace equipment is a significant source of cross-contamination in the medical field.
Raw materials deserve their own quality assurance as well. Make sure your GMP certified facility can obtain quality raw materials, inspect, handle, and store those starting materials properly before they enter the production line.
Processes need to be well-defined and well-documented so that during an audit process a GMP auditor can follow them easily. Remember that policies may change over time as you improve.

One way to display GMP compliance is with an audit certificate from a respected auditing service. A compliant organization with the appropriate good manufacturing practices (GMP) certificate shows that it provides:

Quality control and stands behind its products.
Process validation with complete control over what happens on the factory floor.
Incident response systems to identify potential problems and analyze them to prevent future incidents.

Who Needs To Be GMP-Compliant?

Compliance with FDA regulations, especially regarding GMP, is mandatory for basically all pharmaceutical manufacturers and medical device production facilities, as it guarantees:

Consumer safety. Because consumers can’t judge the safety or effectiveness of a drug or medical product on their own, GMP-certified facilities are the guarantee on which they must rely. Not only are they safe from contaminated pharmaceuticals, but they can also trust that labels and dosage instructions are correct, for instance.
Industry reputation. A facility with a GMP audit certificate has a better reputation than one without. It means that the company cares about quality and meets FDA requirements.
Robust testing. Quality control of medicines and devices cannot rely exclusively on testing samples of the final product. Businesses can only verify small batches this way and need to turn to more robust process validation methods that GMP provides.

Even if you outsource medical manufacturing, finding a GMP-compliant and FDA-approved contractor is always a good idea.

While a lack of attention to GMP doesn’t necessarily mean a harmful final product, there are still heavy legal consequences depending on the severity of the violation. For example, raw materials or poorly cleaned equipment could cause cross-contamination of the manufacturing line.

The result is costly product recalls and injunctions from the FDA, not to mention subsequent potential lawsuits and damage to your brand’s reputation. Therefore, pursuing GMP compliance is always in the company’s best interest.

Jumpstart cGMP with CfPIE Compliance Programs

Good manufacturing practices are government-backed standards for controlling pharmaceutical manufacturing quality at the process level.

GMP certification improves your product output and makes you more trustworthy, bringing significant benefits that outweigh the cost of compliance.

Looking to become a GMP compliant facility? Get your GMP audit certificate with our GMP Facility Compliance Program , a program designed specifically for pharmaceutical and medical device manufacturing facilities.

Quality Assurance vs. Quality Control in the Pharmaceutical Industry

Thu, 25 Aug 2022 22:21:39 GMT

When people’s health and lives are on the line, pharmaceutical companies should spare no expense in providing due diligence over their own drug and medical device manufacturing lines. Checking for defects in the finished product matters even more when the stakes are this high, hence the need for quality assurance (QA) and quality control (QC).

Both procedures help medical companies and pharmaceutical manufacturers improve their product quality, conduct risk management and mitigation, and better follow regulatory requirements and standards. Both are essential if you work with quality management system (QMS) for a company in the biotechnology or pharmaceutical manufacturing fields. You can also reference our previous blog post on the importance of pharmaceutical quality assurance. Read it here

First, let’s discuss the differences between quality assurance and quality control. What’s the subtle yet key difference between the two procedures, and how do you gain their benefits as a pharmaceutical or medical device manufacturing organization?

What Is Quality Assurance and Quality Control?

The official definitions for QA and QC can be found on the ISO standards website, but here we will dig deeper into the precise differences between the two.

Quality assurance ensures that the final product coming out of the production line is both safe and effective. Whether it’s a medicine or a medical device, the effects of its use must be intended or at least expected. Quality assurance activities are directly integrated into the manufacturing process.

Quality control activities revolve around the set of procedures used to check and verify that a final product meets pre-established quality standards.

Together, both play a vital role in ensuring your organization is following best practices on the way to becoming compliant with relevant regulatory agencies like the FDA.

What Is the Relationship Between QA and QC in the Pharmaceutical Industry?

Both terms sound similar, are necessary for an overall quality management system, and are often used interchangeably, but the important differences between QA and QC are:

Timing: QA aims to take a proactive stance by focusing on preventive actions to minimize and eliminate defects before they occur during manufacturing, while QC, which is more reactive, identifies possible quality issues after the fact and verifies the quality of the output.
Duration: QA is a long-term process that covers the entire development cycle, while QC is more short-term and happens at the end of the manufacturing process during the testing phase.
Steps: QA may involve producing detailed documentation, processing audit checklists, and supplier management. QC covers product sampling, testing, and inspections of raw material, products, devices, etc.
Responsibility: All life science manufacturing companies should aim to establish a culture of quality in their organizations. Everyone should be involved in quality assurance efforts. And while quality control is just as important, most companies designate the responsibility to a dedicated QC department.

Every manufacturer in the medical field practices both processes rigorously in order to conform to the high standards of the industry.

How Do I Learn Quality Assurance and Quality Control?

The only question left to answer now is “How do I instill QA and QC principles in my organization and start reaping the benefits?”. Quality assurance training courses are now available, and they can be useful for boosting various aspects of quality management.

Quality risk management: The potential for defects can never be fully eliminated, but proper quality training can be used to keep those risks low while making the benefits worthwhile.
Compliance: Healthcare regulations are notoriously stringent such as Good Manufacturing Practices followed by drug and medical device manufacturers. Training will ensure you stay compliant by calibrating equipment properly, keeping detailed documentation, and generally improving QA and QC testing.
Brand trust and reputation: Customers are more likely to work with you when they know that their health is in good hands. Implementing QA and QC training is an excellent way to demonstrate your dedication to safety standards and maintain the level of quality your customers expect.
Skill development: Providing coursework for your personnel makes them more proficient at their jobs, thereby strengthening your quality management program. Experienced staff are better at checking for errors, conducting comprehensive audits, and investigating issues.

Training is also a way to demonstrate legal compliance through certification programs and, as medical findings and standards change, even experienced staff will still need a refresher course now and again.

Getting Your QA and QC Training From the Right Place

The benefits you get from QA and QC training greatly depend on where you’re getting it from. Regardless, any organization operating in the pharmaceutical, medical device, cosmetics, and other life science industries must have effective QA and QC processes in place.

For industry-grade coursework taught by certified professionals in the field, be sure to check out Quality Assurance/Quality Control for Biologics and Biopharmaceuticals .

Quality assurance and quality control specialists can’t afford to miss this opportunity and may also be interested in exploring other on-site and virtual programs offered by CfPIE.

What Does a Medical Technical Writer Do?

Thu, 25 Aug 2022 14:54:28 GMT

Technical writing is a valuable skill in any industry that must bridge the communication gap between highly technical teams and non-technical audiences.

The medical and biotechnology fields are no exception.

What Kinds of Companies Hire Technical Writers?

What Is the Scope of Medical Writing?

What Does a Medical Technical Writer Do?

What Are Some Upcoming Technical Writing Skills of 2022?

What Courses Should a Medical Technical Writer Take to Stay Current?

So what does a technical writer do in the medical industry and what skills will be necessary to enter into the medical writing profession in the coming years? Read on to find out.

What Kinds of Companies Hire Technical Writers?

Technical writers are found throughout IT, engineering, healthcare, and manufacturing industries, to name a few. Basically, any field that deals in highly technical jargon, e.g., instruction manuals and scientific publications, needs someone to help translate it into more broadly understandable language.

Biologists, engineers, chemists, and other medical professionals responsible for the technical implementation of these solutions are unlikely to have the skills needed to communicate with a layman audience, hence the need for technical writers to act as intermediates.

Medical technical writing exists because pharmaceuticals and medical devices are notoriously complicated and require user manuals and patient education materials to understand them fully. In this regard, the work of a medical writer directly impacts patient wellbeing.

And the industry will likely continue to have more opportunities for technical writing jobs in the future. Medical equipment and devices will always be in need of updates, and new pharmaceuticals will continuously need to be researched and released to the public.

What Is the Scope of Medical Writing?

How is technical writing used in pharmaceuticals? It’s worth understanding the scope of what medical writing may cover. For example, medical writers draft and publish works such as:

User manuals for medical devices
Operating instructions for equipment
Medical educational materials
Marketing materials
Scientific articles
Regulatory documentation
Clinical study reports
Reference guides
Content about medical procedures

But it takes more than just an understanding of the English language to craft medical documents. Technical writers take on a variety of roles in their organizations.

What Does a Medical Technical Writer Do?

Beyond just writing, medical writers have a variety of responsibilities that contribute to their workflows:

Collaborating with others: Writing technical documentation requires the input of manufacturing staff, business partners, and upper management, among others. Technical writers will have to work closely with these groups to ensure that the information presented is not only accurate, but also aligned with the content standards of the organization.
Process mapping: Some technical pieces have to do with transcribing process data into easily understandable reports. A writer’s job here would be to cross-check any process deviations or critical gaps in the manufacturing. An analysis of project boundaries and scope would also be included here.
Contributing to marketing: Sometimes technical writers are employed to create business presentations, website content, promotional content, and newsletters in order to inform others of the benefits of a certain drug or medical device without any of the complex language of the source material.
Crafting proposals: Technical proposal writing in biotechnology and pharmaceutical companies has to do with providing a persuasive pitch for a medical solution backed up by technical facts and details. The writer introduces the product, explains how the company has used it to solve a medical issue, and any other details of the solution.
Processing feedback: Feedback and reviews must be taken into account to improve the writing and add in more details without introducing redundancies.
Staying up-to-date: It’s the responsibility of the writer to have up-to-date medical knowledge and learn medical vocabulary that reflects current standards of medical findings and regulations. Technical writing courses exist for this reason.

We’ll also cover why a technical writer certification matters for mastering these roles in any modern pharmaceutical business.

What Are Some Upcoming Technical Writing Skills of 2022?

In addition to hard skills (like medical knowledge and a mastery of the English language and its mechanics), companies hiring technical writers are looking for these specific skill sets:

An attention to detail that will ensure no essential information is left out of the final product
Communication skills to collaborate with various departments and get their input
Proficiency with writing tools, such as templates many companies may utilize
Familiarity with laws and regulations that apply to the pharmaceutical industry
Design skills to craft attractive documents. The use of subheadings, tables, figures, and lists, for instance, can make content more accessible to the end user.
An ability to identify the target audience. Whether it’s a professional doctor, an industry partner, or a regular consumer, you’ll have to understand who your audience is in order to tailor the content appropriately.

Medical writers today obtain these skills partly through industry experience but also through degrees in journalism, communications, medicine, or the sciences, though most companies won’t expect all of these skills from technical writing candidates. In fact, it’s not uncommon to see professional technical writers obtaining most of their training while on the job through online coursework.

What Courses Should a Medical Technical Writer Take to Stay Current?

Education is a recurring point we’ve made in this article. That’s why technical writer certification programs should be high on your to-do list if you’re interested in entering or advancing a medical writing career.

CfPIE offers an entire certification program tailored for medical writers, covering topics like:

Communications with the FDA and Medical Device Submissions
GCP and GLP topics for risk management and undergoing studies
Technical Writing for Pharma, Biotech and Med Devices
Writing Effective SOP and Other Process Documents

Nowhere else will you find such a comprehensive course structure that includes everything from medical device technical writing courses to FDA approval guidelines. CfPIE enables you to learn these topics through certified instructors with the flexibility of either customized on-site training for multiple employees, or pre-scheduled public virtual training options.

The Guidelines to Follow When Developing Combination Products

Wed, 03 Aug 2022 21:28:46 GMT

Combination devices and products have become more widely used in recent years because they greatly improve treatment effectiveness and enable better outcomes for patients. However, government regulations regarding them are still in their early stages, and pharmaceutical companies run into complications when it comes to bringing them to market.

What Is a Combination Product?

- Defining the Primary Mode of Action (PMOA)

- Know the Regulatory Guidelines

Have a cGMP Quality Compliance Strategy in Place

Want to Learn More About Developing and Marketing Combination Products?

It’s worth understanding how combination products work, the applicable regulations, how those laws will change over time, and what you can do to develop a compliance strategy for your medical organization.

What Is a Combination Product?

Before discussing regulation, let’s go over what the concept entails and some examples of combination products.

The appropriately-named combination product is a medical product consisting of a drug and a device working together. Sometimes a biological product is involved. There are three main types of drug-device combination products:

Single-entity: Two components mixed together to form a single entity. An example of a single chemical entity would be a pre-filled syringe for administering the drug.
Co-packaged: Both parts are included in the same package and are intended to be used together. A popular example you’re familiar with is a first-aid kit that contains both ointment (a drug) and a bandage (a medical device).
Cross-labeled: Both parts are packaged separately but are meant to be used together for an intended effect. For instance, a drug that must be activated with a light source could be used alongside a laser.

Combination products have a variety of therapeutic benefits over traditional dosage methods. They are often more convenient for the patient too, especially when both components are packaged together in a single treatment. We’ve seen an increase in combination product use in response to the growing trends of outpatient care and healthcare at home.

At the same time, there’s quite a bit of regulatory uncertainty as the FDA still struggles with defining the designation of combination products. Businesses that produce combination products must likewise complete their own due diligence and proactively work towards compliance when submitting these items for review.

Defining the Primary Mode of Action (PMOA)

A major step in getting a new medical product or treatment on the market is to submit it to the right regulatory office for legal review. It’s advisable to get in contact with the relevant agencies who handle regulation of combination products early on to minimize the impact of potential delays and refusals. What’s one of the biggest pitfalls of getting a combination product reviewed by healthcare agencies? It’s the Primary Mode of Action (PMOA).

Let’s say that your company is submitting a product for a request for designation (RFD) to formally classify it. The agency you’re working with must rely on the information you provide. A common issue is that there isn’t enough intel to distinguish a Primary Mode of Action, which is critical for the first approval.

A mode of action (MOA) is exactly how a medical product achieves its intended therapeutic effect. Drugs and devices can have multiple modes of action, though the legal concept of a Primary Mode of Action dictates what single MOA results in the most significant intended effect.

In the event that a PMOA cannot be defined clearly or with certainty, the FDA will attempt to assign a PMOA itself by using historical precedents.

Know the Regulatory Guidelines

Beyond the review process, medical compliance specialists must know about the related guidelines for combination products. The Office of Combination Products (OCP), as its name suggests, is the government office responsible for these laws.

The OCP was established under the Medical Device User Fee and Modernization Act of 2022 (MDUFMA). You can review what it aims to achieve in the Federal Food, Drug, and Cosmetic Act here , but the general duties include:

Resolving issues regarding combination products
Creating the regulatory framework that control their production and release
Classifying medical products as drugs, devices, biological products, or combination products
Conducting pre-market review of combination products
Working with the Food and Drug Administration for these purposes

The problem, however, is that these laws are specific only to the United States, but most pharmaceutical businesses operate internationally. The approval process for combination products is fairly straightforward right now under the FDA, but it’s far more difficult abroad.

Europe, for instance, has no central body for product approvals, and individual countries often don’t have specific laws. Addressing concerns in these regions will involve:

Engaging with local governments early on: Not only will you have to clear up national requirements, but you’ll also need to work with regional and local jurisdictions as well.
Clearing up regulations on clinical trials: Clinical trials are often conducted overseas and involve materials sent from elsewhere. Make sure you fully understand import and export regulations.
Deploy internal staff in foreign regions: Having teams “on the ground” in a locale will help you understand local jurisdictions better.

Healthcare laws are already notoriously stringent, and the still developing world of combination products only complicates matters. However, businesses can still thrive in this market if they set up a formal quality control and compliance strategy when crafting and bringing combination products into the market.

Have a cGMP Quality Compliance Strategy in Place

A compliance strategy is multi-faceted and requires the attention of multiple departments around the organization. The mindset you need to have should consider the following:

Look at Combination Products as an Entire Entity

Combination products should be viewed holistically. That is, both “parts” must be manufactured under the right supervision and quality control standards while following manufacturing practice requirements. Because regulations differ between drugs and devices, it’s important for both the device manufacturer and the pharmaceutical production facility to communicate when jointly developing a combination product.

Build an Understanding Over the “Design Freeze”

A design freeze happens during a product’s development lifecycle when the design has been finalized and approved and changes are no longer allowed. In the medical world, a freeze occurs for a medical device right before the validation stage because any changes at that point would require additional clinical studies and another submission to the governing body.

Freezes are necessary to keep costs under control and minimize delays when bringing a product to market. However, while drug manufacturers generally handle design freezes well, device production facilities often scramble to release the latest generation of electronics and devices.

This potential conflict over the design freeze can be a point of friction when working with combination products that requires coordination between the two.

Take Advantage of Risk-Based Decision-Making

The risk involved in single-entity or co-packaged combination product manufacturing is largely for the patient. Both the drug and device companies must communicate to ascertain exactly how the finished product will work in the body and how stable it will be once both parts are combined.

Studies may be required that look at the two components independent of each other as well as working together under a single combination release.

Want to Learn More About Developing and Marketing Combination Products?

The procedure for approving combination products for sale is still evolving, and it’s understandable if you have questions or concerns. In addition to the aforementioned best practices, make sure you establish strong quality control standards for both the device and the drug portions of a combination product, as well as the application of current good manufacturing practice regulations. You’re working towards not only a faster time to market but also safer treatments for your patients.

You now have more knowledge about combination product examples and how regulation works in this space. The next step is to engage with formal pharmaceutical training regarding drug-device combinations.

Among other useful courses, CfPIE offers its Introduction to Medical Combination Products taught by certified instructors with experience in the field. Register today to get started!

Cleaning Validation Guidelines: The Basics You Need to Know

Sat, 25 Jun 2022 14:39:05 GMT

Whenever you visit a restaurant, you typically trust that the chefs in the kitchen have washed their knives and bowls before preparing your meal. Likewise, governments are interested in ensuring that medical manufacturing facilities have properly cleaned their equipment and tools involved in the production of pharmaceutical products and medical devices.

Drug and medical device cleaning validation is a moral and legal responsibility for manufacturers in the medical field.

What Is Cleaning Validation?

How Is Sanitation Typically Performed in a Medical Context?

How Often Should Cleaning Validation Be Conducted?

Are All Pharma Equipment and Medical Device Cleaning Processes Clearly Understood?

What Procedures Are in Place To Meet Regulatory Compliance?

Make Sure Your Laboratory Personnel Are Following FDA Cleaning Validation Protocols

What Is Cleaning Validation?

Considered a major component of maintaining Current Good Manufacturing Practices (CGMP), cleaning validation is the practice of proving through well-documented and verifiable means that the cleaning procedures in a manufacturing facility are effective and protect equipment and other tools from contamination.

The cleaning validation guidelines set by the FDA are important for the same reason cleaning and sanitizing in the pharmaceutical industry are necessary. When drugs or medical devices become contaminated during manufacturing (especially if the Active Pharmaceutical Ingredients are impacted), then the resulting finished product can pose a threat to public health and patient safety.

Here are a few key takeaways from the FDA’s guide on cleaning validation:

Pharmaceutical manufacturers and other medical organizations must have written general procedures (SOPs) that details how cleaning processes are carried out and validated. They should include how cleaning is carried out for each batch of drugs, what the process for cleaning looks like and other essential details.
A stakeholder must be nominated to oversee performing and approving the validation study, acceptance criteria, and when revalidation is needed.
Written validation protocols must be prepared in advance for studies being carried out for a specific manufacturing system or piece of equipment. These protocols must state sampling procedures, what analytical methods will be used, and define the sensitivity to those methods.
A final validation report must be approved by management, in which they verify which cleaning processes are valid and provide a conclusion that states they have been carried out to an “acceptable level.”

GMP cleaning must be done regularly to avoid any potential risks caused by these contaminated products, which can range from downtime and wasted materials to costly fines and sanctions from the FDA.

How Is Sanitation Typically Performed in a Medical Context?

There is no industry standard on exactly how cleaning should be performed in medical device or pharmaceutical production facilities, but a few of the common methods are below:

Standard washing using spray devices, wash tanks, a rinse cycle, and a drying cycle
Immersion that involves soaking the equipment within the cleaning agent
Ultrasonic cleaning, which is more suitable for delicate components like filling needles
Pressure cleaning that involves high-pressure sprays to dislodge large pieces of residue

And, of course, there will always be a place for tried-and-true manual washing, which involves staff members brushing and wiping down equipment by hand.

How Often Should Cleaning Validation Be Conducted?

While official process validation guidelines don’t specify a frequency to conduct cleaning validation, the FDA does mention in its cGMP reports that the interval must be short enough so that drug adulteration does not occur.

From the management side, you should aim to conduct cleaning procedures regularly, especially during major changes in facility operations such as:

Drug formulas
Major Equipment
Cleaning processes
Cleaning agents

Just as important is the ability to verify that your cleaning procedures are effective at preventing contamination, which is what cleaning validation is meant to accomplish.

Are All Pharma Equipment and Medical Device Cleaning Processes Clearly Understood?

They should be. Medical businesses must clearly define several aspects of the cleaning procedure:

Solubility of the contaminants
Nature of the surfaces being cleaned
Exact cleaning equipment, agents, and procedures
Manufacturer’s recommendations regarding agent temperature, volume, and application method

Cleaning validation guidelines for medical devices and pharmaceuticals must be understood by all laboratory and manufacturing facility personnel.

What Procedures Are in Place To Meet Regulatory Compliance?

Applying cleaning validation guidance is mandatory to be compliant with FDA approvals. That is, the FDA verifies your compliance with several cleaning regulations by:

Inspecting the cleanliness of equipment before use
Ensuring maintenance and sanitation is properly recorded and paper or electronic records are available for review if necessary
Protecting clean lab equipment before it’s used

The steps you take to ensure proper cleaning validation also help you stay compliant with regulatory requirements and other FDA guidelines.

Make Sure Your Laboratory Personnel Are Following FDA Cleaning Validation Protocols

The quality of your facility and equipment has a huge impact on the safety and effectiveness of your pharmaceuticals and medical devices. Medical manufacturers spare no expense in preventing contaminated goods from entering the marketing, potentially compromising on the business’s reputation and public health.

If you’re directly involved in conducting cleaning validation protocols for your organization, but aren’t sure where you can get it cleaning validation training and what instructors you can trust, consider registering for CfPIE’s “ Best Practices for an Effective Cleaning Validation Program ” course today!

And if your company has 10 or more employees interested in clearing validation training, reach out to us for more information on virtual or on-site in-house customized training.

See Related Course:

Best Practices for an Effective Cleaning Validation Program

The Benefits of Good Laboratory Practice Training

Thu, 23 Jun 2022 22:31:50 GMT

The medical industry hosts a large number of health-related clinical studies in order to research new pharmaceuticals and develop future treatments. The testing procedures often involve potentially dangerous materials and practices that require meeting regulatory and environmental requirements, in order to protect public health and the environment.

What Is Good Laboratory Practice? An Overview

Why GLP Matters To the Medical Industry

Instilling GLP Values Into Your Facility Operations

Are Your Employees GLP Certified? Make Sure They Are with CfPIE

The Organization for Economic Co-operation and Development (OECD) is an international organization comprising several nations across North America, Europe, Australia, Japan, and various others. Its main goal is to promote economic progress on an international scale and sort out problems regarding world trade.

Among its responsibilities is implementing Good Laboratory Practices (GLP) for healthcare-related studies that medical companies must adhere to. But what does GLP cover, and why should you consider a GLP certification course ?

What Is Good Laboratory Practice? An Overview

In other words, testing facilities undergoing research studies must report to the appropriate authorities to make sure that their clinical trial activities are safe and controlled. GLP demands that medical companies fulfill various obligations when it comes to the overall safety of their clinical or exploratory studies:

Testing facilities and equipment must be properly maintained for undergoing studies.
Operating procedures and laboratory practice regulations must be standardized and properly documented.
Data and reports must be collected to keep records of daily operations.
Facility staff, including quality assurance specialists and management teams, must have adequate training and be held accountable to GLP compliance.

Good Laboratory Practice originally began under the United States Food and Drug Administration back in the 1970s, but today has expanded into Canada (with the Standards Council of Canada), Denmark, New Zealand, and now the world through OECD.

So why is there so much interest in GLP among medical organizations around the world?

Why GLP Matters To the Medical Industry

You might be wondering why businesses in this field invest in GLP training for their staff. Following Good Laboratory Practice guidelines has a number of benefits for both public health and the facility’s regular operations.

Improving Operations Through Recorded Measurements

Once studies have generated findings, it’s then possible to verify those conclusions using empirical data and processes by backtracking where they came from. The end result is a more trustworthy study.

Ensuring Data Quality

Laboratory studies are intended to collect potentially useful information that could lead to the development of new drugs and treatments. This data is considered more reliable when it’s collected under a GLP-compliant lab, resulting in:

More confidence in the conclusions and findings of the laboratory study, which also reduces the need for regulatory compliance investigations.
More productivity when it comes to generating useful results and avoiding false findings.
Stronger reputation for the facility and the company as a whole.

Accelerating the Time-To-Market

The ultimate result of these benefits is an improved time-to-market for new pharmaceutical products. Instead of wasting time with ineffective studies, additional testing, or going through investigations to find out what went wrong, GLP ensures that you have all your data ready from the beginning to empower conclusive results.

Instilling GLP Values Into Your Facility Operations

Good Laboratory Practices can’t be implemented overnight. It takes quite a bit of forward planning and collaboration among everyone in the business to achieve true Good Laboratory Practices.

For instance, an official Quality Management System is necessary to fulfill the basic requirements (such as documenting data and operating procedures) and measuring tools and equipment must be regularly cleaned and calibrated before use.

Are Your Employees GLP Certified? Make Sure They Are with CfPIE

Compliance with GLP is necessary in a heavily regulated environment like the medical industry.

Businesses that focus on GLP compliance can develop and produce new pharmaceuticals and treatments in a cost-effective manner. Compliance managers will also have a better understanding of compliance requirements, best practices, and other critical information related to GLP certification .

Are you looking to become GLP certified? CfPIE’s dedicated GLP Certification Program is designed for industry professionals looking to become GLP certified. If your organization or testing facility has more than 10 employees looking to get certified, we also offer complete program tracks on-site at your facility.

In addition, if you are looking to get your facility itself certified, CfPIE may be able to help through our GLP Facility Certification Program .

Common Causes of Deviations in the Pharmaceutical Industry

Thu, 26 May 2022 01:08:43 GMT

Process deviations in manufacturing are unavoidable, yet controllable, problems that pharmaceutical companies must account for during production timelines. Even small variations early on in the process can result in significant problems downstream, which can lead to defective products, setbacks during release, and medical regulations violations.

No matter how well-documented and controlled your pharma manufacturing process is, deviation management will always be a necessity. In order to protect the health and safety of their patients and reputation in the medical industry, pharmaceutical manufacturers must understand where deviations come from and how they impact product quality.

FDA Rulings on Deviation in the Pharmaceutical Industry

In the past, facilities only had to collect metrics on the first three batches and the end product to receive validation. But 2011 marked a major shift in the way the U.S. Food and Drug Administration handled deviations in pharma.

The key term to know is “continuous process manufacturing,” which the FDA installed after receiving product recalls and complaints for otherwise “validated” products. This mandate requires that manufacturers adopt a continuous process control to monitor their performance, rather than at specific points. Consult the FDA’s official guide on continuous process validation for more information.

Common Sources of Process Deviations

It isn’t sufficient to simply know what deviation is in pharma; medical facilities must be aware of the types of deviation or the true root causes for why the planned process could go awry to some extent.

Contamination: Possibly the most well-known issue that arises in drug production is impurities and contamination by microorganisms or viruses. Microbiological root cause analysis data can help identify the contaminants.
Equipment: Equipment failure can always occur in any setting with machinery and moving parts. Mis-calibrated sensors also pose a threat to the quality of medical devices coming out of the factory. Predictive maintenance is the best defense to avoid process issues.
Human error: The staff on the factory floor are often a weak link in the production chain. For example, carelessness or genuine mistakes can result in cleaning procedures not being fully followed. Human error is a diminishing concern thanks to automation, but you can reduce its incidence further by providing machinery operators proper training and oversight.
Process controls: Disruptions in production, such as those caused by equipment failure, and unknown variables impacting standard procedures can each generate deviations. Controlling processes starts with data and metrics, and most businesses rely on multivariate data analysis to check for deviations.
Raw materials: Perhaps the issue isn’t within your facility at all, but rather coming from external suppliers. Whether there’s a defect with the raw materials themselves or the vendor contaminated them in transit, screening your materials beforehand prevents these defects from impacting the quality of your final product.

It’s worth noting that Good Manufacturing Practices set by the FDA considers all deviations to be unplanned. However, a term exists known as “planned deviation” which refers to temporary changes in the production process that have been pre-approved for a certain period.

What Often Causes Those Deviations?

One of the challenges to addressing process deviations in pharmaceutical companies is that the typical approach, deviation investigations, often skips the details and results in a failed attempt to grasp what truly is wrong with the process. For example:

Production processes are poorly defined by the research and development team before being sent to the facilities.
Collecting accurate information required for production is delayed, resulting in an uninformed process.
During a typical deviation investigation, the actual problem is not discovered. Auditors may instead find a symptom rather than a true cause.
Performance metrics and deviation reports are not recorded and presented properly, leaving management in the dark about what’s going on.
Roles are not properly defined, so those responsible for deviations are never held accountable, and auditors will often notate deviations without any action by management being taken.
The business in general fails to see deviations as a threat or does not take any corrective action, even as repeat problems occur as a result.

Many of these types of errors in pharmaceutical analysis are actually addressed directly in the FDA’s 2011 ruling on continuous process validation mentioned above. Once a company takes on a culture of analysis and continuous improvement, deviations become much less of a hassle.

Understanding CAPA Root Cause Analysis

Let’s end our discussion with a rundown of Corrective and Preventive Action (CAPA). The FDA requires that medical manufacturers adopt this practice as part of a root cause analysis.

Imagine you work for a medical device production facility. When a deviation causes a noticeable issue in the final product, that deviation triggers a chain of events and symptoms that ultimately leads to a faulty device or presents a potential risk to public health. The next step is to determine exactly what that initial deviation was through a root cause analysis.

Not only can you improve the quality of your output through CAPA, but it can also help prevent problems down the line and give you valuable insights into improving the continuous manufacturing process.

Because a root cause analysis is heavily data-driven, you will be seeing a lot of scatter plots, flow charts, and other tools on your journey to learning exactly “why” a problem first developed.

CfPIE Gives You the Training You Need To Address Pharma Deviations

CAPA, root cause analysis, and other methods to address deviations in medical manufacturing are far more complicated than can be explained in this article. If you’re interested in getting your company up-to-date with the latest best practices for addressing pharma deviations; begin your proactive approach to continuous quality improvement by getting in touch with CfPIE and reviewing our training course on Pharmaceutical Root Cause Analysis of Failures & Deviations - Developing an Effective CAPA Strategy

Learn deviation management and other topics we offer from certified instructors by registering for your next CfPIE course today.

How Quality Control Is Done in the Pharmaceutical Industry

Sat, 23 Apr 2022 20:45:08 GMT

There’s a lot at stake in the pharmaceutical manufacturing sector. Unsafe drugs and treatments can endanger the lives of your patients and draw the attention of strict regulators. That’s why quality control matters so much in this industry, and the most successful facilities spare no expense to make sure their staff are prepared for the meticulous QA checks involved.

Why Quality Control in the Pharmaceutical Industry Matters

It’s up to pharmaceutical production facilities to make sure that the products they release are both safe and effective. This way, they can stay compliant with the regulations of the industry, ensure the well-being of their patients, and build up their reputation in the market.

Quality control goes beyond just checking the finished product, though that step is certainly important. Pharma companies must consider every aspect of quality control, from verifying the quality of the raw materials going into the process, the production steps that may change the makeup of those materials, and ensuring that standard operating procedures have been followed in every step until the final product ships out. It is also important for employees who work in pharmaceutical industry to have basic GMP training for QC laboratories, and be familiar with the cGMPs and other regulations as they impact quality control labs.

Related: Learn more on the importance of pharmaceutical quality assurance .

Why It’s Important To Check Pharmaceutical Raw Materials For Quality

Much like in other manufacturing industries, the quality of pharmaceutical output relies greatly on the quality of the raw materials put into the process. That’s why quality control procedures must be implemented from the very beginning, where the suppliers provide the components, materials, and other supplies that contribute to the final product.

Monitoring your pharmaceutical raw materials can be done in many ways, and it’s up to the QC department to make sure defective units don’t move on to production.

Safety: The obvious first consideration is whether the raw materials will be safe for consumption. For instance, are they known to cause allergies in those who are allergic to certain medications? Do they contain known carcinogens?
Compatibility: While raw materials might be safe by themselves, how will they react through different manufacturing stages, and what effects will they have in the final product? Understanding these mechanisms can be challenging, so it’s more important than ever to screen your raw materials and have quality control methods in place applicable to each manufacturing stage.
Supply chain availability: How much of the raw material does your supplier have in stock. In the event that the availability runs out, are you able to procure a replacement?
Vendor reliability: In the same vein, look at the reputation of the supplier and whether it’s had a history of positive experiences with other medical companies.
Tracking alterations: Make sure there’s a clear avenue of communication between you and the vendor. If any changes are made to your production process or the materials themselves, you want to ensure they don’t negatively impact product quality. For instance, a new method of packaging could change the materials while they’re in transit.

Medical resources can be derived from a wide variety of sources, from plant material to organic matter and even synthetic production lines. Pharmaceutical quality control involves an understanding of complex production processes and the dependencies of multiple raw materials.

What Types of Raw Materials Are There?

One of the most important raw materials is known as the API — or active pharmaceutical ingredient. These are the components of the final product that contribute to its intended effect, whether it’s to lower blood pressure or relieve a fever.

It’s worth noting that some active ingredients only show up during the production timeline, with intermediaries existing prior. It sometimes takes multiple combinations of chemical reactions to achieve the desired effect.

But drugs are almost never purely active ingredients. Other components known as excipients are also added to achieve other important functions, such as:

Keeping the materials bound together
Ensuring shelf stability
Making consumption of the drug easier

Quality control must apply to both APIs and excipients, as either may be potentially dangerous if the right QA procedures are not conducted. For instance, some patients are allergic to sulfites used in some pharmaceutical products.

Ensure the Pharmaceutical Quality Control’s Supply Chain Process Goes Smoothly

Screening for quality issues throughout the pharmaceutical manufacturing process helps ensure that the raw materials conform to your standards and that your final products are free of impurities and work as intended.

The job of the QC department is a vital one, and quality control teams need biotech quality assurance training to undergo the right QC procedures.

If you’re interested in certification courses for the medical industry, CfPIE offers coursework in quality control for pharma and biopharma organizations. Talk with us today to schedule your first Quality Assurance/Quality Control for Biologics and Biopharmaceuticals courses.

The Essential Role of Cleaning and Sanitization in Pharmaceutical Manufacturing

Tue, 22 Mar 2022 22:37:15 GMT

The cleaning validation guidelines by the FDA require that pharmaceutical manufacturers not only sanitize equipment to prevent contamination but also thoroughly establish written procedures for doing so. Good manufacturing practices apply especially to the medical industry to ensure safety and effectiveness in the drugs, medical devices, and other products put on the market.

Because of the high penalties for noncompliance and the great reputational risk, all pharmaceutical manufacturers must make serious efforts to stick to cleaning validation guidelines.

While there have been multiple peer-reviewed studies on the topic, this article will cover the basics of cleaning, sanitization, and validation in the context of medical manufacturing.

Why Pharmaceutical Facility Sanitization Matters

It’s no secret that a clean workstation matters, as any office worker or kitchen chef can attest to. The maintenance of equipment and workstations is especially important in the medical field for obvious reasons. Preparing the workstation of a medical manufacturing facility involves the following.

Cleaning: In the context of medical manufacturing, cleaning refers to the removal of dirt, debris, and residues from every piece of medical equipment, supplies, and environment. The effectiveness of cleaning procedures is determined by a visual inspection and then verified through laboratory testing.
Sanitation: As a related concept, sanitation has to do with clearing out microbiological contamination, usually through a chemical sanitation process. Most regular cleaning procedures are not intended to cover microbial contaminants. And, since pharmaceutical manufacturing facilities need a relatively clean equipment surface before you start sanitizing, regular cleaning is usually done first.
Sterilization: The environment and air quality of the facility matters too, hence why these companies invest in High-Efficiency Particulate Air (HEPA) filters and give some rooms positive air pressure to prevent outside contaminants from entering through the air.

Of course, the entire process is far more complicated than what is described here. For instance, your choice of cleaning agent matters, depending on the nature of the surface and the contaminants. What temperature is optimum for its use? How long is the exposure period? What should the pH and concentration be?

It’s all worth it in the end to avoid biological, chemical, or environmental contamination from messing with the safety and effectiveness of the final product.

What Procedures Must Be Set in Stone?

One of the requirements of FDA cleaning validation is clearly establishing and writing down proper maintenance procedures that staff on the factory floor must adhere to. Some examples in this regard are:

Assignment of responsibility for the inspection of equipment to clean each piece of equipment and determine cleanliness
Cleaning schedules for maintaining and sanitizing the workplace
Detailed procedures of disassembling and setting back up certain equipment for deep cleaning
Detailed sanitization procedures, tools, and sanitizing agents to be used
Pharmaceutical decontamination protocols and preventative measures to protect equipment from contamination
Formal inspections of factory equipment
Records of maintenance, inspections, and cleaning

Ensuring a safe environment for drug and device production relies on proper procedures for inspecting and documenting cleaning activities.

What Does “Cleaning Validation” Entail According to the FDA?

Validation is the act of showing that cleaning procedures are effective for a particular use case within a particular environment. You must specify these details in your written procedures and ensure that they are followed precisely in the field.

Strength of the sanitizing agent
Concentration of the agent and the solvent used
Temperature
pH
Procedure for disassembling equipment for cleaning

For instance, while it may make sense to use more of a cleaning agent, doing so may cause an imbalance in the pH or mess with the exact concentration necessary for the job. The result is an invalid cleaning procedure.

What Types of Contamination Should Medical Production Facilities Look For?

Cleaning validation for medical devices, drug product containers, and packaging materials primarily aim to prevent contamination in the first place rather than respond to it afterward. There are many ways for contaminants to introduce themselves into your production line.

Biological: Much like with food products, micro-organisms like bacteria, molds, and viruses may end up in the final product and render it unsafe for use. Your choice of sanitizing agent matters just as much as your cleaning procedure to prevent biological contaminants.
Chemical: You introduce the risk of chemical contamination whenever different products are processed using the same equipment without proper sanitization beforehand. There’s even a risk when your cleaning agents come into contact with the product as well. The best defense against this problem is to validate the cleaning procedure by following the written instructions exactly.
Environmental: Some steps in the manufacturing process, like bottle filling and packaging, put the final product in contact with the external environment. Sterilization of the air in the facility matters for this reason.

Sanitization works as a pre-emptive measure against contamination because prevention is the best defense in medical manufacturing. Visual inspections cannot reliably detect contamination in pharmaceuticals, as most contaminants are invisible to the eye and difficult to detect.

Also, steroids, antibiotics, hormones, and other similar materials can all cause significant changes in the body even in small amounts. For this reason, facilities working with them need to be extra careful to avoid cross-contamination by sanitizing equipment regularly and isolating such materials during the production line.

How Should a Sanitizing Agent Be Chosen?

There are many different types of agents to use for pharmaceutical facility sanitization, and the choice of which one to use comes down to particular circumstances. However, you almost never stop at using just one.

Sanitizers kill the majority of bacteria on most surfaces. They are applied after initial cleaning and, according to good manufacturing practices, can include 70% alcohol, chlorines, QUATs, hydrogen peroxide, and sodium hydroxide.

Other options exist as well for different purposes. Disinfectants kill certain bacteria, viruses, and fungi. And sporicide kills bacterial spores.

What Role Does Personal Hygiene Play in a Facility?

While sanitizing workstation equipment and the facility environment matters, don’t forget to educate staff members on their own cleanliness. For example:

Wearing hygienic clothing like gloves and protective equipment when working with, storing, or loading medical materials.
Segregating clean and dirty clothing and working with a certified contractor or in-house facility for laundering the clothes.
The use of hand sanitizers and disinfectants

Getting staff members on board with your sanitization efforts is one of the best ways to ensure that cleaning validation practices are followed properly.

Learn More About Cleaning Validation at CfPIE

Do you or your facility staff need certified training on cleaning validation and other related topics? Get in touch with CfPIE. Our course: “ Best Practices for an Effective Cleaning Validation Program ,” provides practical guidance on regulatory compliance.

Whether you need drug or medical device cleaning validation, you will find immense value in this course taught by certified instructors in the medical industry. Register today to get started!

Why Are Computer System Validation Specialists Needed in the Pharmaceutical Industry?

Sun, 13 Mar 2022 02:10:37 GMT

The pharmaceutical industry directly impacts the health of the general public, and because of this, is highly regulated.

Regulatory bodies have put regulations in place that extend to virtually every touchpoint in the manufacturing process. Any computer system involved in the manufacturing of pharmaceuticals must meet industry standards, perform its job reliably and consistently in a way that is safe, secure, and traceable. This also means pharmaceutical companies must be able to prove system functionality and reliability to any regulatory body to do business in specific regions.

The rise of computers has fundamentally changed the way we manufacture and manage drugs and healthcare products. It’s also why Computer system validation (CSV) was created.

Computer system validation is a process that tests computer systems, verifies results, and documents all validation activities in a way that meets applicable regulations . Every step involved in the production of pharmaceuticals, such as discovery, trials, manufacturing, distribution, and storage must undergo computerized system validation.

CSV specialists’ crucial role creates an ongoing demand for employees with the right qualifications. Anyone interested in reskilling their employees or themselves must receive specialized training to adequality validate systems in accordance with FDA regulations .

It’s time to examine exactly what computer system validation is along with discussing specific regulations that create the need for the role.

What is Computer System Validation and How is it Done?

Pharmaceutical computer system validation has strict requirements due to the importance and complexity of pharmaceutical manufacturing. Fortunately, CSV specialists have formalized guidance to help them adequately test and validate computer systems in accordance with FDA requirements.

Good Automated Manufacturing Practice (GAMP 5) is a set of standardized guidelines that breaks down the computer system validation process into specific life cycle phases, with each life cycle containing particular activities. The pharmaceutical industry widely uses GAMP 5 computer system validation to adequately satisfy the FDA’s criteria described in FDA 21 CFR 11.

FDA 21 CFR 11 describes specific controls that regulators need to see about each computer system. GAMP 5 provides actionable steps to achieve those controls.

The four GAMP 5 life cycle phases include:

Concept: A high-level understanding of the specific system
Project: A detailed description of the system and its objectives
Operation: How is the system managed while in operation?
Retirement: How is the system retired?

Additionally, support processes take place throughout every phase, such as document management, security management, risk management, and more.

Computer System Validation Basics

We know that CSV specialists follow a standardized process, but at a more basic level, what can a CSV specialist do? The exact tasks will vary based on the computer system being validated, but example duties of the role include:

Maintaining accurate validation documentation through the process
Write validation reports, review, and approve all SOPs involved in the validation
Stay informed about changes and advances in the pharmaceutical industry with specific attention on regulatory requirements
Involved in both external inspections and internal audits
Recommend specific upgrades for existing processes
Implement those upgrades
Train the validation team or other staff members in the correct usage of computer systems to comply with regulations
Review and update validation documents

Adequately performing each of the above duties, along with any others that may arise, calls for specialized training. General knowledge of computer systems is helpful, but will not be enough to be an effective CSV specialist without additional training.

Examples of Computer System Validation Regulation

Pharmaceutical manufacturing is a highly regulated industry. The controls and checks put in place by regulatory authorities help protect the general public while also giving patients confidence in the drugs being prescribed.

Examples of current pharmaceutical regulations are:

The Food and Drug Administration (FDA): Products manufactured anywhere in the world that are intended to supply the United States are subject to FDA regulations. FDA regulations don’t lock companies into a specific way of manufacturing their products but rather confirm that each company's approach fulfills the regulatory requirements. Code of Federal Regulations, Current Good Manufacturing Practice for Finished Pharmaceuticals describes the FDA’s specific take on GMP.
European Medicines Agency (EMA): The EMA is responsible for evaluating and monitoring the safety of every pharmaceutical product that will supply the European Union. The EU cGMPs Eudralex documents dictate the requirements for manufacturing pharmaceuticals intended for usage in the EU.
International Society of Pharmaceutical Engineers (ISPE): This not-for-profit group provides the pharmaceutical industry with frameworks that are widely used in the pharmaceutical industry. This includes the ISPE Baseline Guide and GAMP 5.

Additional regulatory and guidance organizations are:

Pharmaceuticals and Medical Devices Agency (PMDA)
The International Conference of Harmonisation (ICH)
The World Health Organization (WHO)
The International Organization of Standardization (ISO).

CSV in pharma helps prove that the company’s computerized systems are abiding by the given regulations. It’s the responsibility of the CSV specialist to understand each applicable regulation for computerized system compliance. Also, they are to ensure the computer system validation is applied to any automated system applications at every step of the process to satisfy each requirement.

Where is Computer System Validation Used in the Pharma Industry?

CSV specialists can be found throughout the pharmaceutical industry and may have different job titles, such as:

CSV Lead
CSV Engineer
CSV Support Analyst
CSV Subject Matter Expert
CSV Specialist

Any computer system involved in the research, clinical testing, manufacturing, distribution, and storage processes must be validated by a CSV specialist. Some example computer systems are:

Laboratory Information Management System (LIMS)
Distributed Control System (DCS)
Enterprise Resource Planning (ERP) Systems
Laboratory Instrument Systems (LIS)
Batch Record System
Chromatography Data System (CDS)
Clinical Trial Monitoring Systems
PLC for Controlled Packaging Equipment
Manufacturing Execution System (MES)
Supervisory Control and Data Acquisition (SCADA)
Building Management Systems (BMS)

A CSV specialist must test and document that the given system is reliably operating within accordance with applicable regulations. The aforementioned GAMP 5 process provides a framework for CSV specialists to analyze all of these different systems and more without needing to create a process for each system.

Qualifications for Becoming a Computer System Validation Specialist

To work in computer system validation in the pharma industry companies want applicants to demonstrate several qualifications, such as:

An associate’s or bachelor's degree in a computer-related field, although many organizations will not accept an associate’s degree
Excellent analytical and problem-solving skills
Demonstrable writing and communication skills
Able to work effectively on a team
A Computer System Validation (CSV) certification

Anyone looking to become a CSV specialist will greatly benefit from a specific certification. CFPIE’s CSV course will take attendees from an introductory level to understanding the intricacies of GAMP 5 and other frameworks with a focus on meeting FDA regulations.

Are you ready to receive the training you need to succeed as a CSV specialist? Sign up today for CFPIE’s Computer System Validation training course to gain the skills needed to succeed in your new role.

Looking for Work in the Pharmaceutical Industry? Here are 6 Essential Skills You Need

Wed, 16 Feb 2022 21:58:46 GMT

Medicine and pharmaceuticals make up an incredibly lucrative and rewarding field to work in. At the same time, the medical industry is also notoriously challenging, and finding work in a pharmaceutical company takes a lot of experience and knowledge that goes beyond what even a detailed CV can cover.

We all know that basic skills like professionalism and communication are important, just as they are for any other job. But pharmaceutical companies are looking for professionals with a particular set of skills. All individuals, and especially those who aim to specialize in a subfield and apply for pharmaceutical industry positions, should choose an active learning approach.

What You Should Consider When Deciding to Start Your Career in Pharma

A career in the pharmaceutical industry can be incredibly rewarding, both professionally and from a compensation standpoint. However, with the pharma and biotech industry constantly evolving, it is critical to stay up to date with certification courses and develop the critical thinking skills that will help you advance in your career .

Here are a few important things to consider when it comes to starting your career in pharma:

Understand Good Manufacturing Practice (GMP) regulations: The pharma industry is no stranger to regulation. Luckily, strict industry-wide standards have been created to ensure consistency across the industry regardless of region and location.
The importance of working in a regulated industry: While business executives may complain about regulation — there’s no denying the important role it plays in ensuring high-quality standards, health and safety, and general consistency across the industry.
Focus on GMP certification : Getting your GMP certification will help you stand out from the crowd because it demonstrates that you understand industry best practices.

Top Skills & Knowledge Required to Start Working in the Pharmaceutical & Medical Device Manufacturing Industry

1. Compliance Knowledge

The medical field is notorious for its stringent legal regulations, and the penalty for non-compliance is even more significant:

A non-compliant organization has to pay on average $9.6 million
Damaged reputation with the industry
Loss of trust with patients
Revoked licenses
Business disruptions

Whether we’re talking about good manufacturing practices or cybersecurity measures, you will need to include regulatory knowledge in your formal education.

Medicine is a heavily disciplined work environment, so consider enrolling in GMP certification or any other course that can build up your knowledge on the regulations that apply to your industry.

2. Management and Teamwork

If you want to prove that you can get the job done, you’ll need management skills to help you evaluate risks and make good decisions that will keep progress moving forward despite the setbacks. Adaptability and organizational skills are highlighted here.

Having said that, management isn’t just about giving orders. Being team-oriented is also a must, and it’s often a pitfall for new workers in the field. While you might have been able to get away with finishing schoolwork alone, the real work you do at pharmaceutical industry jobs must be done as a team. The following skills are important to be able to work well with others and collaborate effectively.

Interpersonal skills
People skills
Communication
Diplomatic experience
Conflict resolution

Communication and the ability to build relationships with your peers are especially necessary here, as sharing responsibilities is par for the course. You’ll also be crafting a reliable network that will bring you even more opportunities.

Conflict resolution is important because decision-making is hardly ever unanimous when working with others. Be able to respond to differing opinions with empathy and work out a solution in the end.

3. Problem Solving

Pharmaceutical manufacturing is a very dynamic sector and filled with difficult decisions and continuous pressures. Critical thinking and creativity are a must if you want to be successful here. If you can contribute great ideas on how to move forward when the going gets tough, you will be an important asset to your team.

4. Project Management

From drug research and development to medical device manufacturing, the pharmaceutical industry moves forward one project at a time. To be a successful project manager requires strong planning skills, project management skills, as well as an understanding of how to manage and prioritize tasks.

For instance, you will have to allocate time, money, and general resources to the production of medicines, treatments, and devices. What specific pain points and issues that patients are facing should you focus your attention on? Project management is a vital skill to have if you’re looking for pharmacy manufacturing jobs.

5. Recordkeeping

Documentation is a large part of the pharmaceutical manufacturing and research process. Companies need someone to record findings and test results completely and accurately. Remember, writing production logs is part of the job of developing new products.

Recordkeeping also comes in handy during the auditing process, where you can prove that certain best practices were followed and check for and resolve potential discrepancies.

6. A Willingness To Learn

Science never sleeps. No matter what you’ve learned so far in your career, there are always new developments and discoveries that pharmaceutical specialists must stay up-to-date on.

Keep your company aligned with modern trends in the overall industry. Doing so will allow you to plan for future projects and take advantage of future business opportunities.

Pick Up Hard Industry Skills With CfPIE

Tying into a willingness to learn, keep in mind that there are professional courses taught by certified instructors that will keep your knowledge up-to-date on the pharmaceutical industry.

While the skills above will certainly give you a solid foundation to work from, hard knowledge is what will ultimately help you get your foot in the door of the pharmaceutical and healthcare industry.

For example, getting GMP certified opens the door for positions in quality control, regulatory affairs, auditing, and various other compliance-focused roles.

Are you looking to advance your skills in the pharmaceutical industry? Register for our Good Manufacturing Practices Training and receive a GMP certification online that’ll help you stay compliant with FDA regulations once you’re out in the field.

CFPIE offers many flexible courses that’ll help you further develop your pharmaceutical industry skill set.

Understanding Supplier Audits in the Pharmaceutical Industry

accounts@cc94.com (Conscious Commerce) — Thu, 27 Jan 2022 19:08:35 GMT

The life sciences industry always strives for the highest quality control standards possible. When a company’s products and services can impact the health and well-being of the general public, it’s essential to avoid making mistakes in the manufacturing process.

In the pharmaceutical industry, supplier audits play an important role in ensuring the quality of raw materials being provided by suppliers.

Supplier quality audits are regular inspections that improve the raw materials, equipment, and supplies a company receives from third parties. Not only can they cut down on the chance of defective finished products entering the market, but they also help achieve legal compliance with the health industry’s strict regulatory requirements.

The Need For Precision

In drug production, for instance, even small variations in active pharmaceutical ingredients or the equipment used to manufacture the drugs can have significant impacts on the safety and efficacy of the final product.

The U.S. Food and Drug Administration knows how much upstream activity influences drug production and subsequently requires manufacturers to gain awareness of what their vendors are doing.

Pharmaceutical companies themselves are ultimately responsible for the quality of their output, and grasping the increasingly complex supply chain requires supplier quality management training. It is the responsibility of the pharmaceutical manufacturing companies to conduct external cGMP audits ( Current Good Manufacturing Practices ) to ensure vendors are following proper manufacturing practices and that the raw materials used in production are safe for the consumer using the product.

What Pharmaceutical Audits Cover

Medical audits can vary in their requirements, and one major challenge facing auditors today is what exactly they should be looking for. Pharmaceutical manufacturers must be clear in their expectations of supplier quality and the key performance indicators that must be met. Some of those KPIs may include:

Legal certifications
Batching process
Deviations in product output
History of client complaints and how they responded
Corrective actions to previous infractions
Rates of return

A high rate of return, a poorly managed batching process, or too large of a deviation from the requested quality are all signs of a supplier not following the necessary manufacturing practices. Manufacturers will usually suggest their own training resources or new processes that can address any of these issues.

The scope of the audit also changes depending on the risk level and importance of the supplier in question. A critical supplier would naturally receive an audit with a broader scope and deeper depth than a low-priority one.

Steps To Conducting a Healthcare Supply Chain Audit

When it comes to identifying potential problems in supplier operations and making better decisions to improve patient outcomes, a supplier audit is the key to improving vendor compliance. Some steps you can take to improve auditing capabilities are as follows:

Deciding on the Scope of the Audit

We’ve mentioned before that scope can vary depending on the company and the nature of the vendor. However, all audits must have specific goals in mind beyond just “do better.” They must be able to use real-world metrics to justify specific steps and corrective action to improve future outcomes.

Set goals on what an audit is meant to accomplish. Should it target a supplier’s sustainability policies? Does the compliance record need to be fixed? Or are there specific risks to address?

Know the Steps Involved in Manufacturing

It’s important to visualize the production process of individual products. Build a road map to holistically evaluate where each supplier pitches into the process. Some of the steps to include are:

Sourcing and procurement
Inventory
Manufacturing
Distribution Practices
Administrative tasks like invoicing

Audits will ensure that every step is accounted for and acknowledged as part of quality assurance.

Find Out the Cost of Individual Components

Audits are also an opportunity to discover new savings opportunities. If multiple different products have a low variation among them, you could consolidate or standardize their purchase without cutting down on quality control.

Strategic partnerships in general help you open up about cost information and share ways to boost revenue and eliminate waste. You also have a chance to identify potential shortages and other risks before they happen, as the impact of the pandemic on medical supply chains has been duly noted .

Know All the People Involved Too

It’s also worth noting who the decision-makers are throughout the supply chain. These professionals have control over essential aspects of the supplier’s road map:

The board of directors
Clinical management
Supply chain operators
System performance administrators
Accounts payable department

Communicating with these touchpoints is the key to building stable relationships with the supplier in question.

Implementing Corrective Actions Afterwards

Once an audit report has pinpointed problematic areas, it’s time for the vendor and manufacturer to work out appropriate solutions. Input from both sides matters in this step, as the vendor itself is more aware of its own shortcomings and operations than the auditor.

A strong manufacturer-supplier relationship is then a major goal of the auditing process. Only then can you ensure a steady, consistent source of high-quality materials and operating procedures for sensitive medical supplies and equipment.

Supplier Audit Training

Did you know that you can receive vendor management certifications online from certified instructors? CfPIE’s Auditing and Qualifying Suppliers and Vendors provide vendor management training for individuals working in the pharmaceutical industry.

Will Your Facility Be Ready for FDA Remote Medical Device Inspection?

accounts@cc94.com (Conscious Commerce) — Fri, 21 Jan 2022 17:16:47 GMT

The United States Food and Drug Administration (FDA) is responsible for ensuring the safety and effectiveness of new drugs and medical devices. The organization’s ability to undergo comprehensive onsite inspections of pharmaceuticals and other biomedical products has been significantly reduced as a result of the pandemic, as reported by the Government Accountability Office .

As a result, the FDA has begun a series of remote inspections that will enable strong quality control on pharmaceutical products while still staying in-line with COVID-19 protocols.

Is your facility ready for the FDA virtual inspections? Read on to learn more.

What Are the Implications For Pharmaceutical Manufacturers And Facilities?

It’s worth learning about this new remote interactive evaluation program so that your company is able to stay compliant and ensure the safety of your medical devices before and after they hit the market.

Is It Mandatory?

While you have the option to decline a remote interactive evaluation, be ready to face regulatory delays if you do. It’s heavily recommended to accept the session if you have pending applications in the pipeline. Keep in mind that the facility itself cannot request a remote evaluation without being prompted by the FDA.

Types of FDA Inspections

FDA remote inspections, which are now conducted over video conferencing and screen-sharing, can involve a wide array of tests, including:

Pre- and post-approval inspections
Licensing tests
Surveillance inspections
Compliance checks
Follow-ups

The way FDA remote inspections are handled is considerably different from that of an onsite inspection

FDA Inspection Checklist

What does the process look like for organizing and undergoing a remote evaluation? The exact series of steps will depend on the nature of the inspection, but you can expect to experience:

Prior notification: The FDA will decide a remote evaluation is in order and will notify your facility. There will be a virtual meeting to discuss expectations and logistics and to confirm your acceptance of the terms.
Examination of paperwork: Any relevant documents or records will be reviewed electronically.
Main inspection: Through live streaming technology, the FDA will examine all your operations, data, and facilities. The FDA will also host meetings to discuss any questions or concerns.
Corrective actions: Based on issues discovered either in this inspection or in previous sessions, the FDA may require that your business perform corrective actions. It will verify the effectiveness of your actions, most likely in an in-person inspection outside of the remote one.
Closing debrief: The FDA will verbally update your facility on observations or any outstanding problems during a final meeting with management. Any points discussed are not considered final decisions by the FDA, and the facility is allowed to respond within 15 business days in writing.

It’s worth noting that these remote sessions are not intended to replace regular FDA inspections entirely. Rather, they can be used as a complement to a real inspection or help the approval process for a new drug or medical product. They might also be useful for prioritizing FDA facility inspections.

How To Prepare For Remote Evaluations

Taking a proactive approach to facilitating a successful and seamless remote session helps accelerate the process. Some steps you can take to help include the following.

Get the Technical Components Running

Are your facility’s IT resources strong enough to support a stable video conferencing session? Plan to perform tests and checks so that your technical capacity can support virtual interactions.

Do you have enough bandwidth throughout the facility for the session, especially if you expect to move within the building during the inspection? Will there be an issue with software or firewalls? Are there any security risks to remote conferencing?

Make sure these questions are answered and perform a test run during your preparation phase. You may find that an investment into proper A/V equipment may be in order. Cameras and microphones must be configured correctly to work even in noisy environments within the building.

Finally, keep in mind that the FDA mandates the use of its own IT platforms, such as Microsoft Teams, Zoom for Government, or Adobe Connect. Make sure that your solutions are compatible with these platforms.

Be Able To Share Documentation

The Food and Drug Administration notes that it may request documents during the remote evaluation. Not only do they have to be in a readable digital format (convert your papers into PDFs, for instance), but they must be shared securely.

Check whether your documents are encrypted or otherwise require a password to access. Have them in common readable formats, and be ready to make conversions on-the-fly with proper scanning, printing, and conversion tools.

If you have physical versions of electronic documents, cross-reference them together to make sure everything is complete and up-to-date. Tell your IT department to stay organized as well so that the right document can be brought up in response to any request promptly.

Educate Staff On Inspection Protocols

Your response to FDA remote inspections for drugs or medical devices is only as good as how well your employees understand FDA regulations. Medical training is considered essential for maintaining legal compliance, and there are thankfully classes tailored specifically to inspections and how to undergo them properly. Check also our course spotlight post on what regulators expect and how to prepare for FDA inspections

CfPIE offers “ FDA Inspections - What Regulators Expect and How to Prepare ” for this reason. Whether you are a QA director, a regulatory manager, an auditor, or any other executive at a facility, this course will teach you all about the FDA’s expectations during a remote evaluation. You will know all the responsibilities, planning, and best practices to keep your organization up-to-date and compliant with important regulations.

The class is accredited by the Regulatory Affairs Professionals Society and is considered a recognized course by PharmaTrain.

2022 Career Outlook For Technical Writers: What You Need to Know

accounts@cc94.com (Conscious Commerce) — Wed, 19 Jan 2022 16:10:35 GMT

No matter how talented or experienced you are, you cannot do the entire job alone. That’s why all industries rely on communication between employees and B2B collaboration to empower their products, services, and internal operations.

So what happens when a business operating in a heavily specialized field like pharmaceuticals and medical devices must communicate with clients or partners who can’t understand any of the technical language involved? It hires technical writers to act as the glue between the engineers and the general public.

What are the career outlooks in the 2022 year for professionals with a technical writing certification? Read on to find out why the job outlook for technical writing is growing at a “faster than average” rate of 12% in the coming decade according to the U.S. Bureau of Labor Statistics .

Why Is Technical Writing So Popular?

The demand for technical writing stems from the need to communicate complicated, specialized topics and concepts to “laymen” users such as customers, employees, shareholders, and other partners.

New technologies, medicines, machines, and innovations will always be made. Consequently, there will never be a shortage of complex topics to talk about. The businesses operating in these industries will always have to convey vital information to the public in some capacity.

While it’s true that most writers operate in the computer industry, the prospects for a technical writing career extend beyond the technology sector. From finance, insurance companies, to medical, any industry that deals with complex jargon must be able to simplify its communications so that its readers can understand it clearly.

Use Cases For a Technical Writer Certification

What career paths call for a technical writer’s skill? We’ve already mentioned that a wide variety of industries need it, but let’s go into detail about the occupations you’ll probably be taking on.

Business Reports

Whether we’re talking about news reports, academic papers for universities, or other corporate documentation, reporting writing involves collaboration with multiple business departments and plenty of observation and research to get all the data together.

Case Studies

Customers love being shown real-world examples of how a product or service works. That’s why company websites have entire sections and pages dedicated to case studies, which point out the problems and pain points and how the solution addresses them.

These pieces are designed to build trust and authenticity for the brand. Important details to include are the original problem the client was facing, exactly what actions the company made, and the results at the end.

Copywriting

A technical copywriter is tasked with helping the marketing team gain revenue. These writers craft content for:

Advertising emails
Website copy
Catalogs
Brochures

These publications intend to not only inform customers of the brand’s offerings but also encourage sales through persuasive language and call-to-actions.

User Experience

The customer experience is the top priority for customer-facing organizations. UX refers to what a company is like to interact with, and it’s a vital component of customer satisfaction . A company can easily step over the competition by offering a superior UX.

UX can be the experience of using a website layout or the interface on a software program. Either way, UX writers are in high demand to close the gap between the buyer and the company. They are responsible for thoroughly researching the target audience and developing powerful prototypes of apps and websites.

How Do You Become a Technical Writer?

Some people start out as engineers who transition into writing responsibilities within their own companies; others begin by taking technical writer courses first and choosing an industry later. Either way, there are many career paths to technical writing, though some best practices to start with are:

Brushing up on your writing skills: T he literature essays you wrote in high school probably won’t cut it here. Being able to write not only understandable but also engaging content takes some practice. Simply publishing articles, even if they’re just about general topics, helps immensely to build job-ready skills. Of course, you should always prime yourself on the rules of English grammar while you’re at it.
Gaining experience: Many writers keep a portfolio of their previous projects. It can be an invaluable resource for showing employers that you’re serious about this field.
Finding a niche: What differentiates standard writers from writers with technical skills is their ability to cover specialized fields rather than just general-purpose content. Finding a niche like in medical writing or finance is key to differentiating yourself in the market. It also tends to pay a lot more.

Of course, the skill sets of writing a technical piece require some practices and tactics that don’t necessarily apply in other forms of writing.

What Should a Technical Piece Look Like?

The ideal style that businesses ask for in technical pieces differs from company to company, though most pieces share these common features:

Little to no jargon: Unlike the documentation traded between engineers and developers, the content in technical writing is a lot more succinct. You want to avoid specialized industry terms as well as casual language like idioms. Remember that technical pieces are designed to inform or persuade more than anything else.
A focus on the target audience: Not all readers will have the same level of technical knowledge. While you might need to simplify the language a lot for, say, a casual reader, you probably can afford a few technical terms in a piece for an industry conference.
Consistent structures: Have a few templates ready for individual projects so that you can get started writing more quickly and ensure a consistent structure for every organization you work for.
SEO optimization: The publications made on the marketing side of things ultimately must rely on search engine optimization tactics. Learn more about how businesses rank themselves highly in search engines.

And don’t be afraid to pick up on new tactics the more you work with certain clients. For instance, you’re likely going to be asked to use the active voice more often than the passive voice. Or a client might call for sub-headings, bullet lists, and quotations to break up the monotony of plain paragraphs.

Is There a Technical Writing Certification?

Did you know that it’s possible to get a technical writing certification online? For instance, if you’re interested in the medical writing profession, consider getting a certification specific to the pharmaceutical and medical device industries from CfPIE. A certificate opens up new career opportunities and shows potential employers that you have a strong understanding of essential industry topics, including skills in ethics, communication, and a knowledge of regulatory compliance.

Industries like medical, biotech, and the overall pharmaceutical industry demand thorough skill and experience in their respective fields.

Individuals looking to access this lucrative occupation need the right type of training from qualified instructions. CfPIE is ready to provide aspiring medical technical writers with everything they need .

How to Start Your Journey As a Technical Writer - Everything You Need To Know

accounts@cc94.com (Conscious Commerce) — Tue, 28 Dec 2021 19:21:36 GMT

Are you interested in getting yourself a certificate in technical writing? You aren’t alone. The employment rate for technical writing jobs is expected to grow by 12% in the coming decade , a “faster than average” rate compared to other jobs.

What’s the driving force behind this trend? More and more businesses are operating in the software and electronics markets, which require extensive user manuals so that the end-user knows what to do with the products and services effectively. Bridging the gap between the complicated, technical aspects of the tech market and the “normal” user base is a skill in high demand these days.

Of course, technical writing skills are required across various industries, from medical to finance. Being a technical writer can be a rewarding experience, so let’s talk about how you can jump-start your career with a certification in technical writing.

What Does a Technical Writer Do?

A general description of the job would be converting complex language and high-level jargon into readable content for the average person. Technical writers might publish:

Instruction manuals or user guides
Technical descriptions
Operating procedures
Medical documentation
Staff training materials

These types of publications naturally have a clear and direct style with a neutral tone. They typically feature an active voice the most and are careful with word choice to avoid giving users complicated jargon to work with. People who work in this field are always looking for ways to make their writing style professional and accessible to the general public.

But the work doesn’t end at just writing. Many technical writing professionals also help design and outline the documentation by doing research for a particular target audience, and determining how to present the information most effectively. They might work on graphs and charts to make the publication more readable to that end. Check out our previous blog post on what should high-quality technical writing include for a few key concepts on writing documents with clarity and simplicity.

Technical writers might aim to convey the findings of a complicated research study, for instance through effective writing skills. Or one might be tasked to write an assembly instructions manual to teach customers how to assemble a lamp correctly. There are many ways you can use a technical writing certification, and some professionals even work in a variety of industries doing all types of work, from business consulting to academia to other fields like medical communication, energy, health, and many others.

How Do You Become a Technical Writer?

Writers naturally need skills in written communication, document formatting, and data analysis. But if you want to be taken seriously in the industry and accelerate your technical writing career, consider these major steps:

Work on a Bachelor’s Degree

Peruse the job listings for technical writer positions and you will see that a Bachelor’s Degree is a common prerequisite. Studying topics like journalism, communications, and scientific writing can all boost your chances significantly. You should also take the opportunity to cover the specialized field you intend to work in, such as engineering or medicine.

Get Certified

A technical writer certification is another major stepping stone to consider. Many service providers offer professional training courses tailored to a specific field of technical writing. If you’re thinking about working in a high-skill market like the medical field, definitely put certification high up on your priority list.

Of course, your choice of a training program matters when it comes to receiving high-quality certificates that will impress employers. We’ll talk more about certification and where to find it later.

Study Your Industry of Choice

If you’re interested in writing for finance, study recent economic trends. If you’re joining computer science, look into new developments in cybersecurity or other technologies. The idea is to build up your knowledge of your industry of choice, which will inevitably help in your writing projects.

Tying into the previous point, a certification program will likely offer resources for studying recent news and research in the specific field.

Build Up a Portfolio

Everyone starts off small. Consider doing smaller writing projects in more general fields first, and collect multiple writing samples in your portfolio, including technical writing examples. You will have a chance to gain hands-on experience, improve your technical writing process, and show potential employers your writing skills in a way that can’t be expressed on a single page of a resume.

Start Networking

No one will deny that connections matter. Technical writers should not forget to build up a professional network by attending industry events and building up a list of contacts. You might receive opportunities to work on certain passion projects from your efforts.

Is a Technical Writing Certificate Worth It?

Certification, while technically not mandatory, does go a long way to showing potential employers that you can synthesize complex information and transform it into a readable format, and a technical writer job. Getting a technical writing certificate shows off your dedication and knowledge in the field, and it’s actually not too difficult nowadays to find one.

Especially in high-stakes industries like medicine and pharmaceuticals, companies want to make sure that the technical writers they hire have the necessary skills and knowledge of medical terminology, and are truly ready for the job. To that end, look only to the best technical writing certification programs available.

Look no further than CfPIE for receiving your technical writing certification online. Browse our extensive course outline to find the right technical writing course for Pharma, Biotech and Medical Devices . We offer some of the most qualified instructors available in medical training. Not only do they have deep experience in the industry, but they know the best practices for adult learning to ensure your success. Let’s talk about how you can boost your writing career in the pharmaceutical industry .

IFU For Medical Devices: What US & EU Companies Must Know

accounts@cc94.com (Conscious Commerce) — Tue, 09 Nov 2021 21:54:01 GMT

Medical devices can be complicated to operate, so pharmaceutical manufacturers have a legal duty to write up easy-to-understand instructions for use (IFU) on any medical devices put out on the market.

Exactly what needs to be included is laid out in writing in both the United States and the European Union, with both regions having their own requirements that medical companies must follow.

It is vital to understand medical device regulations in the US and in the EU to ensure safe and effective use of medical devices by end-users who might not be familiar with how they work. IFUs reduce the liability of a pharmaceutical company as well, so it’s within your best interest to focus on writing IFUs.

Read on to learn more about IFUs, their regulations, and other key information you need to know.

United States IFU Legislation

The US has several federal agencies responsible for controlling and regulating public safety. Of them, the Health and Body portion is responsible for, among other things, medical devices. The Food and Drug Administration (FDA), acting under the Federal Food, Drug and Cosmetic Act (FFDCA), has created the Code of Federal Regulations Title 21 that covers medical devices and pharmaceuticals.

Labeling

IFUs specifically are mentioned in the section regarding medical device labeling. “Labels” can take the form of either the sticker on the container, a brochure, booklet, manual, direction sheets, tags, or other similar accompanying literature.

While not exactly “instructions for use” per se, the labels you add to your medical devices are also under regulation by the FDA, so we’ll cover them now. Part 801 of the CFR mentioned previously is our point of focus, as it specifies:

Intended use: Medical Device Manufacturers must designate all the potential applications of a medical device (i.e. what it’s used for and how to use it). Contraindications, by contrast, are instances where the device should not be used because the risk outweighs the benefit.
Directions: In addition to the intended uses, the end-user must have clear directions on how to use a medical device. The details regarding recommended dosage amount, frequency, and method of application must be correct and complete.
Manufacturer identification: The name and address of the manufacturer or distributor must be stated on the package. Phrases like “manufactured for…” or “distributed by…” are necessary when the name on the label is not the same as the producer.
Clear, prominent statements: Required information must be displayed prominently in large text and cannot be cluttered with other design elements. Any symbols used outside of the FDA’s approved standard must be explained clearly as well.
A consistent date format: Whether it’s an expiration or production date, YYYY-MM-DD is the approved format with a few exceptions.
A Unique Device Identifier (UDI): This feature is required for most medical devices and even their accompanying software. It contains elements like a batch number, serial number, expiration date, and manufacturing date. It should be easily scanned by automated machines to quickly enter them into computer systems.

Labeling is only a portion of the medical device compliance process. Various other features and documentation must be included as well.

Quality System Regulations

This portion of the FDA’s rulings has to do with “current Good Manufacturing Practices” when it comes to manufacturing and releasing medical devices. In terms of Instructions for Use, the requirements are:

Device identification on the cover, such as a picture, product name, or model number.
Handling information to prevent damages during transportation.
Storage information for safekeeping and prevention of cross-contamination.
Accurate installation processes.
A place to file service reports to the manufacturer.

The manufacturer must additionally have a system in place for receiving and evaluating consumer complaints and potentially responding with investigations.

Designing the Instruction Manual

The FDA publishes the Guidance on Medical Device Patient Labelling to help pharmaceutical companies write comprehensive instruction manuals for their medical devices. Some of what it asks for are the following.

A table of contents: The instructions will inevitably be long and detailed, so keep organized and make navigation easy with a table of contents.
A glossary: The manual should include consistent terminology to promote understanding. Explain the meaning of the terms and abbreviations you use, especially if your target audience likely does not have medical knowledge.
A risk and benefit section: Health practitioners must make decisions for their patients on whether deploying the use of a medical device is worth it for someone’s specific circumstances. A risk/benefit section facilitates this decision.
Clear operating instructions: Start with any relevant warnings or safety tips before listing out individual steps in a logical order. Include cleaning/maintenance instructions and have an emergency contact in place just in case. It’s recommended to have a list of components with a labelled diagram of each too.
Troubleshooting: Medical devices might cause problems during use. Troubleshooting information is necessary in the manual for this reason, and it typically takes the form of a 3-column table listing out the exact problems, the cause, and the solution.

Special Cases

If a medical device is either not approved for marketing or is under current clinical evaluation, then it is considered an investigational device. As a result, there must be a clear indicator on the product label saying so. The FDA requires that investigational devices have the Investigational Device Exemption (IDE) so that information can be collected as part of premarket approval.

The FDA also specifies a series of IFU regulations regarding in vitro diagnostic devices , medical devices using biological samples to check on the status of one’s health.

European Union IFU Legislation

Compared to analogous legislation in the US, European IFU medical device validation regulations largely separate the requirements for device instructions, packaging, and labeling. They take the form of the (EU) 2017/745 Regulation .

The regulation covers all types of medical devices and their accessories but explicitly does not cover in vitro diagnostic devices, cosmetics, food, or medicinal products. For in vitro diagnostic medical devices, the Regulation (EU) 2017/746 instead will take over.

Classes of Medical Devices

The EU categorizes medical devices into 4 categories: Class I, Class IIa, Class IIb, and Class III.

Class I involves low-risk medical devices like reusable surgical tools and any non-invasive devices.
Class IIa are moderate risk with more invasive devices.
Class IIb are similar to IIa except they also include more long-term invasive devices among others.
Class III are the high-risk medical devices.

Only devices in Class I are exempt from official assessment by a Notified Body, and Instructions for Use are only required for Class IIb and Class III devices since they are complex enough to call for them. In vitro diagnostic devices have a separate but similar classification system of Class A, B, C, and D.

What To Include in the IFU

The EU Regulation contains plenty of data points that must be included in the Instructions for Use for a medical device. We recommend going through and finding all the sections that mention IFU and building a checklist from there. A few requirements we’ve picked out are the following.

Name of the device
Address of the manufacturer
Indication of medicinal substances
Whether or not the device is single-use or reusable
Preparation procedures like sterilization, assembly, or calibration
Intended use and contraindications
Information for the healthcare professional to assist in the implementation of the medical device
Relevant warnings and precautions
Disposal instructions
IT requirements to run any associated software
The CE marking must be visible on the sales packaging

In vitro medical devices are also covered under the Regulation, and the regulatory requirements are similarly comprehensive. To ensure compliance, we recommend:

Identifying which regulations, directives, and standards are applicable to your medical device. Then choose the requirements that apply to the exact type of medical device you are analyzing.
Determining whether you can assess your own medical device or you need a Notified Body from the government to help. Keep in mind our Class distinctions above.
Performing the assessment to check for compliance.
Building a technical file, which includes the description, the label, Instructions for Use, and other important information.
Applying the declaration of conformity to finish the process.

Another question worth asking is who to entrust your IFU writing to. The EU regulation actually uses the term “competent person,” which refers to anybody with experience, education, or qualifications in a particular task.

Whether you have a dedicated writer or a team of experienced IFU specialists, it’s your task to identify what needs to be done and who is competent in the related fields.

Harmonized Standards

Pharmaceutical manufacturing companies have an opportunity to prove compliance with certain essential requirements by using harmonized standards. The C-type standard, for instance, covers a given category of devices, whether they are X-ray equipment, radiotherapy devices, or otherwise. Examples include:

EN 455-1:2000: Medical gloves that can be only used once
EN ISO 11990:2018: Laser equipment
EN 14683:2019+AC:2019: Medical face masks

There are obviously far more out there, so double-check with the Regulations to see which ones are applicable to you.

The Information Management Process

Writing the Instructions for Use is about more than just technical writing. You have to tell your writers what to include and what information is accurate. To that end, businesses must gather and analyze all the technical specifications, compliance procedures, storage instructions, marketing objectives, and other relevant data first. Doing so requires strong collaboration amongst multiple departments.

An information management process helps determine exactly how the IFU will be written, hence why the 82079 standard mentions it directly. The requirements include:

Proper planning for the analysis and creation of the information. The instructions of a medical device must be based on the result of market analysis and a look at the needs of the target audience. A pharmaceutical company must also analyze risk management and look at the legal agreements it has during this phase.
General development of the IFU, including editing and testing. The writers gather information by performing usability testing and looking at information design concepts. They also decide on the content structure.
Distribution of the information for use. How will you package and distribute the content of the IFU? Will it be electronically or physically or both?
Improving the IFU in the future. Writing IFUs should be a regular process. Be ready to take feedback on the medical device and make adjustments to the instructions accordingly.

You don’t want to publish Instructions for Use only to realize that you accidentally left out an important detail or made a mistake in the writing process. An information management process minimizes this risk and ensures that your end user can use the medical device correctly.

Other Considerations

EU regulations generally agree that safety instructions must be included with the product, while non-safety content can be provided separately like online. However, the legislation on medical devices is a little different.

Regulation (EU) No 207/2012 , which understands that some instances may call for online instructions, specifies what circumstances or medical devices call for electronic rather than paper IFUs.

You also should look at translating your instructions too. EU Regulation calls on the languages accepted by the member states when the medical device comes out. Such a requirement extends to both the labeling and the instructions.

The Importance of Medical Device Certification

Medical devices are heavily regulated in both the United States and the European Union. The Instructions for Use specifically have their own requirements on top of the development and labeling of the device itself.

Because understanding all these regulations are paramount to increasing your compliance rate and boosting the effectiveness of your medical devices out on the field, it makes sense why pharmaceutical companies and device manufacturers are looking to give medical device training to their staff.

But where do you look for effective and up-to-date training resources from actual medical professionals? Get in touch with the industry leader in pharmaceutical, biotech, and medical device certifications . We have a training program for your specific needs.

How New Drug Companies Find Out About the FDA’s CGMPs

Tue, 19 Oct 2021 20:31:07 GMT

Regulatory compliance is at the top of the pharmaceutical industry’s priority list. From data privacy to drug manufacturing safety, the consequences for poor compliance are severe legal penalties and a massive loss in trust with customers and business partners.

Among the regulations to keep track of are the Food and Drug Administration (FDA)’s Current Good Manufacturing Practices (CGMPs) regarding pharmaceuticals. The law mandates a level of quality control during the manufacturing process.

What Exactly Does It Cover?

To be specific, following CGMP guidelines is all about having control over your manufacturing processes and facilities to achieve a clean and effective drug product. Following CGMP means that you have:

Facility management
Quality raw materials
Accurate processing operations
Strong quality management systems and Ability to detect and investigate deviations
Proper testing methodologies

Specific fields of pharma regulatory compliance and CGMP requirements for pharmaceutical manufacturers mandated by the FDA include the following:

A well-defined manufacturing process with tight controls to ensure consistency. The language used in the instructions must be “clear and unambiguous.”
A clean and hygienic factory floor that requires you to sanitize equipment regularly. Cross-contamination must be prevented through proper environmental controls.
Proper training for staff members on the factory floor for carrying out quality control and other protocols.
Proper testing of the finished product and documentation of any deviations from what’s expected of the drug. Changes made to the formula during the drug development process must be validated, and recordkeeping must be done throughout the process to record steps and instructions.
Procedures must be available for recalling any batch of medicines sent out that’s later found to have defects.
Complaints and concerns from the market post-launch should be examined, and proper investigations alongside preventative action should take place to remedy the issue.

In general, you can expect a lower chance of experiencing product failure, drug contamination, or other mistakes when you keep track of these FDA minimum regulatory requirements. Either way, following CGMP and other laws like it will overall result in a positive return on investment for your organization, whether we’re talking about drug manufacturing or cosmetic regulatory compliance.

Why “Current”?

The “current” nature of the practices refer to the importance of staying up-to-date with current regulations. Much like medical science and technology, the rules and requirements will always evolve and change. Even if you passed an inspection a few years ago, you might not necessarily be fully CGMP compliant today when considering current needs.

For this reason, regulatory compliance training is heavily recommended on a regular basis. Keep your staff up to date with the current laws and how they apply to your workflow to avoid costly fines and lost trust from noncompliance penalties.

How Does the FDA Test For It?

The FDA formally inspects pharmaceutical manufacturing plants across the globe. It combines these inspections with any reports of defects from the market itself and makes judgments on whether further investigation is needed. If a violation is found, multiple events may occur depending on the nature of the drug and its safety status.

The drug becomes “adulterated,” meaning that it was produced without CGMP standards. An adulterated drug is not necessarily unsafe, however.
Customers currently taking an adulterated drug may choose to continue the treatment under guidance of a medical professional to prevent health hazards from sudden withdrawal.
The FDA may require the company to cancel further manufacturing and distribution of a drug deemed unsafe.

While most CGMP violations result in a voluntary recall by the company, in extreme cases the FDA may bring up a seizure case in court so that the government can take possession of the adulterated products. If appropriate improvements like sanitation, testing, equipment, and training are not provided, the business may be subject to fines and even arrests.

Inspections occur whenever a business submits an application for a new drug product, but they can also happen if the business is suspected of breaching GMP guidelines by another regulatory authority.

The First Step to CGMP Compliance: Staff Training And Compliance Certification

A pharmaceutical company’s management team doesn’t have full control over every step of a complex manufacturing process. The details are all the responsibility of employees on the factory floor, and your compliance level ultimately lies in their hands.

So how do you ensure that you avoid costly incidents? The answer is pharmaceutical training courses. Whether you’re looking for medical device topics, biotechnology lessons, or cosmetics training courses, get in touch with CfPIE and its professional instructors experienced in all sorts of pharmaceutical topics. Get your clinical compliance training up to speed to prevent noncompliance and boost the abilities of your staff.

Why Pharmaceutical Training Courses Are Essential in the Rapidly Evolving Pharma Industry

accounts@cc94.com (Conscious Commerce) — Tue, 19 Oct 2021 20:30:58 GMT

Pharmaceutical development is a challenging and costly process in and of itself, so when it comes to manufacturing the product for the open market, pharma companies in this industry spare no expense in ensuring an error-free assembly line. Part of that effort is putting properly trained staff on the factory floor to improve quality, safety, and efficiency.

Mistakes in manufacturing result in lost resources, slower time-to-market, and damage to the business’s reputation. For these reasons, pharmaceutical training courses are a smart investment for any medical organization, as it contributes directly to staff's professional growth and the company's success.

The Benefits of Pharmaceutical Certification

Pharma training courses are always in high demand and for good reason. Investing in educational programs for your staff has a variety of benefits that you can’t miss in such a competitive and regulated industry like medicine.

Legal Compliance

The medical industry is heavily regulated, and the penalties for failing data privacy, safety, and manufacturing checks are too large to ignore. Staff undergoing GMP training , for instance, are more likely to understand the complicated network of regulatory requirements involved in pharmaceutical manufacturing.

What follows is a higher standard of quality assurance in the products you put out as well as a better ability to audit your own processes to check for potential problems early on.

Competitive Advantages

As long as you choose a certified training provider, you can expect high-quality lessons taught by experienced instructors who will give your staff the knowledge they need to boost your company’s competitive edge in an otherwise cutthroat market.

The investment is easily worth it too, especially if you take advantage of special offers like CfPIE’s cost-saving opportunities like early-bird specials and multiple course discounts.

Staff Morale

When employees get to experience pharmaceutical training from licensed professionals, they are more likely to take pride in their work and strive to perform better out in the field. They have a better grasp on how to take responsibility for their technical tasks and strive to meet and exceed expectations, with the ultimate goal of protecting public health.

In other words, regular training helps build a culture of continual improvement, whether we’re talking about management positions, machine maintenance, or process alignment.

Measurable Progress

The positive impact of pharma training on an organization is easily measurable. The employees often take final examinations on the material they learned and can demonstrate their newfound knowledge of medical processes, technologies, and biopharmaceutical industry practices.

Once out in the field, other benefits that can be seen include:

Better performance and fewer errors during manufacturing
Better quality control of the final products
Ultimately better customer satisfaction and fewer complaints

The competitive advantage pharmaceutical certifications provide you are noticeable not only to you but also your staff and

customers alike.

Where Should You Focus Your Attention?

Management should always be engaged with the professional development of their employees. No matter what you work for, certain general skills are always useful when you’re first starting out and looking for relevant coursework. Those fields are:

General medical knowledge: Focus on the types of diseases your company treats and cures the most. What specific drugs are used most often, and what are their known side effects? Of course, you can’t skimp on learning basic human physiology either.
Legal compliance: To avoid a loss of trust with clients and business partners as well as heavy fines imposed by governments, teach your staff about legal topics like Good Manufacturing Practices (GMP), safety training, and Intellectual Property Rights (IPRs).
Sales and marketing: This last field might not apply to all the employees in your firm, but it’s an invaluable skill since the sales reps need to understand exactly what they’re selling. Providing accurate recommendations while keeping ethical practices in mind is far easier when you have a strong knowledge of current products and trends in the industry.

Many training providers have a large variety of courses available covering various specialized topics. CfPIE, for instance, covers biotechnology, cosmetics, medical devices, and various others. Ask about flexible options too like on-site training, classroom instruction, or virtual lessons.

How Should You Approach Pharmaceutical Training?

Convinced of the potency of pharmaceutical certification training? Then have the right mindset when you’re searching for professional courses. The elements of success here lie in:

Seeing It As a Mandatory Investment Rather Than an Avoidable Expense

Time and time again, businesses have found out that getting the work done right the first time through well-trained employees always saves money over fixing your failures as a result of lack of proper experience.

Many management teams are also worried that training would slow the productivity of the business in the short-term, but the benefits will pay for themselves fairly quickly.

Hiring Professional Instructors

Just because you have subject matter experts in your company already, doesn’t mean they have the experience to convey that knowledge to other staff. You need the qualities of a professional instructor to ensure quality training and proper certification.

Taking Refreshers in the Future

With the rapid growth of the pharma industry, medical practices and knowledge are always evolving, and employees will need to be reminded of their training regularly. Prepare to invest in refresher courses for the same material and the same staff on occasion.

And don’t just speed through it like it’s a checkbox you have to fill out. Go at a reasonable pace to allow participants to absorb all the necessary experience that they need. The attitude that management takes towards training ultimately reflects in its impactfulness.

Choosing Appropriate Coursework

If you want to get the most out of a training course, you need to have the right foundation and prerequisite knowledge. Every class has its own requirements that should be consulted properly before conducting coursework. Otherwise, you’re just wasting your time and money. Bridge all your gaps and choose the courses you need carefully for best results.

The nature of the coursework matters just as much. For instance, would an on-site instructor work best for your workflow, or should travel expenses be paid for optimal training? And is there an examination at the end to test out participants’ progress?

Picking Out the Right Certification Program

There are many pharmaceutical certification providers out there, but not too many can offer a high quality training experience with passionate instructors and accessible delivery methods. CfPIE offers all its courses to medical companies looking to introduce or refresh employees in important medical topics.

Access Industry-Leading Pharmaceutical Training Courses With CfPIE

The pharmaceutical industry is no stranger to changing information, regulations, and trends. It’s not uncommon for the latest FDA regulations to completely overturn established best practices.

For leading pharmaceutical companies, there’s a constant need to keep your best people trained with the most relevant information available.

Are you looking to provide relevant pharmaceutical training to your staff? CfPIE is the go-to training provider to some of the world’s largest pharmaceutical companies. Explore our catalog of courses across all use cases and segments of the pharmaceutical industry.

3 Main Phases of Pharmaceutical Product Development

accounts@cc94.com (Conscious Commerce) — Thu, 30 Sep 2021 15:17:05 GMT

The legal regulations regarding the release of new drugs and pharmaceuticals are rigorous. Precautions are taken both by the company and by the regulatory authority to ensure that every new product is both safe and effective for public use.

Medicine itself is an extremely specialized topic, and the development of new drugs is a long undertaking for even large companies in the pharmaceutical industry. What exactly goes into the creation of these products, and what are the stages of drug development?

If you’re interested in pharmaceutical product development certification , learning about this process is an excellent first step. The United States Food and Drug Administration actually has its own web pages dedicated to the topic. In a nutshell, however, medicine is created, released, and monitored in 3 major phases.

Phase 1: Discovery

There are so many potential vectors and approaches to solving a new disease or condition that it can seem overwhelming to find out where to begin. Researchers find a starting point for developing new pharmaceuticals through several avenues:

Looking at existing treatments and their effects, both intended and unexpected.
Further research into a disease to suggest ways to reverse or fix the condition.
Testing various molecular compounds to determine any effects against diseases.
Exploring new technologies like genetic modifications.

Researchers then whittle down a vast list of potential compounds through testing until they reach a few promising candidates for further study. A compound is analyzed based on several factors such as how the body processes it, its potential benefits and side effects, and how it interacts with other drugs.

Phase 2: Research

Research for new drug developments happens in two phases: preclinical and clinical research. The preclinical phase starts with toxicity testing, one of the highest priorities of pharma product development to ensure that no drug released is immediately toxic to the human body.

Testing is done first in the laboratory (in vitro) before being deployed with real human subjects (in vivo) to verify nontoxicity. The FDA requires the use of good laboratory practices (GLP) for these types of tests. They apply towards the facility, equipment, personnel, procedures, quality assurance, and reports.

The clinical research that follows preclinical testing is a lot more involved, as it aims to address exactly what its impact will be on the human patient:

The company submits an Investigational New Drug (IND) application to the FDA. It explains the results of the animal study if one was conducted, the drug’s current side effects, the planned clinical protocols, and any other relevant data. The FDA may offer guidance during the trials with optional suggestions to the company.
An IND review team is created with specialists from different scientific fields to cover all the bases. In addition to a project manager and medical officer, there might be a statistician for the data, a chemist, a microbiologist for the antimicrobial aspects, or anyone else needed for the project.
The clinical trials are designed to answer specific research questions regarding the product. A study protocol is produced for this purpose, and human subjects are selected to be part of the study. These small-scale trials end once data is collected and analyzed.

Clinical trials end when the developer chooses to file a marketing application. This point may occur once enough data is collected from at least two large clinical trials.

Phase 3: Review

The last of the drug development phases have to do with the release and post-market monitoring procedures. Once the company is confident in the effectiveness and safety of its product, it creates a New Drug Application (NDA) to show intent to release to the public. Such a document includes an exhaustive list of findings:

Clinical trial results
Labeling and directions for use
Safety and abuse information
Patents
Relevant studies conducted outside of the United States

The Food and Drug Administration moves on to decide whether or not the NDA is complete. If so, the review team then spends about 6 to 10 months deciding on whether to approve the new product. This decision comes down to a few steps:

A member specialized in a field of medical science reviews the analogous section of the NDA. For instance, the statistician reviews the clinical data, and the chemist reviews the chemical compounds in the document. Each technical discipline is covered as a result.
FDA inspections are completed at each clinical study site to check for completeness in the reporting of the NDA.
The project manager brings it all together for the FDA’s review decision and approval. At this point, the FDA considers the drug safe and effective for public use.
The “labeling” process follows where the FDA works with the business to define prescription information and best practices for use of the drug.

At the end, the FDA may decide that there are further questions needing additional consideration not mentioned in the NDA. It might organize an Advisory Committee for experts to appeal certain points and the public to make comments.

But the story doesn’t end when the approved drug hits the market. The true test of a pharmaceutical product is how it operates in the field. The FDA may take several precautions post-launch to address any issues that have not come up from clinical testing:

Routine inspections by the FDA cover manufacturing facilities throughout the nation and even internationally for certain products made in other countries. These visits check for good manufacturing practices ( GMP ) and look for any concerns brought up in the market.
Cautions can be added to the labeling to address certain changes to the use of the drug. During the drug development process, the company itself can choose to make a major change to the product through a supplemental application filed to the FDA.
Advertising pharmaceutical products is heavily regulated as well, as businesses cannot be misleading with their claims.
Consumers and healthcare professionals can file complaints and report problems with current drugs through certain FDA programs like MedWatch and MedSun.
Sometimes a developer wants to form a derivative of a current drug on the market, either by changing the dosage, the use case, or the form (tablet, liquid, etc.). In this case, it would file an IND.
Once a patent on a drug expires, a similar generic version can be produced. Manufacturers of generic pharmaceuticals don’t have to go through the same clinical trial process since the products are similar enough to already approved drugs, so they just need bioequivalence studies complemented by an Abbreviated NDA.

A new development to look out for is the FDA’s Sentinel Initiative, which will likely replace post-market assessment in the future. The system scans electronic health databases like insurance databases and registries to gain information on public health in real time.

CfPIE’s Online Programs for Pharmaceutical Development

Developing a new medicine is complicated in and of itself, and there are even more regulations to think about during the entire process. Those looking to contribute to the drug development market need a certificate in pharmaceuticals and clinical trials management .

The key to acquiring enough knowledge and experience to succeed in the medical field is engaging with the right coursework for a product development certificate. So where do you look for pharmaceutical certificate courses ?

The Center for Professional Innovation & Education (CfPIE) has been providing high-quality professional instruction to medical companies with strong needs for skills in pharmaceuticals, medical devices, biotechnology, and other fields.

For drug development specifically, check out our certificate program and its associated courses here . The PDCP stands for Pharmaceutical Development Certified Professional , and it’s ideal for medical organizations to decrease time-to-market through a more knowledgeable staff base.

What Is Pharmaceutical Quality Assurance? And Why is it Important?

Thu, 19 Aug 2021 13:15:08 GMT

Quality assurance is one of the most important aspects of the entire drug manufacturing process. Not only will it help companies protect their reputations, but it will allow them to avoid hefty penalties from regulatory organizations.

This is exactly why anyone involved with quality assurance should receive pharma training that helps ensure compliance.

The purpose of pharmaceutical quality assurance is to ensure that the medication being manufactured will provide the desired effect to the patient. Quality assurance also guarantees that there are no contaminants present and that the medications will meet quality requirements and all relevant regulations.

There are several objectives that must be met with pharmaceutical quality assurance. If a manufacturer falls short of these objectives, they may face heavy fines and possible legal actions that can jeopardize the business.

Today, we’re going to go over the common objectives of pharmaceutical importance. Understanding these objectives will shed light on how important pharmaceutical quality assurance truly is.

Objectives of Pharmaceutical Quality Assurance

There are several objectives of pharmaceutical quality assurance that must all be met. If an organization is unable to meet these quality objectives, it will need to revisit the entire pharmaceuticals manufacturing process. Below are each of the primary objectives that every quality assurance program must strive to meet.

Ensure The Public’s Safety

The ultimate objective of any pharmaceutical manufacturer is to create a product that will keep the public safe. A properly manufactured medication has the potential to greatly improve someone’s life. Creating a quality product has a profound impact on the overall health and well-being of society.

However, if quality assurance is not up to par, the medication that should be saving someone’s life can end up threatening it or causing irreversible harm. Every team member involved in pharmaceutical quality assurance should always keep the person taking the medication in mind.

Strict quality control is required to meet this objective. This includes thorough employee training, continuous improvement of quality management systems, minimizing or eliminating deviation, documenting control, carrying out internal audits, and periodic management reviews.

Protect Against Negative Publicity

In the perfect world, the public would love your organization and be grateful that you’re manufacturing life-saving medications. However, the pharmaceutical industry has seen its share of scandals over the years that have shaken public confidence.

Your ultimate goal should be to gain public confidence, but short of that, the objective is to protect against negative publicity. Having a robust quality assurance system in place will ensure that every drug that’s shipped is safe and effective. Following good manufacturing practices (GMP) and implementing quality inspection policies will help drug manufacturers produce only the highest quality products.

If your organization focuses on the first objective, keeping the public safe, then you should naturally protect against negative publicity.

Continually Increase Production Efficiency

Quality assurance is largely about ensuring that a quality product is being shipped. The second aspect of quality assurance is that it allows your organization to regularly examine the entire manufacturing process, from raw material inspection to product development.

Companies must find ways to innovate to become more efficient at manufacturing drugs, but they shouldn’t do this at the risk of quality. Every relevant regulation must be adhered to while simultaneously efficiently producing medications.

Consider that technologies now exist that allow for many of the production processes to become automated. While embracing this change may seem like it’s focused on increasing production, it also provides manufacturers with tighter control on each stage of production.

Guarantee Compliance

Every drug manufacturer must be able to prove that they are in compliance with any relevant regulations. A robust and thoroughly documented quality assurance system will help drug manufacturers prove that they are meeting regulatory compliance requirements.

Many compliance issues that companies face are not the result of intentional wrongdoing, but instead, the result of poor workflows, human error, or lacking collaboration. Focusing on quality assurance will have the inevitable result of examining each of these factors. Workflows must be examined to prove quality, and increased good manufacturing practices training will help reduce human error.

The Importance of Quality Assurance Training

If medication fails to work as intended or is defective, it can safely be considered a threat to public health. All pharmaceutical companies must strive to ensure that all manufactured drugs are free from contaminants and will achieve their intended purpose. There are several methods and practices used throughout pharmaceutical manufacturing to guarantee the quality of the end result, and all of them begin with training.

One example is drug stability testing, which measures how various properties of a medication change when exposed to various conditions. Training your quality assurance personnel on how to carry out this type of testing will help the quality assurance team understand how the drug should be stored.

We’ve mentioned compliance before, and it bears repeating again. Staying in compliance is one of the primary objectives of any drug manufacturer. However, how can the quality assurance department be expected to stay in compliance if they do not receive proper training?

Every employee involved with drug manufacturing should receive the appropriate training that will allow them to ensure compliance. Learning about good manufacturing practices, for example, will help employees ensure that they are following the best manufacturing practices at every stage. Learn more about why quality assurance training is essential in the pharmaceutical industry

How Will Your Company Ensure Quality?

Every organization involved in pharmaceutical manufacturing absolutely must ensure that they are producing safe and effective products. Failing to do so can harm the general public, the organization’s reputation, and incur heavy fines and other penalties.

Training your employees on good manufacturing practices and other pharmaceutical quality assurance practices will help ensure overall quality. Instead of relying on their formal education alone, employees will have specific training that teaches them how to test for quality, report issues, and protect the public.

Medical Device Validation: Why It’s Important and What You Need to Know About It

accounts@cc94.com (Conscious Commerce) — Thu, 12 Aug 2021 17:57:16 GMT

Medical device validation is the process of ensuring that the medical device being manufactured will function safely and appropriately. The standards for validation and verification are set by regional regulatory bodies as well as international standards, which often overlap when it comes to product requirements.

Every manufacturer involved in producing medical devices must receive the appropriate medical device training . Without the appropriate training, quality assurance managers and employees may fail to properly validate the devices being produced. You can avoid this issue by ensuring that every employee in the manufacturing team has a medical device training certificate .

We’re going to discuss medical device validation, process, testing and verification, explore common challenges faced when validating, and hone in on the importance of this entire practice when it comes to meeting quality system design specifications in the healthcare industry.

What Is Medical Device Validation?

Medical device validation is the process of ensuring that the medical device being manufactured will consistently provide the intended benefits for its use condition. Validation is usually done by a series of tests and inspections. These same practices can also apply to process validation , which ensures that the processes used to manufacture the device meets FDA guidelines when the product itself cannot be inspected.

Verification is closely related to medical device validation but is typically the process of making sure that each element used within the medical device is up to the appropriate standards. Just like with validation, tests and inspection are typically the tools used to carry out verification and to ensure product requirements and design controls are being followed.

There are a plethora of technologies, levels of complexity, and sizes of medical devices that all must be validated. The standards for validating these devices are driven by regulatory organizations and international standards. It’s important for anyone involved in validating devices to receive the appropriate medical device validation training so that they are aware of all relevant regulations.

The Importance of Medical Device Validation in Meeting Quality System Design Specifications

The ultimate purpose of all the rules and regulations that go into medical device validation is to ensure that manufacturers are creating products that will safely be used in medical situations. Even the smallest malfunction can be life-threatening with many medical devices, making validation well worth the time and resources.

Not only will the organization be in compliance with all applicable regulations by carrying out medical device validation, but it can avoid the negative reputation that accompanies producing unsafe devices. Of course, failing to be in compliance will result in various consequences for medical device companies that will impact the business, such as heavy fines.

Challenges in Medical Device Validation

Medical device validation can be challenging due to the diverse range of devices, each with its unique functionality and intended use. Ensuring that a device performs consistently and safely in real-world scenarios requires rigorous testing and documentation. Every product quality manager should be aware of a few new hurdles that must be overcome with validation and verification during the product development process. It’s of the utmost importance that quality managers and related roles receive the appropriate medical device training .

Global Regulatory Differences

Different countries have varying regulations and standards for medical device validation. Understanding these differences is crucial for manufacturers aiming for global distribution.

Cybersecurity for Medical Devices

Medical device validation has become increasingly complex as technology has evolved. Now, many medical devices require software to function, introducing an entirely new element that must be validated. Not only must the software function as intended, but Internet-connected devices must also ensure that they have adequate cybersecurity solutions onboard.

The United States Food and Drug Administration has been aware of the need for cybersecurity for some time and has put more emphasis on security following the 2017 WannaCry ransomware attack that affected life-saving medical devices.

Medical device manufacturers that produce devices reliant on software must ensure that both the hardware and software are validated. This represents a brand new challenge that medical device manufacturers must overcome.

High-Risk Devices Must be Validated

Many medical devices can be considered high-risk as they carry the threat of severe injury or death if they malfunction. These devices are often surgical devices, but there are other types of high-risk devices, such as pacemakers, that are implanted.

High-risk devices must be thoroughly validated and verified to save lives. However, validating these devices is often challenging due to their complexity. This makes validating a high-risk device a challenge that must be resolved. On top of other quality assurance systems, validating the process of manufacturing the device will further ensure that the device will function as expected. Everyone involved with validating high-risk medical devices must take the appropriate medical device training courses.

Processes Must Be Validated If a Product Cannot Be Inspected

There are some products that cannot be reasonably validated by the usual methods. In these situations, the challenge becomes how can a manufacturer ensure that the device is operating effectively if it cannot be properly validated?

In these situations, the manufacturer must then validate the manufacturing process itself. A manufacturer must be able to provide evidence that the process they’ve employed will create a properly functioning medical device. Depending on the relevant regulations, medical device process validation is often enough to remain in compliance.

Role of Technology in Validation

Modern technologies, such as simulation software and advanced testing equipment, play a pivotal role in streamlining the validation process. They allow for more accurate predictions of device performance under various conditions.

Overcome Challenges with Diverse Well-Trained Teams

Experts in different fields must work together to design medical devices that will easily be validated and verified. Design verification is usually the first step to occur before anything has been physically created. Teams with varied disciplines and the appropriate level of training can thoroughly examine if a design will carry out its intended purpose before a prototype is even created.

Consider all the levels of expertise that must work together when it comes to device specifications andcreating a moderately complex medical device. You will need someone with expertise in mechanical engineering, chemistry, software engineering, engineering for integrated chips, prototyping methods, and providing a great user experience. Starting out with the right team will mean that validation and verification in the future are as seamless as possible.

Training and Skill Development

Ensuring that the personnel involved in the validation process are adequately trained is crucial. This ensures that the validation process is conducted accurately and in compliance with regulatory standards.

An expert in software engineering, for example, may not be familiar with the standards in place for developing software for medical devices. The appropriate training is absolutely necessary.

CfPIE offers several courses covering Validation and Design Control for Medical Devices including:

Also, you can prepare your team today by enrolling them in CfPIE’s Certified Medical Device Compliance Professional (CMDCP) Program . Not sure what you need? Explore our wide variety of medical device courses today.

The Difference Between Certified and Compliant is cGMP

Tue, 20 Jul 2021 14:25:05 GMT

Manufacturers in the pharmaceutical industry are subject to intense government regulation due to the serious nature of medications. Every pill or injection must be of a high quality standard and effectively treat the patient.

The FDA is responsible for regulating the manufacturing of medications called current Good Manufacturing Practices (cGMP). What is cGMP? It’s a standard created to guarantee that every pharmaceutical company is producing safe medication. All pharmaceutical manufacturers are required to adhere to this safety standard.

However, the FDA does not require that pharmaceutical companies become cGMP certified. This is an optional certification, but one that’s well worth it. Today, we’re going to examine the difference between cGMP compliance and certification, along with discussing why a business should become certified.

The Vital Difference Between cGMP Compliant and cGMP Certified

The FDA regularly audits pharmaceutical manufacturers to ensure that they are cGMP compliant. However, the FDA does not certify manufacturers, they only determine if the business is in compliance or not.

A manufacturer must demonstrate that they are following the thorough standards set by cGMP in order to be certified. A third-party company, such as CFPIE, will conduct an audit of the manufacturing facility, along with inspecting written policies and examining procedures. If passed, the manufacturer will receive a certification that will last for three years. They will still be audited by the FDA, but having the certification will make the audit process streamlined and pain-free.

All drug manufacturers should conduct regular internal audits to ensure that they will always be found in cGMP compliance, even if they are already certified.

Is cGMP Required for Manufacturers?

Adhering to cGMP is required for pharmaceutical manufacturers. However, manufacturers in other industries have started adopting these practices since they provide tangible benefits and grant insight into the manufacturing process.

Manufacturers making pharmaceuticals will be subject to regular audits by the FDA. If a company is not complying with cGMP regulations, then any medication made by that company is considered “adulterated” under the law, according to the FDA . This label means that the drug was not manufactured in a facility that complies with cGMP, but does not necessarily mean the drug is “bad.”

Manufacturers who fail to comply with cGMP regulations may have the FDA require a recall of the medications being manufactured. The FDA can’t force a company to recall a drug, but they can seize the drug and warn the public about it.

In short, if a business is manufacturing medication and wishes to grow and thrive, it must become cGMP compliant.

Who Should Get GMPCP Certified?

Generally speaking, it is the facility itself that receives the GMP certification. Operating a cGMP facility is typically done by someone who is GMPCP certified. This simply means that they have taken additional training in Good Manufacturing Practices and have become a Certified Professional (GMPCP) .

Any individual who has a job, or wants a job, in pharmaceutical manufacturing management should consider a GMPCP certification a job requirement. This training will impart all of the information required to operate a cGMP facility, in full or in part.

The GMPCP certification program covers a range of topics related to GMP. Students will thoroughly examine everything that goes into creating a cGMP certified facility, from understanding how to document procedures to learning about training employees.

Business Benefits of Becoming cGMP Certified

We now know that every pharmaceutical manufacturer must become cGMP compliant or they risk their products being seized (if determined unsafe). However, many manufacturers choose to become cGMP certified, even though it’s not required.

Why go through the effort of becoming a GMP certified facility? There are plenty of reasons why many businesses choose to undergo the costly process of becoming certified, such as:

Create a competitive advantage: Showcase your business is going above and beyond the given quality standards by receiving a certification. Consumers and partners will both respect that your organization has exceeded the minimum expectations set for them. If your competition is already certified, you need to catch up. If they aren’t, then you’re poised to gain an advantage over them.
Ongoing personnel development: An aspect of cGMP audits is examining training material to make sure that it is up-to-date. Receiving a certification means your training material meets or exceeds the set standard, which means your employees are prepared to keep the facility GMP certified.
Added credibility: Receiving a GMP certification proves your organization’s credibility among consumers. They will see that your organization has taken the steps to ensure their safety and may request your medications from their health care providers. While end-consumers may not be aware of this in many situations, doctors and health care providers will likely be aware of your certification and have greater faith in your product.
Business insights: By preparing for the GMP certification, your organization will be required to thoroughly document all procedures related to the manufacturing of medication. Having this process thoroughly documented may grant insight into how the entire operation could be improved.

Receiving a cGMP certification is the mark of a business that cares about the safety of the general public. It’s not just about remaining in compliance for the sake of it, but for the safety of the people who depend on the medications your business manufactures.

Become cGMP Certified Today

Your business can position itself for success by receiving a cGMP certification. Furthermore, managers and employees can benefit from receiving GMPCP certification. Ultimately, the goal is to guarantee that your business is manufacturing safe medications. Keep this goal in mind, and all the effort of receiving the certification will be worth it.

The courses offered by CFPIE are designed to prepare manufacturers to receive cGMP certification.

Our qualified instructors and hand-crafted course content are sure to provide students with everything they need to know in order to prepare their facility to receive cGMP certification.

5 Key Components of Good Manufacturing Practices

Tue, 06 Jul 2021 14:04:42 GMT

Pharmaceutical companies are tasked with safely manufacturing medication for billions of people around the world who depend on them to survive. This important task cannot be done haphazardly. Measures must be taken to ensure product safety and high quality products are delivered to consumers.

1. Primary Materials and Products
2. Premises

3. People

4. Procedures

5. Processes

Best Practices to Guarantee cGMP Compliance
How to Get cGMP Certified

Achieve cGMP Compliance With CfPIE

The FDA has documented exactly how pharmaceuticals must ensure the quality of the medications being produced. Known as Current Good Manufacturing Practices (cGMP) , this series of regulations must be adhered to by all pharmaceutical companies within the United States. Companies must follow compliance regulatory requirements and may also receive an optional GMP certification to showcase their commitment to quality.

There is a lot to say about cGMP, but most of it can be broken down into five key components that some know as the “five p’s.” Each of these components will help companies produce medications that are safe and effective, along with remaining cGMP compliant . Of course, each component of cGMP must be strictly adhered to in order to receive a cGMP certification.

1. Primary Materials and Products

Primary materials are the raw ingredients used to create a product, which is the end result that is sold to consumers. If the primary materials are not of the utmost quality, flaws can occur in the end result.
As such, one of the core GMP standards is the requirement of a master formula for all products that is perfectly followed, with no deviations, throughout the entire manufacturing process. A quality assurance system must be in place that is composed of regular testing and comparisons.

Companies that choose to receive their GMP certification online will learn everything that’s required by the FDA to ensure they meet product quality standards, beginning with using excellent primary materials.

2. Premises

Laboratories are the backbone of pharmaceutical manufacturing and must be properly maintained. Premises and equipment must be properly maintained to ensure safe and effective conditions for manufacturing medication.

Equipment can experience many variations. As an example, take a fume hood, a common piece of equipment in a laboratory. Some manufacturers keep using fume hoods longer than they should or fail to properly maintain them. In an effort to cut costs, the equipment is overused and is no longer operating effectively. Investing in a replacement fume hood would mean less risk of failure. This same logic can be applied to any laboratory equipment.

3. People

People are the backbone of any business, and that’s no different in pharmaceutical manufacturing. Having trained people operating each facility is required in order to remain cGMP compliant. It will require time and money to train employees on how to abide by GMP quality standards.

Not only is this mandatory, but it will help ensure that your people continually create quality products. Training materials must continually be evaluated to ensure that they are up to date, as well.

4. Procedures

A manufacturer’s procedures will be scrutinized when audited. All procedures must be regularly revisited to ensure that they are making use of the latest technology and science involved in pharmaceutical manufacturing. If a procedure is using outdated technology, the manufacturer may struggle to maintain cGMP compliance.

5. Processes

Processes involved in GMP refer to the documentation that is used to prove that procedures are being followed. Auditors will continually inspect laboratories to guarantee that all GMP procedures are being followed and documented. Maintaining these documents at all times is vital to passing an audit.

It doesn’t matter if a procedure is straightforward or intricate, it must be thoroughly documented down to every detail. This is required, but it’s also a great way to create a roadmap of the entire manufacturing process that can be used to aid in making other decisions.

Best Practices to Guarantee cGMP Compliance

There are plenty of “dos” and “don'ts” to consider when pursuing cGMP compliance or certification. Abiding by these practices will help drug manufacturers better prepare for audits and overall create safer products for consumers. Some key best practices are:

All written procedures should be written professionally in a clear, simple tone that is easily understood by all employees. Vague guidelines or directions might be difficult for employees to follow, and confusion is the last thing a pharmaceutical manufacturer needs.
All equipment should be maintained as per the manufacturer’s instructions
Reduce human error by considering the recommend design and layout of pharmaceutical manufacturers
Audit your own compliance every month, at a minimum
Conduct a detailed competence analysis before hiring any new employees to make sure that only the best and brightest are joining the company

How to Get cGMP Certified

Acquiring a cGMP certification is not mandatory, but is an excellent step to ensure that quality products are being produced. The FDA audits companies to ensure they are not in violation, but they do not grant certifications.

A third-party company will provide the certification. This is not an easy or cheap process. An authorized representative of the company must complete an application process with the certification company. Once reviewed, the manufacturing facility will be audited.

After the facility has demonstrated that they are fully in compliance with current good manufacturing practices, a certification will be granted. Please visit our Frequently Asked Questions section of our website for more information

Achieve cGMP Compliance With CfPIE

Every manufacturer in the pharmaceutical industry in the United States is required to maintain cGMP compliance , while only some decide to become certified. Receiving a certification helps guarantee that you will be found in compliance when audited, along with regularly ensuring that facilities are creating a quality product for consumers.

Are you ready to begin the cGMP certification process? CfPIE offers courses that will help prepare quality assurance and safety managers to make sure that their facilities will pass the certification process.

For manufacturers who believe they are already prepared, we currently offer cGMP certification as well. Contact us to begin the certification process today.

How to Submit Your Medical Device for Testing and FDA Approval

Tue, 29 Jun 2021 16:09:40 GMT

As you're no doubt aware, medical products are subject to incredibly strict guidelines, mandated and overseen by the Food and Drug Administration(FDA).

If you intend to manufacture, market, and sell any form of medical technology, you're going to need to understand the rules by which they're regulated.

And although they may seem overwhelming, the rules aren't quite as complicated as they might at first appear.

Read on to learn what you need to know about submitting your medical product for testing and FDA approval.

How The FDA Defines Medical Devices

Your first step is determining whether or not your product even falls into the proper category for evaluation by the FDA. The agency exclusively deals with medical devices. These are defined by the agency as "any instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar/related article, including a component part or accessory which is either:

Recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them.
Intended for use in the diagnosis of diseases or other conditions, or else in the cure, mitigation, prevention, or treatment of these conditions in humans or animals.
Intended to influence the structure of function of a human or animal's body.

In addition to the above, for a product to be considered a medical device, it must not achieve its primary function via chemical means, nor can it be dependent upon metabolization. It's also important to note that software functions are not included as part of the above definition.

Understanding the FDA's Medical Product Classifications

If your product fits the FDA's definition of a medical device, your next step is to search the FDA Product Classification Database to see if it fits under any of the agency's existing classifications. You may either search by keyword, device class, product code, regulation number, device listing, or other characteristics including Premarket Approval, Premarket Notification, or De Novo.

Once you have determined your device's classification, it may be submitted for FDA approval, provided your establishment is already registered with the FDA . The approval process will vary depending on the nature of your product.

Class III medical devices, which are considered high-risk, must be submitted for Premarket Approval , alongside clinical data to support any claims made about the device's function.
If your device does not require a PMA, you'll need to submit a Premarket Notification (510(k)) to the FDA , provided your device is not exempt. 510(k) exemptions include:
The device is unfinished and being commercially distributed or sold to another firm.
The device is not being commercially distributed.
You are distributing another firm's device, which was manufactured domestically.
If you are a repackager/relabeler.
The device was made outside the US, and received clearance via the foreign manufacturer.
Your device is exempt per regulation 21 CFR 862-892 .

Finally, if your product does not fit the specific definition of a medical device, you'll need to take one of the following actions:

If your product is software-based, follow the process outlined on the FDA's Mobile Medical Applications page.
If your product is intended exclusively for general wellness, it likely classifies as low risk, and is subject to different policies .
If your product includes drugs or a biological component, it may be a combination product .
Depending on the specific characteristics of your product, you may need to submit it for approval via the CBER , CDER , CVM , or CTP .

Ensure Your Medical Device Submissions Are Compliant And Up to Date With CfPIE

Once you've finished the initial application process, it's relatively straightforward from there.

However, if you're looking for a more in-depth explanation, you can register for our upcoming course: Overview of FDA Regulatory Compliance for Medical Devices .

Have additional questions? Get in touch with the CfPIE team today.

What the Baltimore Vaccine Incident Can Teach Us About GMP

Fri, 25 Jun 2021 13:34:34 GMT

After over a year of quarantine restrictions, many of us are fed up with COVID-19 and can’t wait to receive the vaccine. It can be frustrating waiting for the rollout to complete and even more so when some of the vaccine doses end up wasted.

That’s exactly what happened in Baltimore recently. The U.S. Food and Drug Administration recently reported an accident at a plant that made 75 million doses of the Johnson & Johnson coronavirus vaccine inoperable . What exactly happened, and what lessons can we learn as a medical industry to prevent future similar incidents?

It’s worth discussing what exactly led to the Baltimore case and the costs of failing to maintain up-to-date good manufacturing practice (GMP).

What Happened?

The factory in Baltimore contaminated the ingredients for the vaccine. Specifically, it failed to seal off the preparation area properly and accidentally moved production waste through it. The F.D.A. advised the plant to throw out 60 million doses as a result.

In addition, another 15 million doses could have been contaminated at another southeastern Baltimore plant. This second factory was operated by Emergent BioSolutions, a subcontractor for Johnson & Johnson that operated as a government contractor as well for a long time.

10 million doses were determined to be safe by regulators for both internal use and export, mostly because of the continuing need for COVID-19 relief and the safer conditions in which they were produced. Still, the incident represents an unfortunate loss, especially as millions more are still waiting for their vaccinations.

Possible Cross-Contamination

Emergent also manages the creation of vaccines for another vaccine producer, AstraZeneca. The F.D.A. notes that the company failed to separate production lines for AstraZeneca and Johnson & Johnson, resulting in more potential cross-contamination that could render even more doses unusable.

To be specific, while the factory did prepare ingredients separately, workers began using the same warehouse for both doses once production began. Indeed, back in March, the factory discovered traces of key ingredients from the AstraZeneca vaccine in the Johnson & Johnson version and had to throw millions of doses out.

High Excess Waste

The accelerated nature of vaccine production also generated plenty of medical waste, and Emergent allowed its workers through official procedure to move it through the warehouse in wheeled containers, leading to the 60 million doses lost according to the F.D.A.

Concerns Over Previous Infractions

Many regulators were aware of problems at Emergent even before the incident. In September last year, for example, inspectors noticed crowded manufacturing zones with too many equipment and supplies in the same place.

There were also inadequate quality assurance practices and a general disregard for GMP, as the staff at the factory changed significantly over the course of only a few months.

What Was Done In Response?

F.D.A. regulators have since closed down the factory for a few months as investigations are underway into:

The exact cause of the contamination
When the facility may reopen safely
Measures for the other 170 million AstraZeneca and Johnson & Johnson vaccines also produced by Emergent

In the meantime, AstraZeneca production has ceased at the Emergent plants, and Johnson & Johnson vaccines can only continue under the direct supervision of Johnson & Johnson.

Regulators believed that the overloading of the facility’s capacity and overall lax procedures at the factory were partly to account for the high number of disqualified doses, as testing may not have picked up on every case of contamination.

The memo from the F.D.A. also states that even a low contamination level might have an impact on the safety or effectiveness of the vaccine, as no scientific experiments or evidence conclude the opposite.

It’s also worth noting that Emergent was a recipient of government aid totaling about $200 million as of this April, though payments have recently stopped.

What Can We Learn?

Just as important is the response that Emergent and other medical industry entities should make regarding good manufacturing practices. On top of costly resource losses and action from regulators like the F.D.A., incidents like the one in Baltimore damage your reputation among your customers, whose trust matters immensely in such a high-risk industry like medicine.

GMP and CGMP

The answer is good manufacturing practices (GMP), the actions you take to ensure that your output as a facility is consistent and controlled to the overall standards of the business. GMP can apply to almost any market, from food to cosmetics, and it matters especially for the medical field.

Companies focusing on GMP implement proper monitoring and control tools in their facilities. Having a proper GMP system in place prevents incidents like cross-contamination, mislabeling, and other mistakes that negatively impact the usefulness or safety of your pharmaceuticals. They also protect both you, the customer, and the environment from harm and help you adhere to government regulations.

The many facets of GMP alignment include:

Sanitation. Facilities need strong cleaning and hygiene policies in place to prevent contamination.
Maintenance. Any equipment in the facility must be maintained and function as intended. Regular cleaning and storage, as well as checkups to prevent malfunctioning, is a must.
Raw materials. Keeping track of stock and labeling where materials come from is the best way to ensure quality.
Staff training. Everyone working in a pharmaceutical facility must be properly trained in the GMP principles and policies of the company. Up-to-date knowledge is expected.
Audits. All facilities must be inspected and audited occasionally. These checks will make sure that your business is continuing to align with the guidelines.
General quality control. From food to medicine, the F.D.A. requires that products coming out of a facility to be properly processed and not expired.

There’s also another term officially designated by the F.D.A. called “current Good Manufacturing Practices ” or “CGMP.” Because medical practices and knowledge evolve, sometimes faster than the law can keep up, CGMP refers to how GMP itself changes with time.

Process Validation

It doesn’t matter how much confidence you have in a new product, vaccine, or medicine. A single testing phase isn’t enough to catch all the potential problems that could arise. That’s the philosophy behind process validation, another essential step in medical compliance.

Process validation involves the collection and use of data to check every step of the pharmaceutical process, from product design to commercial production all the way to discontinuation. The goal is to always have scientific evidence that the process is capable of delivering safe and effective products.

We often refer to process validation in the form of three phases:

Design, or defining the commercial manufacturing process.
Qualification, to ensure that the process is reproducible and able to meet the demands of commercial manufacturing.
Verification, ongoing assurance that proper controls are maintained during manufacturing.

These steps would have helped prevent incidents like vaccine contamination, and the Baltimore plant occurrence is a testament to the importance of good manufacturing practices in the medical field.

Ensure Your Process Validation Is FDA-Compliant

Process validation plays an important role in ensuring all drugs, medical devices, and other related products are up to the strict standards established by the FDA.

It also provides your teams with a consistent set of rules for validating the processes you use should something go wrong.

Are you looking to keep your knowledge up to date? Sign up for our process validation course today.

Understanding Good Manufacturing Practices (GMP) in Pharma: A Brief Overview

Tue, 25 May 2021 19:25:24 GMT

You have probably never seen two different sized Tylenol in the same bottle. Good Manufacturing Practices (GMP) are why.

Good Manufacturing Practices are the processes designed to ensure products are consistently made according to the high standard set by the World Health Organization (WHO). In the U.S., GMPs are also regulated by the Food and Drug Administration (FDA) and apply not only to pharmaceuticals but to food and cosmetics as well.

The main goal of GMP is to guarantee the safety of the individual ingesting or using the manufactured product, but their effectiveness goes far beyond safety. In pharmaceuticals, these processes allow companies to track details of each product down to the exact pill.

In 2002, IHS Markit (a leader in chemical analysis) estimated that Acetaminophen (APAP) accounts for 75,000-80,000 metric tons of pills per year. This estimation has risen in recent years, and with that many bottles of medications being produced daily, you can imagine the critical nature of the processes needed to keep things running smoothly and safely.

Read on to learn more about Good Manufacturing Practices, examples of what they look like in practice, and other useful information.

Why Are GMPs Important? A Look at GMPs in the Pharmaceutical Industry

Consumers place a lot of trust in the companies they decide to purchase medications from. After all, brands like Tylenol, Advil, Excedrin, and more are all household names in the U.S. A lot of work goes on behind the scenes to guarantee the efficacy of these kinds of goods.

According to the FDA , “A consumer usually cannot detect (through smell, touch, or sight) that a drug product is safe or if it will work. While CGMPs require testing, testing alone is not adequate to ensure quality.”

While it seems easy to look at most goods and identify whether it's safe to use, we don’t have the same luxury when it comes to pills. We assume they will always have the same, consistent results. The reason we can do this so confidently is due to GMPs.

What Are Examples of Best Practices for GMP?

Depending on the manufactured products, the practices and protocols involved in their development may vary slightly. GMP best practices are typically broken down into the following 5 “Ps”:

Products and Primary Materials: These should include a list of any products and primary materials used to produce a finished product. All products should utilize a master formula to ensure consistency, as well as receive frequent testing.
Premises and Equipment: Labs must ensure that all premises and equipment are capable of producing a consistent product and properly maintained to reduce variance and failure.
People: All personnel must receive proper training. It’s highly recommended they receive ongoing GMP quality control training to ensure they understand current procedures and regulations.
Procedures: Any procedures involved in drug manufacturing. Procedures should be up to date, documented, and designed to adhere to current GMP requirements.
Processes: The documentation used to confirm that a specific procedure was followed. Thorough documentation is an essential part of compliance as it improves organizational-wide accountability and visibility into the other areas of drug manufacturing.

GMPs may vary from company to company, but the end goal is always to improve cleanliness, accountability, safety, and compliance.

What Ensures GMPs Are Followed In Practice?

GMPs identify every step along the manufacturing process and are accompanied by proof to ensure all parties involved are following defined procedures.

Checks and Balances

Although drug manufacturing operations are comprehensive, there is no way to anticipate all of the risks associated with any given product.

A recall doesn’t necessarily mean that the checks and balances failed, but rather there were unforeseen factors that played into some aspect of the process. These could include creation, distribution, consumption, or another stage.

GMPs are designed to ensure a plan of action exists should any product need to be recalled. Any complaints and events relating to the recall are researched, and the FDA also has an accessible list of all currently recalled items for transparency and accountability on the side of the respective companies.

GMP Violation Policies

Recalls typically occur when a company is knowingly or unknowingly failing to comply with GMPs outlined by the FDA.

A good example of this is when a product has too little of an active ingredient to be effective, requiring the product to be pulled from shelves due to false advertising of its capabilities.

Recalls happen to protect the public when a company becomes aware that their drug is ineffective or potentially harmful to its users. The FDA also has the ability to seize a drug from a company if they deem it unfit for the public and the company refuses to recall it.

Costly Losses

Pharmaceuticals spend a significant amount of time and money to research, develop, test, manufacture, market, and sell drugs.

Losing months of resources due to inconsistent processes is an avoidable issue. Reputable companies are happy to comply with GMPs because it saves them the headache of self-regulating their process and ensures the highest level of development.

Learn GMP Best Practices With CfPIE’s Pharmaceutical Training Programs

GMPs provide a critical function within the pharmaceutical industry. Ensuring the safety of employees, companies, and consumers should be the top priority for any company.

Are you looking to learn more about Good Manufacturing Practices? CfPIE offers a variety of GMP-focused pharmaceutical training courses, including:

Looking to get your facility GMP-certified? Click to learn more about our GMP certification program .

Have questions about GMP best practices or our pharmaceutical training courses? Get in touch with our team today to learn more.

Global Perspective: The Importance of Understanding Regional Pharmaceutical Practices

Tue, 18 May 2021 14:58:34 GMT

The pharmaceutical industry is constantly evolving to combat persisting and newly occurring diseases worldwide, and the process to take life-saving drugs to market is complex.

Good business practices demand a working knowledge of regional processes, the efficacy of drug development requires, and a deep understanding of all influences on the industry.

But with new drugs hitting the market, the rise of new diseases, and changing regulations, it’s important that you stay up to date with the latest information and best practices.

In this article, we’ll touch on the basics you need to know when it comes to regional pharmaceutical practices.

Same Diseases, Different Approaches

It seems confusing and counterintuitive to address the same disease differently from country to country. However, understanding the nuance and variation in clinic approaches from companies at the country level is imperative.

Pharmaceutical training highlights how important it is to recognize one’s knowledge of available drugs and treatments only scratches the very surface of this industry.

Regionally, there are specific health threats. However, more often than not, we see illnesses previously believed to be refined to certain areas transcend and become widespread.

Chagas is a great example of this. This disease was originally found in South America, Central America, and Mexico, but is now reaching as far as Japan, Australia, and the United States.

Chagas is just one example of a disease that continues to spread. And when you consider the frequency of global travel and rising emigration rates from the most densely affected areas, it’s clear why regional information is critical to the process.

Dynamics of Healthcare in Top Markets

There is no way to fully separate socio-economic elements intertwined with the pharmaceutical industry regardless of location, but knowing what subtle differences processes have cannot be undervalued.

Consider government relationships with medical companies in the EU versus the United States. Having a regulated universal health care system means that the government has a considerable say in what medical efforts receive the majority of funding for research and drug development (R&D).

Europe’s equivalent of the Food and Drug Administration (FDA) is the European Medicines Agency (EMC). The EMC does not have an autonomous say in approving the last stages of any given drug before it reaches commercialization, whereas the FDA does.

Possessing an understanding of healthcare systems in major markets is arguably the best way to provide insight into emerging healthcare trends.

Improve Industry Knowledge With Online Pharmaceutical Training

Possessing knowledge of regional norms and regulations is imperative for success in the pharmaceutical industry. After all, the knowledge you know today may not be relevant in the future.

Online pharmaceutical training courses are a great way for companies to ensure staff is up to date on the latest trends, regional knowledge, and best practices. These courses are taught by experienced industry professionals and provide specialized knowledge and training on a wide variety of topics.

Keep Your Knowledge Up to Date With CfPIE

Are you looking for additional training for your teams? Whether you want to learn the latest FDA regulations, specialized regional information, or anything related to the pharmaceutical, biotech, medical device, and skin & cosmetics industries, CfPIE can help.

Recommended Courses

CfPIE is the leader in life-science training courses, with over one hundred courses available worldwide. We offer our courses both in-person and virtually across North America and Europe.

Gain the industry knowledge you need, bolster your preexisting knowledge, or learn new subject material with our CfPIE’s industry-specific programs. Sign up today to get started.

GMP Certification: Why Get GMP Certified With CfPIE?

Tue, 04 May 2021 14:15:49 GMT

Process standardization is one of the most important factors to ensure consistency in manufacturing. And when it comes to manufacturing drugs, medical devices, skin products, and cosmetics, consistency is everything.

Manufacturers in the pharmaceutical industry must familiarize themselves with the international Good Manufacturing Practices (GMP), the official standards set by the FDA to specify drug quality based on the compliance level of the producer.

Most drug consumers have no way of verifying the effectiveness of their medications, so these practices function essentially as consumer protection. Becoming GMP-certified is one of the best steps you can take as a pharmaceutical manufacturer for several reasons.

Read on to learn why your facility should obtain a GMP certification from CfPIE.

The Key Benefits of a GMP Certification

Any facility looking to follow best practices should seek out a GMP certification. It’s one of the easiest ways to demonstrate your commitment to consistency, current regulations, and to build confidence with your customers.

Here are a few of the main reasons why a GMP certification is a worthwhile investment:

Promote proper quality control: Undergoing the GMP process means that your manufacturing is consistent and aligned with the best industry practices and that your advertising is accurate to the product you are selling.

Enable process validation: Companies with the certification have their plants constantly monitored and controlled at all times and have positive administrative protocols as well, such as worker sanitation, personnel qualification, and record keeping.

Prevent cleanliness issues: Contamination with allergens or other harmful materials is a common issue for the pharmaceutical industry. GMP-compliant organizations always have hygienic work areas with controls in place to prevent cross-contamination.

Ensure legal compliance: This international standard shows any regulatory agency, from the US’s FDA to the EU’s EMA, that you take pharmaceuticals seriously and can proactively ensure compliance with high standards of manufacturing.

Promote a positive reputation: Drug companies will always look for GMP certification when choosing a manufacturer to produce their products. Customers likewise will see the FDA approval as a sign that the product is held to high standards and worthy of consideration.

Build an incident response system: GMP requires companies to have established protocols in case mistakes occur. Records must be made of each step in the manufacturing, and all infractions must be documented. A recall system is also mandatory so that defective batches can be withdrawn from sale and appropriate measures can take place to prevent future incidents.

Stay up-to-date: Medical technology is always advancing, so it’s also worth taking into account current Good Manufacturing Practices (cGMP). This specification shows that not only are your processes aligned with GMP guidelines but also that they use the most up-to-date methods available.

How to Get GMP Certified?

Interested in learning more about our Good Manufacturing Practices certification ? CfPIE offers its own facility certification program to streamline the GMP process.

You’ve seen the benefits that such a certification brings to your organization, so get in touch with us today. Our multi-step process begins with a Discovery Session over the phone or web conference.

CAPA Analysis: It’s Importance and Role Within Root Cause Analysis

Fri, 23 Apr 2021 22:39:46 GMT

When dealing with pharmaceutical products or medical devices, problems in the production and manufacturing process can arise. These might be major failures, complaints from customers or other sources, or issues found during a routine inspection.

If one of these failures does show up, it is necessary to conduct a root cause analysis to determine what happened, why it happened, and if it is a one-time occurrence or a problem with your current processes.

One of the most important tools an organization has is CAPA: corrective actions and preventive actions. A CAPA system is in place to help identify, document, and address any deficiencies and nonconformities found in your organization.

What Is CAPA?

CAPA can be broken down into two separate systems:

Corrective Action: When existing nonconformity is found, action is taken to eliminate the cause so that recurrence is not likely.
Preventive Action: To prevent occurrences of nonconformity, action is taken to identify and eliminate probable causes.

These systems can be in place in almost any industry but for industries like food processing, medical device manufacturing, and pharmaceutical development, this is a legal requirement from the FDA.

Why Implement CAPA?

There are two main reasons why an organization should implement a CAPA analysis system: because it is a good way to identify and rectify failures in your processes and because the FDA requires it under regulations like FDA 21 CFR 820 .

FDA’s Code of Federal Regulations Title 820 is the regulation of quality systems that requires corrective and preventive actions to be documented in medical device manufacturing. The FDA believes CAPA helps accomplish some of the following:

Gathers and analyses information to help locate existing and possibly potential nonconformities
Applies necessary corrective and/or preventive actions
Ensures that these CAPA actions have been successful
Communicates CAPA activities to employees and management, while documenting activities for review

How to Implement CAPA?

CAPA should be implemented as part of a larger quality management system, whether connected to the ISO 9000 standard or other systems like the Good Manufacturing Practice (GMP).

Those in positions of manufacturing and packaging, quality assurance or quality control, and those on investigation teams dealing with Root Cause Analysis will all play a role in implementing CAPA within their processes.

CfPIE: Training for Root Cause Analysis and CAPA Analysis Systems

To understand how to initiate, conduct, and/or manage Root Cause and CAPA investigations in a pharmaceutical, clinical manufacturing, biologics, or medical device environment, CfPIE offers the perfect course: Pharmaceutical Root Cause Analysis of Failures & Deviations - Developing an Effective CAPA Strategy.

This Root Cause Analysis training course is designed for personnel who are responsible for the failure and deviation investigation process in a GMP environment, specifically Root Cause Analysis for CAPA.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

A medical combination product is any therapeutic or diagnostic product that combines pharmaceutical drugs, medical devices, and/or biological products. As technological breakthroughs advance, the FDA expects to review larger and larger numbers of these products.

As separate entities, these products would be handled by a different FDA center, depending on type: the Center for Biologics Evaluation and Research (CBER), the Center for Drug Evaluation and Research (CDER), and the Center for Devices and Radiological Health (CDRH).

This creates regulatory, policy, and review challenges when a combination of devices or drugs are integrated into one product. Each component has a different regulatory pathway, and this can impact the processes needed for development, clinical trials, manufacturing, and advertising.

Regulation of Medical Combination Products

There are various regulatory and statutory provisions pertaining the medical combination products. FDA’s 21 CFR Part 3 and Part 4 contain most of the current regulatory rules in place.

Part 3’s regulations consist of how to classify medical products as drugs, devices, biological products, or combination products. This is where you will find the definition of a medical combination product or device and the requirements for the Request for Designation (RFD).

In Part 4, the regulations listed cover the current good manufacturing practices for medical combination products. It also lists the requirements for post-market safety reporting for these devices.

When planning the development, manufacturing, and desired pathway to market for your product, each decision can impact what the specific regulation of the product will look like. This complexity is why staying in contact with the Office of Combination Products (OCP) throughout the whole process is necessary.

The FDA’s and OCP’s Online Sources for Guidance and Approval

Because of the difficulties surrounding medical combination products and their respective FDA centers, the FDA has numerous online sources for every step of the process. These sources cover jurisdictional, pre-market, and post-market situations.

Some of the circumstances explained in the online sources are:

How to write and prepare a pre-request for designation and request for designation (Pre-RFD and RFD).
Requesting FDA’s feedback on medical combination products.
The early development considerations for combination products.
The current good manufacturing practice requirements.
The post-market safety reporting for combination products.
How to submit a request for post-approval modifications to a combination product previously approved under a BLA, NDA, or PMA.

CfPIE: Helping You Understand Every Step of Developing Medical Combination Products

For the professionals dealing with medical devices and products and who need a firm understanding of the complexities of regulation and approval of combination products, CfPIE offers the course Introduction to Medical Combination Products .

This course will cover the current FDA regulations in regards to developing and marketing combination products. Any of those dealing with product development, manufacturing, quality assurance, and/or regulatory affairs around medical combination products will benefit from this course.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

Characteristics of High-Quality Technical Writing?

Tue, 13 Apr 2021 16:51:12 GMT

Writing, technical or otherwise, plays a large role in each of our lives. From daily emails and official correspondence to reports and other industrial documents, good technical writing is consistently important.

When you are writing technical documents, it is important that your document, article, white paper or anything else that you are writing follows good technical writing characteristics: Accuracy, clarity, targeted for an intended audience, simple and concise, in depth, and communicative and logical.

Keeping each of these points in mind while writing will help you write documents and communications that will always accomplish your goal.

1. Accuracy and Clarity

No matter what you are writing, the main purpose is to be accurate so the reader can clearly understand the meaning. How to be understood comes from writing clearly and correctly. There are a few ways to guarantee clarity.

First, grammar is obviously a necessary requirement. Grammatical errors, incomplete sentences, and confusing word choice or sentence structure will hinder you from being understood. If what you are writing isn’t required reading, this will also lead to the reader giving up on what you wrote.

Your knowledge of the topic is also very important. Understanding what you want to say, understanding the information you are providing makes it much easier for your writing to be understood by the reader.

2. Targeted for an intended audience

When writing technical documents ensure the writing style meets the needs of the specific audience you are targeting. That includes the usage of the right vocabulary, terms and definitions your audience recognizes.

3. Simplicity to Avoid Confusion

An often overlooked secret to great writing is to write simply. Short sentences and simple words might feel elementary when writing but will go further in guaranteeing the writing is understood.

Simple writing also helps you avoid tricky grammatical situations and lessens the chance of grammatical errors. Run-on sentences and incorrect punctuation will also be avoided by writing simply.

Some of the greatest writers understood the power of simplicity. Mark Twain’s opinion of flowery language: “As to the adjective, when in doubt, strike it out.” This is even true outside of novels for professional writing. Thomas Jefferson explains, “The most valuable of all talents is that of never using two words when one will do.”

4. In-Depth

Technical writing should be comprehensive covering the entire scope or process. If you are writing about instructions on how to use a medical device, your audience expects you to explain in a step-by-step style that is easy to follow and logical. The goal should be to help the end user achieve the intended purpose.

5. Communication Is Key

With all of this said, it is important to not forget the purpose of any writing: communication. Whether you are informing about a topic, requesting an action, or asking a question, you are communicating.

This means you will need to always keep your reader in mind while writing. What information do they currently have? What do you want them to know after reading? Are you persuading or just informing?

Writing for a particular audience will drive what you write and how you write. With technical writing, knowing your audience is even more important because the topic might require understanding a certain industry or profession.

CfPIE: Your Source for Technical Writing Training

Since clear and concise communication is so important when it comes to technical writing, our training course Technical Writing for Pharma, Biotech and Med Devices is beneficial for all. The course will help you learn how to organize and deliver information for the intended audience, as well as how to write clear and readable documents, and how to revise and refine your own and others' writing.

Whether you are considering a career in medical writing or you are looking to take your writing skills to a whole new level, you will find CfPIE's course comprehensive and learn the fundamentals of effective writing in the regulated environment

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

Regulation of Pharmaceutical Marketing: What You Need to Know

Tue, 06 Apr 2021 16:56:52 GMT

After designing, testing, and gaining approval for your drug or medical device, it is time to put the product on the market. Part of this process is the advertising and marketing of your drug or medical device.

While those who work in marketing might tend to stretch the truth, this is something necessary to avoid in the pharmaceutical industry. There are rules and regulations put forth by the FDA and the FTC (Federal Trade Commission), amongst other federal, local, and industry organizations.

If any of your promotional materials violate the law, this could lead to huge fines and criminal liability. Your organization would have to handle a disruption in your operations while you deal with inquiries from federal or local officials.

Understanding the regulations and policies in place that are governing the marketing of drugs and medical devices will help you avoid the above situations, saving you time and money. So what laws are in place governing advertising? And what does enforcement of these laws look like?

FDA Laws Governing Advertising

The regulations that govern the promotion and advertising of prescription drugs can be found in Title 21 of the Code of Federal Regulations Part 202 .

Some of the major requirements found in these regulations are below:

The uses promoted match what is on the label and consistent with what the FDA approved.
Any information included cannot be misleading or false.
If benefit claims or efficacy is included, it must be balanced with information about the associated risks.

The regulations for medical devices, covered by 21 U.S. Code § 352 , are very similar to prescription drugs. Your advertisement cannot be false or misleading and should contain only information found on the product labeling that has been previously approved.

Role of the FTC

The Federal Trade Commission (FTC) in the US has the responsibility of protecting consumers and competition. They have the authority to go after businesses through law enforcement, advocacy, or education.

The main overlap with the FDA is when companies are promoting any product that makes health claims. The FTC requires that companies support their advertising claims with solid proof.

Monitoring and Enforcement of Rules and Regulations

The FDA monitors advertising and promotion in a few different ways. They will first review promotional materials submitted during the initial dissemination. They then conduct routine surveillance, looking out for any violations of the rules.

The FDA also has a “bad ad program” that works with and educates health care professionals. This way, the professionals know how they can help the FDA ensure that all advertising and promotional materials are truthful.

If violations are found, the company can receive one of two types of letters. The Notice of Violation (NOV) usually requires the company to stop using the promotional material found in violation.

The company can also receive a warning letter. This will usually require the company to provide corrective advertising of the false information they put out. This process can be costly for a company, both in cost and reputation.

CfPIE: Helping You Understand Pharmaceutical Marketing Regulations

For those who work in drug and device advertising, marketing, and promotion, CfPIE is here to help you understand all aspects and actors of the regulation process. Our course Marketing & Advertising of Pharmaceutical & Medical Devices will provide attendees with a better understanding of the issues that can affect all marketing and promotional activities.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

Medical Device Submission: What Go to Market Pathways Can You Take?

Tue, 23 Mar 2021 17:20:34 GMT

Any medical device that will be marketed and sold in the United States must receive the necessary approval from the FDA through their regulatory process. There are multiple pathways to navigate this regulatory process.

Most companies use and are aware of the 501(k) process which is the most commonly used. The other two commonly used pathways are PMA and de Novo. There are actually seven different pathways, all with their own benefits and challenges.

Understanding these options will help you communicate more effectively with regulatory professionals and the FDA. It will also help you understand how regulation can impact the development process, aiding in getting products to market quickly and efficiently, avoiding problems before they even occur.

A brief overview of each pathway is necessary to better decide which option is best for you and your medical device.

1. Premarket Notification / 510(k)

The majority of Class II and certain Class I devices require Premarket Notification 510(k) . When submitting a 510(k), you are providing evidence to the FDA that your device is “substantially equivalent” to a similar device already on the market.

Your device must share the same use and characteristics as this previous device. Through this process, you will compare and contrast the devices showing your product is similar in effectiveness and safety.

2. Premarket Approval (PMA)

Because of the higher risk of Class III devices, they are required to have Premarket Approval to be marketed in the US. If your Class I or II device is unable to prove equivalency through a 501(k), this option might be required for your device as well.

During this process, you will be required to provide scientific evidence through a clinical trial to prove the effectiveness and safety of your device. After providing evidence, the FDA has a multi-step review process before providing an approval or denial of the device.

3. Product Development Protocol (PDP)

If the technology which your device uses is well established in the industry, the Product Development Protocol (PDP) pathway is another option for you. With this method, the clinical process and the gathering of information for approval are merged into one mechanism.

This pathway is structured as a contract between you and the FDA, agreeing on how the effectiveness and safety of the device will be shown. The contract will describe the design and development process before starting so if you follow the agreed-upon process, your device will be considered having a PMA once completed.

4. De Novo

For those developing a lower risk, novel device and can provide evidence showing the low risk, the de Novo pathway is a possible option for you. There must be no device already on the market that is similar in which you could use a 501(k) to submit a de Novo request.

Once your Class I or II device goes through this risk-based classification process and is approved, it can be used as the predicate device for future 501(k) submissions.

5. Humanitarian Device Exemption (HDE)

If your device is intended for a condition or disease that affects a small portion of the population, the Humanitarian Device Exemption (HDE) might be the best option for you. This is because you will have difficulty gathering the necessary clinical evidence with the rarity of the disease and there is not a comparable device already on the market.

The HDE pathway starts with the FDA granting you a Humanitarian Use Device (HUD) exemption. This exemption is for devices used to treat a condition or disease that affects less than 8,000 individuals in the US per year. Then after developing the device, you will apply for the HCE for review and approval.

6. Custom Device Exemption (CDE)

Devices that are custom-made for a specific patient, ordered by an individual physician or dentist, can be approved through the Custom Device Exemption (CDE). Your device will be exempted from the 510(k) or PMA process.

For this exemption, you are limited to no more than 5 units built per year. The product must be designed to treat a specific condition that no other device is available to treat. It is also required to be manufactured on a case-by-case basis for the specific needs of a patient.

7. Expanded Access Program (EAP)

When there is an emergency and a seriously ill patient has no other alternatives, the Expanded Access Program (EAP) is a way for the device to be quickly approved for the benefit of the patient. This is sometimes called “compassionate use” and will help the patient gain access to a product outside of clinical trials.

There are very strict requirements for a device to use the EAP. All of the following must apply:

The patient’s life is immediately threatened by disease or condition
There is no alternative device for this purpose
Enrollment in a clinical trial isn’t possible
The benefits to the patient outweigh any risks involved
Providing the device will not interfere with ongoing trials

CfPIE: Understanding Medical Device Submission

Choosing the right pathway to market is just one part of the medical device submission process. During our course “ Intro to Medical Device Submission ”, you will understand the regulatory requirements necessary to bring medical devices to market, learning the advantages and challenges of each pathway.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

FDA Authority & Cosmetics: What You Need to Know

Tue, 16 Mar 2021 17:26:10 GMT

Cosmetics and other beauty products are obviously not food or drugs so it might be surprising to some that the FDA has authority over these products. Since these health and beauty products will be put on people’s faces and bodies, it was deemed important to have an authority verifying the safety of the ingredients.

The products that will be marketed and sold in the United States are mainly regulated under two laws: the Federal Food, Drug, and Cosmetic Act ( FD&C Act ) and the Fair Packaging and Labeling Act ( FPLA ).

What does this regulation look like and which cosmetics are affected by this?

FDA Regulated, Not FDA-Approved

A major distinction to understand in comparison to the FDA’s usual approval mechanisms is that the law currently does not require the ingredients or products that are considered cosmetic to be approved by the FDA before going onto the market.

There is one exception to this rule, any color additives used in cosmetic products will need approval by the FDA.

With FDA’s regulatory authority over cosmetics, they do have the right to pursue enforcement action against a company or individual, and their products on the market, who violate any laws. This enforcement is pursued through the Department of Justice.

Which Cosmetics Are Regulated?

To know which cosmetics fall in this category, you first need to know how the FD&C Act defines cosmetics: “articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance”.

This definition can include deodorants, perfumes, facial makeup, lipsticks, fingernail polishes, moisturizers, hair colors, and any other substance used as a part of a cosmetic product. The FDA’s definition of cosmetic does not include soap .

If the product’s purpose is for any type of therapeutic use, it will most likely be considered a drug and fall under a different regulation and approval process than cosmetics.

The Labeling Of Cosmetics

When a cosmetic product is released on the market, the labeling of it becomes very important because this can be one of the main reasons for the FDA to pursue enforcement action against a product.

The FD&C Act lays out what incorrect labeling, or misbranding, could look like:

The label has false or misleading information
The label does not include all information that is legally required
The required information is hidden on the label or not prominent enough
How the container is built or filled is misleading
The color additive doesn’t meet regulations

Also, any product that does not comply with the FPLA is considered misbranded under the FD&C Act. In these cases, the FDA can take action against the product and the company or individual who markets them.

CfPIE: Training for All US Cosmetic Regulations

We offer a 3-day course on everything about US cosmetic manufacturing regulations. The course is designed for professionals in the personal care, cosmetic, and pharmaceutical industries who engage in all phases of product development.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

Preparing for CMC Regulatory Compliance: The Basics & More

Tue, 09 Mar 2021 18:34:44 GMT

Are you familiar with the latest Chemistry, Manufacturing and Controls (CMC) regulatory compliance requirements?

When manufacturing a medical product, there are strict regulations and guidelines for the manufacturing process, the manufacturing facility itself, and any quality control testing. This collection of information is called the CMC.

The CMC landscape and list of requirements continuously and rapidly change. Because of this, compliance with the regulations must be updated and checked regularly. This CMC regulatory compliance is necessary if a product wants to meet both FDA and EMA requirements and expectations.

Any company dealing in pharmaceuticals, biosimilars, or other biologics will need to have a strategy for CMC regulatory compliance prepared. These strategies will serve numerous purposes and should contain 5 specific elements.

What Is CMC Regulatory Compliance?

With a globalized market for pharmaceutical products, it’s necessary to deal with potentially numerous different regulatory agencies. The CMC regulations collect all strategic international regulatory guidelines that have been created to drive the pharmaceutical industry.

Depending on location and product, this could include Quality by Design (QbD), Quality Risk Management (QRM), or Pharmaceutical Quality System (PQS).

Purpose of CMC Regulatory Compliance Strategies

The consequences of non-compliance with CMC regulations could mean loss of approval, delay in approval, or delay in trials. All of these consequences become wasted time and wasted money. This is why having a strategy to stay compliant is a necessity.

By strengthening infrastructure and control systems in place, you can prevent possible non-compliance. Having a strategy to accomplish this goal and stay up-to-date on all rules and regulations can help avoid any of these consequences.

The Five Elements Of A Strategy

For a strategy to remain compliant with all CMC regulations to be effective, 5 core elements should be included:

1. Embrace The Full Spectrum Of CMC Activities

Since CMC encompasses all aspects of a pharmaceutical product, from facility to the process, you must be aware of it all. You should understand how CMC connects to each point in your organization and the task at hand.

2. Address Unique Requirements For Manufacturing

Each specific manufacturing process will have unique requirements. Expect the differences and take your time to become familiar with the ones relevant to all processes you plan on using.

3. Address Unique Requirements For Products

Similar to the second element, each specific biologic product will have unique requirements as well. These should be researched and understood before beginning working with or on a product.

4. Align With Any Other Guidances

Depending on your location and the product you’re manufacturing, there will be other relevant guidances. These could be strategic ICH Q8/Q9/Q10 guidances or something different but it’s important to align your strategies for those as well.

5. Apply Risk-Based Approach

When you take a risk-based approach for these strategies, you will factor in the corporate risk acceptance level into all decisions. Whether connected to the corporate culture or financial situation, this is still a necessary and important aspect of the strategy.

CfPIE: Helping You Prepare For CMC Regulatory Compliance

Our course “ CMC Regulatory Compliance for Biopharmaceuticals & Biosimilars ” is designed for senior management, directors, managers, supervisors, project planners, and professional staff seeking to develop or implement a Chemistry, Manufacturing & Controls (CMC) regulatory compliant strategy.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

The Main Phases of Clinical Research: Going From Preclinical to Phase IV

Tue, 23 Feb 2021 18:54:32 GMT

Over the last few months, people all over the world watched as various COVID-19 vaccinations completed the different phases of clinical research, nearing ever-closer to approval.

Technically, there are four phases of clinical research but each subsequent vaccination announced its success and approval after Phase III.

So, what are the phases and what does that mean for the drug development process ?

Preclinical Research

Before the phases of clinical research begin, there is an important preclinical process. This step is to gather information on the efficacy and toxicity of the drug and the ingredients used. These tests can be conducted on laboratory animals, human cells, and human tissues.

Preclinical research is necessary to prove the drug is safe enough to begin testing on human volunteers.

Phase I

The first phase of clinical research begins on a small group of volunteers, usually less than 100. Volunteers for Phase I are generally healthy volunteers, although there are situations (like cancer) where the volunteers will need to have the disease/condition.

The purpose of this step is mainly to test if the drug is safe for human consumption. In a process called “dose-ranging”, different amounts of doses will be used to test which amounts are most safe and/or most successful on the subjects.

Phase II

Moving up to a few hundred volunteers, Phase II studies the drug on those with the disease or condition for which the drug is being developed. Using the therapeutic dose decided on in Phase I, these tests are to show the efficacy and any side effects of the drug.

Phase II is technically not to show whether the drug will be beneficial or not, but to prepare researchers for Phase III and its larger pool of volunteers, providing data to develop new protocols and research methods for future studies.

Phase III

The largest study before approval, Phase III involves up to a few thousand participants. This study shows the efficacy of a drug, the benefits it can provide, and any side effects from long-term exposure that might have gone undetected in earlier phases. Depending on the drug being tested, this phase will either focus on a specific population or require a more diverse pool of volunteers for drugs meant to be used in a more general population.

With the completion of Phase III, the developer can then combine all information collected during the multiple studies and submit an application to the relevant regulatory authority for approval. Only after approval will a drug undergo Phase IV.

Phase IV

After approval, a drug is released on the market but continues to be monitored. This is called Phase IV or Post-Market Safety Monitoring.

The main purpose of this phase is to monitor the long-term effects of the drug for continuing approval or possible removal from the market. Additional reasons for this phase are to find new purposes for the drug and to test the drug on populations deemed too sensitive for earlier phases (for example, pregnant women are rarely included in Phases I-III).

CfPIE: Your Answer to Understanding the Drug Development Process

Are you looking to learn more about the different phases involved in drug development? Our course, “ The Drug Development Process: From Concept to Market ,” will benefit any who needs an understanding of the drug development process, from those in R&D to marketing and sales personnel. This course will prepare you to understand every part of the process, from beginning to end.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

The Center for Professional Innovation & Education Launches New Laboratory Equipment Validation and Qualification Course

Wed, 10 Feb 2021 19:02:00 GMT

FOR IMMEDIATE RELEASE

Malvern, Pennsylvania – February 10, 2021

The Center for Professional Innovation and Education (CfPIE) is excited to announce our latest course, Laboratory Equipment Validation and Qualification. This virtual course will run March 8 & 9th, and is designed for individuals who perform, supervise, manage, audit, or oversee the validation of text methods in any lab utilizing cGMP, GLP, and similar manufacturing processes.

The course aims to provide participants with a thorough understanding of FDA expectations when it comes to validation and qualification of laboratory equipment, industry best practices, how to plan effective and compliant lab equipment programs, and why these processes are a foundation aspect for maintaining sustainability.

The course will be taught by CfPIE’s Julie Barnhill, Ph.D., who commands deep industry expertise through her work as a consultant with Meridian BioGroup LLC , head of QA Compliance at Osiris Therapeutics and Alpharma, and Director of Quality Control and Analytical Development at Chesapeake Biological Laboratories. She also has extensive expertise advising for biopharma and pharmaceutical companies with products in the preclinical, clinical, and commercial stages of drug development.

Participants will engage in seven sections, which include a detailed introduction, laboratory equipment validation and qualification processes, discussion of roles and responsibilities, software validation, change control, laboratory equipment validation and qualification documentation/creation, and equipment (instrumental) categories.

“After receiving numerous requests from clients for a training session to cover the latest FDA guidelines on equipment validation, CfPIE is excited to deliver a two-day course which thoroughly addresses the FDA’s increased focus on this topic”, Mark Mazzie, CEO, CfPIE.

To learn more about the Laboratory Equipment Validation and Qualification course, please visit the CfPIE website or call 1-610-648-7550.

About CfPIE

The Center for Professional Innovation and Education (CfPIE) is an industry leader in providing technical training for pharmaceutical, biotech, skin and cosmetics, and medical device professionals. CfPIE offers more than 80 courses and 350 sessions annually, both virtually and in person, for medical industry professionals located in North America and Europe.

The Pros and Cons of Using a CRO: The Basics and More

Tue, 09 Feb 2021 19:07:00 GMT

Many companies that are in the process of developing new medicines might outsource work to a Contract Research Organization (CRO).

This decision was possibly made to save money, to guarantee work completed within time and budget constraints, or to benefit from industry expertise.

So what exactly is a CRO and what are the benefits and challenges of outsourcing work to them?

What Is a Contract Research Organization?

CROs are organizations that provide support and services to the medical device or pharmaceutical industries. They are usually hired on a contractual basis to provide services during the development stages. Some CROs will be able to help with all steps of development, from conception to approval, while others specialize in niche jobs like clinical studies and trials.

The Benefits of Using a CRO

The first and most evident benefit of outsourcing work to a CRO is having another entity conducting some or all duties that need to be completed. CROs will already have the staff in place, the experience and equipment needed, and any necessary resources prepared. Not having to prepare all of this will most likely save a company time and money.

Time sensitivity is a large benefit because CROs are set up and prepared to start work as soon as a contract is signed. No time delays will be necessary to wait on hiring, fundraising, or clinic preparation.

If the medicine or device being developed is expected to be approved in a variety of nations or locations, it will be beneficial to hire a CRO that has international experience with the approval process in each jurisdiction. The contracted CRO can have facilities and staff already located in the target location and will have knowledge about local regulations for clinical studies and ultimate approval.

The Challenges of Working With CROs

Outsourcing work to another organization always comes with its challenges, with the most obvious being a lack of direct oversight. Another team in another location is conducting the work so day-to-day supervision is impossible.

Without direct oversight, the consequences of any problems or failures will still fall on the company hiring the CRO. Using a CRO does not mean guaranteed success or approval and the company will still have to deal with any financial burdens born out of a failed study.

Contracts with CRO usually include multiple audits before and during every step conducted. While this provides some level of oversight, it is an important aspect of the process to consider when choosing a CRO or if using one is even the right decision.

Confidentiality is the final major issue when discussing the challenges of outsourcing work. A company is sharing intellectual property and other confidential information with an outside organization and this can be seen as a major risk. Confidentiality agreements play a large role in offsetting this challenge but being cognizant of different laws in different countries is very important.

CfPIE: Your Answer to Training on Everything CROs

Are you looking to learn more about CROs and how they can benefit your organization. Then check out our Selecting and Managing CROs training course.

Our CRO training course will help explain the specific methodology and management techniques to successfully outsource pharmaceutical programs to CROs. This course is designed for personnel in the pharmaceutical, biotechnology, medical device, and biologics industries who use CROs in the process of developing their products for FDA approval.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

European Medicines Agency's (EMA) Process for Vaccine Approval

Tue, 02 Feb 2021 19:13:38 GMT

As each new COVID-19 vaccination is announced, every region waits for approval for distribution to begin. The UK was the first country to approve the first vaccine, with the FDA in the United States of America following soon after.

Citizens in the European Union patiently waited for EU approval as they watched other countries begin distribution. Finally, at the end of December, the EMA announced the approval of the Pfizer and BioNTech vaccination.

So who is the EMA and how do they approve new vaccinations?

What Is the European Medicines Agency (EMA)?

The EMA’s purpose is to protect human and animal health by approving and monitoring medicines and providing transparent clinical data for both patients and healthcare professionals.

Understanding the EMA’s Approval Process

For a medicine like the COVID-19 vaccine to be approved by the EMA, the company developing the medicine must submit data showing they have completed three types of studies: pharmaceutical quality studies, non-clinical studies, and then clinical studies.

Pharmaceutical quality studies are to gather information for the ingredients that go into the medicine, how it is manufactured, and how to store the medicine. The use of each ingredient must be justified as well as the manufacturing technology being used.

The next step is non-clinical studies, studies conducted in the laboratory. The company will need to prove that giving an animal the medicine accomplishes the desired goal. This step also gives information on how the immune system responds to the medicine and how the medicine reaches the tissues and/or organs in the body.

The final study for EMA approval is the clinical studies where the safety and efficacy of the medicine must be proven on humans. Participants and volunteers in these studies are protected by authorities and ethics committees in each nation of the EU. That said, to meet the approval standards of the EMA, the clinical study must comply with good clinical practice (GCP) .

Efficacy of a Medicine

A very important study during this step is the efficacy study. Efficacy is the medicine’s ability to produce the desired effect in ideal situations. Many efficacy studies can be conducted, with varying numbers of participants, but there has to be one main study with over 30,000 participants to truly prove the efficacy of a medicine.

There isn’t a minimum efficacy percentage needed for EMA approval. It is recommended to be at least over 50% but they compare the efficacy rating to the levels of safety and side effects and ease of storage. A medicine with lower efficacy but high levels of safety and few side effects might be approved quicker than a vaccine with a high efficacy rating that comes with numerous side effects.

After approval, long-term clinical studies are essential to continue gathering information on the safety and efficacy of a medicine. While not a part of the EMA’s approval process, this is necessary for many situations but especially with a medicine or vaccine for a virus. As a virus can grow and mutate, long-term studies will provide updated information on the safety and efficacy of the medicine in current, real-world situations.

CfPIE: Your Answer to Training on EMA and EU Regulatory Procedures

Are you looking to expand your knowledge of the EMA and EU regulations? Then make sure to sign up for our European Regulatory Procedures course today.

Our European Regulatory Procedures course will be of value to both those who are new to Regulatory Affairs in the pharmaceutical, biopharmaceutical, and generic drug industries, as well as experienced professionals wishing to refresh their regulatory knowledge.

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

Lyophilization and Its Application for the Pfizer Vaccine

Tue, 19 Jan 2021 19:18:09 GMT

As the news is inundated with stories about COVID-19, the world celebrated when the first vaccine from Pfizer was approved.

This news was quickly followed by stories of the difficult refrigeration and distribution of the vaccine. To alleviate concerns, Pfizer announced studies into a lyophilized version of the vaccine.

What is lyophilization? And how does this impact the future of the vaccine?

What Is Lyophilization? A Brief History and Its Modern Applications

The process of freeze-drying, or lyophilization, is a dehydration process used to preserve any product. This process begins with lowering the temperature of an item to freezing to remove water from the object while maintaining the physical and chemical structures of the original object.

During the next step, the primary drying period, a vacuum is introduced to convert the frozen humidity into vapor through sublimation. A secondary drying period is then performed to remove any additional water molecules that were left unfrozen. An object that has been lyophilized can be reconstituted by adding water back through re-hydration.

Removing humidity for conservation purposes has been used since at least the Egyptians and their mummification processes. In North America, the Inuit have been freeze-drying food rations for generations, using their cold, dry atmosphere. Another common preservation process is applying heat and boiling out the humidity. Re-hydration cannot return the object to its original form with any of these conservation processes.

It wasn’t until Richard Altmann published a freeze-drying process for biological tissue in 1890 that there was a way for the original object to return to its original functionality once water was reintroduced. Further advances and new patents were soon to follow by many scientists.

During World War II, lyophilization was used for the blood plasma and penicillin needed in the field. Prior to this, the supplies were becoming spoiled due to the lack of refrigerated transport. Using lyophilized blood plasma and penicillin reduced the number of amputations and deaths caused by infected wounds, reducing the mortality rate by 12-15%.

In the following decades, applications for lyophilization continued to be found in food processing and pharmaceuticals. Military rations and astronaut food produced by NASA both benefited from lyophilization. The newest frontier for lyophilization is in future variations of vaccines like the Pfizer-BioNTech mRNA-based COVID-19 vaccination.

Limitations of the Current Pfizer Vaccine

In November 2020, Pfizer announced the completion of their Phase 3 study of a COVID vaccine with a success rate of more than 90%. Approval by the FDA followed in December. This was received as positive news by a world still struggling with a global pandemic, but one major difficulty in the distribution of the vaccine was quickly noted.

The Pfizer vaccine must be kept at an incredibly cold temperature of minus 70 degrees celsius (-94°F). This creates a logistical challenge for the distribution and storage of the vaccine. According to the CDC’s vaccine playbook , they are not advising local vaccine managers to purchase specialized freezers that can handle these intense temperatures, which could hinder the widespread distribution of Pfizer’s vaccine.

Because of this, Pfizer has created a packaging unit that keeps the vaccine at correct temperatures using dry ice, but this still leaves room for errors throughout the distribution chain from manufacturing to administration.

The packing units can maintain the -70° C for up to 10 days unopened and up to 30 days with refills of the dry ice. Each opening creates an opportunity for error and possible ruination of a batch of vaccines. Another problem: these specialized freezers can cost up to $20,000 for each unit.

Packaging methods are another cause of concern with this vaccine. There have been a few units that have arrived at their destination in colder temperatures than specified by Pfizer. The units reached -92° C and had to be sent back to Pfizer.

This and other concerns have limited access to the vaccine from all but the wealthiest nations and have led to Pfizer testing new variations of the vaccine for easier storage and distribution.

The Future of the Vaccine with Lyophilization

Pfizer has recently confirmed it is working on a more durable version of their vaccination, using the process of lyophilization. Freeze-drying the vaccine would make it into a powder, allowing distribution to begin sometime this year or next — based on what Pfizer’s CSO Mikael Dolsten told Business Insider .

A powder form of the vaccine would be able to be reconstituted with liquid before administration. Other options would be administering the vaccine through inhalation or intranasally. Dolsten did not confirm which process of administration would be used for the lyophilized version of the Pfizer vaccine.

There are significant benefits of the lyophilized vaccine. Storage and transportation can be conducted under standard refrigeration and not at extreme levels of freezing temperatures. This would be incredibly beneficial to regions of the world without proper storage units for the current form of the vaccine or for regions too far from distribution centers with current transport packages.

The amount of time the vaccine can be stored will be extended by lyophilization as well, but Pfizer is too early in the testing stages to confirm an exact time frame. Hopefully, we’ll know more about the exact benefits provided by lyophilizing the Pfizer vaccine soon.

Russia is also using lyophilization to preserve and transport the vaccine they have manufactured — the Sputnik V. This will make easy the process of transporting the vaccine across Russia and its many remote settlements. They have also applied for approval in over 40 other countries. As of now, North American organizations, European organizations, and the World Health Organization have not approved the Sputnik V for administration, but this is a step in the right direction for using lyophilization on COVID-19 vaccines.

Both mRNA-based vaccines being used against COVID-19 and lyophilized vaccines, in general, are fairly new to the world market. Every progress made with these studies opens up new opportunities for future vaccinations with easy storage and transportation.

CfPIE Is Your Answer for Professional Lyophilization Training

Stay up to date when it comes to the latest on lyophilization training. Our lyophilization course provides attendees with a practical approach to understanding the scientific and engineering principles of lyophilization. This two-day lyophilization training course is designed for those in the pharmaceutical, biomedical, medical device/diagnostic, and biotechnology industries that develop and/or produce lyophilized (freeze-dried) products.

Are you interested in signing up? Click the link below to get started:

Lyophilization Technology-Application of Scientific Principles

Have questions? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

Everything We Know About the New Variant of COVID-19

Tue, 05 Jan 2021 19:23:53 GMT

A new variant of the coronavirus, first detected in the United Kingdom, has prompted dozens of travel bans and strict, tier four mixing rules for millions of people in England, Scotland, and Wales.

The new variant has already been detected in countries such as Canada, Denmark, Belgium, Italy, Australia, and the Netherlands. A similar but independent variant has been identified in South Africa.

What does this new variant mean for the rest of the world? How has it gone from being non-existent to becoming the dominant form of the virus in parts of Europe? Let’s take a look at which questions scientists have been able to answer so far.

Why Are Public Health Officials Concerned?

Public health officials now have high confidence that the new variant of COVID-19 is better able to transmit than other variants. Experts estimate that the new variant may be up to 70% more transmissible .

This particular variant was first detected in September. By November, it was responsible for roughly a quarter of cases in London, escalating to two-thirds of cases by December.

Teasing apart people’s behavior and viral characteristics can be challenging. New strains can become more common simply by appearing in the right place at the right time. London, which only had tier two restrictions until recently, may have acted as the ideal breeding ground.

While scientists do not have absolute certainty that the new variant is more infectious, there is some evidence that this may be the case, including:

The new variant is rapidly replacing other versions of the virus
The new variant hosts mutations that affect important parts of the virus
Some of these mutations have already been shown in the lab to promote greater infection of healthy cells

While more laboratory experimentation is necessary to build a solid case that the new variant can spread more easily, what it has demonstrated so far has been enough to re-introduce lockdown restrictions, travel bans, and similar measures to limit its spread.

How Far Has the New Variant Spread?

Experts believe that the new variant either originated in the UK or had been imported from a country less able to monitor coronavirus mutations. So far, the variant can be found across the UK, with the exception of Northern Ireland. Most cases are concentrated in London.

Public Health England performed a backward tracing analysis using genetic evidence and found that the variant first emerged in England in September, circulating at relatively low levels until roughly mid-November.

Data from Nextstrain, an open-source project that involves the monitoring and analysis of the genomes of viral samples taken from around the world, suggest that cases in Australia and Denmark originated from the UK.

The coronavirus has mutated before. In fact, the Centers for Disease Control stated that the virus mutates its genome every two weeks . However, most of these mutations are inconsequential.

The virus that originated in Wuhan is not the exact same virus we’re seeing around the world today. In February, the D614G mutation emerged in Europe and rapidly became the globally dominant form of the virus. Another mutation, the A222V mutation , was linked to summer holidays in Spain.

At least 40 countries have now banned passenger travel from the UK, including Russia, Chile, Canada, Italy, Iran, and Sweden. While the US has yet to enact a travel ban, several major airlines have made it mandatory for passengers to get tested for COVID-19 prior to boarding planes from the UK to New York.

What Have Scientists Learned About the New Variant?

Scientists have conducted an initial analysis of the new variant, identifying 17 potentially significant alterations . Changes have been made to the spike protein, the part of the virus that lets it attach to healthy cells.

One mutation, called N501Y, alters the most important part of the spike protein—the receptor-binding domain. Experts believe that changes in this part of the virus are likely to lend a helping hand when it comes to ease of infection.

Another mutation, an H69/V70 deletion, involves the removal of a small part of the spike protein, a mutation that has emerged previously in COVID-infected mink. Lab experiments have found that this mutation may double infectivity and could hinder antibody protection.

Most COVID-19 cases from the new variant have been identified in people under 60 years of age. This may be problematic as people who are asymptomatic tend to fall under the same age category. This may be part of the reason why this particular variant is spreading so rapidly.

Will Vaccines Work Against the New Variant?

There is no evidence to suggest that leading vaccines will not work against the new variant. While more research is needed, rapidly increasing transmission will be enough to overwhelm local hospitals, leading to a potentially fatal shortage in resources.

All three leading vaccines have been designed to provoke an immune response against the existing spike protein, training the body’s defenses to attack different parts of it so that, even though it’s mutated, the body will still recognize and eliminate it as a threat.

Instead, experts are worried about the accumulation of mutations over time. The virus may be headed toward what’s known as vaccine escape, in which a virus changes enough to counteract the full effect of a vaccine and continue to infect people.

The new variant could also mean that more people will need to be vaccinated to achieve herd immunity. If the virus becomes more efficient at infecting people, a higher vaccination rate will be required to ensure that normal life can continue without interruption.

Luckily, staying protected from the new variant will involve the same measures we’ve relied on over recent months, including social distancing, mask-wearing, temperature checks, and related precautions.

Keep Your Organization Updated

What are you doing to keep your workforce COVID-ready? Invest in new skills while refreshing those that are out of date with professional training and certification courses from the Center for Professional Innovation and Education (CfPIE) .

Are you interested in staying at the forefront of COVID-19 response efforts? Get in touch with a member of the CfPIE team today by calling 1-610-648-7550 or emailing info@cfpie.com.

Understanding Pharmaceutical Guidelines: GLP vs. GMP

Tue, 08 Dec 2020 20:17:17 GMT

The difference between good manufacturing practices (GMPs) and good laboratory practices (GLPs) aren’t always clear. In practice, confusing one for the other can lead to extra work at best and non-compliance at worst.

We’ve done the legwork and put together a comprehensive guide on GMP, GLP, and major differences between the two.

What Is GLP?

Good laboratory practice is a set of principles that were developed to ensure the quality and integrity of non-clinical laboratory studies. GLP achieves this by governing the processes and conditions under which non-clinical research is conducted, including how research facilities are maintained.

GLP is commonly associated with the pharmaceutical industry and is often applied toward non-clinical animal testing that may be required to support marketing permits for products regulated by government agencies.

GLP also has applications outside the pharma industry. Non-pharmaceutical agents such as food additives, food packaging, and medical devices may similarly require non-clinical research governed by GLPs to gain regulatory approval.

Does GLP Apply to Clinical Studies?

One of the most common misconceptions about GLPs is that they apply to clinical studies. GLP is only ever necessary during non-clinical research and testing. Clinical studies, which involve actual patients, are governed by good clinical practices (GCPs), the World Medical Association’s Declaration of Helsinki, and other regulations intended to protect human participants.

This makes sense when we consider the role of a Study Director. The GLP framework relies on the roles and responsibilities of the Study Director, a single individual that is responsible for both the supervision and execution of all aspects of study. In a clinical setting, Study Directors do not exist.

Is GLP a Scientific Management System?

Another common misconception regarding GLP is that it exists as a scientific management system. This is not the case. GMP and GLP are both quality management systems. GLP defines the standards for study conduct, data collection, data analysis, and reporting but does not touch on scientific standards.

Why is this important? If a study follows GLP, that means its researchers followed the study protocol. It does not mean that the study addresses the scientific hypothesis in question, or even that the study reports meaningful results, just like following a recipe as its written doesn’t mean the end product will turn out to be appetizing.

What Is GMP?

Why do good manufacturing practices exist? Good manufacturing practices regulate the design, monitoring, and operation of manufacturing processes and facilities. GMP regulations fall under the domain of the Food and Drug Administration’s Federal Food, Drug, and Cosmetic Act.

The purpose of GMP regulations is to guarantee that manufacturers, processors, and packagers of drugs, medical devices, and some food products have taken the appropriate steps to ensure that their products are safe and effective.

GMP regulations are designed to protect the consumer by minimizing instances of contamination, mixups, and other errors that may occur at any time during manufacturing and production. GMP regulations carry the force of law, meaning that failure to comply can result in product recall, seizure, hefty fines, or even jail time.

What Are the Major Differences Between GMP and GLP?

Now that we’ve covered the basics let’s examine a few of the key differences between GMP and GLP.

1. Study Director

Under the GLP framework, a single point of contact is required for the study. This individual is known as the Study Director. The Study Director is appointed by testing facility management and is responsible for all aspects of the study.

On the other hand, GMP does not require a single point of contact. No Study Director is chosen or appointed.

2. Quality Assurance

Under GLP, a quality assurance unit is responsible for inspecting study conduct and testing facilities to maintain quality and integrity. The quality assurance unit operates independently of study personnel.

GMP requires a quality control unit. The quality control unit has the obligation and authority to approve or reject any procedure or conditions involved in testing or manufacturing processes, serving as an all-encompassing quality system.

3. Recording and Reporting

Another key difference between GMP and GLP lies in recording and reporting guidelines. Under the GLP framework, all records require the signature or initials of all personnel involved in conducting the procedure in question, along with the appropriate dates. If findings are used in support of a marketing permit, records must be maintained for a minimum of five years post-registration.

In contrast, GMP records are maintained for at least one year following product expiration dates. Records require the signatures of both personnel conducting procedures in question alongside individuals involved in verification processes.

GLP vs. GMP: Laboratory Testing

Perhaps the most dangerous place to confuse GMP and GLP is in the lab. Let’s take a look at how the two sets of principles differ in practice.

Here it’s important to note that GLPs are focused solely on preclinical development. In particular, GLP only applies in the realm of non-clinical research studies typically performed in support of marketing applications. Such studies may involve toxicology, pharmacology, biocompatibility, and other aspects of non-clinical laboratory testing.

GLPs are only relevant in studies that involve test systems such as live organisms, including plants and microorganisms, but not human patients. Findings from these studies give the FDA everything they need to determine the scientific rigor—but not necessarily the value—of non-clinical research.

In contrast, GMPs are concerned with the processes involved in manufacturing. GMP reports demonstrate to the FDA whether regulated products were manufactured according to a set of predetermined standards. For example, lot release and lot conformance testing for products on the market are almost always conducted under GMP regulations to guarantee safety and efficacy.

Become Certified in GMP and GLP

Are you interested in gaining a better understanding of GMP and GLP regulations? Become a certified regulatory professional with training and certification courses from the Center for Professional Innovation and Education (CfPIE).

Check out the following courses to update your regulatory knowledge and skillset:

Interested in learning more about GMP and GLP and how they affect pharmaceutical practices? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

FDA Authorizes Most Accurate Antibody Test Yet

Tue, 17 Nov 2020 20:20:57 GMT

On November 25, the US Food and Drug Administration (FDA) granted an emergency use authorization (EUA) for a quantitative antibody test that can detect and measure levels of COVID-specific neutralizing antibodies.

The test kit, developed by Kantaro Biosciences, is thought to be game-changing in the race to learn more about the virus and what the presence of antibodies may mean when it comes to immunity.

How Does It Work?

The kit was developed in New York City this past spring and was approved for use in the European Union last month. Unlike other antibody tests, Kantaro’s test measures COVID-specific antibodies rather than all antibodies in the body.

Experts have suggested using the Kantaro test as a benchmark for determining whether individuals require a vaccine, which may be available for distribution as soon as next month in the US. For example, if someone is found to have high levels of neutralizing antibodies, they may not immediately need a vaccine.

Kantaro Biosciences—itself a joint venture between Mount Sinai and RenalytixAI, formed in the hope of rapid innovation—recently announced a partnership with Bio-Techne Corporation with the goal of manufacturing up to 10 million tests per month.

What We Still Don’t Know

The body’s immune system produces antibodies to defend against viruses and other foreign pathogens that invade it. But when it comes to COVID-19, the link between antibodies and immunity is not so clear.

Scientists still don’t know how much protection neutralizing antibodies can offer against a COVID-19 infection, how long this potential protection lasts, or how it differs between demographics. A quantitative antibody test may play a critical role in finding the answers.

While the FDA has previously authorized multiple antibody tests, Kantaro’s test kit is the first to offer a number readout regarding a patient’s relative level of antibodies in response to a previous COVID-19 infection.

Because there are still so many unknowns regarding a potential relationship between SARS-CoV-2 antibodies and immunity, experts have warned patients against interpreting results as an indicator of any level of protection against the virus.

The Kantaro test can also provide insight as to whether a vaccine provokes a robust immune response. For example, measuring antibody levels in immunized individuals can help evaluate the effectiveness of a vaccine.

Keeping Your Organization Prepared

Staying ahead of COVID-19 response efforts demands an updated skill set. Get your teams up to speed with professional training and certification courses from the Center for Professional Innovation and Education (CfPIE) .

Are you interested in keeping your organization COVID-ready? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

New Vaccines Are More Than 90% Effective

Tue, 10 Nov 2020 20:24:57 GMT

On November 9, Pfizer and BioNTech announced that their COVID-19 vaccine candidate showed promising results in Phase 3 clinical trials. Preliminary findings suggest that the vaccine can prevent COVID-19 in more than 90% of people.

Only a week later, Moderna announced that its COVID-19 vaccine appears to be 94.5% effective according to the biotechnology company’s ongoing preliminary study. Worldwide, a total of ten vaccine candidates are currently in late-stage testing.

While Pfizer’s vaccine must be shipped and stored below 158 degrees Fahrenheit, Moderna expects their candidate to be stable at normal fridge temperatures of 36 to 48 degrees. It can also be stored for up to six months at -68 degrees.

What Can the Data Tell Us?

An interim analysis of the data from Pfizer’s Phase 3 clinical trial suggests that the vaccine is 90% effective at preventing COVID-19.

The analysis, conducted by an independent data monitoring board, examined 94 infections recorded so far in a study that enrolled nearly 44,000 people across the U.S. and five other countries. Each participant received two injections.

The Food and Drug Administration (FDA) requires U.S. vaccine candidates to be studied in at least 30,000 people . Studies must also include adequate numbers of older adults and other high-risk groups, including minorities and individuals with chronic health problems.

The FDA has also made it mandatory for investigators to track 50% of participants for at least two months to identify any adverse effects. Pfizer expects to reach that milestone by the end of the month, but has already stated the absence of any serious safety concerns.

Moderna’s vaccine is being studied in 30,000 volunteers. An independent monitoring board examined 95 infections that were recorded two weeks after a second dose was administered. Doses were administered 28 days apart.

What Can't the Data Tell Us?

Pfizer and Moderna both warn that initial protection rates may change by the end of their respective studies. It’s important to keep in mind that preliminary findings are only based on cases of COVID-19 reported seven days after the second dose. Pfizer now intends to look for cases 14 days after the second dose.

Moreover, Pfizer has not yet reported how many infections so far have occurred in older people, who are at a higher risk of developing more serious complications. Vaccines are often less effective in older populations—this is why flu and shingles vaccines for seniors contain a higher dose. Moderna’s success rate, however, included older adults above the age of 65.

Another cause for concern is that many people with COVID-19 develop very mild symptoms. Preliminary findings do not make it clear whether the vaccine prevents severe disease or stops transmission entirely.

One other factor involves asymptomatic transmission—participants were only tested if they developed symptoms, leaving it unclear whether vaccinated people could become infected, show no symptoms, and spread the virus unknowingly.

Once the study is complete, Pfizer and Moderna intend to submit their data to a peer-reviewed publication.

What Type of Vaccine Is This?

Pfizer’s vaccine is an mRNA vaccine with the official name of BNT162b2. Multiple drug developers are investigating other types of vaccines with different mechanisms of action.

According to clinical and vaccine immunology, Pfizer’s mRNA vaccine contains a set of genetic instructions on how to create the modified spike protein for the virus that causes COVID-19, SARS-CoV-2. Once injected into the body, the immune system learns to recognize the spike protein.

Moderna’s vaccine candidate uses similar mRNA technology—its official name is mRNA-1273. Vaccines developed by CureVac and Arcturus Therapeutics (partnered with Duke-NUS) are currently in Phase 2 trials.

Staying at the Forefront of COVID-19 Response Efforts

Now is the time to invest in new skills for your organization. Get your teams up to speed with professional training and certification courses from the Center for Professional Innovation and Education (CfPIE) .

Are you interested in keeping your organization COVID-ready? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

How Effective Does a COVID-19 Vaccine Need to Be?

Tue, 03 Nov 2020 20:28:34 GMT

The “effectiveness” of a vaccine can refer to a constellation of factors: What percentage of vaccinated people develop antibodies? How well do antibodies protect against the disease? How long does this protection last?

Over the summer, the Food and Drug Administration (FDA) announced that, to receive a regulatory green light, an experimental COVID-19 vaccine must “prevent disease or decrease its severity in at least 50% of people who are vaccinated.”

The FDA has established a threshold for effectiveness that makes it possible for a vaccine to become available that helps only half of the people receiving it while offering no benefit to the other half. It’s also possible that the vaccine may have varying effects—preventing the disease in some while reducing its severity in others.

What’s Considered Normal Effectiveness?

A vaccine that’s only 50% effective can still make a difference. For example, flu vaccine effectiveness varies widely from year to year—ranging between 20% and 60% over the last decade. And yet, year after year, flu vaccines reduce illness, hospitalizations, and deaths.

No vaccine is 100% effective. But some are better than others. Among the most successful is the measles vaccine. According to the Centers for Disease Control and Prevention (CDC), two doses of the measles vaccine is 97% effective in preventing the disease.

Is 50% Effectiveness Enough?

A near-perfect COVID-19 vaccine may not be necessary at all—depending on how many people took it. For example, experts say that if everyone took a 60% effective vaccine, the pandemic could still be tamed via herd immunity.

Clinical trials assessing the safety and effectiveness of multiple COVID-19 vaccine candidates are currently underway. Through Operation Warp Speed, the government has provided billions of dollars to various biotechnology companies developing vaccines. For example, Moderna has received nearly $2.5 billion to support the development of its vaccine candidate.

While most trials are evaluating whether a vaccine prevents COVID-19, findings may reveal additional information, such as whether a vaccinated individual that still contracts the virus becomes less sick than someone who hasn’t been vaccinated.

Study results may also tell us who benefits most from vaccination by comparing men and women, age groups, and people with and without underlying health conditions. Long-term follow-ups are expected to tell us whether vaccines reduce hospitalizations and deaths.

It’s important to keep in mind that a successful vaccine candidate won’t translate to an immediate end to the pandemic. According to the experts, immunizing millions of people will take time, during which precautions such as face masks, social distancing, and routine hand-washing will remain as crucial as ever.

Leading COVID-19 Efforts

What are you doing to keep your organization at the forefront of COVID-19 research and response? Now is a critical time to invest in new skills and training. Get your teams up to speed with professional training and certification courses from the Center for Professional Innovation and Education (CfPIE) .

Are you interested in keeping your organization COVID-ready? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

FDA Approves the First Treatment for COVID-19

Tue, 27 Oct 2020 19:33:15 GMT

On October 22, the Food and Drug Administration (FDA) approved remdesivir to treat COVID-19, making it the first and only COVID-19 treatment to have received full federal approval .

While the drug’s developer, Gilead Sciences, was granted an emergency use authorization (EUA) for remdesivir at the beginning of May, federal approval requires additional evidence to support safety and efficacy.

Remdesivir is now approved for patients over the age of twelve who are hospitalized with COVID-19. The drug is administered intravenously, typically for five days. Gilead will sell the drug under its brand name, Veklury.

How Does Remdesivir Work?

Remdesivir is an antiviral drug initially developed as a treatment for the Ebola virus and hepatitis C. The drug works by interfering with the reproduction of viral genes.

A clinical trial funded by the National Institutes of Health found that remdesivir reduced the length of hospital stays among patients with moderate symptoms from fifteen days to just eleven. President Trump received remdesivir after showing symptoms earlier this month.

However, remdesivir has not yet been shown to have a significant effect on the mortality rate of COVID-19. The World Health Organization (WHO) recently reported preliminary data indicating that the drug did not benefit patients with severe symptoms.

Many infectious disease experts believe antivirals like remdesivir work best when administered early. Severe COVID-19 is thought to be driven primarily by an overly forceful immune response—an antiviral like remdesivir may act as a buffer against such an overreaction.

Since its EUA in May, remdesivir has been administered to thousands of patients across the country. For patients with private insurance, the drug costs $3,120 per treatment course.

Conflicting Evidence

The clinical trial led by the WHO found that remdesivir had little to no effect on the duration of any given patient’s hospital stay or their chances of survival.

The “solidarity” trial evaluated the effects of four potential drug regimens side-by-side, including remdesivir, hydroxychloroquine, anti-HIV drug combination lopinavir/ritonavir, and interferon.

The trial included 11,266 adult COVID-19 patients across more than thirty countries. While hydroxychloroquine and lopinavir/ritonavir trials ceased in June after proving ineffective, other trials continued in more than 500 hospitals.

The WHO reported that drug regimens appeared to have little to no effect on 28-day mortality rates or the length of hospital stays.

While the trial appears to offer a global perspective, many infectious disease experts have criticized its open-label design and lack of uniformity. Failing to include a placebo group and allowing both patients and doctors to know which treatment is being administered can skew results.

Leading COVID-19 Efforts

Are you interested in keeping your organization COVID-ready? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

Your Guide to Preparing a Validation Protocol

Tue, 20 Oct 2020 19:37:48 GMT

Validation involves much more than end-product testing. Confirming a product’s safety solely through end-product testing is dangerous—how can you be sure that every pill will be the same?

That’s where a validated process comes in. The pharmaceutical industry relies on validation to make sure medicines and vaccines are safe and effective. That means scrutinizing the processes, systems, and equipment relied on throughout manufacturing.

What Is a Validation Protocol?

A validation protocol details how validation will be conducted. The purpose of a validation protocol is to define the test scripts that must be followed to guarantee that processes and equipment are ready to manufacture safe and effective end products.

If you work in pharmaceutical or medical device manufacturing, you may have heard of the related terms IQ, OQ, and PQ. These stand for Installation Qualification, Operational Qualification, and Performance Qualification.

These are procedures used to test whether systems (mechanical, piping, or software) are installed correctly, fulfill design requirements and specifications, and meet operational standards.

What Are the Different Parts of a Validation Protocol?

Validation protocols can be hundreds of pages in length. Templates themselves are typically around 50 to 60 pages long. Elements of a validation protocol must include:

Product characteristics. A validation protocol must show what a system is meant to achieve or produce.
Manufacturing equipment. What equipment is necessary? Equipment must be described in terms of installation and functional features.
Test scripts. How will tests be conducted? What instruments will be necessary?
Acceptance criteria. Here we will define the range of acceptable test results, including checksheets to document test results.
Final approval. This section includes all documentation showing that a validation process has been successfully completed.

How Do Companies Achieve Validation?

Validation includes observing, testing, and documenting measurements and comparing results against expected outcomes. Validation takes place at all stages of a product lifecycle—including research and development, manufacturing, and distribution.

So, how do companies actually achieve this? The FDA recommends “an integrated team approach to process validation that includes expertise from a variety of disciplines (e.g., process engineering, industrial pharmacy, analytical chemistry, microbiology, statistics, manufacturing, and quality assurance).”

Keep in mind that validation isn’t only required when constructing new manufacturing processes from scratch—validation is necessary whenever a change is made to existing processes, equipment, or systems. Validation ensures that these changes do not affect the quality or consistency of finished products.

Leading COVID-19 Response Efforts

What are you doing to keep your organization COVID-ready? Invest in new skills with hands-on training and certification courses from the Center for Professional Innovation and Education (CfPIE) .

Stay on top of changing regulations with the following courses offered by CfPIE:

Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

FDA Regulatory Relaxations Due to COVID-19

Tue, 13 Oct 2020 20:45:36 GMT

Over recent months, the U.S. Food and Drug Administration (FDA) has relaxed regulations in several areas to keep up with the COVID-19 pandemic. Regulatory relaxations have been made to address interruptions in the supply chain, expedite clinical trials and product reviews, and increase the accessibility of both diagnostic tests and treatments.

But at what cost? And how are these changes impacting your business?

Let’s take a closer look at the FDA’s responses and how they’ve impacted public health and safety.

Why Is Regulatory Flexibility Important?

The FDA is responsible for evaluating drugs, medical devices, and diagnostic tools. The regulatory agency faces the delicate challenge of weighing risks against benefits—a delicate balancing act that becomes increasingly critical in the face of a public health emergency.

The idea behind regulatory flexibility is to cut costs for manufacturers and hasten access to medical products. But regulatory shortcuts come at a cost. Once the pandemic is over, postmarket surveillance of modified medical devices and temporarily-approved drugs will reveal true risk levels.

Regulatory shortcuts aren’t the agency’s only weapon. The FDA has also established the resource-intensive Coronavirus Treatment Acceleration Program , “a public-private approach to bring coronavirus treatments to market as fast as possible” by increasing FDA involvement.

Regulatory Actions Taken by the FDA in Response to the COVID-19 Pandemic

We’ve compiled a list of some of the most significant regulatory actions the agency has taken—alongside the effects of these actions on public health and safety.

1. Blood Donation Guidelines

Gay and bisexual men no longer have to wait a year before giving blood. At the beginning of April, the FDA reduced its recommended deferral period for male blood donors who have had sex with another male from one year to three months.

The COVID-19 pandemic has led to a drastic drop in blood supply. Thousands of blood drives have been canceled alongside the closure of schools, businesses, and other institutions. Donors and volunteers alike have avoided blood donation centers due to social distancing guidelines.

Since its introduction in 2015—a regulatory revision that replaced a lifetime prohibition on blood donation by gay and bisexual men—the initial 12-month waiting period has been heavily criticized as discriminatory and antiquated.

In a statement , the FDA said, “Maintaining an adequate blood supply is vital to public health. Blood donors help patients of all ages — accident and burn victims, heart surgery and organ transplant patients, and those battling cancer and other life-threatening conditions.”

The FDA intends to keep its new recommendations in place once the pandemic is over.

2. New COVID-19 Tests

On March 11, the FDA allowed states to independently authorize laboratory-developed diagnostic COVID-19 tests within their borders. Manufacturers could then distribute tests without a formal emergency use authorization (EUA).

Within weeks, the agency began issuing warnings regarding fraudulent diagnostic tests. On April 24, the FDA announced that many antibody tests on the market were producing a significant number of false-positive results .

In response, the FDA tightened restrictions surrounding antibody tests, resulting in the removal of 27 tests from the market in late May. An antibody test developed by Chembio Diagnostics had its EUA revoked.

While the FDA has returned to standard EUA protocol and has issued EUAs for more than 200 diagnostic tests, initial regulatory failings undermined public confidence in COVID-19 testing and may have slowed testing efforts.

3. Antimalarial Drugs Against COVID-19

On March 28, the FDA issued an EUA for the use of antimalarial drugs hydroxychloroquine and chloroquine phosphate as a treatment against COVID-19 in hospitalized patients. President Donald Trump tweeted that the drugs “have a real chance to be one of the biggest game-changers in the history of medicine.”

In April, the FDA released a warning statement highlighting the need for close patient supervision. On June 15, the FDA revoked the EUA , citing study results that revealed greater risk and less benefit to COVID-19 patients. The back-and-forth has led to public confusion regarding whether these drugs are effective against COVID-19.

4. Food Labeling

To mitigate potential supply chain disruptions, the FDA announced that it would temporarily relax food labeling guidelines. Manufacturers of packaged foods can now substitute certain ingredients without updating labels.

The updated guidelines were meant to prevent issues that could arise if manufacturers found themselves unable to obtain certain ingredients. The guidelines refer to ingredients that are present in foods in relatively minute quantities, and the ingredients cannot include one of the top eight food allergens (peanuts, eggs, milk, fish, shellfish, tree nuts, wheat, and soybeans).

Despite their specifications, the new guidelines raised concerns among consumers. Nearly 3,000 of these consumers have written to the FDA regarding the new guidelines.

The Regulatory Aftermath of COVID-19

Other examples of regulatory flexibility on behalf of the FDA include:

Streamlining clinical trials. The FDA has released a document outlining reduced data requirements for clinical trials during the COVID-19 pandemic.
Addressing supply chain shortages. In an effort to hastily increase the supply of respiratory devices, the FDA loosened restrictions on companies that change suppliers or switch medical device components.
Protecting staff. The regulatory agency postponed routine on-site inspections of domestic and overseas manufacturing facilities.

Once the COVID-19 pandemic is over, the FDA will be left with yet another balance to strike. Will the agency return to previous operations? Which changes are worth continuing? Continued regulatory flexibility may lead to increased access to medical products, less expensive products, and greater efficiency.

On the other hand, relaxed data requirements and fewer inspections may undermine the agency’s ability to assess health and safety risks.

Leading COVID-19 Response Efforts

What are you doing to keep your organization COVID-ready? Invest in new skills with hands-on training and certification courses from the Center for Professional Innovation and Education (CfPIE) .

Stay on top of changing regulations with the following courses offered by CfPIE:

Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

Is the Second Wave of Coronavirus Coming?

Tue, 22 Sep 2020 20:47:15 GMT

On March 11, the World Health Organization (WHO) officially characterized the COVID-19 outbreak as a pandemic. Since then, COVID-19 has swept across the globe. While scientists and public health authorities have made considerable progress in slowing the spread of the virus, the pandemic is by no means over.

The question many researchers are now trying to answer is whether the world is headed toward a second wave of COVID-19. Moreover, what have we learned in the past few months—and how can it help us mitigate the potential consequences of a second (or third) wave?

What Happened in 1918?

The COVID-19 pandemic is often compared to the 1918 Spanish Flu, a pandemic that came in three distinct waves and killed an estimated 50 million people worldwide. The first wave began in March 1918. The second wave dominated the fall, and the third wave emerged in the spring of 1919. Much of the spread of the Spanish Flu was thought to occur due to World War I.

The second wave of the Spanish Flu was by far the deadliest. Scientists have speculated that this increase in lethality occurred due to mutations in the flu virus—although this is still hotly debated given that mutations typically take much longer to develop and propagate.

What Can We Learn From the 1918 Spanish Flu Pandemic?

While the 1918 Spanish Flu involved a highly contagious respiratory virus, there are a few distinctions between the COVID-19 pandemic and the Spanish Flu pandemic that are often overlooked.

The 1918 pandemic was caused by a different family of viruses than the novel coronavirus. Why does this matter? SARS-CoV-2, the virus responsible for COVID-19, appears more stable than the 1918 influenza virus. The spike protein that enables SARS-CoV-2 to attach to and attack human cells has been found to be especially resistant to mutation.

But what else has changed since 1918? The world’s population has almost tripled from less than 2 billion to roughly 7.6 billion. Moreover, the widespread introduction of commercial air travel can now carry infections across the world faster than trains and ships alone.

What Is Herd Immunity?

In 1918, some cities saw infections start to level off as they approached herd immunity. So, what is herd immunity, and how does it work? Herd immunity is a public health term that refers to the protection a community receives from a disease outbreak when enough people in the community have become immune.

Scientists believe that herd immunity will be less helpful with the current COVID-19 pandemic than it was a century ago with the Spanish Flu. Infectious disease experts at Johns Hopkins University estimate that nearly 70% of today's population would need to be immune to the novel coronavirus before herd immunity would take effect.

In contrast, only 35% of the population in 1918 needed to be immune before herd immunity kicked in. Another key detail about COVID-19 is that scientists still don’t know whether recovered individuals gain immunity. A safe and effective vaccine remains in development and may not see the light of day for months to come.

What's Happening Around the World?

Global response to the COVID-19 pandemic has been widely varied since the beginning of the outbreak. Let’s take a look at the number of infections around the world, and how many countries are preventing, preparing for, or already bracing the second wave of COVID-19.

According to the European Centre for Disease Prevention and Control (ECDC), daily case numbers in the European Union and the United Kingdom have reached record highs of more than 45,000 infections on a 14-day notification rate . European public health officials have backed down on reopening plans, imposing restrictions once more.

What factors are driving the sudden spike in infections? The surge emerges following the end of summer vacation. Experts believe students returning to school and employees commuting to city centers may be largely responsible. Another factor may be a mental one—people may have dropped their guard alongside relaxing restrictions. Evidence has shown that young people may be especially prone to such a mindset.

Despite the recent rise in cases, Europe continues to fare more favorably than the United States. While Europe has reported 4.4 million infections and more than 217,000 deaths among a population of 750 million, the U.S. has suffered 6.7 million cases and 198,000 deaths among a population of only 330 million.

Certain countries have brought the virus under control by taking strict preventative measures and launching rampant testing campaigns. For example, China and New Zealand have declared the virus eliminated. Although both countries have had small outbreaks since then, strict quarantine restrictions and a widespread test and trace system have succeeded in quickly snuffing out local outbreaks.

Fewer Deaths

A second wave may not involve a dramatic increase in deaths. Why? Scientists now have a better understanding of the virus, and doctors have developed more effective treatment methods, especially for patients with severe symptoms. Treatments such as dexamethasone, a steroid treatment that targets lung inflammation, has seen positive results among COVID-19 patients, especially when used early on.

While drugs like remdesivir—an antiviral that was given an emergency use authorization (EUA) by the Food and Drug Administration (FDA) back in May—have helped decrease mortality rates among hospitalized COVID-19 patients, doctors have also learned simple yet effective techniques for tackling the virus. For example, flipping a patient onto their stomach—a technique known as “proning”—allows oxygen to flow more effectively through the patient’s body.

Keep Your Organization Prepared

Keeping your workforce updated is more important than ever. But watching the news is not enough. In the midst of a global public health emergency, life sciences training must become a top priority.

Are you interested in keeping your organization COVID-ready? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

Everything We Know About Convalescent Plasma for COVID-19 Treatment

Tue, 15 Sep 2020 20:55:20 GMT

On August 23, the Food and Drug Administration (FDA) granted an emergency use authorization (EUA) for a novel COVID-19 treatment. Since then, more than 72,000 patients with the virus in the U.S. have been treated with convalescent plasma therapy. But convalescent plasma may not be the answer we were hoping for.

First, the nature of convalescent plasma has its limitations when it comes to widespread administration. Unlike other typical new drugs, plasma cannot be manufactured in bulk—its availability is limited by blood donations from recovered COVID-19 patients. President Trump has urged these individuals to come forward in a nationwide campaign to collect plasma.

But the therapy has other issues. Since the FDA issued an EUA, convalescent plasma has been shrouded in controversy. What do we know about its mechanisms, and why has the treatment been so controversial?

What Is Convalescent Plasma Therapy?

Convalescent plasma (CP) therapy involves transfusing blood plasma from patients who have recovered from COVID-19 into the blood of patients who are currently suffering from an ongoing COVID-19 infection. The idea is to transfer defensive antibodies which are contained in the plasma.

Before the plasma is transfused, it must be purified and tested for safety. Plasma is typically screened for HIV, hepatitis types B and C, as well as SARS-CoV-2. The treatment involves the injection of approximately 8 ounces of plasma over a 1- to 2-hour period . Additional transfusions may be administered if determined clinically necessary.

No Solid Evidence

Despite an EUA from the FDA, the National Institutes of Health (NIH) determined that there was no solid evidence for or against the treatment of COVID-19 patients with convalescent plasma. The NIH finding emerged less than ten days after the FDA granted temporary approval of the treatment.

"There are currently no data from well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety of convalescent plasma for the treatment of COVID-19," the NIH announced online .

Despite reports from the President and top health officials of a 35% reduction in COVID-related deaths after treatment with convalescent plasma, this statistic appears to have been miscalculated based on a study by the Mayo Clinic which only includes a specific subset of patients: those who were under 80 years of age, had not been placed on ventilators, and received treatment within three days of diagnosis.

Another study from China, published in the Journal of the American Medical Association, showed similar results to the Mayo Clinic study. Neither studies found a significant effect of convalescent plasma therapy on reducing death rates among COVID-19 patients. Instead, they suggested clinical improvement among a specific subgroup of patients.

Leading COVID-19 Response Efforts

What are you doing to keep your organization COVID-ready? Refresh or build your organization’s skillset with hands-on training and certification courses from The Center for Professional Innovation and Education (CfPIE) .

Are you interested in keeping your organization engaged and prepared? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com.

How to Become a Medical Writer in the Competitive Pharmaceutical Industry

Wed, 02 Sep 2020 21:02:39 GMT

The field of medicine is always expanding. With each new research study, an article communicating the usefulness of its findings is submitted to leading medical journals and other outlets. Submit, review, and publish is the process by which the scientific community and the public at large remain informed about recent developments, driving new research and shaping public policy.

In the era of COVID-19, effective communication is in higher demand than ever before. With health and safety at the forefront of public consciousness, information must be relayed to a number of different audiences—from drug regulators and healthcare professionals to consumers—with promptness, clarity, and, above all, accuracy.

Trained medical writers—and quality medical writing—are paramount to scientific research, knowledge translation, and public guidance, especially during states of emergency.

Are you wondering about how to become a medical writer? Let’s take a look at what steps you can take on your path to publication.

What Do Medical Writers Write?

First, let’s examine the types of materials medical writers are responsible for outputting. These include a wide range of scientific documents such as:

Regulatory documents
Grant proposals
Journal manuscripts
Educational resources
Promotional content
News articles

In other words, medical writing is an umbrella term for any science-related writing, from abstracts to advertisements. Types of publishers vary as much as content type, including but not limited to:

Universities
Peer-reviewed journals
Government agencies
Biotechnology companies
Pharmaceutical companies
News outlets

What Are the Main Types of Medical Writing?

Not sure which type of medical writing is right for you? The field can be roughly broken down into the following categories (although other types of medical writing do exist):

Regulatory writing. This is the branch of medical writing that deals directly with relevant governing bodies. Regulatory writing also includes clinical trial documentation.
Biomedical journalism. These medical writers communicate to the public in the form of blog and magazine articles, press releases, and more.
Manuscript writing. This category of medical writing involves writing, editing, and submitting to peer-reviewed medical journals.
Patient education. These medical writers develop patient-facing content that appears at the doctor’s office, in hospitals, or online. Their focus is helping patients understand and navigate their condition.
Medical marketing. These are copywriters whose objective is to promote awareness about a drug, medical device, or other health-related product.

As a medical writer, you have the option of going down any of these routes, from consumer-friendly magazines and news outlets to esteemed medical journals. While the publishers of medical journals tend to pay less, pharmaceutical companies are well-known in the industry for high budgets.

High-quality medical writing conveys information to its intended audience in a way that permits immediate understanding. This audience can range between physicians, medical researchers, and the general public.

Regardless of the outlet, medical writing is usually linked to disease or its treatment. Given its subject matter, content must be fully compliant with regulatory bodies such as the FDA.

How Much Can I Make as a Medical Writer?

According to a survey by the American Medical Writers Association , the salaries for those with a relevant bachelor’s degree working full-time was between $73,522 and $90,640.

Those with advanced degrees earned on average between $91,797 and $101,872.

Informed medical writing lies at the heart of medical research and public health. What qualities must medical writers possess to perform their job?

Superior writing skills
Strong grasp of medical concepts and terminology
Familiarity with editing and publishing
Intimate understanding of the research process
Ability to interpret statistical data
Dedication to ethical reporting
Keen understanding of regulatory guidelines

Your First Steps to Becoming a Medical Writer

Are you interested in how to become a medical writer? Here are a few steps you can take to make sure you’re well-equipped for the next job that comes your way.

1. Learn PubMed

Scientific databases like PubMed and MEDLINE are an invaluable resource for medical writers. Try becoming familiar with the structure of a journal article, citations, and the submission process.

2. Practice the AMA Style

Get acquainted with the American Medical Association style. Consumer publications tend to use other styles of writing, including AP and Chicago. Refreshing your grammar skills couldn’t hurt, either.

3. Choose Your Speciality

The field of medical writing is as broad as it is diverse. Your clients value specialized expertise. In practice, this may mean narrowing your job title from “freelance medical writer” to “healthcare content marketer.”

4. Start Networking

One of the best ways to build your professional network is to volunteer for professional associations like the American Medical Writers Association (AMWA) . This is an excellent way to learn more about the field and find clients at the same time.

5. Get Certified

A certificate in the field of medical writing contributes to your credibility as a professional. Regardless of the field, employers generally view training and certification as a verification of your skills.

Become a Certified Medical Writing Professional (CMWP)

Training in medical writing is highly worthwhile for any organization in the medical industry. A variety of resources are available for interested health professionals to acquire the necessary skill set to master the science—and art—of medical writing.

The Center for Professional Innovation and Education (CfPIE) provides the standard for global high-quality life sciences training.

Become a Certified Medical Writing Professional (CMWP) with CfPIE’s comprehensive program, which gives participants:

In-depth guidance on medical and technical writing
Lessons on how to comply with regulatory agencies
Insights into the submission process
Guidelines for product marketing
Certification for medical writing

Are you interested in furthering your life sciences career by becoming a certified medical writer? Get in touch with our team at 1-610-648-7550 or info@cfpie.com for any questions about our medical writing courses or certifications.

Healthy and Infected: What We Know About the Asymptomatic Spread of COVID-19

Tue, 25 Aug 2020 21:07:12 GMT

One of the mysteries of the COVID-19 pandemic has been that seemingly healthy individuals can spread the virus to others. This method of transmission, known as asymptomatic spread, has made it difficult to isolate infected individuals and prevent outbreaks.

But how does asymptomatic spread work exactly? And what consequences will it have if we reopen schools and businesses without a vaccine?

The Difference Between Asymptomatic and Presymptomatic

By the time an individual infected with COVID-19 starts showing the telltale symptoms of dry cough, fever, and fatigue, they may have already spread the virus to dozens of people. Such a patient is known as a presymptomatic transmitter.

An asymptomatic transmitter, on the other hand, never feels sick. Asymptomatic spread becomes particularly challenging for public health officials when the virus in question is as highly infectious as SARS-CoV-2. Moreover, this mode of transmission is not as uncommon as we once thought.

According to estimates from the CDC, up to 40% of infections in the U.S. are asymptomatic. This type of transmission isn’t exclusive to COVID-19, either—we see the same behavior in other, less lethal viruses, such as influenza and common colds.

What Do We Know About Asymptomatic COVID-19 Spread?

A study from South Korea published in early August showed that people without symptoms carry just as much virus in their nose, throat, and lungs as their symptomatic counterparts—and for nearly the same amount of time.

The study analyzed 193 symptomatic and 110 asymptomatic patients isolated at a community treatment center in Cheonan. Of patients who were initially asymptomatic, around 30% were truly asymptomatic, while the rest turned out to be presymptomatic.

Back in June, the WHO was criticized for, and promptly withdrew, a comment claiming that asymptomatic transmission of COVID-19 was “rare.” The 30% figure from South Korea aligns with what other scientists have modeled as a 40% asymptomatic transmission rate. In a television interview, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, referred to the same 40% figure.

The results from South Korea confirm what we’ve long suspected—that seemingly healthy individuals can indeed spread the virus to others.

The likelihood of asymptomatic transmission, however, is still poorly understood. While a lack of symptoms may mean less coughing and sneezing, asymptomatic people may carry on with their business, infecting others in the process.

Who Is More Likely to Be Asymptomatic?

When it comes to the virus’s general prognosis, it appears that younger people are spared the worst outcomes. According to an analysis of more than 17 million British health records , risk of dying from a COVID-19 infection is linked to old age. But why is that the case?

One of the theories currently gaining traction in the scientific community is that younger people have increased exposure to more than one coronavirus, lending some protection or immunity against COVID-19.

Historically, asymptomatic spread has been overlooked by researchers. We tend to focus on patients who require immediate care.

Few studies have documented the silent spread of viruses. One study conducted in New York City in 2019 reported that 55% of people who tested positive with a respiratory virus were symptom-free. Moreover, asymptomatic infection rates trended upwards of 70%. Despite these findings, asymptomatic spread of viruses remains controversial among researchers .

Taking a Step Forward Against COVID-19

More information about SARS-CoV-2 is coming to light every day. Understanding the nature of the virus will have an enormous impact on our projections and reopening policies.

What are you doing to keep your organization at the forefront of response efforts? Sharpen your organization’s skill set with hands-on training and certification courses from The Center for Professional Innovation and Education (CfPIE) .

Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

FDA Approves Cheaper, Faster Saliva Test for COVID-19

Tue, 18 Aug 2020 21:11:21 GMT

On August 15, the FDA issued an emergency use authorization (EUA) to the Yale School of Public Health for its COVID-19 saliva test, SalivaDirect. While Yale’s saliva test is the fifth of its kind to be FDA-approved, the test is unique in requiring no swab or specialized collection device.

FDA Commissioner Stephen Hahn called the test’s innovative techniques “groundbreaking” in their efficiency, highlighting the test’s potential to mitigate shortages in crucial test components, such as reagents.

Why Is SalivaDirect ‘Groundbreaking’?

Unlike its predecessors, SalivaDirect requires no extraction of nucleic acids. Instead, the test uses enzymes to degrade the virus, exposing its genetic material for molecular detection. While extraction increases sensitivity, it’s a cumbersome, slow, and expensive process.

According to Dr. Nathan Grubaugh of Yale University, the SalivaDirect method saves up to 2 hours of work and eliminates 75% of the costs. But that’s not all.

Because the virus is stable in saliva for prolonged periods of time—and at high temperatures—expensive collection tubes and preservatives were found to be unnecessary. This discovery, alongside simplified testing techniques, whittles the cost of each sample to an estimated $10 . The leading COVID-19 saliva test, developed at Rutgers University, currently costs consumers up to $150.

According to Dr. Grubaugh, getting a handle on the pandemic—even before a vaccine—means the nationwide implementation of “cheap alternatives like SalivaDirect.”

Yale’s saliva test is less complicated, less expensive, and less invasive than traditional testing methods. As yet another bonus, patients can view their results within hours—24 hours at most—rather than weeks. Moreover, saliva samples can be self-collected, lowering the risk of infection for healthcare professionals.

The Future of COVID-19 Testing

Since partnering with Yale in June, the NBA has been using SalivaDirect and other saliva tests to screen players, coaches, and staff in preparing them for the upcoming basketball season. Compared to traditional nasopharyngeal (NP) swabbing, results are nearly identical.

While Yale’s test and related research were partially funded by the NBA and the National Basketball Players Association, none of the parties involved—including Yale—plan on charging royalties for test administration, according to ESPN . The NBA and its associated union contributed more than $500,000 towards SalivaDirect.

Following the FDA-granted EUA, Yale’s saliva test is now available to diagnostic labs across the country. Multiple vendors have been approved to provide reagents and instruments for constructing the test, proactively addressing potential supply chain issues.

SalivaDirect may be the game-changer we were hoping for. Until now, creating cheaper, more accessible diagnostic tests that reduce turnaround time and can scale without friction was one of the major pain points in COVID-19 response efforts.

Leading the Fight Against COVID-19

What are you doing to keep your organization COVID-ready? Refresh and expand your organization’s skill set with hands-on training and certification courses from The Center for Professional Innovation and Education (CfPIE) .

Are you interested in quality life sciences training for your staff? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

Antibody Tests for COVID-19: What Can They Tell Us?

Tue, 11 Aug 2020 21:15:20 GMT

On July 31st, the FDA authorized the first two antibody tests designed to give more than a yes-or-no response. Instead of merely indicating the presence or absence of COVID-19 antibodies, these tests display an estimated quantity of such antibodies present in an individual’s blood.

Since the beginning of April, the FDA has approved 33 antibody tests, all of which provide a positive or negative result. The two semi-quantitative tests are altered versions of previously approved assays developed by Siemens under their Atellica and ADVIA Centaur labels.

The new assays are designed to detect IgG antibodies. These typically appear in the blood weeks after symptoms begin to show. Compared to other types of antibodies, IgG antibodies remain in circulation for much longer after an infection has subsided.

So, why has the FDA introduced a semi-quantitative approach? What can antibody tests tell us that we don’t already know? The answers may not be as clear-cut as we’d like.

Do Antibodies Signal Immunity?

Antibody tests reveal if someone has already been exposed to an infection. Lab-based assays detect the presence of Y-shaped proteins in an individual’s blood or serum.

Antibody tests aren’t usually used to diagnose an ongoing infection. That’s because it takes some time for the body to generate antibodies.

So, what can the number of antibodies in an individual’s blood tell us about their response to a previous SARS-CoV-2 infection?

In short, we don’t know yet. We’re still figuring out what the presence of antibodies may mean . Semi-quantitative antibody tests are simply another set of tools for scientists to study the effects of COVID-19 on the immune system.

The FDA has warned the public that antibody test results do not indicate any level of immunity from the virus. Moreover, antibody tests do not detect active or asymptomatic infections—social distancing procedures and mask-wearing mandates should still be followed wherever possible.

T Cells: Looking Beyond Antibodies

The body’s immune response to an infection is incredibly complex. New evidence shows that focusing on antibodies may not actually give us the full picture we’re hoping for.

The human body’s first line of defense against a potential intruder is non-specific—the body simply makes itself as inhospitable as possible (e.g., raising body temperature).

Once the innate immune system has been overwhelmed by a pathogen, the adaptive immune system kicks in. That’s when markers like protective antibodies and killer T cells emerge. Antibodies keep the virus from invading healthy cells, while killer T cells destroy cells that have already been invaded and infected.

The goal is to stop the virus from spreading within our bodies. It makes sense, then, that antibodies and T cells would appear in tandem. That’s the way our immune systems typically respond—except, it seems, in the case of a COVID-19 infection.

Until now, we’ve relied on antibody tests over T cell tests because the former are cheaper, faster, and easier to administer while the latter must be performed in a specialized lab. If antibody and T cell responses occur in tandem, relying on antibody tests only makes sense. But that’s no longer the case.

Scientists around the world have uncovered a perplexing detail about the immune response to COVID-19. In a subset of people who tested positive for the virus, no antibodies were detected— only T cells .

What does this mean about the body’s immune response to severe cases of COVID-19? Will this affect how a vaccine may or may not be effective? Much of the work that has been done is only preliminary.

Leading COVID-19 Response Efforts

What are you doing to keep your organization COVID-ready? Sharpen your organization’s skill set with hands-on training and certification courses from The Center for Professional Innovation and Education (CfPIE) .

Are you interested in keeping your organization engaged and prepared? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

Quicker, Less Accurate COVID-19 Testing May Be Pivotal to Preventing Outbreaks

Tue, 04 Aug 2020 21:19:07 GMT

To slow the spread of COVID-19, we need better testing. However, as we’re now hearing from leading public health officials, better might not necessarily mean more accurate—at least, not anymore.

Since the start of the pandemic, we’ve prioritized accuracy over other critical factors, including speed and accessibility. While this approach may have been practical in March, when cases were just beginning to climb, today’s testing objectives revolve around flagging as many infections as possible, as fast as possible.

Quantity Over Quality

With almost 5 million confirmed cases nationwide, public health officials need to move fast. That’s where a quantity-over-quality strategy comes into play. To stop outbreaks before they begin, we need easily distributable test kits that will yield results in a matter of days rather than weeks.

When it comes to nationwide COVID-19 testing efforts, there have been two primary causes for concern: lack of accessibility and poor turnaround times. Less intricate—and less accurate—testing techniques may solve both.

With many cities experiencing turnaround times of over a week—sometimes over three weeks—accuracy no longer matters as much as you may think. Besides, even the most accurate test is rendered useless when results aren’t delivered within an acceptable timeframe. And given the highly infectious nature of COVID-19, that timeframe is a mere 2 to 3 days.

New Testing Techniques

For the most part, we’ve relied so far on PCR-based testing. While accurate, PCR tests are significantly more time- and labor-intensive than other testing techniques, mainly because they require samples to be processed in-lab.

One low-tech alternative to PCR testing is antigen testing. While a PCR machine amplifies COVID-19 RNA—and is sensitive to even the tiniest amounts of it—antigen testing relies on protein identification. Antigen tests are less intrusive and yield results in just minutes. PCR testing, on the other hand, takes at least 24 hours to provide a definitive yes-or-no answer. Moreover, in the current testing climate, 24-hour PCR results are still far from attainable.

There are limitations. Some antigen tests have a false negative rate of more than 50% . But this may not be as alarming as you may think.

Viral loads fluctuate over the course of an infection. Once antigen testing becomes more readily available, detecting a highly infectious individual becomes increasingly likely with each test that’s administered. In other words, with repetitive testing, lower sensitivity ceases to matter as much.

However, will antigen testing become as accessible as we need it to be? As things stand, mass production and distribution of COVID-19 test kits remains a daunting challenge. With a spotty supply chain and unreliable leadership, a testing rethink may not be plausible after all.

In a scenario where we successfully produce, distribute, and regulate antigen testing efforts en masse, repeated antigen testing may deliver the peace of mind required to reopen schools, offices, and other institutions.

Keep Your Organization Up-To-Date

What are you doing to keep your organization COVID-ready? Sharpen your skills with hands-on training and certification courses from The Center for Professional Innovation and Education (CfPIE) .

Are you interested in leading COVID-19 response efforts? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

FDA Authorizes First COVID-19 Diagnostic Test for Individuals Without Symptoms

Tue, 28 Jul 2020 21:44:05 GMT

On July 24, the FDA authorized its first COVID-19 diagnostic test for people who haven’t shown any symptoms . This form of broad-based screening is meant to test individuals who don’t suspect that they’ve come into contact with anyone with the disease.

Since testing efforts began, diagnostic tests had been reserved for individuals with telltale symptoms of a COVID-19 infection, such as fever and dry cough. Efforts had also been targeted toward high-risk populations, including the immunocompromised and front-line healthcare workers.

Asymptomatic and Pooled Testing From LabCorp

The FDA issued an emergency use authorization (EUA) for LabCorp’s RE-PCR Test, which now includes testing asymptomatic COVID-19 carriers.

The EUA also gives the green light for pooled sample testing, a technique by which multiple samples can be evaluated as a single test. Individual tests are performed should the group test reveal a positive result.

Asymptomatic spread has been a particularly difficult challenge to overcome. LabCorp’s test is a step toward preventing outbreaks while conserving testing manpower and resources. The test may even provide the threshold of certainty required to reopen businesses, schools, and other organizations.

Conserving Testing Resources

LabCorp’s CEO Adam Schechter revealed that COVID-19 is spreading faster than the company can keep up , lengthening turnaround times for results. The company is currently processing more than 160,000 tests per day, amounting to over a million each week.

The company has expanded its testing capacity by just over 8 times since the early stages of the pandemic during late March. The problem is that the number of cases in the US is outrunning the number of tests the company can produce within an effective time frame.

For individuals who aren’t in the hospital, turnaround time should be within the range of 2 to 3 days. The sooner a carrier is identified, the easier it is to trace the people they’ve been in contact with. Average turnaround time currently is roughly 3 to 5 days.

Batch testing may be the strategy we need to get ahead of asymptomatic transmission. This approach was first FDA-approved for Quest Diagnostics in the second last week of July. Quest Diagnostics and LabCorp account for more than half of commercial testing efforts in the US.

There is one caveat. Because positive results are buried within a group, batch testing works best in areas of low prevalence. However, COVID-19 surges are occurring across the country, with tens of thousands of new infections cropping up every day. The total number of confirmed cases jumped from 3 to 4 million in just two weeks.

Keep Your Organization Engaged

In the wake of COVID-19 response efforts, healthcare organizations everywhere are focused on professional training.

What are you doing to keep your organization COVID-ready? Invest in new skills with hands-on training and certification courses from The Center for Professional Innovation and Education (CfPIE) . Stay on top of response efforts by expanding your employees’ professional skill set.

Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

Pfizer Strikes $1.95 Billion Deal With US Government to Produce Millions of COVID-19 Vaccine Doses

Tue, 21 Jul 2020 21:47:45 GMT

On July 22nd, the US Department of Health and Human Services announced an agreement with Pfizer Inc. for the mass production and nationwide delivery of 100 million COVID-19 vaccine doses. The agreement also reserved an additional 500 million doses for the US.

Pfizer and its partner, BioNTech, must still complete a phase 3 clinical trial to prove their vaccine’s efficacy. Given approval by the FDA, which would likely come in the form of an EUA, nationwide delivery is set to begin in the last quarter of 2020.

Operation Warp Speed

The deal with Pfizer is part of Operation Warp Speed (OWS) , a federal effort to collect various COVID-19 vaccines. The program's goal is to have at least one safe and effective defense against the virus readily available for the American public by January of next year.

According to the WHO, 24 vaccines are currently being evaluated in clinical trials around the globe. Many countries are scrambling for a vaccine. According to Johns Hopkins, COVID-19 has infected more than 15 million people worldwide , 4 million of which are American.

Pfizer and BioNTech: Leading Vaccine Candidates

Pfizer and BioNTech received the FDA’s Fast Track designation at the beginning of July for two of their four experimental COVID-19 vaccines. The designation is meant to speed up the regulatory review process for unauthorized treatments and vaccines in the face of an unmet medical need.

The designation was granted following the release of preliminary Phase 1/2 data from studies conducted in the United States and Germany. The leading vaccine was shown to generate antibodies against SARS-CoV-2, the virus responsible for COVID-19. Some of these were neutralizing antibodies, meaning they appear to interfere with the virus’ core functions.

While the vaccine spurred immune responses, mild side effects—especially fever—were common among participants and exacerbated at higher doses. Levels of neutralizing antibodies were 1.8 to 2.8 times higher in vaccinated patients that recovered.

It should be noted that the relationship between antibody levels and immunity is still unclear. While antibodies contribute to the immune response, a vaccine that targets antibody levels only may not be enough to effectively halt the spread of COVID-19. Pfizer's phase 3 study aims to prove that vaccinated individuals are 50% less susceptible to becoming infected.

Keep Your Staff Updated

For public health organizations everywhere, now is the time to invest in life sciences training. Staying prepared means more than staying updated. What are you doing to keep your workforce COVID-ready?

Invest in new skills while refreshing those that are out of date with professional training and certification courses from the Center for Professional Innovation and Education (CfPIE) . We offer a wide selection of pharmaceutical training programs and more.

Make sure your organization follows best practices, maintains compliance, and offers the skills that are necessary to tackle an unprecedented public health emergency.

Questions? Get in touch with a member of the CfPIE team today by calling 1-610-648-7550 or emailing info@cfpie.com.

Moderna's Phase 3 COVID-19 Vaccine Trial Will Begin Later This Month

Tue, 14 Jul 2020 21:52:41 GMT

The WHO marked the six-month anniversary of the COVID-19 outbreak on June 29th. After six grueling months of widespread deaths and economic shutdowns, people are desperate for a glimmer of hope. For many, Moderna’s mRNA vaccine—which saw human trials in a record-breaking 63 days—is more than just a glimmer of hope, it’s a potential solution.

While the Massachusetts-based biotech company has experienced its fair share of setbacks, with modifications of the testing protocol delaying its phase 3 trial, the trial is still set to begin in July. Here’s what it will look like.

Moderna’s Race for a COVID-19 Vaccine

On January 11th, Chinese authorities released the genetic sequence of COVID-19. Fast forward a month, and Moderna has already shipped the first clinical batch of its frontrunner vaccine candidate, mRNA-1273, to the NIH. Phase 1 begins—and reveals promising results.

Moderna’s early-stage trial demonstrated the production of neutralizing antibodies in 8 participants, and binding antibodies in all participants. On May 12th, Moderna’s vaccine received the FDA’s Fast Track designation , rapidly accelerating its regulatory review process.

While Moderna is progressing quickly through clinical trials—with many industry experts predicting that mRNA-1273 will be the first COVID-19 vaccine to reach the market—the company is still somewhat new to the game.

Compared to its established competitors, Moderna has never conducted a clinical trial of comparable size to the one it plans on launching later this month. Nor has it had a single product approved.

What the Phase 3 Trial Will Look Like

Moderna’s Phase 2 trial involved 600 participants across eight states. Participants were screened based on physical exams and were segmented into two age groups: adults above and below the age of 55.

Phase 3 will be fifty times the size of phase 2, involving 30,000 individuals across 87 locations. Participants will be randomly selected to receive the experimental 100-microgram dose or a placebo. Immunizations will take place on the first day of the trial, as well as 29 days later.

Ultimately, Moderna’s success is only a piece of the puzzle. Globally, over a hundred COVID-19 vaccine candidates are undergoing clinical trials, with many demonstrating encouraging peer-reviewed results. Should Moderna’s mRNA-1273 fail to live up to its expectations, many other candidates are ready to offer continued hope.

Keep Your Organization Updated

Now is the time to keep your pharmaceutical organizations up-to-date with the latest news regarding COVID-19. But staying updated isn’t enough to stay prepared—life sciences training should be a number one priority for healthcare organizations.

What are you doing to keep your staff COVID-ready? Invest in new skills while refreshing old ones with professional training and certification courses from the Center for Professional Innovation and Education (CfPIE) .

Are you interested in sharpening the skills of your organization? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

The Race Toward a COVID-19 Vaccine: Three Months Later

Mon, 06 Jul 2020 21:59:38 GMT

As of July 2020, more than 11 million cases of COVID-19 have been reported worldwide, with the number of deaths at half a million and counting.

Since the start of the month, the U.S. has confirmed 50,000 cases a day for three straight days . But those numbers are optimistic—former FDA Commissioner Dr. Scott Gottlieb warned that actual spikes might have been in the 400,000 to 500,000 range due to limited testing capacity.

Testing at scale has been an ongoing issue in the U.S. since the beginning of the outbreak. But where are we on the vaccine front?

FDA Implements New Threshold

The FDA has released a strict set of requirements for prospective COVID-19 vaccines . Among these is proof that the vaccine candidate is at least 50% more effective than a placebo.

This threshold is comparable to the performance of the flu vaccine over the last decade, which has fluctuated between 19% and 60% efficacy , according to the CDC. In the wake of the announcement, concerns have been raised as to whether 50% efficacy is enough to stop the spread of COVID-19—which is more easily transmitted and has a higher death rate than the flu.

Major Players: What Progress Has Been Made?

C ureVac

CureVac has joined forces with Tesla to manufacture mRNA vaccines using mobile molecular printers . Tesla CEO Elon Musk calls them “RNA microfactories,” and plans on shipping to remote locations in need of on-site vaccine production.

Pfizer Inc. and BioNTech

A 45-patient trial has shown promising results for one of Pfizer and BioNTech’s four mRNA vaccine candidates. Doses given to COVID-19 patients elevated antibody levels by up to 2.8 times. Phase 3 trials could begin as early as July.

Moderna

The NIH claims partial ownership of Modern’s frontrunner COVID-19 vaccine. Why does this matter? Patent rights would allow the federal government to lower costs and widen distribution without Moderna’s consent.

Major Players: Recent Updates on COVID-19 Treatments

G ilead Sciences

The Trump administration has been widely criticized for setting aside Gilead Sciences’ entire Remdesivir supply for the month of July—plus the majority of its stock for the next two months, amounting to more than 500,000 doses.

Eusa Pharma

Eusa Pharma won FDA approval for phase 3 trial testing of Sylvant, an IL-6 inhibitor that targets COVID-induced lung inflammation. This is the last hurdle for Eusa Pharma to overcome before Sylvant reaches hospitals.

Key Takeaways

For pharmaceutical organizations everywhere, staying updated is more important than ever. But watching the news is not enough. In the midst of a global public health emergency, life sciences training must become a top priority.

Are you interested in keeping your organization COVID-ready? Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing info@cfpie.com .

Accuracy Concerns With COVID-19 Diagnostic Test

Tue, 16 Jun 2020 22:11:50 GMT

The FDA has alerted the public to preliminary data suggesting that a COVID-19 diagnostic test may yield inaccurate results . In particular, Abbott’s ID NOW, a test that is being used to examine White House officials, may have led to missed cases of COVID-19 and infected patients who have been falsely cleared.

Abbott’s ID NOW is a point-of-care test that can be performed quickly with a healthcare professional present. Unlike other tests—which require samples to be shipped to a lab to be evaluated—Abbott’s ID NOW takes only fifteen minutes to yield results. The ID NOW was granted an emergency use authorization (EUA) by the FDA back in March.

Rapid test results have been widely regarded as a key player in halting any further spread of COVID-19. The Trump administration has shipped upwards of 235,000 Abbott ID NOW tests to U.S. public health laboratories. At the same time, Abbott itself claims to have distributed 1.8 million tests to healthcare facilities across the country.

COVID-19 Test Accuracy Called Into Question

While no diagnostic test is 100 percent accurate, studies using the Abbott ID NOW have emerged with startlingly high false negatives rates. One study indicated that the test might miss as many as half of all positive COVID-19 cases, overlooking a third of cases detected with a rival test developed by Cepheid. Abbott has disputed the results, citing improper specimen handling and user error, and claiming a false negative rate of 0.02 percent when testing instructions are followed correctly.

The FDA and Abbott Laboratories are currently investigating whether test results are misrepresented when different types of nasal swabs are used to collect samples and whether viral transport media—used to transport samples—may play a role. In April, Abbott warned healthcare professionals not to use transport chemicals after research from the Cleveland Clinic revealed a 15 percent false-negative rate when samples were stored with these chemicals.

It should be noted that research against the ID NOW has not been published or peer-reviewed in a medical journal and included 100 patients. Abbott has called attention to independent study results that have found accuracy rates of 90 percent or higher using the ID NOW.

The Danger of False Negatives

False-negative results prevent infected patients from seeking immediate treatment while increasing the risk of patients unknowingly spreading the virus to others. In the long run, a high rate of false negatives obscures the true scope of an outbreak.

While the Abbott ID NOW can diagnose positive cases in mere minutes, negative results may need to be reinforced by the results of other tests, such as a high-sensitivity authorized molecular test. For now, Abbott and the FDA have issued a notification letter to users recommending symptomatic patients with negative test results to confirm results with another test. Abbott plans on initiating post-market studies to evaluate the accuracy of the ID NOW.

Keep Your Organization Up-To-Date With CfPIE

Have you taken steps to ensure that your staff is caught up with the latest developments in the industry? Here at the Center for Professional Innovation and Education (CfPIE) , we provide quality life science training and certification courses.

To learn more about FDA regulatory compliance—we recommend the following courses:

Questions? Get in touch with our team today by calling 1-610-648-7550 or emailing info@cfpie.com .

FDA Authorizes First Standalone, At-Home Sample Collection Kit for COVID-19

Tue, 09 Jun 2020 22:15:59 GMT

The FDA has authorized Everlywell’s standalone, at-home sample collection kit for COVID-19 , the first of its kind to receive an emergency use authorization (EUA) for use with multiple diagnostic tests.

In the past, kits and tests have been restricted to each other, with each kit authorized for use with a particular test. In contrast, Everlywell has offered its kit independent of any one test or testing lab, opening the door for multiple labs to receive Everlywell’s samples. An at-home testing kit whose results can be sent to multiple labs and analyzed using various tests expands access to testing and prevents potential transmission of the virus.

Nasal Samples Collected at Home and Mailed Overnight

Everlywell, a home health testing startup, was one of the first companies to announce the development of an at-home sample collection kit for COVID-19. The FDA has now authorized its kit for at-home use by individuals who have completed an online questionnaire, which acts as a preliminary screening for COVID-19 symptoms. A healthcare provider must review the questionnaire before a testing kit is provided.

Using Everlywell’s diagnostic kit, an individual can self-collect nasal swabs, which are placed in a saline-filled tube. Samples are transported overnight to a CLIA-certified lab, where they are tested. The FDA has currently authorized—with individual EUAs—two diagnostic tests performed at pre-approved labs for analyzing samples collected using Everlywell’s at-home kit. Results are returned to the patient over the web, using Everlywell’s network of independent physicians.

The FDA has noted that pairing Everlywell’s kit with other diagnostic tests is a distinct possibility, given that test providers submit the necessary verification for emergency approval.

Reducing the Bottleneck in Testing

For companies who intend to follow Everlywell’s footsteps in developing an at-home testing kit, the FDA has published Everlywell’s data showing that nasal swabs can remain stable during overnight shipping, reducing the burden of proof.

Opening up testing, whether through self-administered kits or broadened sample-test compatibility, is regarded by the FDA as one of the keys to combating the COVID-19 pandemic.

Keep Your Industry Knowledge Current With CfPIE

The COVID-19 situation is evolving with each passing day. Are your staff up-to-date with the latest trends in the pharmaceutical industry?

The Center for Professional Innovation and Education (CfPIE) has joined forces with leading pharmaceutical and biotechnology companies through its wide range of course options for professional development. Update your organization with hands-on training and certification using CfPIE.

Are you interested in learning more about the FDA’s strategy to broaden the testing footprint for COVID-19? We recommend enrolling in the following courses:

Keep your organization in the loop with CfPIE’s quality life science training and certification courses.

Get in touch with the CfPIE team today by calling 1-610-648-7550 or emailing info@cfpie.com.

How We Can Prepare the Pharmaceutical Supply Chain for the Coronavirus

Tue, 26 May 2020 22:22:44 GMT

Pandemics and their associated lockdowns, distancing measures, and economic interruptions can have massive implications for global supply chains. The pharmaceutical industry suffers this fate thanks to the recent COVID-19 coronavirus disease.

Many experts agree that the nation’s pharmaceutical supply chains are not prepared for this situation, but changes in public policy and actions on behalf of the industry can make a difference.

How Pandemics Negatively Impact Pharmaceutical Supply Chains

It’s no secret that COVID has damaged the global economy in many sectors, but specialized fields like medicine are especially vulnerable for a few reasons:

Drug development is slow to respond to sudden changes in supply and demand because of complex manufacturing processes. These markets take approximately half a year longer than consumer-grade ones to accommodate large events like COVID.
The workers in pharmaceutical companies are highly-skilled, so finding replacements is a challenge should any go absent. New employees must be given training to deal with challenging work environments.
Reserve drug supplies in many hospitals will deplete more quickly than usual during the pandemic, making rationing necessary for many pharmaceutical companies. The United States Food and Drug Administration (FDA) maintains a list of drugs currently on shortage, which is expected to grow as demand rises while production capacity lowers.

There is no agreement on the best way to minimize the impact of supply chain disruptions. However, many experts in the field make the following suggestions.

Conservation of Resources

Data is the key to balancing the supply chain. Hospitals, clinics, and pharmacies should update manufacturers on current drug supply levels regularly. The FDA already has regulations in place for policies like this.

Optimize Production

Just as important as conservation is optimization. While collaborating with local governments, pharmaceutical organizations can make business decisions based on current needs in each region. This strategy mitigates “panic buying” and allows medicine producers to determine what drugs to make and where to send them.

Online Medical Assistance

Having online resources available to patients at home minimizes time spent in the hospital, reducing the use of medical supplies. New patients also won’t have to travel to receive care and risk contamination.

Digital Transformations in General

Drug manufacturing is currently plagued with slow monitoring and inefficient scheduling. A conversion to digital management would enable more advanced planning and faster, more flexible ways to optimize production lines.

Ensuring Authenticity

Counterfeit drugs disguised as trusted brands have always been an issue the World Health Organization has dealt with. It’s an even larger problem amid COVID-19, so medical businesses from hospitals to clinics must emphasize the use of product identifiers as asked by the FDA.

Investing in Education

Are you doing your part as an entity in the industry? One simple step you can take to make a difference is educating your organization’s staff on essential topics from medical device manufacturing to compliance and regulation.

Are you interested in learning more about how your organization can improve its supply chain? Check out our pharmaceutical and biotech training programs . You can contact the Center for Professional Innovation and Education today by calling 1-610-648-7550 or emailing them at info@cfpie.com .

Should the Pharmaceutical Industry Address Overseas Manufacturing Amid COVID-19?

Tue, 19 May 2020 22:27:08 GMT

Recent reports from the United States Food and Drug Administration (FDA) have shown that only 28% of manufacturing for active pharmaceutical ingredients occurs within the nation. While international collaboration on commerce and health are not uncommon, the recent COVID-19 coronavirus pandemic has introduced concerns on whether the country should remain reliant on external supply chains.

United States Senator Chris Coons even stated that domestic medical manufacturing should become the new focus as global supplies become scarce amid the virus. He also emphasized the importance of a federal office for pandemic preparation. What exactly is the situation for domestic production of pharmaceuticals, and what changes should be made?

A Push to Overseas Production

In the past, American medicines were produced domestically, but manufacturing has recently shifted to other countries. The FDA has measured about a 10% decrease from 2013 to 2019 in domestic facilities according to a study by Boston University and the Massachusetts Institute of Technology.

For instance, Abbott Laboratories, a company that operated from the 90s to the 2000s, had shut down several plants within the nation to outsource the labor elsewhere.

Reasons for this general trend include different tax policies, cheaper labor, or lower environmental laws. Many medical businesses have merged and purchased other companies as well, contributing to the move.

The Problem

COVID-19 presents a significant issue with global supply chains, pharmaceutical ones included. The need for social distancing can interrupt work schedules, and the increased demand for supplies can cut into inventory.

Most important, there’s a chance that exports may require restriction or even a complete stall. In these cases, it will be difficult to obtain the medication and supplies necessary to fight the virus.

The Issue with Solving It

Experts agree that moving manufacturing back to American soil will be expensive and time-consuming. Figures have ranged into the billions of dollars and usually involve a couple decades at least.

Additionally, there are genuine reasons to have overseas manufacturing in some cases. During pandemics, a company can shift its operations from one nation to another in case infections plague one facility.

Government Action

The government-led Biomedical Advanced Research and Development Authority (BARDA) may spearhead new developments and vaccines for COVID-19. Congress allocated $3.5 billion toward the organization earlier this year, a significant increase from previous fundings.

Among its activities are projects to fund research into experimental products and building domestic networks of production facilities. It also focuses on contributing to the National Pharmaceutical Stockpile, the United States’ national inventory of essential medical supplies, antibiotics, and vaccines.

BARDA has begun supporting Johnson & Johnson and Moderna in their efforts to not only develop a vaccine but also scale up manufacturing to accommodate the millions of doses necessary.

Stay up to Date With Proper Medical Education

You can do your part by investing in professional medical training for your organization. Whether it’s for adherence to compliance legislation or just additional knowledge for staff, consider trying out CfPIE’s selection of industry-grade coursework with topics ranging from medical devices to pharma and biotech.

Are you interested in our pharmaceutical and biotech training programs ? Contact CfPIE today by calling 1-610-648-7550 or emailing info@cfpie.com if you’d like to learn more.

FDA Revises Policy on Antibody Tests: New Focus on Access and Accuracy

Tue, 12 May 2020 14:12:08 GMT

On March 16th, the U.S. Food and Drug Administration (FDA) issued a policy regarding antibody tests designed to answer population-level questions about the prevalence of COVID-19. The policy was widely criticized for its permissive guidelines as, in recent weeks, more than 250 companies introduced serology tests to the market. In response, the FDA revised its initial policy on May 4th, imposing newly stringent standards for precision.

Antibody tests, otherwise known as serology tests, are instrumental in the fight against COVID-19. Asymptomatic carriers may be primarily responsible for fueling the spread of the virus — the FDA considered the development and implementation of an early detection tool as one of their top priorities.

Serology tests, which detect whether an individual’s immune system has reacted to an infection of SARS-CoV-2, reveal whether one has ever been infected. When delivered to entire communities, the results from antibody tests can answer critical questions about disease prevalence, susceptibility, and immunity — which inform the development of novel therapies against the virus.

Poor Test Performance

In issuing their initial policy on antibody tests, the FDA prioritized rapid availability over standards for accuracy and precision. Developers were required to submit their own proof regarding the accuracy of their products — and, in response, the FDA had set no standards or cutoffs regarding what was accepted as accurate.

This policy resulted in general confusion as products designed by established companies were competing against unverified tests. While companies were never allowed to claim that their antibody tests had been authorized by the FDA, many of the tests that emerged in the market were doing precisely that, in addition to false claims of approval for at-home use.

As of May 4th, companies offering COVID-19 antibody tests are required to submit proof that they meet the agency’s specificity and sensitivity criteria. Developers must provide verification in the next ten days or suspend distribution and face removal from the market. The FDA has promised to crack down on fraudulent test kits with false claims of FDA approval or at-home use.

The process of applying for agency review involves submitting a request for an emergency use authorization (EUA), which allows the FDA to temporarily authorize the distribution and use of unapproved products in the face of a public health emergency. An EUA is by no means equivalent to full FDA clearance and is only valid for the duration of the crisis. The FDA has newly authorized at least ten antibody tests under EUAs, and over 200 tests remain under review.

Keep Your Organization Up-To-Date With CfPIE

What steps are you taking to ensure your staff remains knowledgeable about the latest regulations and trends in the industry?

The Center for Professional Innovation and Education (CfPIE) has partnered with leading pharmaceutical and biotechnology companies by providing them with hands-on training and certification for industry professionals.

Are you interested in learning more about how the FDA’s response to the COVID-19 crisis has impacted the pharmaceutical industry? We recommend enrolling the following courses:

Contact the CfPIE team today at 1-610-648-7550 or info@cfpie.com if you’re interested in learning about quality life science training and certification courses.